reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD012069-bib-0001,"Abali O, Mukaddes NM. ",Methylphenidate induced hallucinations: case report,,2007,,    ,['citation-other']," Abali O, Mukaddes NM. Methylphenidate induced hallucinations: case report. Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology]2007; Vol. 17, issue 4:195‐7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+induced+hallucinations:+case+report&author=O+Abali&author=NM+Mukaddes&publication_year=2007&hl=en']",,, Abali 2007 {published data only}  ,included,CD012069-bbs2-0001,
CD012069-bib-0002,"Abbas E, Desoysa R. ",Use of methylphenidate for attention‐deficit‐hyperactivity disorder in childhood, Developmental Medicine and Child Neurology ,2006,48,    ,['citation-journal']," Abbas E, Desoysa R. Use of methylphenidate for attention‐deficit‐hyperactivity disorder in childhood.  Developmental Medicine and Child Neurology 2006;48(Suppl 107):23. [DOI: 10.1111/j.1469‐8749.2006.tb12600.x]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Use+of+methylphenidate+for+attention‐deficit‐hyperactivity+disorder+in+childhood&author=E+Abbas&author=R+Desoysa&publication_year=2006&hl=en']",,, Abbas 2006 {published data only}  ,included,CD012069-bbs2-0002,
CD012069-bib-0003,"Abbasi SH, Heidari S, Mohammadi MR, Tabrizi M, Ghaleiha A, Akhondzadeh S. ",Acetyl‐L‐carnitine as an adjunctive therapy in the treatment of attention‐deficit/hyperactivity disorder in children and adolescents: a placebo‐controlled trial, Child Psychiatry and Human Development ,2011,42,    ,['citation-journal']," Abbasi SH, Heidari S, Mohammadi MR, Tabrizi M, Ghaleiha A, Akhondzadeh S. Acetyl‐L‐carnitine as an adjunctive therapy in the treatment of attention‐deficit/hyperactivity disorder in children and adolescents: a placebo‐controlled trial.  Child Psychiatry and Human Development 2011;42(3):367‐75. [DOI: 10.1007/s10578‐011‐0220‐y; PUBMED: 21336630]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s10578-011-0220-y', 'https://scholar.google.com/scholar_lookup?title=Acetyl‐L‐carnitine+as+an+adjunctive+therapy+in+the+treatment+of+attention‐deficit/hyperactivity+disorder+in+children+and+adolescents:+a+placebo‐controlled+trial+&author=SH+Abbasi&author=S+Heidari&author=MR+Mohammadi&author=M+Tabrizi&author=A+Ghaleiha&author=S+Akhondzadeh&publication_year=2011&hl=en']",,https://doi.org/10.1007/s10578-011-0220-y, Abbasi 2011 {published data only}  ,included,CD012069-bbs2-0003,
CD012069-bib-0004,Adrian N. ,Explosive outbursts associated with methylphenidate, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal'], Adrian N. Explosive outbursts associated with methylphenidate.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(6):618‐9. [DOI: 10.1097/00004583‐200106000‐00002; PUBMED: 11392335]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1097/00004583-200106000-00002', 'https://scholar.google.com/scholar_lookup?title=Explosive+outbursts+associated+with+methylphenidate&author=N+Adrian&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200106000-00002, Adrian 2001 {published data only}  ,included,CD012069-bbs2-0004,
CD012069-bib-0005,"Agarwal V, Sitholey P. ",Combination of atomoxetine and methylphenidate in attention deficit/hyperactivity disorder: a case report, Journal of the Canadian Academy of Child and Adolescent Psychiatry ,2008,17,    ,['citation-journal']," Agarwal V, Sitholey P. Combination of atomoxetine and methylphenidate in attention deficit/hyperactivity disorder: a case report.  Journal of the Canadian Academy of Child and Adolescent Psychiatry 2008;17(3):160. [PMC2527769]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Combination+of+atomoxetine+and+methylphenidate+in+attention+deficit/hyperactivity+disorder:+a+case+report+&author=V+Agarwal&author=P+Sitholey&publication_year=2008&hl=en']",,, Agarwal 2008 {published data only}  ,included,CD012069-bbs2-0005,
CD012069-bib-0006,"Aguilera‐Albesa S, Yoldi‐Petri ME, Molins‐Castiella T, Durá‐Travé T. ",Hallucinations caused by the introduction of methylphenidate at low doses, Revista de Neurologia ,2010,51,    ,['citation-journal']," Aguilera‐Albesa S, Yoldi‐Petri ME, Molins‐Castiella T, Durá‐Travé T. Hallucinations caused by the introduction of methylphenidate at low doses.  Revista de Neurologia 2010;51(4):254‐5. [PUBMED: 20648469]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Hallucinations+caused+by+the+introduction+of+methylphenidate+at+low+doses&author=S+Aguilera‐Albesa&author=ME+Yoldi‐Petri&author=T+Molins‐Castiella&author=T+Durá‐Travé&publication_year=2010&hl=en']",20648469,, Aguilera‐Albesa 2010 {published data only}  ,included,CD012069-bbs2-0006,
CD012069-bib-0007,"Akhondzadeh S, Tavakolian R, Davari‐Ashtiani R, Arabgol F, Amini H. ",Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial, Progress in Neuro Psychopharmacology and Biological Psychiatry ,2003,27,    ,['citation-journal']," Akhondzadeh S, Tavakolian R, Davari‐Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.  Progress in Neuro Psychopharmacology and Biological Psychiatry 2003;27(5):841‐5. [DOI: 10.1016/S0278‐5846(03)00117‐9; PUBMED: 12921918]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0278-5846(03)00117-9', 'https://scholar.google.com/scholar_lookup?title=Selegiline+in+the+treatment+of+attention+deficit+hyperactivity+disorder+in+children:+a+double+blind+and+randomized+trial+&author=S+Akhondzadeh&author=R+Tavakolian&author=R+Davari‐Ashtiani&author=F+Arabgol&author=H+Amini&publication_year=2003&hl=en']",,https://doi.org/10.1016/S0278-5846(03)00117-9, Akhondzadeh 2003 {published data only}  ,included,CD012069-bbs2-0007,
CD012069-bib-0008,"Akhondzadeh S, Mohammadi MR, Khademi M. ",Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial, BMC Psychiatry ,2004,4,    ,['citation-journal']," Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.  BMC Psychiatry 2004;4(9):1‐6. [DOI: 10.1186/1471‐244X‐4‐9; PMC400741; PUBMED: 15070418]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1471-244X-4-9', 'https://scholar.google.com/scholar_lookup?title=Zinc+sulfate+as+an+adjunct+to+methylphenidate+for+the+treatment+of+attention+deficit+hyperactivity+disorder+in+children:+a+double+blind+and+randomized+trial+&author=S+Akhondzadeh&author=MR+Mohammadi&author=M+Khademi&publication_year=2004&hl=en']",,https://doi.org/10.1186/1471-244X-4-9, Akhondzadeh 2004 {published data only}  ,included,CD012069-bbs2-0008,
CD012069-bib-0009,"Alpaslan AH, Coşkun KŞ, Kocak U, Gorücü Y. ",Stuttering associated with the use of short‐acting oral methylphenidate, Klinik Psikofarmakoloji Bülteni [Journal of Clinical Psychopharmacology] ,2015,35,    ,['citation-journal']," Alpaslan AH, Coşkun KŞ, Kocak U, Gorücü Y. Stuttering associated with the use of short‐acting oral methylphenidate.  Klinik Psikofarmakoloji Bülteni [Journal of Clinical Psychopharmacology] 2015;35(6):739‐41. [DOI: 10.1097/JCP.0000000000000403; PUBMED: 26436866]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0000000000000403', 'https://scholar.google.com/scholar_lookup?title=Stuttering+associated+with+the+use+of+short‐acting+oral+methylphenidate&author=AH+Alpaslan&author=KŞ+Coşkun&author=U+Kocak&author=Y+Gorücü&publication_year=2015&hl=en']",,https://doi.org/10.1097/JCP.0000000000000403, Alpaslan 2015 {published data only}  ,included,CD012069-bbs2-0009,
CD012069-bib-0010,"Altin M, El‐Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, et al. ",Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non‐Western countries, Drugs in Context ,2013,2013,    ,['citation-journal']," Altin M, El‐Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, et al. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non‐Western countries.  Drugs in Context 2013;2013:212260. [DOI: 10.7573/dic.212260; PMC3884848]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.7573/dic.212260', 'https://scholar.google.com/scholar_lookup?title=Pharmacological+treatment+for+attention+deficit+hyperactivity+disorder:+functional+outcomes+in+children+and+adolescents+from+non‐Western+countries+&author=M+Altin&author=AA+El‐Shafei&author=M+Yu&author=D+Desaiah&author=T+Treuer&author=N+Zavadenko&publication_year=2013&hl=en']",,https://doi.org/10.7573/dic.212260, Altin 2013 {published data only}  ,included,CD012069-bbs2-0010,
CD012069-bib-0011,"Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, et al. ",Predictors and consequences of adherence to the treatment of pediatric patients with attention‐deficit/hyperactivity disorder in Central Europe and East Asia, Patient Preference and Adherence ,2013,30,    ,['citation-journal']," Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, et al. Predictors and consequences of adherence to the treatment of pediatric patients with attention‐deficit/hyperactivity disorder in Central Europe and East Asia.  Patient Preference and Adherence 2013;30(7):987‐95. [DOI: 10.2147/PPA.S50628; PMC3794850; PUBMED: 24124351]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2147/PPA.S50628', 'https://scholar.google.com/scholar_lookup?title=Predictors+and+consequences+of+adherence+to+the+treatment+of+pediatric+patients+with+attention‐deficit/hyperactivity+disorder+in+Central+Europe+and+East+Asia+&author=J+Hong&author=D+Novick&author=T+Treuer&author=W+Montgomery&author=VS+Haynes&author=S+Wu&publication_year=2013&hl=en']",,https://doi.org/10.2147/PPA.S50628, Altin 2013 {published data only}  ,included,CD012069-bbs2-0010,
CD012069-bib-0012,"Truer T, Feng Q, Desaiah D, Altin M, Wu S, El‐Shafei A, et al. ","Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention‐deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates", International Journal of Clinical Practice ,2014,68,    ,['citation-journal']," Truer T, Feng Q, Desaiah D, Altin M, Wu S, El‐Shafei A, et al. Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention‐deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates.  International Journal of Clinical Practice 2014;68(9):1152‐62. [DOI: 10.1111/ijcp.12437; PUBMED: 24703228]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/ijcp.12437', 'https://scholar.google.com/scholar_lookup?title=Predictors+of+pharmacological+treatment+outcomes+with+atomoxetine+or+methylphenidate+in+patients+with+attention‐deficit/hyperactivity+disorder+from+China,+Egypt,+Lebanon,+Russian+Federation,+Taiwan,+and+United+Arab+Emirates+&author=T+Truer&author=Q+Feng&author=D+Desaiah&author=M+Altin&author=S+Wu&author=A+El‐Shafei&publication_year=2014&hl=en']",,https://doi.org/10.1111/ijcp.12437, Altin 2013 {published data only}  ,included,CD012069-bbs2-0010,
CD012069-bib-0013,"Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S. ","Modafinil as a treatment for Attention‐Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial", Progress in Neuro Psychopharmacology & Biological Psychiatry ,2008,32,    ,['citation-journal']," Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S. Modafinil as a treatment for Attention‐Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.  Progress in Neuro Psychopharmacology & Biological Psychiatry 2008;32(1):145‐9. [DOI: 10.1016/j.pnpbp.2007.07.025; PUBMED: 17765380]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.pnpbp.2007.07.025', 'https://scholar.google.com/scholar_lookup?title=Modafinil+as+a+treatment+for+Attention‐Deficit/Hyperactivity+Disorder+in+children+and+adolescents:+a+double+blind,+randomized+clinical+trial+&author=S+Amiri&author=MR+Mohammadi&author=M+Mohammadi&author=GH+Nouroozinejad&author=M+Kahbazi&author=S+Akhondzadeh&publication_year=2008&hl=en']",,https://doi.org/10.1016/j.pnpbp.2007.07.025, Amiri 2008 {published data only}  ,included,CD012069-bbs2-0011,
CD012069-bib-0014,"Arabgol F, Panaghi L, Nikzad V. ",Risperidone versus methylphenidate in treatment of preschool children with attention‐deficit hyperactivity disorder, Iranian Journal of Pediatrics ,2015,25,    ,['citation-journal']," Arabgol F, Panaghi L, Nikzad V. Risperidone versus methylphenidate in treatment of preschool children with attention‐deficit hyperactivity disorder.  Iranian Journal of Pediatrics 2015;25(1):1‐6. [DOI: 10.5812/ijp.265; PMC4505976]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.5812/ijp.265', 'https://scholar.google.com/scholar_lookup?title=Risperidone+versus+methylphenidate+in+treatment+of+preschool+children+with+attention‐deficit+hyperactivity+disorder+&author=F+Arabgol&author=L+Panaghi&author=V+Nikzad&publication_year=2015&hl=en']",,https://doi.org/10.5812/ijp.265, Arabgol 2015 {published data only}  ,included,CD012069-bbs2-0012,
CD012069-bib-0015,"Ardic UA, Ercan ES, Ercan E, Yuce D, Basay BK. ",Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: a retrospective chart review in Turkish children with attention deficit hyperactivity disorder, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2014,24,    ,['citation-journal']," Ardic UA, Ercan ES, Ercan E, Yuce D, Basay BK. Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: a retrospective chart review in Turkish children with attention deficit hyperactivity disorder.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2014;24(4):342‐9. [DOI: 10.5455/bcp.20141009112739]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.5455/bcp.20141009112739', 'https://scholar.google.com/scholar_lookup?title=Osmotic+release+oral+system+methylphenidate+is+more+effective+than+immediate+release+methylphenidate:+a+retrospective+chart+review+in+Turkish+children+with+attention+deficit+hyperactivity+disorder+&author=UA+Ardic&author=ES+Ercan&author=E+Ercan&author=D+Yuce&author=BK+Basay&publication_year=2014&hl=en']",,https://doi.org/10.5455/bcp.20141009112739, Ardic 2014 {published data only}  ,included,CD012069-bbs2-0013,
CD012069-bib-0016,"Ercan ES, Akyol‐Ardic U, Ercan E, Yuce D, Kabukcu‐Basay B. ",OROS‐MPH is more effective than IR‐MPH in Turkish children: a retrospective chart review, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2014,24,    ,['citation-journal']," Ercan ES, Akyol‐Ardic U, Ercan E, Yuce D, Kabukcu‐Basay B. OROS‐MPH is more effective than IR‐MPH in Turkish children: a retrospective chart review.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2014;24(1):306‐7. [DOI: 10.5455/bcp.20141009112739]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=OROS‐MPH+is+more+effective+than+IR‐MPH+in+Turkish+children:+a+retrospective+chart+review+&author=ES+Ercan&author=U+Akyol‐Ardic&author=E+Ercan&author=D+Yuce&author=B+Kabukcu‐Basay&publication_year=2014&hl=en']",,, Ardic 2014 {published data only}  ,included,CD012069-bbs2-0013,
CD012069-bib-0017,"Arman AR, Yilmaz S, Carkaxhiu G, Soysal D, Akalin F. ",Risk assessment using heart rate variability due to methylphenidate treatment in children with attention deficit hyperactivity disorder,,2013,,    ,['citation-other']," Arman AR, Yilmaz S, Carkaxhiu G, Soysal D, Akalin F. Risk assessment using heart rate variability due to methylphenidate treatment in children with attention deficit hyperactivity disorder. European Child and Adolescent Psychiatry. 15th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP); 2013 Jul 1; Dublin (Ireland). New York: Springer, 2013; Vol. 22:S302‐S303. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Risk+assessment+using+heart+rate+variability+due+to+methylphenidate+treatment+in+children+with+attention+deficit+hyperactivity+disorder+&author=AR+Arman&author=S+Yilmaz&author=G+Carkaxhiu&author=D+Soysal&author=F+Akalin&publication_year=2013&hl=en']",,, Arman 2013 {published data only}  ,included,CD012069-bbs2-0014,
CD012069-bib-0019,Arnold LE. ,"Questions regarding your study ""A double‐blind, placebo‐controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder"" [personal communication]",,,,   ,['citation-other']," Arnold LE. Questions regarding your study ""A double‐blind, placebo‐controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder"" [personal communication]. Email to: EL Ramstad 17 October 2013. CENTRAL    ",[''],,, Arnold 2004 {published data only}  ,included,CD012069-bbs2-0015,
CD012069-bib-0018,"Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, et al. ","A double‐blind, placebo‐controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder",,2004,,    ,['citation-other']," Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, et al. A double‐blind, placebo‐controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology2004; Vol. 14, issue 4:542‐54. [DOI: 10.1089/cap.2004.14.542; PUBMED: 15662146]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+double‐blind,+placebo‐controlled+withdrawal+trial+of+dexmethylphenidate+hydrochloride+in+children+with+attention+deficit+hyperactivity+disorder+&author=LE+Arnold&author=RL+Lindsay&author=CK+Conners&author=SB+Wigal&author=AJ+Levine&author=DE+Johnson&publication_year=2004&hl=en']",,, Arnold 2004 {published data only}  ,included,CD012069-bbs2-0015,
CD012069-bib-0020,"Arnold LE, Bozzolo DR, Hodgkins P, McKay M, Beckett‐Thurman L, Greenbaum M, et al. ",Switching from oral extended‐release methylphenidate to the methylphenidate transdermal system: continued attention‐deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion, Current Medical Research and Opinion ,2010,26,    ,['citation-journal']," Arnold LE, Bozzolo DR, Hodgkins P, McKay M, Beckett‐Thurman L, Greenbaum M, et al. Switching from oral extended‐release methylphenidate to the methylphenidate transdermal system: continued attention‐deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion.  Current Medical Research and Opinion 2010;26(1):129‐37. [DOI: 10.1185/03007990903437412; PMC3875401; PUBMED: 19916704]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1185/03007990903437412', 'https://scholar.google.com/scholar_lookup?title=Switching+from+oral+extended‐release+methylphenidate+to+the+methylphenidate+transdermal+system:+continued+attention‐deficit/hyperactivity+disorder+symptom+control+and+tolerability+after+abrupt+conversion+&author=LE+Arnold&author=DR+Bozzolo&author=P+Hodgkins&author=M+McKay&author=L+Beckett‐Thurman&author=M+Greenbaum&publication_year=2010&hl=en']",,https://doi.org/10.1185/03007990903437412, Arnold 2010 {published data only}  ,included,CD012069-bbs2-0016,
CD012069-bib-0021,"Bukstein OG, Arnold LE, Landgraf JM, Hodgkins P. ",Does switching from oral extended‐release methylphenidate to the methylphenidate transdermal system affect health‐related quality‐of‐life and medication satisfaction for children with attention‐deficit/hyperactivity disorder?, Child and Adolescent Psychiatry and Mental Health ,2009,3,    ,['citation-journal']," Bukstein OG, Arnold LE, Landgraf JM, Hodgkins P. Does switching from oral extended‐release methylphenidate to the methylphenidate transdermal system affect health‐related quality‐of‐life and medication satisfaction for children with attention‐deficit/hyperactivity disorder?.  Child and Adolescent Psychiatry and Mental Health 2009;3(1):39. [DOI: 10.1186/1753‐2000‐3‐39; PMC2796990; PUBMED: 20003260]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1753-2000-3-39', 'https://scholar.google.com/scholar_lookup?title=Does+switching+from+oral+extended‐release+methylphenidate+to+the+methylphenidate+transdermal+system+affect+health‐related+quality‐of‐life+and+medication+satisfaction+for+children+with+attention‐deficit/hyperactivity+disorder?+&author=OG+Bukstein&author=LE+Arnold&author=JM+Landgraf&author=P+Hodgkins&publication_year=2009&hl=en']",,https://doi.org/10.1186/1753-2000-3-39, Arnold 2010 {published data only}  ,included,CD012069-bbs2-0016,
CD012069-bib-0022,"Artul S, Artoul F, Habib G, Nseir W, Bisharat B, Nijim Y. ",Severe recurrent pancreatitis in a child with ADHD after starting treatment with methylphenidate (Ritalin), Case Reports in Gastrointestinal Medicine ,2014,2014,    ,['citation-journal']," Artul S, Artoul F, Habib G, Nseir W, Bisharat B, Nijim Y. Severe recurrent pancreatitis in a child with ADHD after starting treatment with methylphenidate (Ritalin).  Case Reports in Gastrointestinal Medicine 2014;2014:319162. [DOI: 10.1155/2014/319162; PMC3965929; PUBMED: 24711932; PUBMED: 24711932]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1155/2014/319162', 'https://scholar.google.com/scholar_lookup?title=Severe+recurrent+pancreatitis+in+a+child+with+ADHD+after+starting+treatment+with+methylphenidate+(Ritalin)+&author=S+Artul&author=F+Artoul&author=G+Habib&author=W+Nseir&author=B+Bisharat&author=Y+Nijim&publication_year=2014&hl=en']",,https://doi.org/10.1155/2014/319162, Artul 2014 {published data only}  ,included,CD012069-bbs2-0017,
CD012069-bib-0023,"Arun P, Sahni S. ",Methylphenidate and suicidal ideation: report of two cases, Indian Journal of Psychiatry ,2014,56,    ,['citation-journal']," Arun P, Sahni S. Methylphenidate and suicidal ideation: report of two cases.  Indian Journal of Psychiatry 2014;56(1):79‐81. [DOI: 10.4103/0019‐5545.124721; PMC3927251]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4103/0019-5545.124721', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+suicidal+ideation:+report+of+two+cases&author=P+Arun&author=S+Sahni&publication_year=2014&hl=en']",,https://doi.org/10.4103/0019-5545.124721, Arun 2014 {published data only}  ,included,CD012069-bbs2-0018,
CD012069-bib-0024,Ashkenasi A. ,Effect of transdermal methylphenidate wear times on sleep in children with ADHD, Journal of Neurology ,2012,259,    ,['citation-journal'], Ashkenasi A. Effect of transdermal methylphenidate wear times on sleep in children with ADHD.  Journal of Neurology 2012;259(Suppl 1):S33‐4. [DOI: 10.1007/s00415‐012‐6524‐4]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Effect+of+transdermal+methylphenidate+wear+times+on+sleep+in+children+with+ADHD&author=A+Ashkenasi&publication_year=2012&hl=en']",,, Ashkenasi 2011 {published data only}  ,included,CD012069-bbs2-0019,
CD012069-bib-0025,Ashkenasi A. ,Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder, Pediatric Neurology ,2011,45,    ,['citation-journal'], Ashkenasi A. Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder.  Pediatric Neurology 2011;45(6):381‐6. [DOI: 10.1016/j.pediatrneurol.2011.09.003; PUBMED: 22115000]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/j.pediatrneurol.2011.09.003', 'https://scholar.google.com/scholar_lookup?title=Effect+of+transdermal+methylphenidate+wear+times+on+sleep+in+children+with+attention+deficit+hyperactivity+disorder+&author=A+Ashkenasi&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.pediatrneurol.2011.09.003, Ashkenasi 2011 {published data only}  ,included,CD012069-bbs2-0019,
CD012069-bib-0026,"Atzori P, Ancilletta B, Usala T, Danjou F, Zuddas A. ",Predictive parameters for methylphenidate use and compliance in children with attention deficit hyperactivity disorder, European Neuropsychopharmacology ,2006,16,    ,['citation-journal']," Atzori P, Ancilletta B, Usala T, Danjou F, Zuddas A. Predictive parameters for methylphenidate use and compliance in children with attention deficit hyperactivity disorder.  European Neuropsychopharmacology 2006;16(Suppl 1):S73‐4. [DOI: 10.1016/S0924‐977X(06)80087‐8]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(06)80087-8', 'https://scholar.google.com/scholar_lookup?title=Predictive+parameters+for+methylphenidate+use+and+compliance+in+children+with+attention+deficit+hyperactivity+disorder+&author=P+Atzori&author=B+Ancilletta&author=T+Usala&author=F+Danjou&author=A+Zuddas&publication_year=2006&hl=en']",,https://doi.org/10.1016/S0924-977X(06)80087-8, Atzori 2009 {published data only}  ,included,CD012069-bbs2-0020,
CD012069-bib-0027,"Atzori P, Usala T, Carucci S, Danjou F, Zuddas A. ",Predictive factors for persistent use and compliance of immediate‐release methylphenidate: a 36‐month naturalistic study, Journal of Child and Adolescent Psychopharmacology ,2009,19,    ,['citation-journal']," Atzori P, Usala T, Carucci S, Danjou F, Zuddas A. Predictive factors for persistent use and compliance of immediate‐release methylphenidate: a 36‐month naturalistic study.  Journal of Child and Adolescent Psychopharmacology 2009;19(6):673‐81. [DOI: 10.1089/cap.2008.0146; PUBMED: 20035585]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2008.0146', 'https://scholar.google.com/scholar_lookup?title=Predictive+factors+for+persistent+use+and+compliance+of+immediate‐release+methylphenidate:+a+36‐month+naturalistic+study+&author=P+Atzori&author=T+Usala&author=S+Carucci&author=F+Danjou&author=A+Zuddas&publication_year=2009&hl=en']",,https://doi.org/10.1089/cap.2008.0146, Atzori 2009 {published data only}  ,included,CD012069-bbs2-0020,
CD012069-bib-0028,"Ayaz M, Ayaz AB, Soylu N, Yüksel S. ",Medication persistence in Turkish children and adolescents with attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2014,24,    ,['citation-journal']," Ayaz M, Ayaz AB, Soylu N, Yüksel S. Medication persistence in Turkish children and adolescents with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2014;24(8):442‐7. [DOI: 10.1089/cap.2014.0002; PUBMED: 25010598]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2014.0002', 'https://scholar.google.com/scholar_lookup?title=Medication+persistence+in+Turkish+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=M+Ayaz&author=AB+Ayaz&author=N+Soylu&author=S+Yüksel&publication_year=2014&hl=en']",,https://doi.org/10.1089/cap.2014.0002, Ayaz 2014 {published data only}  ,included,CD012069-bbs2-0021,
CD012069-bib-0029,"Balázs J, Dallos G, Keresztény A, Czobor P, Gádoros J. ",Methylphenidate treatment and dyskinesia in children with attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2011,21,    ,['citation-journal']," Balázs J, Dallos G, Keresztény A, Czobor P, Gádoros J. Methylphenidate treatment and dyskinesia in children with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2011;21(2):133‐8. [DOI: 10.1089/cap.2010.0030; PUBMED: 21486166]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2010.0030', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+treatment+and+dyskinesia+in+children+with+attention‐deficit/hyperactivity+disorder+&author=J+Balázs&author=G+Dallos&author=A+Keresztény&author=P+Czobor&author=J+Gádoros&publication_year=2011&hl=en']",,https://doi.org/10.1089/cap.2010.0030, Balázs 2011 {published data only}  ,included,CD012069-bbs2-0022,
CD012069-bib-0030,"Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Kilian JM, Katusic SK. ","Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study", Pediatrics ,2013,132,    ,['citation-journal']," Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Kilian JM, Katusic SK. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study.  Pediatrics 2013;132(4):637‐44. [DOI: 10.1542/peds.2012‐2354]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2012-2354', 'https://scholar.google.com/scholar_lookup?title=Mortality,+ADHD,+and+psychosocial+adversity+in+adults+with+childhood+ADHD:+a+prospective+study+&author=WJ+Barbaresi&author=RC+Colligan&author=AL+Weaver&author=RG+Voigt&author=JM+Kilian&author=SK+Katusic&publication_year=2013&hl=en']",,https://doi.org/10.1542/peds.2012-2354, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0031,"Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, et al. ","How common is attention‐deficit/hyperactivity disorder? Incidence in a population‐based birth cohort in Rochester, Minn", Archives of Pediatrics and Adolescent Medicine ,2002,156,    ,['citation-journal']," Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, et al. How common is attention‐deficit/hyperactivity disorder? Incidence in a population‐based birth cohort in Rochester, Minn.  Archives of Pediatrics and Adolescent Medicine 2002;156(3):217‐24. [PUBMED: 11876664]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpedi.156.3.217', 'https://scholar.google.com/scholar_lookup?title=How+common+is+attention‐deficit/hyperactivity+disorder?+Incidence+in+a+population‐based+birth+cohort+in+Rochester,+Minn+&author=WJ+Barbaresi&author=SK+Katusic&author=RC+Colligan&author=VS+Pankratz&author=AL+Weaver&author=KJ+Weber&publication_year=2002&hl=en']",11876664,https://doi.org/10.1001/archpedi.156.3.217, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0032,"Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. ",Long‐term stimulant medication treatment of attention‐deficit/hyperactivity disorder: results from a population‐based study, Journal of Developmental and Behavioral Pediatrics ,2006,27,    ,['citation-journal']," Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long‐term stimulant medication treatment of attention‐deficit/hyperactivity disorder: results from a population‐based study.  Journal of Developmental and Behavioral Pediatrics 2006;27(1):1‐10. [PUBMED: 16511362]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004703-200602000-00001', 'https://scholar.google.com/scholar_lookup?title=Long‐term+stimulant+medication+treatment+of+attention‐deficit/hyperactivity+disorder:+results+from+a+population‐based+study+&author=WJ+Barbaresi&author=SK+Katusic&author=RC+Colligan&author=AL+Weaver&author=CL+Leibson&author=SJ+Jacobsen&publication_year=2006&hl=en']",16511362,https://doi.org/10.1097/00004703-200602000-00001, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0033,"Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. ",Long‐term stimulant medication treatment of attention‐deficit/hyperactivity disorder: results from a population‐based study, Journal of Developmental and Behavioral Pediatrics ,2014,27,    ,['citation-journal']," Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long‐term stimulant medication treatment of attention‐deficit/hyperactivity disorder: results from a population‐based study.  Journal of Developmental and Behavioral Pediatrics 2014;27(1):448‐57. [PUBMED: 16511362]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/DBP.0000000000000099', 'https://scholar.google.com/scholar_lookup?title=Long‐term+stimulant+medication+treatment+of+attention‐deficit/hyperactivity+disorder:+results+from+a+population‐based+study+&author=WJ+Barbaresi&author=SK+Katusic&author=RC+Colligan&author=AL+Weaver&author=CL+Leibson&author=SJ+Jacobsen&publication_year=2014&hl=en']",16511362,https://doi.org/10.1097/DBP.0000000000000099, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0034,"Harris MN, Voigt RG, Barbaresi WJ, Voge GA, Kilian JM, Weaver AL, et al. ",ADHD and learning disabilities in former late preterm infants: a population‐based birth cohort, Pediatrics ,2013,132,    ,['citation-journal']," Harris MN, Voigt RG, Barbaresi WJ, Voge GA, Kilian JM, Weaver AL, et al. ADHD and learning disabilities in former late preterm infants: a population‐based birth cohort.  Pediatrics 2013;132(3):630‐6. [DOI: 10.1542/peds.2012‐3588; PMC3876753; PUBMED: 23979091]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2012-3588', 'https://scholar.google.com/scholar_lookup?title=ADHD+and+learning+disabilities+in+former+late+preterm+infants:+a+population‐based+birth+cohort+&author=MN+Harris&author=RG+Voigt&author=WJ+Barbaresi&author=GA+Voge&author=JM+Kilian&author=AL+Weaver&publication_year=2013&hl=en']",,https://doi.org/10.1542/peds.2012-3588, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0035,"Harstad EB, Weaver AL, Katusic SK, Colligan RC, Kumar S, Chan E, et al. ","ADHD, stimulant treatment, and growth: a longitudinal study", Pediatrics. ,2014,134,    ,['citation-journal']," Harstad EB, Weaver AL, Katusic SK, Colligan RC, Kumar S, Chan E, et al. ADHD, stimulant treatment, and growth: a longitudinal study.  Pediatrics. 2014;134(4):935‐44. [DOI: 10.1542/peds.2014‐0428; PUBMED: 25180281]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2014-0428', 'https://scholar.google.com/scholar_lookup?title=ADHD,+stimulant+treatment,+and+growth:+a+longitudinal+study&author=EB+Harstad&author=AL+Weaver&author=SK+Katusic&author=RC+Colligan&author=S+Kumar&author=E+Chan&publication_year=2014&hl=en']",,https://doi.org/10.1542/peds.2014-0428, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0036,"Katusic SK, Barbaresi W, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. ",Case definition in epidemiologic studies of ADHD, Annals of Epidemiology ,2005,15,    ,['citation-journal']," Katusic SK, Barbaresi W, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Case definition in epidemiologic studies of ADHD.  Annals of Epidemiology 2005;15(6):430‐7. [DOI: 10.1016/j.annepidem.2004.12.004; PUBMED: 15967390]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.annepidem.2004.12.004', 'https://scholar.google.com/scholar_lookup?title=Case+definition+in+epidemiologic+studies+of+ADHD&author=SK+Katusic&author=W+Barbaresi&author=RC+Colligan&author=AL+Weaver&author=CL+Leibson&author=SJ+Jacobsen&publication_year=2005&hl=en']",,https://doi.org/10.1016/j.annepidem.2004.12.004, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0037,"Katusic SK, Colligan RC, Barbaresi WJ, Schaid DJ, Jacobsen SJ. ",Potential influence of migration bias in birth cohort studies, Mayo Clinic Proceedings ,1998,73,    ,['citation-journal']," Katusic SK, Colligan RC, Barbaresi WJ, Schaid DJ, Jacobsen SJ. Potential influence of migration bias in birth cohort studies.  Mayo Clinic Proceedings 1998;73(11):1053‐61. [DOI: 10.4065/73.11.1053]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4065/73.11.1053', 'https://scholar.google.com/scholar_lookup?title=Potential+influence+of+migration+bias+in+birth+cohort+studies&author=SK+Katusic&author=RC+Colligan&author=WJ+Barbaresi&author=DJ+Schaid&author=SJ+Jacobsen&publication_year=1998&hl=en']",,https://doi.org/10.4065/73.11.1053, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0038,"Mellon MW, Natchev BE, Katusic SK, Colligan RC, Weaver AL, Voigt RG, et al. ",Incidence of enuresis and encopresis among children with attention‐deficit/hyperactivity disorder in a population‐based birth cohort, Academic Pediatrics ,2013,13,    ,['citation-journal']," Mellon MW, Natchev BE, Katusic SK, Colligan RC, Weaver AL, Voigt RG, et al. Incidence of enuresis and encopresis among children with attention‐deficit/hyperactivity disorder in a population‐based birth cohort.  Academic Pediatrics 2013;13(4):322‐7. [DOI: 10.1016/j.acap.2013.02.008; PMC3886550; PUBMED: 23680296]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.acap.2013.02.008', 'https://scholar.google.com/scholar_lookup?title=Incidence+of+enuresis+and+encopresis+among+children+with+attention‐deficit/hyperactivity+disorder+in+a+population‐based+birth+cohort+&author=MW+Mellon&author=BE+Natchev&author=SK+Katusic&author=RC+Colligan&author=AL+Weaver&author=RG+Voigt&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.acap.2013.02.008, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0039,"Yoshimasu K, Barbaresi WJ, Colligan RC, Kilian JM, Voigt RG, Weaver AL, Katusic SK. ",Written‐language disorder among children with and without ADHD in a population‐based birth cohort., Pediatrics ,2011,128,    ,['citation-journal']," Yoshimasu K, Barbaresi WJ, Colligan RC, Kilian JM, Voigt RG, Weaver AL, Katusic SK. Written‐language disorder among children with and without ADHD in a population‐based birth cohort..  Pediatrics 2011;128(3):605‐12. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2010-2581', 'https://scholar.google.com/scholar_lookup?title=Written‐language+disorder+among+children+with+and+without+ADHD+in+a+population‐based+birth+cohort.+&author=K+Yoshimasu&author=WJ+Barbaresi&author=RC+Colligan&author=JM+Kilian&author=RG+Voigt&author=AL+Weaver&author=SK+Katusic&publication_year=2011&hl=en']",,https://doi.org/10.1542/peds.2010-2581, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0040,"Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Kilian JM, Weaver AL, et al. ",Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population‐based birth cohort study," Journal of Child Psychology and Psychiatry, and Allied Disciplines ",2012,53,    ,['citation-journal']," Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Kilian JM, Weaver AL, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population‐based birth cohort study.  Journal of Child Psychology and Psychiatry, and Allied Disciplines 2012;53(10):1036‐43. [DOI: 10.1111/j.1469‐7610.2012.02567.x; PMC3608464; PUBMED: 22647074]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1469-7610.2012.02567.x', 'https://scholar.google.com/scholar_lookup?title=Childhood+ADHD+is+strongly+associated+with+a+broad+range+of+psychiatric+disorders+during+adolescence:+a+population‐based+birth+cohort+study+&author=K+Yoshimasu&author=WJ+Barbaresi&author=RC+Colligan&author=RG+Voigt&author=JM+Kilian&author=AL+Weaver&publication_year=2012&hl=en']",,https://doi.org/10.1111/j.1469-7610.2012.02567.x, Barbaresi 2006 {published data only}  ,included,CD012069-bbs2-0023,
CD012069-bib-0041,"Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, et al. ",Bupropion versus methylphenidate in the treatment of attention‐deficit hyperactivity disorder, Journal of the American Academy of Child and Adolescent Psychiatry ,1995,34,    ,['citation-journal']," Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, et al. Bupropion versus methylphenidate in the treatment of attention‐deficit hyperactivity disorder.  Journal of the American Academy of Child and Adolescent Psychiatry 1995;34(5):649‐57. [DOI: 10.1097/00004583‐199505000‐00017; PUBMED: 7775360]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199505000-00017', 'https://scholar.google.com/scholar_lookup?title=Bupropion+versus+methylphenidate+in+the+treatment+of+attention‐deficit+hyperactivity+disorder+&author=LL+Barrickman&author=PJ+Perry&author=AJ+Allen&author=S+Kuperman&author=SV+Arndt&author=KJ+Herrmann&publication_year=1995&hl=en']",,https://doi.org/10.1097/00004583-199505000-00017, Barrickman 1995 {published data only}  ,included,CD012069-bbs2-0024,
CD012069-bib-0042,"Alfred A, Lindermueller A, Mattejat F, Dichter S, Schaeuble B. ",Transitioning onto OROS MPH is associated with improved functioning and quality of life in adolescents with ADHD, European Psychiatry. 18th European Congress of Psychiatry. 2010 Feb 27‐March 2; Munich (Germany) ,2010,25,    ,['citation-journal']," Alfred A, Lindermueller A, Mattejat F, Dichter S, Schaeuble B. Transitioning onto OROS MPH is associated with improved functioning and quality of life in adolescents with ADHD.  European Psychiatry. 18th European Congress of Psychiatry. 2010 Feb 27‐March 2; Munich (Germany) 2010;25(Suppl 1):375. [DOI: 10.1016/S0924‐9338(10)70372‐2]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-9338(10)70372-2', 'https://scholar.google.com/scholar_lookup?title=Transitioning+onto+OROS+MPH+is+associated+with+improved+functioning+and+quality+of+life+in+adolescents+with+ADHD+&author=A+Alfred&author=A+Lindermueller&author=F+Mattejat&author=S+Dichter&author=B+Schaeuble&publication_year=2010&hl=en']",,https://doi.org/10.1016/S0924-9338(10)70372-2, Berek 2011 {published data only}  ,included,CD012069-bbs2-0025,
CD012069-bib-0043,"Berek M, Kordon A, Hargarter L, Mattejat F, Slawik L, Rettig K, et al. ","Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?", Child & Adolescent Psychiatry & Mental Health ,2011,5,    ,['citation-journal']," Berek M, Kordon A, Hargarter L, Mattejat F, Slawik L, Rettig K, et al. Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?.  Child & Adolescent Psychiatry & Mental Health 2011;5(1):26. [DOI: 10.1186/1753‐2000‐5‐26]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1753-2000-5-26', 'https://scholar.google.com/scholar_lookup?title=Improved+functionality,+health+related+quality+of+life+and+decreased+burden+of+disease+in+patients+with+ADHD+treated+with+OROS®+MPH:+is+treatment+response+different+between+children+and+adolescents?+&author=M+Berek&author=A+Kordon&author=L+Hargarter&author=F+Mattejat&author=L+Slawik&author=K+Rettig&publication_year=2011&hl=en']",,https://doi.org/10.1186/1753-2000-5-26, Berek 2011 {published data only}  ,included,CD012069-bbs2-0025,
CD012069-bib-0044,"Kordon A, Hultzsch W, Mattejat F, Dichter S, Schaeuble B. ",Transitioning onto OROS MPH is associated with improved functioning and quality of life in children and adolescents with ADHD,,2010,,    ,['citation-other']," Kordon A, Hultzsch W, Mattejat F, Dichter S, Schaeuble B. Transitioning onto OROS MPH is associated with improved functioning and quality of life in children and adolescents with ADHD. European Psychiatry. 18th European Congress of Psychiatry. 2010 Feb 27‐March 2; Munich (Germany). 2010; Vol. 25, issue Suppl 1:962. [DOI: 10.1016/S0924‐9338(10)70953‐6]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Transitioning+onto+OROS+MPH+is+associated+with+improved+functioning+and+quality+of+life+in+children+and+adolescents+with+ADHD+&author=A+Kordon&author=W+Hultzsch&author=F+Mattejat&author=S+Dichter&author=B+Schaeuble&publication_year=2010&hl=en']",,, Berek 2011 {published data only}  ,included,CD012069-bbs2-0025,
CD012069-bib-0045,"Niederkirchner K, Slawik L, Wermelskirchen D, Rettig K, Schauble B. ",Transitioning to OROS® methylphenidate from atomoxetine is effective in children and adolescents with ADHD, Expert Review of Neurotherapeutics ,2011,11,    ,['citation-journal']," Niederkirchner K, Slawik L, Wermelskirchen D, Rettig K, Schauble B. Transitioning to OROS® methylphenidate from atomoxetine is effective in children and adolescents with ADHD.  Expert Review of Neurotherapeutics 2011;11(4):499‐508. [DOI: 10.1586/ern.11.18]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1586/ern.11.18', 'https://scholar.google.com/scholar_lookup?title=Transitioning+to+OROS®+methylphenidate+from+atomoxetine+is+effective+in+children+and+adolescents+with+ADHD+&author=K+Niederkirchner&author=L+Slawik&author=D+Wermelskirchen&author=K+Rettig&author=B+Schauble&publication_year=2011&hl=en']",,https://doi.org/10.1586/ern.11.18, Berek 2011 {published data only}  ,included,CD012069-bbs2-0025,
CD012069-bib-0046,"Schaeuble B, Mattejat F, Rettig K, Kordon A, Berek M. ",Changes in function and quality of life aspects in children with ADHD after transitioning onto OROS MPH,,2011,,    ,['citation-other']," Schaeuble B, Mattejat F, Rettig K, Kordon A, Berek M. Changes in function and quality of life aspects in children with ADHD after transitioning onto OROS MPH. European Child and Adolescent Psychiatry.14th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP); June 11‐15 2011; Helsinki (Finland). 2011; Vol. Suppl 1:S131. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Changes+in+function+and+quality+of+life+aspects+in+children+with+ADHD+after+transitioning+onto+OROS+MPH+&author=B+Schaeuble&author=F+Mattejat&author=K+Rettig&author=A+Kordon&author=M+Berek&publication_year=2011&hl=en']",,, Berek 2011 {published data only}  ,included,CD012069-bbs2-0025,
CD012069-bib-0047,"Wolff C, Alfred A, Lindermüller A, Rettig K, Mattejat F, Gerwe M, et al. ","Effect of transitioning from extended‐release methylphenidate onto osmotic, controlled‐release methylphenidate in children/adolescents with ADHD: results of a 3‐month non‐interventional study", Current Medical Research and Opinion ,2011,27,    ,['citation-journal']," Wolff C, Alfred A, Lindermüller A, Rettig K, Mattejat F, Gerwe M, et al. Effect of transitioning from extended‐release methylphenidate onto osmotic, controlled‐release methylphenidate in children/adolescents with ADHD: results of a 3‐month non‐interventional study.  Current Medical Research and Opinion 2011;27(Suppl 2):35‐44. [DOI: 10.1185/03007995.2011.601733; PUBMED: 21787126]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1185/03007995.2011.601733', 'https://scholar.google.com/scholar_lookup?title=Effect+of+transitioning+from+extended‐release+methylphenidate+onto+osmotic,+controlled‐release+methylphenidate+in+children/adolescents+with+ADHD:+results+of+a+3‐month+non‐interventional+study+&author=C+Wolff&author=A+Alfred&author=A+Lindermüller&author=K+Rettig&author=F+Mattejat&author=M+Gerwe&publication_year=2011&hl=en']",,https://doi.org/10.1185/03007995.2011.601733, Berek 2011 {published data only}  ,included,CD012069-bbs2-0025,
CD012069-bib-0048,"Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. ","Height, weight, IGF‐I, IGFBP‐3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment", Hormone Research ,2005,63,    ,['citation-journal']," Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IGF‐I, IGFBP‐3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment.  Hormone Research 2005;63(4):159‐64. [DOI: 10.1159/000084683; PUBMED: 15795512]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1159/000084683', 'https://scholar.google.com/scholar_lookup?title=Height,+weight,+IGF‐I,+IGFBP‐3+and+thyroid+functions+in+prepubertal+children+with+attention+deficit+hyperactivity+disorder:+effect+of+methylphenidate+treatment+&author=A+Bereket&author=S+Turan&author=MG+Karaman&author=G+Haklar&author=F+Ozbay&author=MY+Yazgan&publication_year=2005&hl=en']",,https://doi.org/10.1159/000084683, Bereket 2005 {published data only}  ,included,CD012069-bbs2-0026,
CD012069-bib-0049,"Bernhard MK, Hugle B, Merkenschlager A. ",Elevated liver enzymes under therapy with methylphenidate in a boy with T‐cell leukemia,,2009,,    ,['citation-other']," Bernhard MK, Hugle B, Merkenschlager A. Elevated liver enzymes under therapy with methylphenidate in a boy with T‐cell leukemia. Journal of Pediatric Neurology2009; Vol. 7, issue 3:297‐9. [DOI: 10.3233/JPN‐2009‐0303]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Elevated+liver+enzymes+under+therapy+with+methylphenidate+in+a+boy+with+T‐cell+leukemia&author=MK+Bernhard&author=B+Hugle&author=A+Merkenschlager&publication_year=2009&hl=en']",,, Bernhard 2009 {published data only}  ,included,CD012069-bbs2-0027,
CD012069-bib-0050,"Blader JC, Pliszka SR, Jensen PS, Schooler NR, Kafantaris V. ",Stimulant‐responsive and stimulant‐refractory aggressive behavior among children with ADHD, Pediatrics ,2010,126,    ,['citation-journal']," Blader JC, Pliszka SR, Jensen PS, Schooler NR, Kafantaris V. Stimulant‐responsive and stimulant‐refractory aggressive behavior among children with ADHD.  Pediatrics 2010;126(4):e796‐806. [DOI: 10.1542/peds.2010‐0086; PMC2956067; PUBMED: 20837589]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2010-0086', 'https://scholar.google.com/scholar_lookup?title=Stimulant‐responsive+and+stimulant‐refractory+aggressive+behavior+among+children+with+ADHD+&author=JC+Blader&author=SR+Pliszka&author=PS+Jensen&author=NR+Schooler&author=V+Kafantaris&publication_year=2010&hl=en']",,https://doi.org/10.1542/peds.2010-0086, Blader 2010 {published data only}  ,included,CD012069-bbs2-0028,
CD012069-bib-0051,Blader Joseph C. ,Methylphenidate dose may reduce aggressive behavior in children with ADHD, Brown University Child & Adolescent Psychopharmacology Update ,2010,12,    ,['citation-journal'], Blader Joseph C. Methylphenidate dose may reduce aggressive behavior in children with ADHD.  Brown University Child & Adolescent Psychopharmacology Update 2010;12(12):1‐7. [DOI: 10.1002/cpu.20129]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+dose+may+reduce+aggressive+behavior+in+children+with+ADHD&author=C+BladerJoseph&publication_year=2010&hl=en']",,, Blader 2010 {published data only}  ,included,CD012069-bbs2-0028,
CD012069-bib-0052,"Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Benecke R, et al. ",Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate, Biological Psychiatry ,2007,62,    ,['citation-journal']," Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Benecke R, et al. Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate.  Biological Psychiatry 2007;62(9):963‐9. [DOI: 10.1016/j.biopsych.2007.05.010; PUBMED: 17719015]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.biopsych.2007.05.010', 'https://scholar.google.com/scholar_lookup?title=Restoration+of+disturbed+intracortical+motor+inhibition+and+facilitation+in+attention+deficit+hyperactivity+disorder+children+by+methylphenidate+&author=J+Buchmann&author=W+Gierow&author=S+Weber&author=J+Hoeppner&author=T+Klauer&author=R+Benecke&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.biopsych.2007.05.010, Buchmann 2007 {published data only}  ,included,CD012069-bbs2-0029,
CD012069-bib-0053,"Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Wittsock M, et al. ",Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH), Neuroscience Letters ,2006,405,    ,['citation-journal']," Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Wittsock M, et al. Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH).  Neuroscience Letters 2006;405(1‐2):14‐8. [DOI: 10.1016/j.neulet.2006.06.026; PUBMED: 16815631]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.neulet.2006.06.026', 'https://scholar.google.com/scholar_lookup?title=Modulation+of+transcallosally+mediated+motor+inhibition+in+children+with+attention+deficit+hyperactivity+disorder+(ADHD)+by+medication+with+methylphenidate+(MPH)+&author=J+Buchmann&author=W+Gierow&author=S+Weber&author=J+Hoeppner&author=T+Klauer&author=M+Wittsock&publication_year=2006&hl=en']",,https://doi.org/10.1016/j.neulet.2006.06.026, Buchmann 2007 {published data only}  ,included,CD012069-bbs2-0029,
CD012069-bib-0054,"Buchmann J, Wolters A, Haessler F, Bohne S, Nordbeck R, Kunesch E. ",Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD), Clinical Neurophysiology ,2003,114,    ,['citation-journal']," Buchmann J, Wolters A, Haessler F, Bohne S, Nordbeck R, Kunesch E. Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD).  Clinical Neurophysiology 2003;114(11):2036‐42. [PUBMED: 14580601]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S1388-2457(03)00208-6', 'https://scholar.google.com/scholar_lookup?title=Disturbed+transcallosally+mediated+motor+inhibition+in+children+with+attention+deficit+hyperactivity+disorder+(ADHD)+&author=J+Buchmann&author=A+Wolters&author=F+Haessler&author=S+Bohne&author=R+Nordbeck&author=E+Kunesch&publication_year=2003&hl=en']",14580601,https://doi.org/10.1016/S1388-2457(03)00208-6, Buchmann 2007 {published data only}  ,included,CD012069-bbs2-0029,
CD012069-bib-0055,"Cakin‐Memik N, Yildiz O, Sişmanlar SG, Karakaya I, Ağaoğlu B. ",Priapism associated with methylphenidate: a case report, Turkish Journal of Pediatrics ,2010,52,    ,['citation-journal']," Cakin‐Memik N, Yildiz O, Sişmanlar SG, Karakaya I, Ağaoğlu B. Priapism associated with methylphenidate: a case report.  Turkish Journal of Pediatrics 2010;52(4):430‐4. [PUBMED: 21043394]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Priapism+associated+with+methylphenidate:+a+case+report&author=N+Cakin‐Memik&author=O+Yildiz&author=SG+Sişmanlar&author=I+Karakaya&author=B+Ağaoğlu&publication_year=2010&hl=en']",21043394,, Cakin‐Memik 2010 {published data only}  ,included,CD012069-bbs2-0030,
CD012069-bib-0056,"Çetin FH, Işik Taner Y, Taş Torun Y, Tunca H. ",Atomoxetine and methylphenidate for the treatment of attention deficit hyperactivity disorder: a six‐month follow‐up study,,2013,,    ,['citation-other']," Çetin FH, Işik Taner Y, Taş Torun Y, Tunca H. Atomoxetine and methylphenidate for the treatment of attention deficit hyperactivity disorder: a six‐month follow‐up study. Improved choices of psychotropic medications: better mental health outcomes. 5th International Congress on Psychopharmacology and International Symposium on Child and Adolescent Psychopharmacology (TAP‐ICP); October 30‐November 3 2013; Antalya (Turkey). 2013; Vol. 23:S80. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Atomoxetine+and+methylphenidate+for+the+treatment+of+attention+deficit+hyperactivity+disorder:+a+six‐month+follow‐up+study+&author=FH+Çetin&author=Y+IşikTaner&author=Y+TaşTorun&author=H+Tunca&publication_year=2013&hl=en']",,, Çetin 2015 {published data only}  ,included,CD012069-bbs2-0031,
CD012069-bib-0057,"Çetin FH, Taş TY, Işik Taner Y. ",Atomoxetine versus OROS methylphenidate in attention deficit hyperactivity disorder: a six‐month follow up study for efficacy and adverse effects, Turkiye Klinikleri Journal of Medical Sciences ,2015,35,    ,['citation-journal']," Çetin FH, Taş TY, Işik Taner Y. Atomoxetine versus OROS methylphenidate in attention deficit hyperactivity disorder: a six‐month follow up study for efficacy and adverse effects.  Turkiye Klinikleri Journal of Medical Sciences 2015;35(2):88‐96. [DOI: 10.5336/medsci.2015‐43336]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.5336/medsci.2015-43336', 'https://scholar.google.com/scholar_lookup?title=Atomoxetine+versus+OROS+methylphenidate+in+attention+deficit+hyperactivity+disorder:+a+six‐month+follow+up+study+for+efficacy+and+adverse+effects+&author=FH+Çetin&author=TY+Taş&author=Y+IşikTaner&publication_year=2015&hl=en']",,https://doi.org/10.5336/medsci.2015-43336, Çetin 2015 {published data only}  ,included,CD012069-bbs2-0031,
CD012069-bib-0058,"Chandler ML, Barnhill JL, Gualtieri CT, Patterson DR. ",Tryptophan antagonism of stimulant‐induced tics, Journal of Clinical Psychopharmacology ,1989,9,    ,['citation-journal']," Chandler ML, Barnhill JL, Gualtieri CT, Patterson DR. Tryptophan antagonism of stimulant‐induced tics.  Journal of Clinical Psychopharmacology 1989;9(1):69‐70. [PUBMED: 2708560]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004714-198902000-00027', 'https://scholar.google.com/scholar_lookup?title=Tryptophan+antagonism+of+stimulant‐induced+tics&author=ML+Chandler&author=JL+Barnhill&author=CT+Gualtieri&author=DR+Patterson&publication_year=1989&hl=en']",2708560,https://doi.org/10.1097/00004714-198902000-00027, Chandler 1989 {published data only}  ,included,CD012069-bbs2-0032,
CD012069-bib-0059,"Bruxel EM, Salatino‐Oliveira A, Genro JP, Zeni CP, Polanczyk GV, Chazan R, et al. ",Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention‐deficit/hyperactivity disorder treated with methylphenidate, Pharmacogenomics Journal ,2013,13,    ,['citation-journal']," Bruxel EM, Salatino‐Oliveira A, Genro JP, Zeni CP, Polanczyk GV, Chazan R, et al. Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention‐deficit/hyperactivity disorder treated with methylphenidate.  Pharmacogenomics Journal 2013;13(5):476‐80. [DOI: 10.1038/tpj.2012.25; PUBMED: 22688218]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1038/tpj.2012.25', 'https://scholar.google.com/scholar_lookup?title=Association+of+a+carboxylesterase+1+polymorphism+with+appetite+reduction+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+treated+with+methylphenidate+&author=EM+Bruxel&author=A+Salatino‐Oliveira&author=JP+Genro&author=CP+Zeni&author=GV+Polanczyk&author=R+Chazan&publication_year=2013&hl=en']",,https://doi.org/10.1038/tpj.2012.25, Chazan 2011 {published data only}  ,included,CD012069-bbs2-0033,
CD012069-bib-0060,"Chazan R, Borowski C, Pianca T, Ludwig H, Rohde LA, Polanczyk G. ","Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention‐deficit/hyperactivity disorder? A naturalistic study from a developing count", Journal of Clinical Psychopharmacology ,2011,31,    ,['citation-journal']," Chazan R, Borowski C, Pianca T, Ludwig H, Rohde LA, Polanczyk G. Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention‐deficit/hyperactivity disorder? A naturalistic study from a developing count.  Journal of Clinical Psychopharmacology 2011;31(3):309‐17. [DOI: 10.1097/JCP.0b013e318217b4df; PUBMED: 21508864]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Do+phenotypic+characteristics,+parental+psychopathology,+family+functioning,+and+environmental+stressors+have+a+role+in+the+response+to+methylphenidate+in+children+with+attention‐deficit/hyperactivity+disorder?+A+naturalistic+study+from+a+developing+count+&author=R+Chazan&author=C+Borowski&author=T+Pianca&author=H+Ludwig&author=LA+Rohde&author=G+Polanczyk&publication_year=2011&hl=en']",,, Chazan 2011 {published data only}  ,included,CD012069-bbs2-0033,
CD012069-bib-0061,"Salatino‐Oliveira A, Genro JP, Zeni C, Polanczyk GV, Chazan R, Guimarães AP, et al. ",Catechol‐O‐methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention‐deficit/hyperactivity disorder, Biological Psychiatry ,2011,70,    ,['citation-journal']," Salatino‐Oliveira A, Genro JP, Zeni C, Polanczyk GV, Chazan R, Guimarães AP, et al. Catechol‐O‐methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention‐deficit/hyperactivity disorder.  Biological Psychiatry 2011;70(3):216‐21. [DOI: 10.1016/j.biopsych.2011.03.025; PUBMED: 21550019]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.biopsych.2011.03.025', 'https://scholar.google.com/scholar_lookup?title=Catechol‐O‐methyltransferase+valine158methionine+polymorphism+moderates+methylphenidate+effects+on+oppositional+symptoms+in+boys+with+attention‐deficit/hyperactivity+disorder+&author=A+Salatino‐Oliveira&author=JP+Genro&author=C+Zeni&author=GV+Polanczyk&author=R+Chazan&author=AP+Guimarães&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.biopsych.2011.03.025, Chazan 2011 {published data only}  ,included,CD012069-bbs2-0033,
CD012069-bib-0062,"Cherland E, Fitzpatrick R. ",Psychotic side effects of psychostimulants: a 5‐year review, Canadian Journal of Psychiatry ,1999,44,    ,['citation-journal']," Cherland E, Fitzpatrick R. Psychotic side effects of psychostimulants: a 5‐year review.  Canadian Journal of Psychiatry 1999;44(8):811‐3. [DOI: 10.1177/070674379904400810; PUBMED: 10566114]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/070674379904400810', 'https://scholar.google.com/scholar_lookup?title=Psychotic+side+effects+of+psychostimulants:+a+5‐year+review&author=E+Cherland&author=R+Fitzpatrick&publication_year=1999&hl=en']",,https://doi.org/10.1177/070674379904400810, Cherland 1999 {published data only}  ,included,CD012069-bbs2-0034,
CD012069-bib-0063,"Cho S‐C, Kim B‐N, Cummins TD, Kim J‐W, Bellgrove MA. ",Norepinephrine transporter ‐3081(A/T) and alpha‐2A‐adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS‐methylphenidate treatment,,2012,,    ,['citation-other']," Cho S‐C, Kim B‐N, Cummins TD, Kim J‐W, Bellgrove MA. Norepinephrine transporter ‐3081(A/T) and alpha‐2A‐adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS‐methylphenidate treatment. Journal of Psychopharmacology2012; Vol. 26, issue 3:380‐9. [DOI: 10.1177/0269881111405356]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Norepinephrine+transporter+‐3081(A/T)+and+alpha‐2A‐adrenergic+receptor+MspI+polymorphisms+are+associated+with+cardiovascular+side+effects+of+OROS‐methylphenidate+treatment+&author=S‐C+Cho&author=B‐N+Kim&author=TD+Cummins&author=J‐W+Kim&author=MA+Bellgrove&publication_year=2012&hl=en']",,, Cho 2012 {published data only}  ,included,CD012069-bbs2-0035,
CD012069-bib-0064,"Chou WJ, Chen SJ, Chen YS, Liang HY, Lin CC, Tang CS, et al. ",Remission in children and adolescents diagnosed with attention‐deficit/ hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate, Journal of Child and Adolescent Psychopharmacology ,2012,22,    ,['citation-journal']," Chou WJ, Chen SJ, Chen YS, Liang HY, Lin CC, Tang CS, et al. Remission in children and adolescents diagnosed with attention‐deficit/ hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.  Journal of Child and Adolescent Psychopharmacology 2012;22(3):215‐25. [DOI: 10.1089/cap.2011.0006; PMC3373222; PUBMED: 22537358]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2011.0006', 'https://scholar.google.com/scholar_lookup?title=Remission+in+children+and+adolescents+diagnosed+with+attention‐deficit/+hyperactivity+disorder+via+an+effective+and+tolerable+titration+scheme+for+osmotic+release+oral+system+methylphenidate+&author=WJ+Chou&author=SJ+Chen&author=YS+Chen&author=HY+Liang&author=CC+Lin&author=CS+Tang&publication_year=2012&hl=en']",,https://doi.org/10.1089/cap.2011.0006, Chou 2012a {published data only}  ,included,CD012069-bbs2-0036,
CD012069-bib-0065,"WJ Chou, LJ Wang. ",The family impact in children and adolescent with ADHD after the switch of treatment from immediate‐release MPH to OROS‐MPH, Neuropsychiatrie de l'Enfance et de l'Adolescence ,2012,60,    ,['citation-journal']," WJ Chou, LJ Wang. The family impact in children and adolescent with ADHD after the switch of treatment from immediate‐release MPH to OROS‐MPH.  Neuropsychiatrie de l'Enfance et de l'Adolescence 2012;60(5S):S262. [DOI: 10.1016/j.neurenf.2012.04.683]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+family+impact+in+children+and+adolescent+with+ADHD+after+the+switch+of+treatment+from+immediate‐release+MPH+to+OROS‐MPH+&author=Chou+WJ&author=Wang+LJ&publication_year=2012&hl=en']",,, Chou 2012b {published data only}  ,included,CD012069-bbs2-0037,
CD012069-bib-0066,"Cockcroft K, Ashwal J, Bentley A. ",Sleep and daytime sleepiness in methylphenidate medicated and un‐medicated children with attention‐deficit/hyperactivity disorder (ADHD), African Journal of Psychiatry ,2009,12,    ,['citation-journal']," Cockcroft K, Ashwal J, Bentley A. Sleep and daytime sleepiness in methylphenidate medicated and un‐medicated children with attention‐deficit/hyperactivity disorder (ADHD).  African Journal of Psychiatry 2009;12(4):275‐9. [PUBMED: 20033109]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4314/ajpsy.v12i4.49043', 'https://scholar.google.com/scholar_lookup?title=Sleep+and+daytime+sleepiness+in+methylphenidate+medicated+and+un‐medicated+children+with+attention‐deficit/hyperactivity+disorder+(ADHD)+&author=K+Cockcroft&author=J+Ashwal&author=A+Bentley&publication_year=2009&hl=en']",20033109,https://doi.org/10.4314/ajpsy.v12i4.49043, Cockcroft 2009 {published data only}  ,included,CD012069-bbs2-0038,
CD012069-bib-0067,"Cohen HA, Ashkenazi A, Nussinovitch M, Gross S, Frydman M. ",Fixed drug eruption of the scrotum due to methylphenidate, Annals of Pharmacotherapy ,1992,26,    ,['citation-journal']," Cohen HA, Ashkenazi A, Nussinovitch M, Gross S, Frydman M. Fixed drug eruption of the scrotum due to methylphenidate.  Annals of Pharmacotherapy 1992;26(11):1378‐9. [DOI: 10.1177/106002809202601107; PUBMED: 1477441]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/106002809202601107', 'https://scholar.google.com/scholar_lookup?title=Fixed+drug+eruption+of+the+scrotum+due+to+methylphenidate&author=HA+Cohen&author=A+Ashkenazi&author=M+Nussinovitch&author=S+Gross&author=M+Frydman&publication_year=1992&hl=en']",,https://doi.org/10.1177/106002809202601107, Cohen 1992 {published data only}  ,included,CD012069-bbs2-0039,
CD012069-bib-0068,"Coignoux Y, Estingoy P, Bastard A. ","From hyperactivity to schizophrenia? Clinical, neurobiological and therapeutic discussion of a case"," Annales Médico‐psychologiques, Revue Psychatrique ",2009,167,    ,['citation-journal']," Coignoux Y, Estingoy P, Bastard A. From hyperactivity to schizophrenia? Clinical, neurobiological and therapeutic discussion of a case [De l'hyperactivité à la schizophrénie? Discussion clinique, neurobiologique et thérapeutique, à propos d'un cas].  Annales Médico‐psychologiques, Revue Psychatrique 2009;167(1):57‐65. [DOI: 10.1016/j.amp.2008.11.006]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.amp.2008.11.006', 'https://scholar.google.com/scholar_lookup?title=From+hyperactivity+to+schizophrenia?+Clinical,+neurobiological+and+therapeutic+discussion+of+a+case+&author=Y+Coignoux&author=P+Estingoy&author=A+Bastard&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.amp.2008.11.006, Coignoux 2009 {published data only}  ,included,CD012069-bbs2-0040,
CD012069-bib-0069,"Confino‐Cohen R, Goldberg A. ",Successful desensitization of methylphenidate‐induced rash, Journal of Child and Adolescent Psychopharmacology ,2005,15,    ,['citation-journal']," Confino‐Cohen R, Goldberg A. Successful desensitization of methylphenidate‐induced rash.  Journal of Child and Adolescent Psychopharmacology 2005;15(4):703‐5. [DOI: 10.1089/cap.2005.15.703; PUBMED: 16190802]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2005.15.703', 'https://scholar.google.com/scholar_lookup?title=Successful+desensitization+of+methylphenidate‐induced+rash&author=R+Confino‐Cohen&author=A+Goldberg&publication_year=2005&hl=en']",,https://doi.org/10.1089/cap.2005.15.703, Confino‐Cohen 2005 {published data only}  ,included,CD012069-bbs2-0041,
CD012069-bib-0070,"Congologlu MA, Turkbay T, Ciyiltepe M, Durukan I, Dogangun B, Yuce M. ",Immediate effects of methylphenidate on vocal acoustic parameters in children with attention deficit hyperactivity disorder, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2009,19,    ,['citation-journal']," Congologlu MA, Turkbay T, Ciyiltepe M, Durukan I, Dogangun B, Yuce M. Immediate effects of methylphenidate on vocal acoustic parameters in children with attention deficit hyperactivity disorder.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2009;19(4):365‐72. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Immediate+effects+of+methylphenidate+on+vocal+acoustic+parameters+in+children+with+attention+deficit+hyperactivity+disorder+&author=MA+Congologlu&author=T+Turkbay&author=M+Ciyiltepe&author=I+Durukan&author=B+Dogangun&author=M+Yuce&publication_year=2009&hl=en']",,, Congologlu 2009 {published data only}  ,included,CD012069-bbs2-0042,
CD012069-bib-0071,"Corrigall R, Ford T. ",Methylphenidate euphoria, Journal of the American Academy of Child and Adolescent Psychiatry ,1996,35,    ,['citation-journal']," Corrigall R, Ford T. Methylphenidate euphoria.  Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(11):1421. [DOI: 10.1097/00004583‐199611000‐00005; PUBMED: 8936903]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199611000-00005', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+euphoria&author=R+Corrigall&author=T+Ford&publication_year=1996&hl=en']",,https://doi.org/10.1097/00004583-199611000-00005, Corrigall 1996 {published data only}  ,included,CD012069-bbs2-0043,
CD012069-bib-0072,"Cortese S, Panei P, Arcieri R, Germinario EA, Capuano A, Margari L, et al. ",Safety of methylphenidate and atomoxetine in children with Attention‐Deficit/Hyperactivity Disorder (ADHD): data from the Italian National ADHD Registry, CNS Drugs ,2015,29,    ,['citation-journal']," Cortese S, Panei P, Arcieri R, Germinario EA, Capuano A, Margari L, et al. Safety of methylphenidate and atomoxetine in children with Attention‐Deficit/Hyperactivity Disorder (ADHD): data from the Italian National ADHD Registry.  CNS Drugs 2015;29(10):865‐77. [DOI: 10.1007/s40263‐015‐0266‐7; PUBMED: 26293742]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s40263-015-0266-7', 'https://scholar.google.com/scholar_lookup?title=Safety+of+methylphenidate+and+atomoxetine+in+children+with+Attention‐Deficit/Hyperactivity+Disorder+(ADHD):+data+from+the+Italian+National+ADHD+Registry+&author=S+Cortese&author=P+Panei&author=R+Arcieri&author=EA+Germinario&author=A+Capuano&author=L+Margari&publication_year=2015&hl=en']",,https://doi.org/10.1007/s40263-015-0266-7, Cortese 2015 {published data only}  ,included,CD012069-bbs2-0044,
CD012069-bib-0073,"Coşkun M, Zoroglu S. ",Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination, Journal of Clinical Psychopharmacology ,2008,28,    ,['citation-journal']," Coşkun M, Zoroglu S. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.  Journal of Clinical Psychopharmacology 2008;28(6):723‐5. [DOI: 10.1097/JCP.0b013e31818ce752; PUBMED: 19011457]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0b013e31818ce752', 'https://scholar.google.com/scholar_lookup?title=Tactile+and+visual+hallucinations+in+a+child+with+methylphenidate+and+fluoxetine+combination&author=M+Coşkun&author=S+Zoroglu&publication_year=2008&hl=en']",,https://doi.org/10.1097/JCP.0b013e31818ce752, Coşkun 2008 {published data only}  ,included,CD012069-bbs2-0045,
CD012069-bib-0074,"Coşkun M, Tutkunkardas MD, Zoroglu S. ",OROS methylphenidate‐induced skin eruptions,,2009,,    ,['citation-other']," Coşkun M, Tutkunkardas MD, Zoroglu S. OROS methylphenidate‐induced skin eruptions. Journal of Child and Adolescent Psychopharmacology2009; Vol. 19, issue 5:593‐4. [DOI: 10.1089/cap.2009.0009; PUBMED: 19877987]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=OROS+methylphenidate‐induced+skin+eruptions&author=M+Coşkun&author=MD+Tutkunkardas&author=S+Zoroglu&publication_year=2009&hl=en']",,, Coşkun 2009a {published data only}  ,included,CD012069-bbs2-0046,
CD012069-bib-0075,"Coşkun M, Zoroglu S. ",A report of two cases of sexual side effects with OROS methylphenidate, Journal of Child and Adolescent Psychopharmacology ,2009,19,    ,['citation-journal']," Coşkun M, Zoroglu S. A report of two cases of sexual side effects with OROS methylphenidate.  Journal of Child and Adolescent Psychopharmacology 2009;19(4):477‐9. [DOI: 10.1089/cap.2008.0161; PUBMED: 19702503]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2008.0161', 'https://scholar.google.com/scholar_lookup?title=A+report+of+two+cases+of+sexual+side+effects+with+OROS+methylphenidate&author=M+Coşkun&author=S+Zoroglu&publication_year=2009&hl=en']",,https://doi.org/10.1089/cap.2008.0161, Coşkun 2009b {published data only}  ,included,CD012069-bbs2-0047,
CD012069-bib-0076,"Coşkun M, Ahmetoglu E, Ozturk M. ",Mirtazapine treatment for comorbid anxiety/depressive disorders in young subjects with attention‐deficit hyperactivity disorder: case series, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2010,20,    ,['citation-journal']," Coşkun M, Ahmetoglu E, Ozturk M. Mirtazapine treatment for comorbid anxiety/depressive disorders in young subjects with attention‐deficit hyperactivity disorder: case series.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2010;20(3):246‐51. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/10177833.2010.11790666', 'https://scholar.google.com/scholar_lookup?title=Mirtazapine+treatment+for+comorbid+anxiety/depressive+disorders+in+young+subjects+with+attention‐deficit+hyperactivity+disorder:+case+series+&author=M+Coşkun&author=E+Ahmetoglu&author=M+Ozturk&publication_year=2010&hl=en']",,https://doi.org/10.1080/10177833.2010.11790666, Coşkun 2010 {published data only}  ,included,CD012069-bbs2-0048,
CD012069-bib-0077,Coşkun M. ,Methylphenidate induced obsessive‐compulsive symptoms treated with sertraline, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2011,21,    ,['citation-journal'], Coşkun M. Methylphenidate induced obsessive‐compulsive symptoms treated with sertraline.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2011;21(3):274. [DOI: 10.5455/bcp.20110904061403]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.5455/bcp.20110904061403', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+induced+obsessive‐compulsive+symptoms+treated+with+sertraline&author=M+Coşkun&publication_year=2011&hl=en']",,https://doi.org/10.5455/bcp.20110904061403, Coşkun 2011 {published data only}  ,included,CD012069-bbs2-0049,
CD012069-bib-0078,"Babaki ME, Ashtiani RD, Razjooyan K, Amini H. ",Comparing the effects of buspirone and methylphenidate in children with attention deficit hyperactivity disorder,,2009,,    ,['citation-other']," Babaki ME, Ashtiani RD, Razjooyan K, Amini H. Comparing the effects of buspirone and methylphenidate in children with attention deficit hyperactivity disorder. Iranian Journal of Psychiatry and Clinical Psychology2009; Vol. 15, issue 3:223‐30. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparing+the+effects+of+buspirone+and+methylphenidate+in+children+with+attention+deficit+hyperactivity+disorder+&author=ME+Babaki&author=RD+Ashtiani&author=K+Razjooyan&author=H+Amini&publication_year=2009&hl=en']",,, Davari‐Ashtiani 2010 {published data only}  ,included,CD012069-bbs2-0050,
CD012069-bib-0079,"Davari‐Ashtiani R, Shahrbabaki ME, Razjouyan K, Amini H, Mazhabdar H. ",Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double‐blind and randomized trial, Child Psychiatry and Human Development ,2010,41,    ,['citation-journal']," Davari‐Ashtiani R, Shahrbabaki ME, Razjouyan K, Amini H, Mazhabdar H. Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double‐blind and randomized trial.  Child Psychiatry and Human Development 2010;41(6):641‐8. [DOI: 10.1007/s10578‐010‐0193‐2; PUBMED: 20517641]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s10578-010-0193-2', 'https://scholar.google.com/scholar_lookup?title=Buspirone+versus+methylphenidate+in+the+treatment+of+attention+deficit+hyperactivity+disorder:+a+double‐blind+and+randomized+trial+&author=R+Davari‐Ashtiani&author=ME+Shahrbabaki&author=K+Razjouyan&author=H+Amini&author=H+Mazhabdar&publication_year=2010&hl=en']",,https://doi.org/10.1007/s10578-010-0193-2, Davari‐Ashtiani 2010 {published data only}  ,included,CD012069-bbs2-0050,
CD012069-bib-0080,"Shahrbabaki ME, Sabzevari L, Haghdoost A, Davari‐Ashtiani R. ",Buspiron versus methylphenidate in the treatment of children with ADHD,,2012,,    ,['citation-other']," Shahrbabaki ME, Sabzevari L, Haghdoost A, Davari‐Ashtiani R. Buspiron versus methylphenidate in the treatment of children with ADHD. Brain, Mind and Development. 20th World IACAPAP (International Association for Child and Adolescent Psychiatry and Allied Professions) Congress; July 21‐25 2012; Paris (France). 2012; Vol. 60:Suppl 1. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Buspiron+versus+methylphenidate+in+the+treatment+of+children+with+ADHD&author=ME+Shahrbabaki&author=L+Sabzevari&author=A+Haghdoost&author=R+Davari‐Ashtiani&publication_year=2012&hl=en']",,, Davari‐Ashtiani 2010 {published data only}  ,included,CD012069-bbs2-0050,
CD012069-bib-0081,"Delignieres A, Querne L, Bourel‐Ponchel E, Ardoint A, Berquin P. ",Attention‐deficit disorders and epilepsy in childhood: use methylphenidate treatment?,,2011,,    ,['citation-other']," Delignieres A, Querne L, Bourel‐Ponchel E, Ardoint A, Berquin P. Attention‐deficit disorders and epilepsy in childhood: use methylphenidate treatment?. European Journal of Paediatric Neurology. 9th Congress of the European Paediatric Neurology Society (EPNS); May 11‐14 2011; Cavtat (Croatia). 2011; Vol. 15:S127‐8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit+disorders+and+epilepsy+in+childhood:+use+methylphenidate+treatment?&author=A+Delignieres&author=L+Querne&author=E+Bourel‐Ponchel&author=A+Ardoint&author=P+Berquin&publication_year=2011&hl=en']",,, Delignieres 2011 {published data only}  ,included,CD012069-bbs2-0051,
CD012069-bib-0082,"Dirksen SJ, D'Imperio JM, Birdsall D, Hatch SJ. ",A postmarketing clinical experience study of Metadate CD, Current Medical Research and Opinion ,2002,18,    ,['citation-journal']," Dirksen SJ, D'Imperio JM, Birdsall D, Hatch SJ. A postmarketing clinical experience study of Metadate CD.  Current Medical Research and Opinion 2002;18(7):371‐80. [PUBMED: 12487502]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1185/030079902125001100', ""https://scholar.google.com/scholar_lookup?title=A+postmarketing+clinical+experience+study+of+Metadate+CD&author=SJ+Dirksen&author=JM+D'Imperio&author=D+Birdsall&author=SJ+Hatch&publication_year=2002&hl=en""]",12487502,https://doi.org/10.1185/030079902125001100, Dirksen 2002 {published data only}  ,included,CD012069-bbs2-0052,
CD012069-bib-0083,"Dittmann RW, Banaschewski T, Schacht A, Wehmeier PM. ","Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD‐related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment", Attention Deficit and Hyperactivity Disorders ,2014,6,    ,['citation-journal']," Dittmann RW, Banaschewski T, Schacht A, Wehmeier PM. Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD‐related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment.  Attention Deficit and Hyperactivity Disorders 2014;6(2014):291‐302. [DOI: 10.1007/s12402‐014‐0136‐z; PUBMED: 24705867]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-014-0136-z', ""https://scholar.google.com/scholar_lookup?title=Findings+from+the+observational+COMPLY+study+in+children+and+adolescents+with+ADHD:+core+symptoms,+ADHD‐related+difficulties,+and+patients'+emotional+expression+during+psychostimulant+or+nonstimulant+ADHD+treatment+&author=RW+Dittmann&author=T+Banaschewski&author=A+Schacht&author=PM+Wehmeier&publication_year=2014&hl=en""]",,https://doi.org/10.1007/s12402-014-0136-z, Dittmann 2014 {published data only}  ,included,CD012069-bbs2-0053,
CD012069-bib-0084,"Dodangi N, Tehrani‐Doost M, Mahmoudi‐Gharaei J, Rajabi G. ",Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD,,2011,,    ,['citation-other']," Dodangi N, Tehrani‐Doost M, Mahmoudi‐Gharaei J, Rajabi G. Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD. European Child and Adolescent Psychiatry. 14th International Congress of ESCAP European Society for Child and Adolescent Psychiatry; June 11‐15 2011; Helsinki (Finland). 2011; Vol. 20:S116. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Duloxetine+in+comparison+with+methylphenidate+in+treatment+of+adolescents+with+ADHD&author=N+Dodangi&author=M+Tehrani‐Doost&author=J+Mahmoudi‐Gharaei&author=G+Rajabi&publication_year=2011&hl=en']",,, Dodangi 2011 {published data only}  ,included,CD012069-bbs2-0054,
CD012069-bib-0085,"Mahmoudi‐Gharaei J, Dodangi N, Tehrani‐Doost M, Faghihi T. ",Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open‐label study, Human Psychopharmacology ,2011,26,    ,['citation-journal']," Mahmoudi‐Gharaei J, Dodangi N, Tehrani‐Doost M, Faghihi T. Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open‐label study.  Human Psychopharmacology 2011;26(2):155‐60. [DOI: 10.1002/hup.1188; PUBMED: 21455975]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/hup.1188', 'https://scholar.google.com/scholar_lookup?title=Duloxetine+in+the+treatment+of+adolescents+with+attention+deficit/hyperactivity+disorder:+an+open‐label+study+&author=J+Mahmoudi‐Gharaei&author=N+Dodangi&author=M+Tehrani‐Doost&author=T+Faghihi&publication_year=2011&hl=en']",,https://doi.org/10.1002/hup.1188, Dodangi 2011 {published data only}  ,included,CD012069-bbs2-0054,
CD012069-bib-0086,"Becker A, Roessner V, Breuer D, Döpfner M, Rothenberger A. ",Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD, European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Becker A, Roessner V, Breuer D, Döpfner M, Rothenberger A. Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD.  European Child and Adolescent Psychiatry 2011;20(Suppl 2):S267‐75. [DOI: 10.1007/s00787‐011‐0204‐2; PMC3180591; PUBMED: 21901415]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0204-2', 'https://scholar.google.com/scholar_lookup?title=Relationship+between+quality+of+life+and+psychopathological+profile:+data+from+an+observational+study+in+children+with+ADHD+&author=A+Becker&author=V+Roessner&author=D+Breuer&author=M+Döpfner&author=A+Rothenberger&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-011-0204-2," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0087,"Breuer D, Görtz‐Dorten A, Rothenberger A, Döpfner M. ","Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings", European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Breuer D, Görtz‐Dorten A, Rothenberger A, Döpfner M. Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings.  European Child and Adolescent Psychiatry 2011;20(Suppl 2):S289‐96. [DOI: 10.1007/s00787‐011‐0206‐0; PMC3180560; PUBMED: 21901413]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0206-0', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+daily+profiles+of+ADHD+and+ODD+symptoms,+and+symptomatology+related+to+ADHD+medication,+by+parent+and+teacher+ratings+&author=D+Breuer&author=A+Görtz‐Dorten&author=A+Rothenberger&author=M+Döpfner&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-011-0206-0," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0088,"Döpfner M, Breuer D, Walter D, Rothenberger A. ","An observational study of once‐daily modified‐release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality‐of‐life outcomes", European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Döpfner M, Breuer D, Walter D, Rothenberger A. An observational study of once‐daily modified‐release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality‐of‐life outcomes.  European Child and Adolescent Psychiatry 2011;20(Suppl 2):S277‐88. [DOI: 10.1007/s00787‐011‐0205‐1; PMC3098980; PUBMED: 21901414]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0205-1', 'https://scholar.google.com/scholar_lookup?title=An+observational+study+of+once‐daily+modified‐release+methylphenidate+in+ADHD:+the+effect+of+previous+treatment+on+ADHD+symptoms,+other+externalising+symptoms+and+quality‐of‐life+outcomes+&author=M+Döpfner&author=D+Breuer&author=D+Walter&author=A+Rothenberger&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-011-0205-1," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0089,"Döpfner M, Görtz‐Dorten A, Breuer D, Rothenberger A. ","An observational study of once‐daily modified‐release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety", European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Döpfner M, Görtz‐Dorten A, Breuer D, Rothenberger A. An observational study of once‐daily modified‐release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety.  European Child and Adolescent Psychiatry 2011;20(Suppl 2):S243‐55. [DOI: 10.1007/s00787‐011‐0202‐4; PMC3180616; PUBMED: 21901417]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0202-4', 'https://scholar.google.com/scholar_lookup?title=An+observational+study+of+once‐daily+modified‐release+methylphenidate+in+ADHD:+effectiveness+on+symptoms+and+impairment,+and+safety+&author=M+Döpfner&author=A+Görtz‐Dorten&author=D+Breuer&author=A+Rothenberger&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-011-0202-4," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0090,"Döpfner M, Rothenberger A, Ose C. ","Assessment of Equasym XL under routine conditions by physicians, parents, teachers, and children", International Journal of Neuropsychopharmacology ,2008,11,    ,['citation-journal']," Döpfner M, Rothenberger A, Ose C. Assessment of Equasym XL under routine conditions by physicians, parents, teachers, and children.  International Journal of Neuropsychopharmacology 2008;11(Suppl 1):290. [DOI: 10.1017/S1461145708009462]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+Equasym+XL+under+routine+conditions+by+physicians,+parents,+teachers,+and+children+&author=M+Döpfner&author=A+Rothenberger&author=C+Ose&publication_year=2008&hl=en']",,," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0091,"Görtz‐Dorten A, Breuer D, Hautmann C, Rothenberger A, Döpfner M. ",What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale,,2011,,    ,['citation-other']," Görtz‐Dorten A, Breuer D, Hautmann C, Rothenberger A, Döpfner M. What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale. European Child and Adolescent Psychiatry2011; Vol. 20, issue Suppl 2:S297‐307. [DOI: 10.1007/s00787‐011‐0207‐z; PMC3180627]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=What+contributes+to+patient+and+parent+satisfaction+with+medication+in+the+treatment+of+children+with+ADHD?+A+report+on+the+development+of+a+new+rating+scale+&author=A+Görtz‐Dorten&author=D+Breuer&author=C+Hautmann&author=A+Rothenberger&author=M+Döpfner&publication_year=2011&hl=en']",,," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0092,"Rothenberger A, Becker A, Breuer D, Döpfner M. ","An observational study of once‐daily modified‐release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence", European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Rothenberger A, Becker A, Breuer D, Döpfner M. An observational study of once‐daily modified‐release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence.  European Child and Adolescent Psychiatry 2011;20(Suppl 2):257‐65. [DOI: 10.1007/s00787‐011‐0203‐3; PMC3180635]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0203-3', 'https://scholar.google.com/scholar_lookup?title=An+observational+study+of+once‐daily+modified‐release+methylphenidate+in+ADHD:+quality+of+life,+satisfaction+with+treatment+and+adherence+&author=A+Rothenberger&author=A+Becker&author=D+Breuer&author=M+Döpfner&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-011-0203-3," Döpfner 2011a, OBSEER {published data only}  ",included,CD012069-bbs2-0055,
CD012069-bib-0093,"Döpfner M, Ose C, Fischer R, Ammer R, Scherag A. ","Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention‐deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet® retard and Concerta® ‐ a randomized, controlled, double‐blind multicenter clinical crossover trial", Journal of Child & Adolescent Psychopharmacology ,2011,21,    ,['citation-journal']," Döpfner M, Ose C, Fischer R, Ammer R, Scherag A. Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention‐deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet® retard and Concerta® ‐ a randomized, controlled, double‐blind multicenter clinical crossover trial.  Journal of Child & Adolescent Psychopharmacology 2011;21(5):445‐54. [DOI: 10.1089/cap.2010.0082; PMC3205792; PUBMED: 21790298]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+the+efficacy+of+two+different+modified+release+methylphenidate+preparations+for+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+in+a+natural+setting:+comparison+of+the+efficacy+of+Medikinet®+retard+and+Concerta®+‐+a+randomized,+controlled,+double‐blind+multicenter+clinical+crossover+trial+&author=M+Döpfner&author=C+Ose&author=R+Fischer&author=R+Ammer&author=A+Scherag&publication_year=2011&hl=en']",,, Döpfner 2011b {published data only}  ,included,CD012069-bbs2-0056,
CD012069-bib-0094,"Döpfner M, Ose C, Fischer R, Ammer R, Scherag A. ",The CoMeCo‐trial: comparison of the efficacy of two methylphenidate preparations for children and adolescents with ADHD in a natural setting," European Child and Adolescent Psychiatry.14th International Congress of ESCAP European Society for Child and Adolescent Psychiatry (ESCAP); June 11‐15, 2011; Helsinki (Finland) ",2011,20,    ,['citation-journal']," Döpfner M, Ose C, Fischer R, Ammer R, Scherag A. The CoMeCo‐trial: comparison of the efficacy of two methylphenidate preparations for children and adolescents with ADHD in a natural setting.  European Child and Adolescent Psychiatry.14th International Congress of ESCAP European Society for Child and Adolescent Psychiatry (ESCAP); June 11‐15, 2011; Helsinki (Finland) 2011;20:S116. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+CoMeCo‐trial:+comparison+of+the+efficacy+of+two+methylphenidate+preparations+for+children+and+adolescents+with+ADHD+in+a+natural+setting+&author=M+Döpfner&author=C+Ose&author=R+Fischer&author=R+Ammer&author=A+Scherag&publication_year=2011&hl=en']",,, Döpfner 2011b {published data only}  ,included,CD012069-bbs2-0056,
CD012069-bib-0095,"Döpfner M, Breuer D, Ose C, Fischer R. ",Methylphenidate with modified release in routine treatment, Monatsschrift Kinderheilkunde ,2011,159,    ,['citation-journal']," Döpfner M, Breuer D, Ose C, Fischer R. Methylphenidate with modified release in routine treatment [Methylphenidat mit modifizierter Freisetzung in der Routineversorgung].  Monatsschrift Kinderheilkunde 2011;159(11):1119‐25. [DOI: 10.1007/s00112‐011‐2413‐7]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00112-011-2413-7', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+with+modified+release+in+routine+treatment&author=M+Döpfner&author=D+Breuer&author=C+Ose&author=R+Fischer&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00112-011-2413-7, Döpfner 2011c {published data only}  ,included,CD012069-bbs2-0057,
CD012069-bib-0096,"Dubnov‐Raz G, Perry A, Berger I. ",Body mass index of children with attention‐deficit/hyperactivity disorder, Journal of Child Neurology ,2011,26,    ,['citation-journal']," Dubnov‐Raz G, Perry A, Berger I. Body mass index of children with attention‐deficit/hyperactivity disorder.  Journal of Child Neurology 2011;26(3):302‐8. [DOI: 10.1177/0883073810380051; PUBMED: 20929910]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/0883073810380051', 'https://scholar.google.com/scholar_lookup?title=Body+mass+index+of+children+with+attention‐deficit/hyperactivity+disorder&author=G+Dubnov‐Raz&author=A+Perry&author=I+Berger&publication_year=2011&hl=en']",,https://doi.org/10.1177/0883073810380051, Dubnov‐Raz 2011 {published data only}  ,included,CD012069-bbs2-0058,
CD012069-bib-0097,"Yang R, Mao S, Zhang S, Li R, Zhao Z. ",Body mass index of children with attention‐deficit/hyperactivity disorder,,2012,,    ,['citation-other']," Yang R, Mao S, Zhang S, Li R, Zhao Z. Body mass index of children with attention‐deficit/hyperactivity disorder. Journal of Child Neurology2012; Vol. 27, issue 4:545‐6. [DOI: 10.1177/0883073811435326]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Body+mass+index+of+children+with+attention‐deficit/hyperactivity+disorder&author=R+Yang&author=S+Mao&author=S+Zhang&author=R+Li&author=Z+Zhao&publication_year=2012&hl=en']",,, Dubnov‐Raz 2011 {published data only}  ,included,CD012069-bbs2-0058,
CD012069-bib-0098,"Dupuy FE, Clarke AR, Barry RJ, McCarthy R, Selikowitz M. ",EEG coherence in girls with attention‐deficit/hyperactivity disorder: stimulant effects in good responders, International Journal of Psychophysiology ,2008,70,    ,['citation-journal']," Dupuy FE, Clarke AR, Barry RJ, McCarthy R, Selikowitz M. EEG coherence in girls with attention‐deficit/hyperactivity disorder: stimulant effects in good responders.  International Journal of Psychophysiology 2008;70(3):151‐7. [DOI: 10.1016/j.ijpsycho.2008.07.012; PUBMED: 18708101]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ijpsycho.2008.07.012', 'https://scholar.google.com/scholar_lookup?title=EEG+coherence+in+girls+with+attention‐deficit/hyperactivity+disorder:+stimulant+effects+in+good+responders+&author=FE+Dupuy&author=AR+Clarke&author=RJ+Barry&author=R+McCarthy&author=M+Selikowitz&publication_year=2008&hl=en']",,https://doi.org/10.1016/j.ijpsycho.2008.07.012, Dupuy 2008 {published data only}  ,included,CD012069-bbs2-0059,
CD012069-bib-0099,"Durá‐Travé T, Yoldi‐Petri ME, Gallinas‐Victoriano F, Zardoya‐Santos P. ",Effects of osmotic‐release methylphenidate on height and weight in children with attention‐deficit hyperactivity disorder (ADHD) following up to four years of treatment,,2012,,    ,['citation-other']," Durá‐Travé T, Yoldi‐Petri ME, Gallinas‐Victoriano F, Zardoya‐Santos P. Effects of osmotic‐release methylphenidate on height and weight in children with attention‐deficit hyperactivity disorder (ADHD) following up to four years of treatment. Journal of Child Neurology2012; Vol. 27, issue 5:604‐9. [DOI: 10.1177/0883073811422752; PUBMED: 22190507]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effects+of+osmotic‐release+methylphenidate+on+height+and+weight+in+children+with+attention‐deficit+hyperactivity+disorder+(ADHD)+following+up+to+four+years+of+treatment+&author=T+Durá‐Travé&author=ME+Yoldi‐Petri&author=F+Gallinas‐Victoriano&author=P+Zardoya‐Santos&publication_year=2012&hl=en']",,, Durá‐Travé 2012 {published data only}  ,included,CD012069-bbs2-0060,
CD012069-bib-0100,"Durá‐Travé T, Yoldi‐Petri ME, Zardoya‐Santos P. ",Nutrition and attention deficit hyperactivity disorder: developmental follow‐up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled‐release methylphenidate, Revista de Neurologia ,2011,53,    ,['citation-journal']," Durá‐Travé T, Yoldi‐Petri ME, Zardoya‐Santos P. Nutrition and attention deficit hyperactivity disorder: developmental follow‐up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled‐release methylphenidate [Nutrición y trastorno por déficit de atención/hiperactividad: seguimiento evolutivo de las variables antropométricas de un grupo de pacientes en tratamiento con metilfenidato de liberación osmótica].  Revista de Neurologia 2011;53(5):257‐64. [PUBMED: 21796603]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Nutrition+and+attention+deficit+hyperactivity+disorder:+developmental+follow‐up+of+the+anthropometric+variables+of+a+group+of+patients+receiving+treatment+with+osmotic+controlled‐release+methylphenidate+&author=T+Durá‐Travé&author=ME+Yoldi‐Petri&author=P+Zardoya‐Santos&publication_year=2011&hl=en']",21796603,, Durá‐Travé 2012 {published data only}  ,included,CD012069-bbs2-0060,
CD012069-bib-0105,Efron D. ,Methylphenidate versus dextroamphetamine in ADHD, Journal of the American Academy of Child and Adolescent Psychiatry ,1999,38,    ,['citation-journal'], Efron D. Methylphenidate versus dextroamphetamine in ADHD.  Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(5):500. [PUBMED: 10230180]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1097/00004583-199905000-00009', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+versus+dextroamphetamine+in+ADHD&author=D+Efron&publication_year=1999&hl=en']",10230180,https://doi.org/10.1097/00004583-199905000-00009, Efron 1997 {published data only}  ,included,CD012069-bbs2-0061,
CD012069-bib-0101,"Efron D, Jarman FC, Barker MJ. ",Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder, Journal of Paediatrics and Child Health ,1998,34,    ,['citation-journal']," Efron D, Jarman FC, Barker MJ. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder.  Journal of Paediatrics and Child Health 1998;34(3):288‐92. [DOI: 10.1046/j.1440‐1754.1998.00224.x]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1046/j.1440-1754.1998.00224.x', 'https://scholar.google.com/scholar_lookup?title=Child+and+parent+perceptions+of+stimulant+medication+treatment+in+attention+deficit+hyperactivity+disorder+&author=D+Efron&author=FC+Jarman&author=MJ+Barker&publication_year=1998&hl=en']",,https://doi.org/10.1046/j.1440-1754.1998.00224.x, Efron 1997 {published data only}  ,included,CD012069-bbs2-0061,
CD012069-bib-0102,"Efron D, Jarman FC, Barker MJ. ",Medium‐term outcomes are comparable with short‐term outcomes in children with attention deficit hyperactivity disorder treated with stimulant medication, Journal of Paediatrics and Child Health ,2000,36,    ,['citation-journal']," Efron D, Jarman FC, Barker MJ. Medium‐term outcomes are comparable with short‐term outcomes in children with attention deficit hyperactivity disorder treated with stimulant medication.  Journal of Paediatrics and Child Health 2000;36(5):457‐61. [PUBMED: 11036801]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1046/j.1440-1754.2000.00555.x', 'https://scholar.google.com/scholar_lookup?title=Medium‐term+outcomes+are+comparable+with+short‐term+outcomes+in+children+with+attention+deficit+hyperactivity+disorder+treated+with+stimulant+medication+&author=D+Efron&author=FC+Jarman&author=MJ+Barker&publication_year=2000&hl=en']",11036801,https://doi.org/10.1046/j.1440-1754.2000.00555.x, Efron 1997 {published data only}  ,included,CD012069-bbs2-0061,
CD012069-bib-0103,"Efron D, Jarman FC, Barker MJ. ","Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double‐blind, crossover trial", Pediatrics ,1997,100,    ,['citation-journal']," Efron D, Jarman FC, Barker MJ. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double‐blind, crossover trial.  Pediatrics 1997;100(6):E6. [PUBMED: 9382907]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.100.6.e6', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+versus+dexamphetamine+in+children+with+attention+deficit+hyperactivity+disorder:+a+double‐blind,+crossover+trial+&author=D+Efron&author=FC+Jarman&author=MJ+Barker&publication_year=1997&hl=en']",9382907,https://doi.org/10.1542/peds.100.6.e6, Efron 1997 {published data only}  ,included,CD012069-bbs2-0061,
CD012069-bib-0104,"Efron D, Jarman FC, Barker MJ. ","Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double‐blind, crossover trial", Pediatrics ,1997,100,    ,['citation-journal']," Efron D, Jarman FC, Barker MJ. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double‐blind, crossover trial.  Pediatrics 1997;100(4):662‐6. [PUBMED: 9310521]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.100.4.662', 'https://scholar.google.com/scholar_lookup?title=Side+effects+of+methylphenidate+and+dexamphetamine+in+children+with+attention+deficit+hyperactivity+disorder:+a+double‐blind,+crossover+trial+&author=D+Efron&author=FC+Jarman&author=MJ+Barker&publication_year=1997&hl=en']",9310521,https://doi.org/10.1542/peds.100.4.662, Efron 1997 {published data only}  ,included,CD012069-bbs2-0061,
CD012069-bib-0106,"El‐Fiky MR, El‐Nahas GM, El‐Shahawy HH, Abdel Aziz MF, Ali DH, Khalifa NM. ",Study the gender differences in ADHD children: is the response to CNS stimulants a case of one fits both?, Indian Streams Research Journal ,2014,4,    ,['citation-journal']," El‐Fiky MR, El‐Nahas GM, El‐Shahawy HH, Abdel Aziz MF, Ali DH, Khalifa NM. Study the gender differences in ADHD children: is the response to CNS stimulants a case of one fits both?.  Indian Streams Research Journal 2014;4(5):1‐10. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Study+the+gender+differences+in+ADHD+children:+is+the+response+to+CNS+stimulants+a+case+of+one+fits+both?+&author=MR+El‐Fiky&author=GM+El‐Nahas&author=HH+El‐Shahawy&author=MF+AbdelAziz&author=DH+Ali&author=NM+Khalifa&publication_year=2014&hl=en']",,, El‐Fiky 2014 {published data only}  ,included,CD012069-bbs2-0062,
CD012069-bib-0107,"El‐Zein RA, Abdel‐Rahman SZ, Hay MJ, Lopez MS, Bondy ML, Morris DL, et al. ",Cytogenetic effects in children treated with methylphenidate, Cancer Letters ,2005,230,    ,['citation-journal']," El‐Zein RA, Abdel‐Rahman SZ, Hay MJ, Lopez MS, Bondy ML, Morris DL, et al. Cytogenetic effects in children treated with methylphenidate.  Cancer Letters 2005;230(2):284‐91. [DOI: 10.1016/j.canlet.2005.01.003; PUBMED: 16297714]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.canlet.2005.01.003', 'https://scholar.google.com/scholar_lookup?title=Cytogenetic+effects+in+children+treated+with+methylphenidate&author=RA+El‐Zein&author=SZ+Abdel‐Rahman&author=MJ+Hay&author=MS+Lopez&author=ML+Bondy&author=DL+Morris&publication_year=2005&hl=en']",,https://doi.org/10.1016/j.canlet.2005.01.003, El‐Zein 2005 {published data only}  ,included,CD012069-bbs2-0063,
CD012069-bib-0108,"Preston RJ, Kollins SH, Swanson JM, Greenhill LL, Wigal T, Elliott GR, et al. ",Comments on 'Cytogenetic effects in children treated with methylphenidate' by El‐Zein et al, Cancer Letters ,2005,230,    ,['citation-journal']," Preston RJ, Kollins SH, Swanson JM, Greenhill LL, Wigal T, Elliott GR, et al. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El‐Zein et al.  Cancer Letters 2005;230(2):292‐4. [DOI: 10.1016/j.canlet.2005.05.038; PUBMED: 16019134]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.canlet.2005.05.038', ""https://scholar.google.com/scholar_lookup?title=Comments+on+'Cytogenetic+effects+in+children+treated+with+methylphenidate'+by+El‐Zein+et+al+&author=RJ+Preston&author=SH+Kollins&author=JM+Swanson&author=LL+Greenhill&author=T+Wigal&author=GR+Elliott&publication_year=2005&hl=en""]",,https://doi.org/10.1016/j.canlet.2005.05.038, El‐Zein 2005 {published data only}  ,included,CD012069-bbs2-0063,
CD012069-bib-0109,"Famularo R, Fenton T. ",The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: a preliminary report, Journal of Clinical Psychiatry ,1987,48,    ,['citation-journal']," Famularo R, Fenton T. The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: a preliminary report.  Journal of Clinical Psychiatry 1987;48(3):112‐4. [PUBMED: 3818551]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+methylphenidate+on+school+grades+in+children+with+attention+deficit+disorder+without+hyperactivity:+a+preliminary+report+&author=R+Famularo&author=T+Fenton&publication_year=1987&hl=en']",3818551,, Famularo 1987 {published data only}  ,included,CD012069-bbs2-0064,
CD012069-bib-0110,"Faraone SV, Giefer EE. ",Long‐term effects of methylphenidate transdermal delivery system treatment of ADHD on growth, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Faraone SV, Giefer EE. Long‐term effects of methylphenidate transdermal delivery system treatment of ADHD on growth.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(9):1138‐47. [DOI: 10.1097/chi.0b013e31806ad1d7; PUBMED: 17712237]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/chi.0b013e31806ad1d7', 'https://scholar.google.com/scholar_lookup?title=Long‐term+effects+of+methylphenidate+transdermal+delivery+system+treatment+of+ADHD+on+growth+&author=SV+Faraone&author=EE+Giefer&publication_year=2007&hl=en']",,https://doi.org/10.1097/chi.0b013e31806ad1d7, Faraone 2007a {published data only}  ,included,CD012069-bbs2-0065,
CD012069-bib-0111,"Feeney DJ, Klykylo WM. ",Medication‐induced seizures, Journal of the American Academy of Child and Adolescent Psychiatry ,1997,36,    ,['citation-journal']," Feeney DJ, Klykylo WM. Medication‐induced seizures.  Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(8):1018‐9. [DOI: 10.1097/00004583‐199708000‐00007; PUBMED: 9256580]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199708000-00007', 'https://scholar.google.com/scholar_lookup?title=Medication‐induced+seizures&author=DJ+Feeney&author=WM+Klykylo&publication_year=1997&hl=en']",,https://doi.org/10.1097/00004583-199708000-00007, Feeney 1997 {published data only}  ,included,CD012069-bbs2-0066,
CD012069-bib-0112,"Fernández‐Fernández MA, Rufo‐Campos M, Mateos‐Checa R, Muñoz‐Cabello B, Madruga‐Garrido M, Blanco‐Martínez B. ",Cardiovascular side effects secondary to treatment with methylphenidate, Revista de Neurologia ,2010,50,    ,['citation-journal']," Fernández‐Fernández MA, Rufo‐Campos M, Mateos‐Checa R, Muñoz‐Cabello B, Madruga‐Garrido M, Blanco‐Martínez B. Cardiovascular side effects secondary to treatment with methylphenidate [Reacciones adversas cardiovasculares secundarias al tratamiento con metilfenidato].  Revista de Neurologia 2010;50(9):573‐4. [PUBMED: 20443179]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+side+effects+secondary+to+treatment+with+methylphenidate&author=MA+Fernández‐Fernández&author=M+Rufo‐Campos&author=R+Mateos‐Checa&author=B+Muñoz‐Cabello&author=M+Madruga‐Garrido&author=B+Blanco‐Martínez&publication_year=2010&hl=en']",20443179,, Fernández‐Fernández 2010 {published data only}  ,included,CD012069-bbs2-0067,
CD012069-bib-0113,"Fernández‐Fernández MA, Rufo‐Campos M, Mateos‐Checa R, Muñoz‐Cabello B, Madruga‐Garrido M, Blanco‐Martínez B. ",Infantile psychosis secondary to methylphenidate, Revista de Neurologia ,2011,52,    ,['citation-journal']," Fernández‐Fernández MA, Rufo‐Campos M, Mateos‐Checa R, Muñoz‐Cabello B, Madruga‐Garrido M, Blanco‐Martínez B. Infantile psychosis secondary to methylphenidate.  Revista de Neurologia 2011;52(7):446‐7. [PUBMED: 21425116]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.33588/rn.5207.2010739', 'https://scholar.google.com/scholar_lookup?title=Infantile+psychosis+secondary+to+methylphenidate&author=MA+Fernández‐Fernández&author=M+Rufo‐Campos&author=R+Mateos‐Checa&author=B+Muñoz‐Cabello&author=M+Madruga‐Garrido&author=B+Blanco‐Martínez&publication_year=2011&hl=en']",21425116,https://doi.org/10.33588/rn.5207.2010739, Fernández‐Fernández 2011 {published data only}  ,included,CD012069-bbs2-0068,
CD012069-bib-0114,Findling RL. ,"Open‐label treatment of comorbid depression and attentional disorders with co‐administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series", Journal of Child and Adolescent Psychopharmacology ,1996,6,    ,['citation-journal']," Findling RL. Open‐label treatment of comorbid depression and attentional disorders with co‐administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.  Journal of Child and Adolescent Psychopharmacology 1996;6(3):165‐75. [DOI: 10.1089/cap.1996.6.165; PUBMED: 9231310]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.1996.6.165', 'https://scholar.google.com/scholar_lookup?title=Open‐label+treatment+of+comorbid+depression+and+attentional+disorders+with+co‐administration+of+serotonin+reuptake+inhibitors+and+psychostimulants+in+children,+adolescents,+and+adults:+a+case+series+&author=RL+Findling&publication_year=1996&hl=en']",,https://doi.org/10.1089/cap.1996.6.165, Findling 1996 {published data only}  ,included,CD012069-bbs2-0069,
CD012069-bib-0115,"Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, et al. ","Long‐term tolerability of the methylphenidate transdermal system in pediatric attention‐deficit/hyperactivity disorder: a multicenter, prospective, 12‐month, open‐label, uncontrolled, phase III extension of four clinical trials", Clinical Therapeutics ,2009,31,    ,['citation-journal']," Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, et al. Long‐term tolerability of the methylphenidate transdermal system in pediatric attention‐deficit/hyperactivity disorder: a multicenter, prospective, 12‐month, open‐label, uncontrolled, phase III extension of four clinical trials.  Clinical Therapeutics 2009;31(8):1844‐55. [DOI: 10.1016/j.clinthera.2009.08.002; PUBMED: 19808143]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.clinthera.2009.08.002', 'https://scholar.google.com/scholar_lookup?title=Long‐term+tolerability+of+the+methylphenidate+transdermal+system+in+pediatric+attention‐deficit/hyperactivity+disorder:+a+multicenter,+prospective,+12‐month,+open‐label,+uncontrolled,+phase+III+extension+of+four+clinical+trials+&author=RL+Findling&author=SB+Wigal&author=OG+Bukstein&author=SW+Boellner&author=HB+Abikoff&author=JM+Turnbow&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.clinthera.2009.08.002, Findling 2009 {published data only}  ,included,CD012069-bbs2-0070,
CD012069-bib-0116,"Turnbow JM, Findling RL, López FA, Burnside JC, Bukstein OG. ",12‐month safety and efficacy of methylphenidate transdermal system in attention‐deficit/hyperactivity disorder, European Neuropsychopharmacology ,2008,18,    ,['citation-journal']," Turnbow JM, Findling RL, López FA, Burnside JC, Bukstein OG. 12‐month safety and efficacy of methylphenidate transdermal system in attention‐deficit/hyperactivity disorder.  European Neuropsychopharmacology 2008;18(s4):S562‐3. [DOI: 10.1016/S0924‐977X(08)70857‐5]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(08)70857-5', 'https://scholar.google.com/scholar_lookup?title=12‐month+safety+and+efficacy+of+methylphenidate+transdermal+system+in+attention‐deficit/hyperactivity+disorder+&author=JM+Turnbow&author=RL+Findling&author=FA+López&author=JC+Burnside&author=OG+Bukstein&publication_year=2008&hl=en']",,https://doi.org/10.1016/S0924-977X(08)70857-5, Findling 2009 {published data only}  ,included,CD012069-bbs2-0070,
CD012069-bib-0117,"Findling RL, Katic A, Rubin R, Moon E, Civil R, Li Y. ","A 6‐month, open‐label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention‐deficit/hyperactivity disorder", Journal of Child and Adolescent Psychopharmacology ,2010,20,    ,['citation-journal']," Findling RL, Katic A, Rubin R, Moon E, Civil R, Li Y. A 6‐month, open‐label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2010;20(5):366‐75. [DOI: 10.1089/cap.2009.0122; PUBMED: 20973707]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2009.0122', 'https://scholar.google.com/scholar_lookup?title=A+6‐month,+open‐label,+extension+study+of+the+tolerability+and+effectiveness+of+the+methylphenidate+transdermal+system+in+adolescents+diagnosed+with+attention‐deficit/hyperactivity+disorder+&author=RL+Findling&author=A+Katic&author=R+Rubin&author=E+Moon&author=R+Civil&author=Y+Li&publication_year=2010&hl=en']",,https://doi.org/10.1089/cap.2009.0122, Findling 2010 {published data only}  ,included,CD012069-bbs2-0071,
CD012069-bib-0118,"Findling RL, Turnbow J, Burnside J, Melmed R, Civil R, Li Y. ","A randomized, double‐blind, multicenter, parallel‐group, placebo‐controlled, dose‐optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents", CNS Spectrums ,2010,15,    ,['citation-journal']," Findling RL, Turnbow J, Burnside J, Melmed R, Civil R, Li Y. A randomized, double‐blind, multicenter, parallel‐group, placebo‐controlled, dose‐optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents.  CNS Spectrums 2010;15(7):419‐30. [PUBMED: 20625364]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1017/S1092852900000353', 'https://scholar.google.com/scholar_lookup?title=A+randomized,+double‐blind,+multicenter,+parallel‐group,+placebo‐controlled,+dose‐optimization+study+of+the+methylphenidate+transdermal+system+for+the+treatment+of+ADHD+in+adolescents+&author=RL+Findling&author=J+Turnbow&author=J+Burnside&author=R+Melmed&author=R+Civil&author=Y+Li&publication_year=2010&hl=en']",20625364,https://doi.org/10.1017/S1092852900000353, Findling 2010 {published data only}  ,included,CD012069-bbs2-0071,
CD012069-bib-0119,Keating GM. ,Methylphenidate transdermal system in attention‐deficit hyperactivity disorder in adolescents: profile report,,2012,,    ,['citation-other']," Keating GM. Methylphenidate transdermal system in attention‐deficit hyperactivity disorder in adolescents: profile report. Drugs in R&D. G.M. Keating, Adis, Private Bag 65901, 41 Centorian Drive, Mairangi Bay, North Shore 0754, Auckland, New Zealand. E‐mail: [email protected], 2012; Vol. 12, issue 3:171‐3. [DOI: 10.2165/11207490‐000000000‐00000; PMC3585903; PUBMED: 22934753]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+transdermal+system+in+attention‐deficit+hyperactivity+disorder+in+adolescents:+profile+report+&author=GM+Keating&publication_year=2012&hl=en']",,, Findling 2010 {published data only}  ,included,CD012069-bbs2-0071,
CD012069-bib-0120,"Gadow D, Nolan E, Sprafkin J, Sverd J. ",School observations of children with attention‐deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment, Journal of Developmental and Behavioral Pediatrics ,1995,16,    ,['citation-journal']," Gadow D, Nolan E, Sprafkin J, Sverd J. School observations of children with attention‐deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.  Journal of Developmental and Behavioral Pediatrics 1995;16(3):167–76. [PUBMED: 7560119]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004703-199506000-00004', 'https://scholar.google.com/scholar_lookup?title=School+observations+of+children+with+attention‐deficit+hyperactivity+disorder+and+comorbid+tic+disorder:+effects+of+methylphenidate+treatment+&author=D+Gadow&author=E+Nolan&author=J+Sprafkin&author=J+Sverd&publication_year=1995&hl=en']",7560119,https://doi.org/10.1097/00004703-199506000-00004, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0121,"Gadow D, Sverd J, Sprafkin J, Nolan EE, Ezor SN. ",Efficacy of methylphenidate for attention‐deficit hyperactivity disorder in children with tic disorder, Annual Progress in Child Psychiatry and Child Development ,1995,52,    ,['citation-journal']," Gadow D, Sverd J, Sprafkin J, Nolan EE, Ezor SN. Efficacy of methylphenidate for attention‐deficit hyperactivity disorder in children with tic disorder.  Annual Progress in Child Psychiatry and Child Development 1995;52(6):494‐522. [PUBMED: 7771914]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpsyc.1995.03950180030005', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+methylphenidate+for+attention‐deficit+hyperactivity+disorder+in+children+with+tic+disorder+&author=D+Gadow&author=J+Sverd&author=J+Sprafkin&author=EE+Nolan&author=SN+Ezor&publication_year=1995&hl=en']",7771914,https://doi.org/10.1001/archpsyc.1995.03950180030005, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0123,"Gadow KD, Nolan EE, Sverd J. ",Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short‐term behavioral effects in school settings, Journal of the American Academy of Child and Adolescent Psychiatry ,1992,31,    ,['citation-journal']," Gadow KD, Nolan EE, Sverd J. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short‐term behavioral effects in school settings.  Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(3):462‐71. [DOI: 10.1097/00004583‐199205000‐00012; PUBMED: 1592778]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199205000-00012', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+in+hyperactive+boys+with+comorbid+tic+disorder:+II.+Short‐term+behavioral+effects+in+school+settings+&author=KD+Gadow&author=EE+Nolan&author=J+Sverd&publication_year=1992&hl=en']",,https://doi.org/10.1097/00004583-199205000-00012, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0122,"Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. ",Anxiety and depression symptoms and response to methylphenidate in children with attention‐deficit hyperactivity disorder and tic disorder, Journal of Clinical Psychopharmacology ,2002,22,    ,['citation-journal']," Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. Anxiety and depression symptoms and response to methylphenidate in children with attention‐deficit hyperactivity disorder and tic disorder.  Journal of Clinical Psychopharmacology 2002;22(3):267‐74. [PUBMED: 12006897]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004714-200206000-00007', 'https://scholar.google.com/scholar_lookup?title=Anxiety+and+depression+symptoms+and+response+to+methylphenidate+in+children+with+attention‐deficit+hyperactivity+disorder+and+tic+disorder+&author=KD+Gadow&author=EE+Nolan&author=J+Sverd&author=J+Sprafkin&author=J+Schwartz&publication_year=2002&hl=en']",12006897,https://doi.org/10.1097/00004714-200206000-00007, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0124,"Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S. ",Long‐term methylphenidate therapy in children with comorbid attention‐deficit hyperactivity disorder and chronic multiple tic disorder, Archives of General Psychiatry ,1999,56,    ,['citation-journal']," Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S. Long‐term methylphenidate therapy in children with comorbid attention‐deficit hyperactivity disorder and chronic multiple tic disorder.  Archives of General Psychiatry 1999;56(4):330‐6. [PUBMED: 10197827]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpsyc.56.4.330', 'https://scholar.google.com/scholar_lookup?title=Long‐term+methylphenidate+therapy+in+children+with+comorbid+attention‐deficit+hyperactivity+disorder+and+chronic+multiple+tic+disorder+&author=KD+Gadow&author=J+Sverd&author=J+Sprafkin&author=EE+Nolan&author=S+Grossman&publication_year=1999&hl=en']",10197827,https://doi.org/10.1001/archpsyc.56.4.330, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0125,"Nolan EE, Gadow KD. ",Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate, Journal of the American Academy of Child and Adolescent Psychiatry ,1997,36,    ,['citation-journal']," Nolan EE, Gadow KD. Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate.  Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(5):597‐604. [DOI: 10.1097/00004583‐199705000‐00009; PUBMED: 9136493]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199705000-00009', 'https://scholar.google.com/scholar_lookup?title=Children+with+ADHD+and+tic+disorder+and+their+classmates:+behavioral+normalization+with+methylphenidate+&author=EE+Nolan&author=KD+Gadow&publication_year=1997&hl=en']",,https://doi.org/10.1097/00004583-199705000-00009, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0126,"Nolan EE, Gadow KD. ",Relation between ratings and observations of stimulant drug response in hyperactive children, Journal of Clinical Child Psychology ,1994,23,    ,['citation-journal']," Nolan EE, Gadow KD. Relation between ratings and observations of stimulant drug response in hyperactive children.  Journal of Clinical Child Psychology 1994;23(1):78‐90. [DOI: 10.1207/s15374424jccp2301_10]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1207/s15374424jccp2301_10', 'https://scholar.google.com/scholar_lookup?title=Relation+between+ratings+and+observations+of+stimulant+drug+response+in+hyperactive+children+&author=EE+Nolan&author=KD+Gadow&publication_year=1994&hl=en']",,https://doi.org/10.1207/s15374424jccp2301_10, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0127,"Sprafkin J, Gadow KD. ",Double‐blind versus open evaluations of stimulant drug response in children with attention‐deficit hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,1996,6,    ,['citation-journal']," Sprafkin J, Gadow KD. Double‐blind versus open evaluations of stimulant drug response in children with attention‐deficit hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 1996;6(4):215‐28. [DOI: 10.1089/cap.1996.6.215; PUBMED: 9231315]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.1996.6.215', 'https://scholar.google.com/scholar_lookup?title=Double‐blind+versus+open+evaluations+of+stimulant+drug+response+in+children+with+attention‐deficit+hyperactivity+disorder+&author=J+Sprafkin&author=KD+Gadow&publication_year=1996&hl=en']",,https://doi.org/10.1089/cap.1996.6.215, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0128,"Sverd J, Gadow KD, Nolan EE, Sprafkin J, Ezor SN. ",Methylphenidate in hyperactive boys with comorbid tic disorder: I. Clinic evaluations,,1992,,    ,['citation-other']," Sverd J, Gadow KD, Nolan EE, Sprafkin J, Ezor SN. Methylphenidate in hyperactive boys with comorbid tic disorder: I. Clinic evaluations. Advances in Neurology1992; Vol. 58:271‐81. [PUBMED: 1414633]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+in+hyperactive+boys+with+comorbid+tic+disorder:+I.+Clinic+evaluations&author=J+Sverd&author=KD+Gadow&author=EE+Nolan&author=J+Sprafkin&author=SN+Ezor&publication_year=1992&hl=en']",1414633,, Gadow 1995 {published data only}  ,included,CD012069-bbs2-0072,
CD012069-bib-0129,"Galland BC, Tripp EG, Gray A, Taylor BJ. ",Apnea‐hypopnea indices and snoring in children diagnosed with ADHD: a matched case‐control study, Sleep and Breathing ,2011,15,    ,['citation-journal']," Galland BC, Tripp EG, Gray A, Taylor BJ. Apnea‐hypopnea indices and snoring in children diagnosed with ADHD: a matched case‐control study.  Sleep and Breathing 2011;15(3):455‐62. [DOI: 10.1007/s11325‐010‐0357‐0; PUBMED: 20440568]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s11325-010-0357-0', 'https://scholar.google.com/scholar_lookup?title=Apnea‐hypopnea+indices+and+snoring+in+children+diagnosed+with+ADHD:+a+matched+case‐control+study+&author=BC+Galland&author=EG+Tripp&author=A+Gray&author=BJ+Taylor&publication_year=2011&hl=en']",,https://doi.org/10.1007/s11325-010-0357-0, Galland 2010 {published data only}  ,included,CD012069-bbs2-0073,
CD012069-bib-0130,"Galland BC, Tripp EG, Taylor BJ. ",Methylphenidate effects on sleep in children, Brown University Child and Adolescent Psychopharmacology Update ,2010,12,    ,['citation-journal']," Galland BC, Tripp EG, Taylor BJ. Methylphenidate effects on sleep in children.  Brown University Child and Adolescent Psychopharmacology Update 2010;12(3):5‐6. [DOI: 10.1002/cpu.20111]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+effects+on+sleep+in+children&author=BC+Galland&author=EG+Tripp&author=BJ+Taylor&publication_year=2010&hl=en']",,, Galland 2010 {published data only}  ,included,CD012069-bbs2-0073,
CD012069-bib-0131,"Galland BC, Tripp EG, Taylor BJ. ",The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case‐control study, Journal of Sleep Research ,2010,19,    ,['citation-journal']," Galland BC, Tripp EG, Taylor BJ. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case‐control study.  Journal of Sleep Research 2010;19(2):366‐73. [DOI: 10.1111/j.1365‐2869.2009.00795.x; PUBMED: 20050995]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1365-2869.2009.00795.x', 'https://scholar.google.com/scholar_lookup?title=The+sleep+of+children+with+attention+deficit+hyperactivity+disorder+on+and+off+methylphenidate:+a+matched+case‐control+study+&author=BC+Galland&author=EG+Tripp&author=BJ+Taylor&publication_year=2010&hl=en']",,https://doi.org/10.1111/j.1365-2869.2009.00795.x, Galland 2010 {published data only}  ,included,CD012069-bbs2-0073,
CD012069-bib-0132,"Garg J, Arun P, Chavan BS. ",Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder, International Journal of Applied and Basic Medical Research ,2015,5,    ,['citation-journal']," Garg J, Arun P, Chavan BS. Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder.  International Journal of Applied and Basic Medical Research 2015;5(2):114‐8. [DOI: 10.4103/2229‐516X.157162; PMC4456885]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4103/2229-516X.157162', 'https://scholar.google.com/scholar_lookup?title=Comparative+efficacy+of+methylphenidate+and+atomoxetine+in+oppositional+defiant+disorder+comorbid+with+attention+deficit+hyperactivity+disorder+&author=J+Garg&author=P+Arun&author=BS+Chavan&publication_year=2015&hl=en']",,https://doi.org/10.4103/2229-516X.157162, Garg 2014 {published data only}  ,included,CD012069-bbs2-0074,
CD012069-bib-0133,"Garg J, Arun P, Chavan BS. ",Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder, Indian Pediatrics ,2014,51,    ,['citation-journal']," Garg J, Arun P, Chavan BS. Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder.  Indian Pediatrics 2014;51(7):550‐4. [PUBMED: 25031133]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s13312-014-0445-5', 'https://scholar.google.com/scholar_lookup?title=Comparative+short+term+efficacy+and+tolerability+of+methylphenidate+and+atomoxetine+in+attention+deficit+hyperactivity+disorder+&author=J+Garg&author=P+Arun&author=BS+Chavan&publication_year=2014&hl=en']",25031133,https://doi.org/10.1007/s13312-014-0445-5, Garg 2014 {published data only}  ,included,CD012069-bbs2-0074,
CD012069-bib-0134,"Gau SS, Shen HY, Soong WT, Gau CS. ","An open‐label, randomized, active‐controlled equivalent trial of osmotic release oral system methylphenidate in children with attention‐deficit/hyperactivity disorder in Taiwan", Journal of Child and Adolescent Psychopharmacology ,2006,16,    ,['citation-journal']," Gau SS, Shen HY, Soong WT, Gau CS. An open‐label, randomized, active‐controlled equivalent trial of osmotic release oral system methylphenidate in children with attention‐deficit/hyperactivity disorder in Taiwan.  Journal of Child and Adolescent Psychopharmacology 2006;16(4):441‐55. [DOI: 10.1089/cap.2006.16.441; PUBMED: 16958569]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2006.16.441', 'https://scholar.google.com/scholar_lookup?title=An+open‐label,+randomized,+active‐controlled+equivalent+trial+of+osmotic+release+oral+system+methylphenidate+in+children+with+attention‐deficit/hyperactivity+disorder+in+Taiwan+&author=SS+Gau&author=HY+Shen&author=WT+Soong&author=CS+Gau&publication_year=2006&hl=en']",,https://doi.org/10.1089/cap.2006.16.441, Gau 2006 {published data only}  ,included,CD012069-bbs2-0075,
CD012069-bib-0135,"Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, et al. ","National survey of adherence, efficacy, and side effects of methylphenidate in children with attention‐deficit/hyperactivity disorder in Taiwan", Journal of Clinical Psychiatry ,2008,69,    ,['citation-journal']," Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention‐deficit/hyperactivity disorder in Taiwan.  Journal of Clinical Psychiatry 2008;69(1):131‐40. [PUBMED: 18312048]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4088/JCP.v69n0118', 'https://scholar.google.com/scholar_lookup?title=National+survey+of+adherence,+efficacy,+and+side+effects+of+methylphenidate+in+children+with+attention‐deficit/hyperactivity+disorder+in+Taiwan+&author=SS+Gau&author=SJ+Chen&author=WJ+Chou&author=H+Cheng&author=CS+Tang&author=HL+Chang&publication_year=2008&hl=en']",18312048,https://doi.org/10.4088/JCP.v69n0118, Gau 2008 {published data only}  ,included,CD012069-bbs2-0076,
CD012069-bib-0136,"Arcieri R, Germinario EP, Bonati M, Masi G, Zuddas A, Vella S, et al. ",Cardiovascular measures in children and adolescents with attention‐deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine, Journal of Child and Adolescent Psychopharmacology ,2012,22,    ,['citation-journal']," Arcieri R, Germinario EP, Bonati M, Masi G, Zuddas A, Vella S, et al. Cardiovascular measures in children and adolescents with attention‐deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.  Journal of Child and Adolescent Psychopharmacology 2012;22(6):423‐31. [PUBMED: 23362511]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2012.0014', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+measures+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+who+are+new+users+of+methylphenidate+and+atomoxetine+&author=R+Arcieri&author=EP+Germinario&author=M+Bonati&author=G+Masi&author=A+Zuddas&author=S+Vella&publication_year=2012&hl=en']",23362511,https://doi.org/10.1089/cap.2012.0014, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0137,"Balia C, Anedda A, Granitzio F, Carucci S, Zuddas A. ",Long term therapy with methylphenidate induces modest effects on growth in ADHD children, European Neuropsychopharmacology ,2013,23,    ,['citation-journal']," Balia C, Anedda A, Granitzio F, Carucci S, Zuddas A. Long term therapy with methylphenidate induces modest effects on growth in ADHD children.  European Neuropsychopharmacology 2013;23(Suppl 1):S80. [DOI: 10.1016/S0924‐977X(13)70090‐7]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(13)70090-7', 'https://scholar.google.com/scholar_lookup?title=Long+term+therapy+with+methylphenidate+induces+modest+effects+on+growth+in+ADHD+children&author=C+Balia&author=A+Anedda&author=F+Granitzio&author=S+Carucci&author=A+Zuddas&publication_year=2013&hl=en']",,https://doi.org/10.1016/S0924-977X(13)70090-7, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0138,"Didoni A, Sequi M, Panei P, Bonati M, Lombardy ADHD Registry Group. ",One‐year prospective follow‐up of pharmacological treatment in children with attention‐deficit/hyperactivity disorder, European Journal of Clinical Pharmacology ,2011,67,    ,['citation-journal']," Didoni A, Sequi M, Panei P, Bonati M, Lombardy ADHD Registry Group. One‐year prospective follow‐up of pharmacological treatment in children with attention‐deficit/hyperactivity disorder.  European Journal of Clinical Pharmacology 2011;67(10):1061‐7. [DOI: 10.1007/s00228‐011‐1050‐3; PUBMED: 21538145]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00228-011-1050-3', 'https://scholar.google.com/scholar_lookup?title=One‐year+prospective+follow‐up+of+pharmacological+treatment+in+children+with+attention‐deficit/hyperactivity+disorder+&author=A+Didoni&author=M+Sequi&author=P+Panei&author=M+Bonati&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00228-011-1050-3, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0139,"Germinario EP, Arcieri R, Bonati M, Zuddas A, Masi G, Vella S, et al. ",Attention‐deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study, Journal of Child and Adolescent Psychopharmacology ,2013,23,    ,['citation-journal']," Germinario EP, Arcieri R, Bonati M, Zuddas A, Masi G, Vella S, et al. Attention‐deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.  Journal of Child and Adolescent Psychopharmacology 2013;23(7):440‐7. [DOI: 10.1089/cap.2012.0086; PMC3778954]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2012.0086', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit/hyperactivity+disorder+drugs+and+growth:+an+Italian+prospective+observational+study+&author=EP+Germinario&author=R+Arcieri&author=M+Bonati&author=A+Zuddas&author=G+Masi&author=S+Vella&publication_year=2013&hl=en']",,https://doi.org/10.1089/cap.2012.0086, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0142,"Panei P, Arcieri R. ",ADHD register: post‐marketing evaluation of the benefit‐risk profile of drugs and promotion of the appropriateness, Recenti Progressi in Medicina ,2013,104,    ,['citation-journal']," Panei P, Arcieri R. ADHD register: post‐marketing evaluation of the benefit‐risk profile of drugs and promotion of the appropriateness [Il registro dell'ADHD: valutazione post‐marketing del profilo beneficio‐rischio dei farmaci e promozione dell'appropriatezza].  Recenti Progressi in Medicina 2013;104(6):254‐61. [DOI: 10.1701/1295.14326; PUBMED: 23801229]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=ADHD+register:+post‐marketing+evaluation+of+the+benefit‐risk+profile+of+drugs+and+promotion+of+the+appropriateness+&author=P+Panei&author=R+Arcieri&publication_year=2013&hl=en']",,, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0140,"Panei P, Arcieri R, Bonati M, Bugarini M, Didoni A, Germinario E. ",Safety of psychotropic drug prescribed for attention‐deficit/hyperactivity disorder in Italy, Adverse Drug Reaction Bulletin ,2010,260,    ,['citation-journal']," Panei P, Arcieri R, Bonati M, Bugarini M, Didoni A, Germinario E. Safety of psychotropic drug prescribed for attention‐deficit/hyperactivity disorder in Italy.  Adverse Drug Reaction Bulletin 2010;260:999‐1002. [old.iss.it/binary/uvco/cont/Safety_of_psychotropic_drug_prescribed_for_1.pdf]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/FAD.0b013e3283383a63', 'https://scholar.google.com/scholar_lookup?title=Safety+of+psychotropic+drug+prescribed+for+attention‐deficit/hyperactivity+disorder+in+Italy+&author=P+Panei&author=R+Arcieri&author=M+Bonati&author=M+Bugarini&author=A+Didoni&author=E+Germinario&publication_year=2010&hl=en']",,https://doi.org/10.1097/FAD.0b013e3283383a63, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0141,"Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. ",Italian attention‐deficit/hyperactivity disorder registry, Pediatrics ,2004,114,    ,['citation-journal']," Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. Italian attention‐deficit/hyperactivity disorder registry.  Pediatrics 2004;114(2):514. [PUBMED: 15286248]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.114.2.514', 'https://scholar.google.com/scholar_lookup?title=Italian+attention‐deficit/hyperactivity+disorder+registry&author=P+Panei&author=R+Arcieri&author=S+Vella&author=M+Bonati&author=N+Martini&author=A+Zuddas&publication_year=2004&hl=en']",15286248,https://doi.org/10.1542/peds.114.2.514, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0143,"Peddis C, Esu L, Tronci MG, Carucci S, Panei P, Zuddas A. ",The Italian ADHD National Registry: 3 years of active pharmacovigilance in developmental neuropsychiatry, European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Peddis C, Esu L, Tronci MG, Carucci S, Panei P, Zuddas A. The Italian ADHD National Registry: 3 years of active pharmacovigilance in developmental neuropsychiatry.  European Child and Adolescent Psychiatry 2011;20(Suppl 1):S125. [DOI: 10.1007/s00787‐011‐0181‐5]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+Italian+ADHD+National+Registry:+3+years+of+active+pharmacovigilance+in+developmental+neuropsychiatry+&author=C+Peddis&author=L+Esu&author=MG+Tronci&author=S+Carucci&author=P+Panei&author=A+Zuddas&publication_year=2011&hl=en']",,, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0144,"Peddis C, Sanna E, Usala T, Arcieri R, Germinario E, Bugarini M, et al. ",Active pharmacovigilance in developmental neuropsychiatry: the Italian ADHD National Registry, European Child and Adolescent Psychiatry ,2010,19,    ,['citation-journal']," Peddis C, Sanna E, Usala T, Arcieri R, Germinario E, Bugarini M, et al. Active pharmacovigilance in developmental neuropsychiatry: the Italian ADHD National Registry.  European Child and Adolescent Psychiatry 2010;19(Suppl 1):S27. [DOI: 10.1007/s00787‐010‐0117‐5]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Active+pharmacovigilance+in+developmental+neuropsychiatry:+the+Italian+ADHD+National+Registry+&author=C+Peddis&author=E+Sanna&author=T+Usala&author=R+Arcieri&author=E+Germinario&author=M+Bugarini&publication_year=2010&hl=en']",,, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0145,"Ruggiero S, Rafaniello C, Bravaccio C, Grimaldi G, Granato R, Pascotto A, et al. ",Safety of attention‐deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study, Journal of Child and Adolescent Psychopharmacology ,2012,22,    ,['citation-journal']," Ruggiero S, Rafaniello C, Bravaccio C, Grimaldi G, Granato R, Pascotto A, et al. Safety of attention‐deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study.  Journal of Child and Adolescent Psychopharmacology 2012;22(6):415‐22. [DOI: 10.1089/cap.2012.0003; PUBMED: 23234585]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2012.0003', 'https://scholar.google.com/scholar_lookup?title=Safety+of+attention‐deficit/hyperactivity+disorder+medications+in+children:+an+intensive+pharmacosurveillance+monitoring+study+&author=S+Ruggiero&author=C+Rafaniello&author=C+Bravaccio&author=G+Grimaldi&author=R+Granato&author=A+Pascotto&publication_year=2012&hl=en']",,https://doi.org/10.1089/cap.2012.0003, Germinario 2013 {published data only}  ,included,CD012069-bbs2-0077,
CD012069-bib-0146,"Gerwe M, Stollhoff K, Mossakowski J, Kuehle HJ, Goertz U, Schaefer C, et al. ","Tolerability and effects of OROS® MPH (Concerta®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non‐interventional trial", Attention Deficit and Hyperactivity Disorders ,2009,1,    ,['citation-journal']," Gerwe M, Stollhoff K, Mossakowski J, Kuehle HJ, Goertz U, Schaefer C, et al. Tolerability and effects of OROS® MPH (Concerta®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non‐interventional trial.  Attention Deficit and Hyperactivity Disorders 2009;1(2):175‐86. [DOI: 10.1007/s12402‐009‐0010‐6; PUBMED: 21432582]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-009-0010-6', 'https://scholar.google.com/scholar_lookup?title=Tolerability+and+effects+of+OROS®+MPH+(Concerta®)+on+functioning,+severity+of+disease+and+quality+of+life+in+children+and+adolescents+with+ADHD:+results+from+a+prospective,+non‐interventional+trial+&author=M+Gerwe&author=K+Stollhoff&author=J+Mossakowski&author=HJ+Kuehle&author=U+Goertz&author=C+Schaefer&publication_year=2009&hl=en']",,https://doi.org/10.1007/s12402-009-0010-6, Gerwe 2009 {published data only}  ,included,CD012069-bbs2-0078,
CD012069-bib-0147,Ghanizadeh A. ,"Insomnia, night terror, and depression related to clonidine in attention‐deficit/hyperactivity disorder", Journal of Clinical Psychopharmacology ,2008,28,    ,['citation-journal']," Ghanizadeh A. Insomnia, night terror, and depression related to clonidine in attention‐deficit/hyperactivity disorder.  Journal of Clinical Psychopharmacology 2008;28(6):725‐6. [DOI: 10.1097/JCP.0b013e31818ce741; PUBMED: 19011458]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0b013e31818ce741', 'https://scholar.google.com/scholar_lookup?title=Insomnia,+night+terror,+and+depression+related+to+clonidine+in+attention‐deficit/hyperactivity+disorder+&author=A+Ghanizadeh&publication_year=2008&hl=en']",,https://doi.org/10.1097/JCP.0b013e31818ce741, Ghanizadeh 2008a {published data only}  ,included,CD012069-bbs2-0079,
CD012069-bib-0148,Ghanizadeh A. ,Methylphenidate‐associated enuresis in attention deficit hyperactivity disorder, Journal of Pediatric Urology ,2008,4,    ,['citation-journal'], Ghanizadeh A. Methylphenidate‐associated enuresis in attention deficit hyperactivity disorder.  Journal of Pediatric Urology 2008;4(4):306‐7. [DOI: 10.1016/j.jpurol.2007.10.001; PUBMED: 18644535]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/j.jpurol.2007.10.001', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐associated+enuresis+in+attention+deficit+hyperactivity+disorder&author=A+Ghanizadeh&publication_year=2008&hl=en']",,https://doi.org/10.1016/j.jpurol.2007.10.001, Ghanizadeh 2008b {published data only}  ,included,CD012069-bbs2-0080,
CD012069-bib-0150,Ghanizadeh A. ,"Questions regarding 'Insomnia, night terror, and depression related to clonidine in attention‐deficit/hyperactivity disorder' [personal communication]",,,,   ,['citation-other']," Ghanizadeh A. Questions regarding 'Insomnia, night terror, and depression related to clonidine in attention‐deficit/hyperactivity disorder' [personal communication]. Email to: EL Ramstad 4 July 2013. CENTRAL    ",[''],,, Ghanizadeh 2008c {published data only}  ,included,CD012069-bbs2-0081,
CD012069-bib-0149,"Ghanizadeh A, Aghakhani K. ",Photophobia and methylphenidate, Psychopharmacology Bulletin ,2008,41,    ,['citation-journal']," Ghanizadeh A, Aghakhani K. Photophobia and methylphenidate.  Psychopharmacology Bulletin 2008;41(1):171‐3. [PUBMED: 18362880]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Photophobia+and+methylphenidate&author=A+Ghanizadeh&author=K+Aghakhani&publication_year=2008&hl=en']",18362880,, Ghanizadeh 2008c {published data only}  ,included,CD012069-bbs2-0081,
CD012069-bib-0151,Ghanizadeh A. ,Excessive talking triggered by methylphenidate in a boy with ADHD, Pharmacopsychiatry ,2009,42,    ,['citation-journal'], Ghanizadeh A. Excessive talking triggered by methylphenidate in a boy with ADHD.  Pharmacopsychiatry 2009;42(1):35‐6. [DOI: 10.1055/s‐0028‐1083821; PUBMED: 19153945]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1055/s-0028-1083821', 'https://scholar.google.com/scholar_lookup?title=Excessive+talking+triggered+by+methylphenidate+in+a+boy+with+ADHD&author=A+Ghanizadeh&publication_year=2009&hl=en']",,https://doi.org/10.1055/s-0028-1083821, Ghanizadeh 2009 {published data only}  ,included,CD012069-bbs2-0082,
CD012069-bib-0152,"Ghanizadeh A, Haghighat R. ",Nortriptyline for treating enuresis in ADHD‐‐a randomized double‐blind controlled clinical trial, Pediatric Nephrology ,2012,27,    ,['citation-journal']," Ghanizadeh A, Haghighat R. Nortriptyline for treating enuresis in ADHD‐‐a randomized double‐blind controlled clinical trial.  Pediatric Nephrology 2012;27(11):2091‐7. [DOI: 10.1007/s00467‐012‐2211‐z; PUBMED: 22700161]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00467-012-2211-z', 'https://scholar.google.com/scholar_lookup?title=Nortriptyline+for+treating+enuresis+in+ADHD‐‐a+randomized+double‐blind+controlled+clinical+trial+&author=A+Ghanizadeh&author=R+Haghighat&publication_year=2012&hl=en']",,https://doi.org/10.1007/s00467-012-2211-z, Ghanizadeh 2012 {published data only}  ,included,CD012069-bbs2-0083,
CD012069-bib-0153,"Ghanizadeh A, Sayyari Z, Mohammadi MR. ",Effect of methylphenidate and folic acid on ADHD symptoms and quality of life and aggression: a randomized double blind placebo controlled clinical trial, Iranian Journal of Psychiatry ,2013,8,    ,['citation-journal']," Ghanizadeh A, Sayyari Z, Mohammadi MR. Effect of methylphenidate and folic acid on ADHD symptoms and quality of life and aggression: a randomized double blind placebo controlled clinical trial.  Iranian Journal of Psychiatry 2013;8(3):108‐12. [PMC3887226; PUBMED: 24454418]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+and+folic+acid+on+ADHD+symptoms+and+quality+of+life+and+aggression:+a+randomized+double+blind+placebo+controlled+clinical+trial+&author=A+Ghanizadeh&author=Z+Sayyari&author=MR+Mohammadi&publication_year=2013&hl=en']",,, Ghanizadeh 2013 {published data only}  ,included,CD012069-bbs2-0084,
CD012069-bib-0154,"Goetz M, Prihodova I, Hrdlicka M. ",Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7‐year old girl, Neuro Endocrinology Letters ,2011,32,    ,['citation-journal']," Goetz M, Prihodova I, Hrdlicka M. Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7‐year old girl.  Neuro Endocrinology Letters 2011;32(5):619‐22. [PUBMED: 22167138]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Long+lasting+complex+nocturnal+hallucinations+during+Osmotic+Release+Oral+System+(OROS)+methylphenidate+treatment+in+a+7‐year+old+girl+&author=M+Goetz&author=I+Prihodova&author=M+Hrdlicka&publication_year=2011&hl=en']",22167138,, Goetz 2011 {published data only}  ,included,CD012069-bbs2-0085,
CD012069-bib-0155,"Goez HR, Scott O, Nevo N, Bennett‐Back O, Zelnik N. ",Using the test of variables of attention to determine the effectiveness of modafinil in children with attention‐deficit hyperactivity disorder (ADHD): a prospective methylphenidate‐controlled trial, Journal of Child Neurology ,2012,27,    ,['citation-journal']," Goez HR, Scott O, Nevo N, Bennett‐Back O, Zelnik N. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention‐deficit hyperactivity disorder (ADHD): a prospective methylphenidate‐controlled trial.  Journal of Child Neurology 2012;27(12):1547‐52. [DOI: 10.1177/0883073812439101; PUBMED: 22447850]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/0883073812439101', 'https://scholar.google.com/scholar_lookup?title=Using+the+test+of+variables+of+attention+to+determine+the+effectiveness+of+modafinil+in+children+with+attention‐deficit+hyperactivity+disorder+(ADHD):+a+prospective+methylphenidate‐controlled+trial+&author=HR+Goez&author=O+Scott&author=N+Nevo&author=O+Bennett‐Back&author=N+Zelnik&publication_year=2012&hl=en']",,https://doi.org/10.1177/0883073812439101, Goez 2012 {published data only}  ,included,CD012069-bbs2-0086,
CD012069-bib-0156,"Zelnik N, Nevo N, Goez H, Bennett‐Back O. ",Modafinil vs. methylphenidate for children and adolescents with ADHD, European Journal of Paediatric Neurology ,2011,15,    ,['citation-journal']," Zelnik N, Nevo N, Goez H, Bennett‐Back O. Modafinil vs. methylphenidate for children and adolescents with ADHD.  European Journal of Paediatric Neurology 2011;15(Suppl 1):S126‐7. [DOI: 10.1016/S1090‐3798(11)70442‐1]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S1090-3798(11)70442-1', 'https://scholar.google.com/scholar_lookup?title=Modafinil+vs.+methylphenidate+for+children+and+adolescents+with+ADHD&author=N+Zelnik&author=N+Nevo&author=H+Goez&author=O+Bennett‐Back&publication_year=2011&hl=en']",,https://doi.org/10.1016/S1090-3798(11)70442-1, Goez 2012 {published data only}  ,included,CD012069-bbs2-0086,
CD012069-bib-0157,"Gökce S, Önal A. ",Suicide attempt in a 12 year old boy after switching 27 mg to 36 mg of OROS methylphenidate, European Child and Adolescent Psychiatry ,2015,24,    ,['citation-journal']," Gökce S, Önal A. Suicide attempt in a 12 year old boy after switching 27 mg to 36 mg of OROS methylphenidate.  European Child and Adolescent Psychiatry 2015;24:s 219. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Suicide+attempt+in+a+12+year+old+boy+after+switching+27+mg+to+36+mg+of+OROS+methylphenidate&author=S+Gökce&author=A+Önal&publication_year=2015&hl=en']",,, Gökce 2015 {published data only}  ,included,CD012069-bbs2-0087,
CD012069-bib-0158,"Golubchik P, Golubchik L, Sever JM, Weizman A. ",The beneficial effect of methylphenidate in ADHD with comorbid separation anxiety, International Clinical Psychopharmacology ,2014,29,    ,['citation-journal']," Golubchik P, Golubchik L, Sever JM, Weizman A. The beneficial effect of methylphenidate in ADHD with comorbid separation anxiety.  International Clinical Psychopharmacology 2014;29(5):274‐8. [DOI: 10.1097/YIC.0000000000000034; PUBMED: 24743562]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/YIC.0000000000000034', 'https://scholar.google.com/scholar_lookup?title=The+beneficial+effect+of+methylphenidate+in+ADHD+with+comorbid+separation+anxiety&author=P+Golubchik&author=L+Golubchik&author=JM+Sever&author=A+Weizman&publication_year=2014&hl=en']",,https://doi.org/10.1097/YIC.0000000000000034, Golubchik 2011 {published data only}  ,included,CD012069-bbs2-0088,
CD012069-bib-0159,"Golubchik P, Kodesh A, Weizman A. ",Attention‐deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?, Clinical Neuropharmacology ,2013,36,    ,['citation-journal']," Golubchik P, Kodesh A, Weizman A. Attention‐deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?.  Clinical Neuropharmacology 2013;36(5):141‐5. [DOI: 10.1097/WNF.0b013e31829eb204; PUBMED: 24045603]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/WNF.0b013e31829eb204', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit/hyperactivity+disorder+and+comorbid+subsyndromal+depression:+what+is+the+impact+of+methylphenidate+on+mood?+&author=P+Golubchik&author=A+Kodesh&author=A+Weizman&publication_year=2013&hl=en']",,https://doi.org/10.1097/WNF.0b013e31829eb204, Golubchik 2011 {published data only}  ,included,CD012069-bbs2-0088,
CD012069-bib-0161,"Golubchik P, Sever J, Weizman A. ",Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia, International Clinical Psychopharmacology ,2014,29,    ,['citation-journal']," Golubchik P, Sever J, Weizman A. Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia.  International Clinical Psychopharmacology 2014;29(4):212‐5. [DOI: 10.1097/YIC.0000000000000029; PMC4047304; PUBMED: 24448460]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/YIC.0000000000000029', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+treatment+in+children+with+attention+deficit+hyperactivity+disorder+and+comorbid+social+phobia+&author=P+Golubchik&author=J+Sever&author=A+Weizman&publication_year=2014&hl=en']",,https://doi.org/10.1097/YIC.0000000000000029, Golubchik 2011 {published data only}  ,included,CD012069-bbs2-0088,
CD012069-bib-0160,"Golubchik P, Sever J, Weizman A, Zalsman G. ",Methylphenidate treatment in pediatric patients with attention‐deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report, Clinical Neuropharmacology ,2011,34,    ,['citation-journal']," Golubchik P, Sever J, Weizman A, Zalsman G. Methylphenidate treatment in pediatric patients with attention‐deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report.  Clinical Neuropharmacology 2011;34(3):108‐10. [DOI: 10.1097/WNF.0b013e31821f4da9; PUBMED: 21586916]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/WNF.0b013e31821f4da9', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+treatment+in+pediatric+patients+with+attention‐deficit/hyperactivity+disorder+and+comorbid+trichotillomania:+a+preliminary+report+&author=P+Golubchik&author=J+Sever&author=A+Weizman&author=G+Zalsman&publication_year=2011&hl=en']",,https://doi.org/10.1097/WNF.0b013e31821f4da9, Golubchik 2011 {published data only}  ,included,CD012069-bbs2-0088,
CD012069-bib-0162,Gracious BL. ,Atrioventricular nodal re‐entrant tachycardia associated with stimulant treatment, Journal of Child and Adolescent Psychopharmacology ,1999,9,    ,['citation-journal'], Gracious BL. Atrioventricular nodal re‐entrant tachycardia associated with stimulant treatment.  Journal of Child and Adolescent Psychopharmacology 1999;9(2):125‐8. [DOI: 10.1089/cap.1999.9.125; PUBMED: 10461823]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1089/cap.1999.9.125', 'https://scholar.google.com/scholar_lookup?title=Atrioventricular+nodal+re‐entrant+tachycardia+associated+with+stimulant+treatment&author=BL+Gracious&publication_year=1999&hl=en']",,https://doi.org/10.1089/cap.1999.9.125, Gracious 1999 {published data only}  ,included,CD012069-bbs2-0089,
CD012069-bib-0163,"Grcevich S, Rowane WA, Marcellino B, Sullivan‐Hurst S. ",Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2001,11,    ,['citation-journal']," Grcevich S, Rowane WA, Marcellino B, Sullivan‐Hurst S. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2001;11(1):35‐41. [DOI: 10.1089/104454601750143401; PUBMED: 11322743]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/104454601750143401', 'https://scholar.google.com/scholar_lookup?title=Retrospective+comparison+of+Adderall+and+methylphenidate+in+the+treatment+of+attention+deficit+hyperactivity+disorder+&author=S+Grcevich&author=WA+Rowane&author=B+Marcellino&author=S+Sullivan‐Hurst&publication_year=2001&hl=en']",,https://doi.org/10.1089/104454601750143401, Grcevich 2001 {published data only}  ,included,CD012069-bbs2-0090,
CD012069-bib-0164,"Green T, Weinberger R, Diamond A, Berant M, Hirschfeld L, Frisch A, et al. ","The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome", Journal of Child and Adolescent Psychopharmacology ,2011,21,    ,['citation-journal']," Green T, Weinberger R, Diamond A, Berant M, Hirschfeld L, Frisch A, et al. The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome.  Journal of Child and Adolescent Psychopharmacology 2011;21(6):589‐95. [DOI: 10.1089/cap.2011.0042; PUBMED: 22149470]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2011.0042', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+methylphenidate+on+prefrontal+cognitive+functioning,+inattention,+and+hyperactivity+in+velocardiofacial+syndrome+&author=T+Green&author=R+Weinberger&author=A+Diamond&author=M+Berant&author=L+Hirschfeld&author=A+Frisch&publication_year=2011&hl=en']",,https://doi.org/10.1089/cap.2011.0042, Green 2011 {published data only}  ,included,CD012069-bbs2-0091,
CD012069-bib-0165,"Green T, Weinberger R, Weizman A, Kotler M, Gothelf D. ",Effect of methylphenidate on neurocognitive functioning in velocardiofacial syndrome: a randomized placebo‐controlled trial, Biological Psychiatry ,2009,65,    ,['citation-journal']," Green T, Weinberger R, Weizman A, Kotler M, Gothelf D. Effect of methylphenidate on neurocognitive functioning in velocardiofacial syndrome: a randomized placebo‐controlled trial.  Biological Psychiatry 2009;65(Suppl 8):147 S. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+on+neurocognitive+functioning+in+velocardiofacial+syndrome:+a+randomized+placebo‐controlled+trial+&author=T+Green&author=R+Weinberger&author=A+Weizman&author=M+Kotler&author=D+Gothelf&publication_year=2009&hl=en']",,, Green 2011 {published data only}  ,included,CD012069-bbs2-0091,
CD012069-bib-0166,Greenberg LM. ,An objective measure of methylphenidate response: clinical use of the MCA, Psychopharmacology Bulletin ,1987,23,    ,['citation-journal'], Greenberg LM. An objective measure of methylphenidate response: clinical use of the MCA.  Psychopharmacology Bulletin 1987;23(2):279‐82. [PUBMED: 3615775]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=An+objective+measure+of+methylphenidate+response:+clinical+use+of+the+MCA&author=LM+Greenberg&publication_year=1987&hl=en']",3615775,, Greenberg 1987 {published data only}  ,included,CD012069-bbs2-0092,
CD012069-bib-0167,"Greenhill L, Puig‐Antich J, Goetz R, Hanlon C, Davies M. ",Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity, Sleep ,1983,6,    ,['citation-journal']," Greenhill L, Puig‐Antich J, Goetz R, Hanlon C, Davies M. Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity.  Sleep 1983;6(2):91‐101. [PUBMED: 6878986]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/sleep/6.2.91', 'https://scholar.google.com/scholar_lookup?title=Sleep+architecture+and+REM+sleep+measures+in+prepubertal+children+with+attention+deficit+disorder+with+hyperactivity+&author=L+Greenhill&author=J+Puig‐Antich&author=R+Goetz&author=C+Hanlon&author=M+Davies&publication_year=1983&hl=en']",6878986,https://doi.org/10.1093/sleep/6.2.91, Greenhill 1983 {published data only}  ,included,CD012069-bbs2-0093,
CD012069-bib-0168,"Grossman LK, Grossman NJ. ",Methylphenidate and idiopathic thrombocytopenic purpura‐‐is there an association?, Journal of Family Practice ,1985,20,    ,['citation-journal']," Grossman LK, Grossman NJ. Methylphenidate and idiopathic thrombocytopenic purpura‐‐is there an association?.  Journal of Family Practice 1985;20(3):302‐4. [PUBMED: 4038730]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+idiopathic+thrombocytopenic+purpura‐‐is+there+an+association?&author=LK+Grossman&author=NJ+Grossman&publication_year=1985&hl=en']",4038730,, Grossman 1985 {published data only}  ,included,CD012069-bbs2-0094,
CD012069-bib-0169,"Gross‐Tsur V, Joseph A, Shalev RS. ",Hallucinations during methylphenidate therapy, Neurology ,2004,63,    ,['citation-journal']," Gross‐Tsur V, Joseph A, Shalev RS. Hallucinations during methylphenidate therapy.  Neurology 2004;63(4):753‐4. [PUBMED: 15326264]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1212/01.WNL.0000134656.93147.F1', 'https://scholar.google.com/scholar_lookup?title=Hallucinations+during+methylphenidate+therapy&author=V+Gross‐Tsur&author=A+Joseph&author=RS+Shalev&publication_year=2004&hl=en']",15326264,https://doi.org/10.1212/01.WNL.0000134656.93147.F1, Gross‐Tsur 2004 {published data only}  ,included,CD012069-bbs2-0095,
CD012069-bib-0170,"Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. ",Italian attention‐deficit/hyperactivity disorder registry, Pediatrics ,2004,114,    ,['citation-journal']," Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. Italian attention‐deficit/hyperactivity disorder registry.  Pediatrics 2004;114(2):514. [PUBMED: 15286248]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.114.2.514', 'https://scholar.google.com/scholar_lookup?title=Italian+attention‐deficit/hyperactivity+disorder+registry&author=P+Panei&author=R+Arcieri&author=S+Vella&author=M+Bonati&author=N+Martini&author=A+Zuddas&publication_year=2004&hl=en']",15286248,https://doi.org/10.1542/peds.114.2.514, Gross‐Tsur 2004 {published data only}  ,included,CD012069-bbs2-0095,
CD012069-bib-0171,"Gucuyener K, Erdemoglu AK, Senol S, Serdaroglu A, Soysal S, Kockar AI. ",Use of methylphenidate for attention‐deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities, Journal of Child Neurology ,2003,18,    ,['citation-journal']," Gucuyener K, Erdemoglu AK, Senol S, Serdaroglu A, Soysal S, Kockar AI. Use of methylphenidate for attention‐deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.  Journal of Child Neurology 2003;18(2):109‐12. [DOI: 10.1177/08830738030180020601; PUBMED: 12693777]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/08830738030180020601', 'https://scholar.google.com/scholar_lookup?title=Use+of+methylphenidate+for+attention‐deficit+hyperactivity+disorder+in+patients+with+epilepsy+or+electroencephalographic+abnormalities+&author=K+Gucuyener&author=AK+Erdemoglu&author=S+Senol&author=A+Serdaroglu&author=S+Soysal&author=AI+Kockar&publication_year=2003&hl=en']",,https://doi.org/10.1177/08830738030180020601, Gucuyener 2003 {published data only}  ,included,CD012069-bbs2-0096,
CD012069-bib-0172,"Guerreiro MM, Montenegro MA, Piva RT, Moura‐Ribeiro MV. ",Attention deficit disorder: treatment with methylphenidate, Arquivos de Neuro‐Psiquiatria ,1996,54,    ,['citation-journal']," Guerreiro MM, Montenegro MA, Piva RT, Moura‐Ribeiro MV. Attention deficit disorder: treatment with methylphenidate [Distúrbio do déficit de atenção: tratamento com metilfenidato].  Arquivos de Neuro‐Psiquiatria 1996;54(1):25‐9. [DOI: 10.1590/S0004‐282X1996000100004]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1590/S0004-282X1996000100004', 'https://scholar.google.com/scholar_lookup?title=Attention+deficit+disorder:+treatment+with+methylphenidate&author=MM+Guerreiro&author=MA+Montenegro&author=RT+Piva&author=MV+Moura‐Ribeiro&publication_year=1996&hl=en']",,https://doi.org/10.1590/S0004-282X1996000100004, Guerreiro 1996 {published data only}  ,included,CD012069-bbs2-0097,
CD012069-bib-0173,"Haertling F, Mueller B, Bilke‐Hentsch O. ","Effectiveness and safety of a long‐acting, once‐daily, two‐phase release formulation of methylphenidate (Ritalin® LA) in school children under daily practice conditions", Attention Deficit and Hyperactivity Disorders ,2015,7,    ,['citation-journal']," Haertling F, Mueller B, Bilke‐Hentsch O. Effectiveness and safety of a long‐acting, once‐daily, two‐phase release formulation of methylphenidate (Ritalin® LA) in school children under daily practice conditions.  Attention Deficit and Hyperactivity Disorders 2015;7(2):157‐64. [DOI: 10.1007/s12402‐014‐0154‐x; PMC4449385; PUBMED: 25346231]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-014-0154-x', 'https://scholar.google.com/scholar_lookup?title=Effectiveness+and+safety+of+a+long‐acting,+once‐daily,+two‐phase+release+formulation+of+methylphenidate+(Ritalin®+LA)+in+school+children+under+daily+practice+conditions+&author=F+Haertling&author=B+Mueller&author=O+Bilke‐Hentsch&publication_year=2015&hl=en']",,https://doi.org/10.1007/s12402-014-0154-x, Haertling 2015 {published data only}  ,included,CD012069-bbs2-0098,
CD012069-bib-0174,"Halevy A, Shuper A. ",Methylphenidate induction of complex visual hallucinations, Journal of Child Neurology ,2009,24,    ,['citation-journal']," Halevy A, Shuper A. Methylphenidate induction of complex visual hallucinations.  Journal of Child Neurology 2009;24(8):1005‐7. [DOI: 10.1177/0883073808331357; PUBMED: 19502578]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/0883073808331357', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+induction+of+complex+visual+hallucinations&author=A+Halevy&author=A+Shuper&publication_year=2009&hl=en']",,https://doi.org/10.1177/0883073808331357, Halevy 2009 {published data only}  ,included,CD012069-bbs2-0099,
CD012069-bib-0176,,Effects of high‐dose OROS methylphenidate, Brown University Child and Adolescent Psychopharmacology Update ,2009,11,   ,['citation-journal'], Effects of high‐dose OROS methylphenidate.  Brown University Child and Adolescent Psychopharmacology Update 2009;11(8):7‐8. [DOI: 10.1002/cpu.20097]CENTRAL    ,[''],,, Hammerness 2009 {published data only}  ,included,CD012069-bbs2-0100,
CD012069-bib-0175,Daniels SR. ,Cardiovascular effects of methylphenidate, Journal of Pediatrics ,2009,155,    ,['citation-journal'], Daniels SR. Cardiovascular effects of methylphenidate.  Journal of Pediatrics 2009;155(1):A3. [DOI: 10.1016/j.jpeds.2009.05.023]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/j.jpeds.2009.05.023', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+effects+of+methylphenidate&author=SR+Daniels&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.jpeds.2009.05.023, Hammerness 2009 {published data only}  ,included,CD012069-bbs2-0100,
CD012069-bib-0177,"Hammerness P, Georgiopoulos A, Doyle RL, Utzinger L, Schillinger M, Martelon M, et al. ",An open study of adjunct OROS‐methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics, Journal of Child and Adolescent Psychopharmacology ,2009,19,    ,['citation-journal']," Hammerness P, Georgiopoulos A, Doyle RL, Utzinger L, Schillinger M, Martelon M, et al. An open study of adjunct OROS‐methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics.  Journal of Child and Adolescent Psychopharmacology 2009;19(5):493‐9. [DOI: 10.1089/cap.2008.0126; PMC2861956; PUBMED: 19877973]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2008.0126', 'https://scholar.google.com/scholar_lookup?title=An+open+study+of+adjunct+OROS‐methylphenidate+in+children+who+are+atomoxetine+partial+responders:+II.+Tolerability+and+pharmacokinetics+&author=P+Hammerness&author=A+Georgiopoulos&author=RL+Doyle&author=L+Utzinger&author=M+Schillinger&author=M+Martelon&publication_year=2009&hl=en']",,https://doi.org/10.1089/cap.2008.0126, Hammerness 2009 {published data only}  ,included,CD012069-bbs2-0100,
CD012069-bib-0178,"Hammerness P, Biederman J, Petty C, Henin A, Moore CM. ",Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention‐deficit hyperactivity disorder: a controlled pilot study,,2012,,    ,['citation-other']," Hammerness P, Biederman J, Petty C, Henin A, Moore CM. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention‐deficit hyperactivity disorder: a controlled pilot study. CNS Neuroscience and Therapeutics. P. Hammerness, Massachusetts General Hospital, 185 Alewife Brook Parkway, Suite 2000, Cambridge, MA 02138, United States. E‐mail: [email protected]: Blackwell Publishing Ltd (9600 Garsington Road, Oxford OX4 2XG, United Kingdom), 2012; Vol. 18, issue 1:34‐40. [DOI: 10.1111/j.1755‐5949.2010.00226.x; PMC4084790; PUBMED: 21143432]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Brain+biochemical+effects+of+methylphenidate+treatment+using+proton+magnetic+spectroscopy+in+youth+with+attention‐deficit+hyperactivity+disorder:+a+controlled+pilot+study+&author=P+Hammerness&author=J+Biederman&author=C+Petty&author=A+Henin&author=CM+Moore&publication_year=2012&hl=en']",,, Hammerness 2012 {published data only}  ,included,CD012069-bbs2-0101,
CD012069-bib-0179,Haubold KH. ,,Attention Deficit Hyperactivity Disorder ADHD ‐ A Retrospective Population‐based Analysis Concerning the Treatment of Children and Adolescents with Stimulant Medication in a Child and Adolescent Psychiatry Practice [PhD thesis],2009,,   ,['citation-book']," Haubold KH. Attention Deficit Hyperactivity Disorder ADHD ‐ A Retrospective Population‐based Analysis Concerning the Treatment of Children and Adolescents with Stimulant Medication in a Child and Adolescent Psychiatry Practice [PhD thesis]. Tübingen: Eberhard Karls Universität Tübingen, 2009. CENTRAL    ",[''],,, Haubold 2010 {published data only}  ,included,CD012069-bbs2-0102,
CD012069-bib-0180,"Hazell PL, Stuart JE. ",A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children, Journal of the American Academy of Child and Adolescent Psychiatry ,2003,42,    ,['citation-journal']," Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children.  Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(8):886‐94. [DOI: 10.1097/01.CHI.0000046908.27264.00]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.CHI.0000046908.27264.00', 'https://scholar.google.com/scholar_lookup?title=A+randomized+controlled+trial+of+clonidine+added+to+psychostimulant+medication+for+hyperactive+and+aggressive+children+&author=PL+Hazell&author=JE+Stuart&publication_year=2003&hl=en']",,https://doi.org/10.1097/01.CHI.0000046908.27264.00, Hazell 2003 {published data only}  ,included,CD012069-bbs2-0103,
CD012069-bib-0181,Hechtman L. ,Treatment of ADHD in patients unresponsive to methylphenidate, Journal of Psychiatry and Neuroscience ,2011,36,    ,['citation-journal'], Hechtman L. Treatment of ADHD in patients unresponsive to methylphenidate.  Journal of Psychiatry and Neuroscience 2011;36(3):216. [DOI: 10.1503/jpn.110020; PMC3080516]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1503/jpn.110020', 'https://scholar.google.com/scholar_lookup?title=Treatment+of+ADHD+in+patients+unresponsive+to+methylphenidate&author=L+Hechtman&publication_year=2011&hl=en']",,https://doi.org/10.1503/jpn.110020, Hechtman 2011 {published data only}  ,included,CD012069-bbs2-0104,
CD012069-bib-0182,"Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. ",Stimulant therapy and seizure risk in children with ADHD, Pediatric Neurology ,2001,24,    ,['citation-journal']," Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD.  Pediatric Neurology 2001;24(2):99‐102. [PUBMED: 11275457]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0887-8994(00)00240-X', 'https://scholar.google.com/scholar_lookup?title=Stimulant+therapy+and+seizure+risk+in+children+with+ADHD&author=SA+Hemmer&author=JF+Pasternak&author=SG+Zecker&author=BL+Trommer&publication_year=2001&hl=en']",11275457,https://doi.org/10.1016/S0887-8994(00)00240-X, Hemmer 2001 {published data only}  ,included,CD012069-bbs2-0105,
CD012069-bib-0183,"Hollis CP, Thompson A. ",Acute dyskinesia on starting methylphenidate after risperidone withdrawal, Pediatric Neurology ,2007,37,    ,['citation-journal']," Hollis CP, Thompson A. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.  Pediatric Neurology 2007;37(4):287‐8. [DOI: 10.1016/j.pediatrneurol.2007.05.017; PUBMED: 17903675]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.pediatrneurol.2007.05.017', 'https://scholar.google.com/scholar_lookup?title=Acute+dyskinesia+on+starting+methylphenidate+after+risperidone+withdrawal&author=CP+Hollis&author=A+Thompson&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.pediatrneurol.2007.05.017, Hollis 2007 {published data only}  ,included,CD012069-bbs2-0106,
CD012069-bib-0184,"Holtkamp K, Peters‐Wallraf B, Wuller S, Pfäaffle R, Herpertz‐Dahlmann B. ",Methylphenidate‐related growth impairment, Journal of Child and Adolescent Psychopharmacology ,2002,12,    ,['citation-journal']," Holtkamp K, Peters‐Wallraf B, Wuller S, Pfäaffle R, Herpertz‐Dahlmann B. Methylphenidate‐related growth impairment.  Journal of Child and Adolescent Psychopharmacology 2002;12(1):55‐61. [DOI: 10.1089/10445460252943579; PUBMED: 12014596]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐related+growth+impairment&author=K+Holtkamp&author=B+Peters‐Wallraf&author=S+Wuller&author=R+Pfäaffle&author=B+Herpertz‐Dahlmann&publication_year=2002&hl=en']",,, Holtkamp 2002 {published data only}  ,included,CD012069-bbs2-0107,
CD012069-bib-0185,"Hong SB, Kim JW, Cho SC, Shin MS, Kim BN, Yoo HJ. ",Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in Korean children with attention‐deficit/Hyperactivity disorder: is there an interaction?,,2012,,    ,['citation-other']," Hong SB, Kim JW, Cho SC, Shin MS, Kim BN, Yoo HJ. Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in Korean children with attention‐deficit/Hyperactivity disorder: is there an interaction?. Journal of Child and Adolescent Psychopharmacology2012; Vol. 22, issue 5:343‐52. [DOI: 10.1089/cap.2011.0076; PUBMED: 23083021]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Dopaminergic+and+noradrenergic+gene+polymorphisms+and+response+to+methylphenidate+in+Korean+children+with+attention‐deficit/Hyperactivity+disorder:+is+there+an+interaction?+&author=SB+Hong&author=JW+Kim&author=SC+Cho&author=MS+Shin&author=BN+Kim&author=HJ+Yoo&publication_year=2012&hl=en']",,, Hong 2012 {published data only}  ,included,CD012069-bbs2-0108,
CD012069-bib-0186,Hulvershorn L. ,Methylphenidate treatment of chronic irritability: symptom improvement and underlying neural mechanisms, Biological Psychiatry ,2015,77,    ,['citation-journal'], Hulvershorn L. Methylphenidate treatment of chronic irritability: symptom improvement and underlying neural mechanisms.  Biological Psychiatry 2015;77(1S):444S. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+treatment+of+chronic+irritability:+symptom+improvement+and+underlying+neural+mechanisms+&author=L+Hulvershorn&publication_year=2015&hl=en']",,, Hulvershorn 2012 {published data only}  ,included,CD012069-bbs2-0109,
CD012069-bib-0187,"Hulvershorn LA, Hummer T, Wang Y, Loth A, Anand A. ",The impact of methylphenidate on corticolimbic functional connectivity in children with ADHD and chronic irritability, Biological Psychiatry ,2012,71,    ,['citation-journal']," Hulvershorn LA, Hummer T, Wang Y, Loth A, Anand A. The impact of methylphenidate on corticolimbic functional connectivity in children with ADHD and chronic irritability.  Biological Psychiatry 2012;71(8):193S. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+impact+of+methylphenidate+on+corticolimbic+functional+connectivity+in+children+with+ADHD+and+chronic+irritability+&author=LA+Hulvershorn&author=T+Hummer&author=Y+Wang&author=A+Loth&author=A+Anand&publication_year=2012&hl=en']",,, Hulvershorn 2012 {published data only}  ,included,CD012069-bbs2-0109,
CD012069-bib-0188,"Ilgenli TF, Congologlu A, Ozturk C, Turkbay T, Akpinar O, Kilicaslan F. ",Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder, Advances in Therapy ,2007,24,    ,['citation-journal']," Ilgenli TF, Congologlu A, Ozturk C, Turkbay T, Akpinar O, Kilicaslan F. Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder.  Advances in Therapy 2007;24(1):182‐8. [PUBMED: 17526476]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/BF02850007', 'https://scholar.google.com/scholar_lookup?title=Acute+effect+of+methylphenidate+on+QT+interval+duration+and+dispersion+in+children+with+attention+deficit+hyperactivity+disorder+&author=TF+Ilgenli&author=A+Congologlu&author=C+Ozturk&author=T+Turkbay&author=O+Akpinar&author=F+Kilicaslan&publication_year=2007&hl=en']",17526476,https://doi.org/10.1007/BF02850007, Ilgenli 2007 {published data only}  ,included,CD012069-bbs2-0110,
CD012069-bib-0189,"Irmak A, Ince‐Tasdelen B, Ozmen S, Oztop DB. ",Treatment choice in association of attention deficit‐hyperactivity disorder with Williams and Moebius Syndromes: case reports, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2014,24,    ,['citation-journal']," Irmak A, Ince‐Tasdelen B, Ozmen S, Oztop DB. Treatment choice in association of attention deficit‐hyperactivity disorder with Williams and Moebius Syndromes: case reports.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2014;24(Suppl 1):226. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Treatment+choice+in+association+of+attention+deficit‐hyperactivity+disorder+with+Williams+and+Moebius+Syndromes:+case+reports+&author=A+Irmak&author=B+Ince‐Tasdelen&author=S+Ozmen&author=DB+Oztop&publication_year=2014&hl=en']",,, Irmak 2014 {published data only}  ,included,CD012069-bbs2-0111,
CD012069-bib-0190,"Işeri E, Kilic BG, Senol S, Karabacak NI. ",Effects of methylphenidate on leptin and appetite in children with attention‐deficit hyperactivity disorder: an open label trial, Methods and Findings in Experimental and Clinical Pharmacology ,2007,29,    ,['citation-journal']," Işeri E, Kilic BG, Senol S, Karabacak NI. Effects of methylphenidate on leptin and appetite in children with attention‐deficit hyperactivity disorder: an open label trial.  Methods and Findings in Experimental and Clinical Pharmacology 2007;29(1):47‐52. [DOI: 10.1358/mf.2007.29.1.1063491; PUBMED: 17344944]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1358/mf.2007.29.1.1063491', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+on+leptin+and+appetite+in+children+with+attention‐deficit+hyperactivity+disorder:+an+open+label+trial+&author=E+Işeri&author=BG+Kilic&author=S+Senol&author=NI+Karabacak&publication_year=2007&hl=en']",,https://doi.org/10.1358/mf.2007.29.1.1063491, Işeri 2007 {published data only}  ,included,CD012069-bbs2-0112,
CD012069-bib-0191,"Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, et al. ",Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study,,2012,,    ,['citation-other']," Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, et al. Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study. Human Psychopharmacology2012; Vol. 27, issue 4:411‐8. [DOI: 10.1002/hup.2242; PUBMED: 22806822]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Bupropion+versus+methylphenidate+in+the+treatment+of+children+with+attention‐deficit/hyperactivity+disorder:+randomized+double‐blind+study+&author=M+Jafarinia&author=MR+Mohammadi&author=A+Modabbernia&author=M+Ashrafi&author=D+Khajavi&author=M+Tabrizi&publication_year=2012&hl=en']",,, Jafarinia 2012 {published data only}  ,included,CD012069-bbs2-0113,
CD012069-bib-0192,Abikoff H. ,Tailored psychosocial treatments for ADHD: the search for a good fit,,2001,,    ,['citation-other']," Abikoff H. Tailored psychosocial treatments for ADHD: the search for a good fit. Journal of Clinical Child Psychology2001; Vol. 30, issue 1:122‐5. [DOI: 10.1207/S15374424JCCP3001_14; PUBMED: 11294070]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Tailored+psychosocial+treatments+for+ADHD:+the+search+for+a+good+fit&author=H+Abikoff&publication_year=2001&hl=en']",,, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0193,"Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, et al. ",National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices, Archives of General Psychiatry ,1997,54,    ,['citation-journal']," Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.  Archives of General Psychiatry 1997;54(9):865‐70. [PUBMED: 9294378]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpsyc.1997.01830210113015', 'https://scholar.google.com/scholar_lookup?title=National+Institute+of+Mental+Health+Collaborative+Multimodal+Treatment+Study+of+Children+with+ADHD+(the+MTA).+Design+challenges+and+choices+&author=LE+Arnold&author=HB+Abikoff&author=DP+Cantwell&author=CK+Conners&author=G+Elliott&author=LL+Greenhill&publication_year=1997&hl=en']",9294378,https://doi.org/10.1001/archpsyc.1997.01830210113015, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0194,"Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, et al. ","NIMH collaborative multimodal treatment study of children with ADHD (MTA): design, methodology, and protocol evolution", Journal of Attention Disorders ,1997,2,    ,['citation-journal']," Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, et al. NIMH collaborative multimodal treatment study of children with ADHD (MTA): design, methodology, and protocol evolution.  Journal of Attention Disorders 1997;2(3):141‐58. [DOI: 10.1177/108705479700200301]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/108705479700200301', 'https://scholar.google.com/scholar_lookup?title=NIMH+collaborative+multimodal+treatment+study+of+children+with+ADHD+(MTA):+design,+methodology,+and+protocol+evolution+&author=LE+Arnold&author=HB+Abikoff&author=DP+Cantwell&author=CK+Conners&author=GR+Elliott&author=LL+Greenhill&publication_year=1997&hl=en']",,https://doi.org/10.1177/108705479700200301, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0195,"Arnold LE, Chuang S, Davies M, Abikoff HB, Conners CK, Elliott GR, et al. ",Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures, Journal of Abnormal Child Psychology ,2004,32,    ,['citation-journal']," Arnold LE, Chuang S, Davies M, Abikoff HB, Conners CK, Elliott GR, et al. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures.  Journal of Abnormal Child Psychology 2004;32(1):39‐51. [PUBMED: 14998110]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1023/B:JACP.0000007579.61289.31', 'https://scholar.google.com/scholar_lookup?title=Nine+months+of+multicomponent+behavioral+treatment+for+ADHD+and+effectiveness+of+MTA+fading+procedures+&author=LE+Arnold&author=S+Chuang&author=M+Davies&author=HB+Abikoff&author=CK+Conners&author=GR+Elliott&publication_year=2004&hl=en']",14998110,https://doi.org/10.1023/B:JACP.0000007579.61289.31, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0196,"Arnold LE, Elliott M, Sachs L, Bird H, Kraemer HC, Wells KC, et al. ","Effects of ethnicity on treatment attendance, stimulant response/dose, and 14‐month outcome in ADHD", Journal of Consulting and Clinical Psychology ,2003,71,    ,['citation-journal']," Arnold LE, Elliott M, Sachs L, Bird H, Kraemer HC, Wells KC, et al. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14‐month outcome in ADHD.  Journal of Consulting and Clinical Psychology 2003;71(4):713‐27. [PUBMED: 12924677]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1037/0022-006X.71.4.713', 'https://scholar.google.com/scholar_lookup?title=Effects+of+ethnicity+on+treatment+attendance,+stimulant+response/dose,+and+14‐month+outcome+in+ADHD+&author=LE+Arnold&author=M+Elliott&author=L+Sachs&author=H+Bird&author=HC+Kraemer&author=KC+Wells&publication_year=2003&hl=en']",12924677,https://doi.org/10.1037/0022-006X.71.4.713, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0197,Carey WB. ,What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits, Pediatrics ,2000,105,    ,['citation-journal'], Carey WB. What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits.  Pediatrics 2000;105(4):863‐4. [PUBMED: 10742336]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1542/peds.105.4.863', 'https://scholar.google.com/scholar_lookup?title=What+the+multimodal+treatment+study+of+children+with+attention+deficit/hyperactivity+disorder+did+and+did+not+say+about+the+use+of+methylphenidate+for+attention+deficits+&author=WB+Carey&publication_year=2000&hl=en']",10742336,https://doi.org/10.1542/peds.105.4.863, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0198,"Conners CK, Epstein JN, March JS, Angold A, Wells KC, Klaric J, et al. ",Multimodal treatment of ADHD in the MTA: an alternative outcome analysis, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal']," Conners CK, Epstein JN, March JS, Angold A, Wells KC, Klaric J, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(2):159‐67. [DOI: 10.1097/00004583‐200102000‐00010; PUBMED: 11211364]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-200102000-00010', 'https://scholar.google.com/scholar_lookup?title=Multimodal+treatment+of+ADHD+in+the+MTA:+an+alternative+outcome+analysis&author=CK+Conners&author=JN+Epstein&author=JS+March&author=A+Angold&author=KC+Wells&author=J+Klaric&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200102000-00010, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0199,"Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, et al. ",Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial, Journal of Child and Adolescent Psychopharmacology ,2003,13,    ,['citation-journal']," Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, et al. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.  Journal of Child and Adolescent Psychopharmacology 2003;13(2):123‐36. [DOI: 10.1089/104454603322163844; PUBMED: 12880507]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/104454603322163844', 'https://scholar.google.com/scholar_lookup?title=Response+to+methylphenidate+in+children+with+attention+deficit+hyperactivity+disorder+and+manic+symptoms+in+the+multimodal+treatment+study+of+children+with+attention+deficit+hyperactivity+disorder+titration+trial+&author=CA+Galanter&author=GA+Carlson&author=PS+Jensen&author=LL+Greenhill&author=M+Davies&author=W+Li&publication_year=2003&hl=en']",,https://doi.org/10.1089/104454603322163844, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0200,"Greene RW, Ablon JS. ",What does the MTA study tell us about effective psychosocial treatment for ADHD?, Journal of Clinical Child Psychology ,2001,30,    ,['citation-journal']," Greene RW, Ablon JS. What does the MTA study tell us about effective psychosocial treatment for ADHD?.  Journal of Clinical Child Psychology 2001;30(1):114‐21. [DOI: 10.1207/S15374424JCCP3001_13; PUBMED: 11294069]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1207/S15374424JCCP3001_13', 'https://scholar.google.com/scholar_lookup?title=What+does+the+MTA+study+tell+us+about+effective+psychosocial+treatment+for+ADHD?&author=RW+Greene&author=JS+Ablon&publication_year=2001&hl=en']",,https://doi.org/10.1207/S15374424JCCP3001_13, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0201,"Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, et al. ",Medication treatment strategies in the MTA Study: relevance to clinicians and researchers, Journal of the American Academy of Child and Adolescent Psychiatry ,1996,35,    ,['citation-journal']," Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, et al. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.  Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(10):1304‐13. [DOI: 10.1097/00004583‐199610000‐00017; PUBMED: 8885584]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199610000-00017', 'https://scholar.google.com/scholar_lookup?title=Medication+treatment+strategies+in+the+MTA+Study:+relevance+to+clinicians+and+researchers&author=LL+Greenhill&author=HB+Abikoff&author=LE+Arnold&author=DP+Cantwell&author=CK+Conners&author=G+Elliott&publication_year=1996&hl=en']",,https://doi.org/10.1097/00004583-199610000-00017, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0202,"Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, et al. ",Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal']," Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(2):180‐7. [DOI: 10.1097/00004583‐200102000‐00012; PUBMED: 11211366]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-200102000-00012', 'https://scholar.google.com/scholar_lookup?title=Impairment+and+deportment+responses+to+different+methylphenidate+doses+in+children+with+ADHD:+the+MTA+titration+trial+&author=LL+Greenhill&author=JM+Swanson&author=B+Vitiello&author=M+Davies&author=W+Clevenger&author=M+Wu&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200102000-00012, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0203,"Hansen L, Thomsen PH. ",How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?, Ugeskr Laeger ,2005,167,    ,['citation-journal']," Hansen L, Thomsen PH. How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?.  Ugeskr Laeger 2005;167(48):4555‐9. [PUBMED: 16324436]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=How+to+treat+ADHD/DAMP?+Is+there+a+conclusive+answer?+A+critical+survey+of+the+MTA+trial?+&author=L+Hansen&author=PH+Thomsen&publication_year=2005&hl=en']",16324436,, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0205,Hinshaw SP. ,Moderators and mediators of treatment response for children with attention‐deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention‐deficit/hyperactivity disorder, Archives of General Psychiatry ,1999,56,    ,['citation-journal'], Hinshaw SP. Moderators and mediators of treatment response for children with attention‐deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention‐deficit/hyperactivity disorder.  Archives of General Psychiatry 1999;56(12):1088‐96. [PUBMED: 10591284]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Moderators+and+mediators+of+treatment+response+for+children+with+attention‐deficit/hyperactivity+disorder:+the+Multimodal+Treatment+Study+of+children+with+attention‐deficit/hyperactivity+disorder+&author=SP+Hinshaw&publication_year=1999&hl=en']",10591284,, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0204,"Hinshaw SP, March JS, Abikoff H, Arnold LE, Cantwell DP, Conners CK, et al. ","Comprehensive assessment of childhood Attention‐Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial", Journal of Attention Disorders ,1997,1,    ,['citation-journal']," Hinshaw SP, March JS, Abikoff H, Arnold LE, Cantwell DP, Conners CK, et al. Comprehensive assessment of childhood Attention‐Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial.  Journal of Attention Disorders 1997;1(4):217‐34. [DOI: 10.1177/108705479700100403]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/108705479700100403', 'https://scholar.google.com/scholar_lookup?title=Comprehensive+assessment+of+childhood+Attention‐Deficit+Hyperactivity+Disorder+in+the+context+of+a+multisite,+multimodal+clinical+trial+&author=SP+Hinshaw&author=JS+March&author=H+Abikoff&author=LE+Arnold&author=DP+Cantwell&author=CK+Conners&publication_year=1997&hl=en']",,https://doi.org/10.1177/108705479700100403, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0206,"Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. ",3‐year follow‐up of the NIMH MTA study, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. 3‐year follow‐up of the NIMH MTA study.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):989‐1002. [DOI: 10.1097/CHI.0b013e3180686d48; PUBMED: 17667478]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/CHI.0b013e3180686d48', 'https://scholar.google.com/scholar_lookup?title=3‐year+follow‐up+of+the+NIMH+MTA+study&author=PS+Jensen&author=LE+Arnold&author=JM+Swanson&author=B+Vitiello&author=HB+Abikoff&author=LL+Greenhill&publication_year=2007&hl=en']",,https://doi.org/10.1097/CHI.0b013e3180686d48, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0207,"Jensen PS, Hinshaw SP, Kraemer HC, Leonora N, Newcorn JH, Abikoff HB, et al. ",ADHD comorbidity findings from the MTA study: comparing comorbid subgroups,,2001,,    ,['citation-other']," Jensen PS, Hinshaw SP, Kraemer HC, Leonora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry2001; Vol. 40, issue 2:147‐58. [DOI: 10.1097/00004583‐200102000‐00009; PUBMED: 11211363]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=ADHD+comorbidity+findings+from+the+MTA+study:+comparing+comorbid+subgroups&author=PS+Jensen&author=SP+Hinshaw&author=HC+Kraemer&author=N+Leonora&author=JH+Newcorn&author=HB+Abikoff&publication_year=2001&hl=en']",,, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0208,"Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, et al. ",Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers, Journal of Developmental and Behavioral Pediatrics ,2001,22,    ,['citation-journal']," Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.  Journal of Developmental and Behavioral Pediatrics 2001;22(1):60‐73. [PUBMED: 11265923]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004703-200102000-00008', 'https://scholar.google.com/scholar_lookup?title=Findings+from+the+NIMH+Multimodal+Treatment+Study+of+ADHD+(MTA):+implications+and+applications+for+primary+care+providers+&author=PS+Jensen&author=SP+Hinshaw&author=JM+Swanson&author=LL+Greenhill&author=CK+Conners&author=LE+Arnold&publication_year=2001&hl=en']",11265923,https://doi.org/10.1097/00004703-200102000-00008, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0209,MTA Cooperative Group. ,A 14‐month randomized clinical trial of treatment strategies for attention‐deficit/hyperactivity disorder, Archives of General Psychiatry ,1999,56,    ,['citation-journal'], MTA Cooperative Group. A 14‐month randomized clinical trial of treatment strategies for attention‐deficit/hyperactivity disorder.  Archives of General Psychiatry 1999;56(12):1073‐86. [DOI: 10.1001/archpsyc.56.12.1073; PUBMED: 10591283]CENTRAL    Link to article     ,"['', 'https://doi.org/10.1001/archpsyc.56.12.1073']",,https://doi.org/10.1001/archpsyc.56.12.1073, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0210,MTA Cooperative Group. ,National Institute of Mental Health multimodal treatment study of ADHD follow‐up: 24‐month outcomes of treatment strategies for attention‐deficit/hyperactivity disorder, Pediatrics ,2004,113,    ,['citation-journal'], MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow‐up: 24‐month outcomes of treatment strategies for attention‐deficit/hyperactivity disorder.  Pediatrics 2004;113(4):754‐61. [PUBMED: 15060224]CENTRAL    Link to article     ,"['', 'https://doi.org/10.1542/peds.113.4.754']",15060224,https://doi.org/10.1542/peds.113.4.754, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0211,MTA Cooperative Group. ,National Institute of Mental Health multimodal treatment study of ADHD follow‐up: changes in effectiveness and growth after the end of treatment, Pediatrics ,2004,113,    ,['citation-journal'], MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow‐up: changes in effectiveness and growth after the end of treatment.  Pediatrics 2004;113(4):762‐9. [PUBMED: 15060225]CENTRAL    Link to article     ,"['', 'https://doi.org/10.1542/peds.113.4.762']",15060225,https://doi.org/10.1542/peds.113.4.762, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0212,"March JS, Swanson JM, Arnold LE, Hoza B, Conners CK, Hinshaw SP, et al. ",Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA), Journal of Abnormal Child Psychology ,2000,28,    ,['citation-journal']," March JS, Swanson JM, Arnold LE, Hoza B, Conners CK, Hinshaw SP, et al. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).  Journal of Abnormal Child Psychology 2000;28(6):527‐41. [PUBMED: 11104315]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1023/A:1005179014321', 'https://scholar.google.com/scholar_lookup?title=Anxiety+as+a+predictor+and+outcome+variable+in+the+multimodal+treatment+study+of+children+with+ADHD+(MTA)+&author=JS+March&author=JM+Swanson&author=LE+Arnold&author=B+Hoza&author=CK+Conners&author=SP+Hinshaw&publication_year=2000&hl=en']",11104315,https://doi.org/10.1023/A:1005179014321, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0213,"Molina BS, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, et al. ","Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects", Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Molina BS, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):1028‐40. [DOI: 10.1097/chi.0b013e3180686d96; PUBMED: 17667481]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/chi.0b013e3180686d96', 'https://scholar.google.com/scholar_lookup?title=Delinquent+behavior+and+emerging+substance+use+in+the+MTA+at+36+months:+prevalence,+course,+and+treatment+effects+&author=BS+Molina&author=K+Flory&author=SP+Hinshaw&author=AR+Greiner&author=LE+Arnold&author=JM+Swanson&publication_year=2007&hl=en']",,https://doi.org/10.1097/chi.0b013e3180686d96, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0214,"Molina BS, Hinshaw SP, Eugene AL, Swanson JM, Pelham WE, Hechtman L, et al. ","Adolescent substance use in the multimodal treatment study of attention‐deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication", Journal of the American Academy of Child and Adolescent Psychiatry ,2013,52,    ,['citation-journal']," Molina BS, Hinshaw SP, Eugene AL, Swanson JM, Pelham WE, Hechtman L, et al. Adolescent substance use in the multimodal treatment study of attention‐deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.  Journal of the American Academy of Child and Adolescent Psychiatry 2013;52(3):250‐63. [DOI: 10.1016/j.jaac.2012.12.014; PMC3589108; PUBMED: 23452682]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jaac.2012.12.014', 'https://scholar.google.com/scholar_lookup?title=Adolescent+substance+use+in+the+multimodal+treatment+study+of+attention‐deficit/hyperactivity+disorder+(ADHD)+(MTA)+as+a+function+of+childhood+ADHD,+random+assignment+to+childhood+treatments,+and+subsequent+medication+&author=BS+Molina&author=SP+Hinshaw&author=AL+Eugene&author=JM+Swanson&author=WE+Pelham&author=L+Hechtman&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jaac.2012.12.014, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0215,"Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. ",The MTA at 8 years: prospective follow‐up of children treated for combined‐type ADHD in a multisite study, Journal of the American Academy of Child and Adolescent Psychiatry ,2009,48,    ,['citation-journal']," Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow‐up of children treated for combined‐type ADHD in a multisite study.  Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(5):484‐500. [DOI: 10.1097/CHI.0b013e31819c23d0; PMC3063150]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/CHI.0b013e31819c23d0', 'https://scholar.google.com/scholar_lookup?title=The+MTA+at+8+years:+prospective+follow‐up+of+children+treated+for+combined‐type+ADHD+in+a+multisite+study+&author=BS+Molina&author=SP+Hinshaw&author=JM+Swanson&author=LE+Arnold&author=B+Vitiello&author=PS+Jensen&publication_year=2009&hl=en']",,https://doi.org/10.1097/CHI.0b013e31819c23d0, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0216,Nieweg EH. ,"Does ADHD medication stop working after 2‐3 years? On the surprising, but little known follow‐up of the MTA study", Tijdschrift voor Psychiatrie ,2010,52,    ,['citation-journal']," Nieweg EH. Does ADHD medication stop working after 2‐3 years? On the surprising, but little known follow‐up of the MTA study [Is adhd‐medicatie na 2‐3 jaar uitgewerkt? Over de verrassende, maar weinig bekendefollow‐up van het mta‐onderzoek].  Tijdschrift voor Psychiatrie 2010;52(4):245‐54. [PUBMED: 20503165]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Does+ADHD+medication+stop+working+after+2‐3+years?+On+the+surprising,+but+little+known+follow‐up+of+the+MTA+study+&author=EH+Nieweg&publication_year=2010&hl=en']",20503165,, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0217,"Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, et al. ",Which treatment for whom for ADHD? Moderators of treatment response in the MTA, Journal of Consulting and Clinical Psychology ,2003,71,    ,['citation-journal']," Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA.  Journal of Consulting and Clinical Psychology 2003;71(3):540‐52. [PUBMED: 12795577]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1037/0022-006X.71.3.540', 'https://scholar.google.com/scholar_lookup?title=Which+treatment+for+whom+for+ADHD?+Moderators+of+treatment+response+in+the+MTA&author=EB+Owens&author=SP+Hinshaw&author=HC+Kraemer&author=LE+Arnold&author=HB+Abikoff&author=DP+Cantwell&publication_year=2003&hl=en']",12795577,https://doi.org/10.1037/0022-006X.71.3.540, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0218,Pelham WE. ,The NIMH multimodal treatment study for attention‐deficit hyperactivity disorder: just say yes to drugs alone?, Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie ,1999,44,    ,['citation-journal'], Pelham WE. The NIMH multimodal treatment study for attention‐deficit hyperactivity disorder: just say yes to drugs alone?.  Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 1999;44(10):981‐90. [DOI: 10.1177/070674379904401004; PUBMED: 10637677]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1177/070674379904401004', 'https://scholar.google.com/scholar_lookup?title=The+NIMH+multimodal+treatment+study+for+attention‐deficit+hyperactivity+disorder:+just+say+yes+to+drugs+alone?+&author=WE+Pelham&publication_year=1999&hl=en']",,https://doi.org/10.1177/070674379904401004, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0219,"Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, et al. ",Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program, Journal of Abnormal Child Psychology ,2000,28,    ,['citation-journal']," Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, et al. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program.  Journal of Abnormal Child Psychology 2000;28(6):507‐25. [PUBMED: 11104314]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1023/A:1005127030251', 'https://scholar.google.com/scholar_lookup?title=Behavioral+versus+behavioral+and+pharmacological+treatment+in+ADHD+children+attending+a+summer+treatment+program+&author=WE+Pelham&author=EM+Gnagy&author=AR+Greiner&author=B+Hoza&author=SP+Hinshaw&author=JM+Swanson&publication_year=2000&hl=en']",11104314,https://doi.org/10.1023/A:1005127030251, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0220,"Richters JE, Arnold LE, Jensen PS, Abikoff H, Conners CK, Greenhill LL, et al. ",NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale, Journal of the American Academy of Child and Adolescent Psychiatry ,1995,34,    ,['citation-journal']," Richters JE, Arnold LE, Jensen PS, Abikoff H, Conners CK, Greenhill LL, et al. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale.  Journal of the American Academy of Child and Adolescent Psychiatry 1995;34(8):987‐1000. [DOI: 10.1097/00004583‐199508000‐00008; PUBMED: 7665456]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199508000-00008', 'https://scholar.google.com/scholar_lookup?title=NIMH+collaborative+multisite+multimodal+treatment+study+of+children+with+ADHD:+I.+Background+and+rationale+&author=JE+Richters&author=LE+Arnold&author=PS+Jensen&author=H+Abikoff&author=CK+Conners&author=LL+Greenhill&publication_year=1995&hl=en']",,https://doi.org/10.1097/00004583-199508000-00008, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0221,"Swanson JM, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw SP, et al. ","Evidence, interpretation, and qualification from multiple reports of long‐term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details", Journal of Attention Disorders ,2008,12,    ,['citation-journal']," Swanson JM, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw SP, et al. Evidence, interpretation, and qualification from multiple reports of long‐term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.  Journal of Attention Disorders 2008;12(1):15‐43. [DOI: 10.1177/1087054708319525; PUBMED: 18573924]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054708319525', 'https://scholar.google.com/scholar_lookup?title=Evidence,+interpretation,+and+qualification+from+multiple+reports+of+long‐term+outcomes+in+the+Multimodal+Treatment+Study+of+children+with+ADHD+(MTA):+Part+II:+supporting+details+&author=JM+Swanson&author=LE+Arnold&author=H+Kraemer&author=L+Hechtman&author=B+Molina&author=SP+Hinshaw&publication_year=2008&hl=en']",,https://doi.org/10.1177/1087054708319525, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0222,"Swanson JM, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw SP, et al. ","Evidence, interpretation, and qualification from multiple reports of long‐term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary", Journal of Attention Disorders ,2008,12,    ,['citation-journal']," Swanson JM, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw SP, et al. Evidence, interpretation, and qualification from multiple reports of long‐term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.  Journal of Attention Disorders 2008;12(1):4‐14. [DOI: 10.1177/1087054708319345; PUBMED: 18573923]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054708319345', 'https://scholar.google.com/scholar_lookup?title=Evidence,+interpretation,+and+qualification+from+multiple+reports+of+long‐term+outcomes+in+the+Multimodal+Treatment+study+of+Children+With+ADHD+(MTA):+part+I:+executive+summary+&author=JM+Swanson&author=LE+Arnold&author=H+Kraemer&author=L+Hechtman&author=B+Molina&author=SP+Hinshaw&publication_year=2008&hl=en']",,https://doi.org/10.1177/1087054708319345, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0223,"Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, et al. ",Effects of stimulant medication on growth rates across 3 years in the MTA follow‐up, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow‐up.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):1015‐27. [DOI: 10.1097/chi.0b013e3180686d7e; PUBMED: 17667480]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/chi.0b013e3180686d7e', 'https://scholar.google.com/scholar_lookup?title=Effects+of+stimulant+medication+on+growth+rates+across+3+years+in+the+MTA+follow‐up&author=JM+Swanson&author=GR+Elliott&author=LL+Greenhill&author=T+Wigal&author=LE+Arnold&author=B+Vitiello&publication_year=2007&hl=en']",,https://doi.org/10.1097/chi.0b013e3180686d7e, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0224,"Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, et al. ",Secondary evaluations of MTA 36‐month outcomes: propensity score and growth mixture model analyses, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, et al. Secondary evaluations of MTA 36‐month outcomes: propensity score and growth mixture model analyses.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):1003‐14. [DOI: 10.1097/CHI.0b013e3180686d63; PUBMED: 17667479]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/CHI.0b013e3180686d63', 'https://scholar.google.com/scholar_lookup?title=Secondary+evaluations+of+MTA+36‐month+outcomes:+propensity+score+and+growth+mixture+model+analyses+&author=JM+Swanson&author=SP+Hinshaw&author=LE+Arnold&author=RD+Gibbons&author=S+Marcus&author=K+Hur&publication_year=2007&hl=en']",,https://doi.org/10.1097/CHI.0b013e3180686d63, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0225,"Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, et al. ",Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal']," Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(2):168‐79. [DOI: 10.1097/00004583‐200102000‐00011; PUBMED: 1121136]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-200102000-00011', 'https://scholar.google.com/scholar_lookup?title=Clinical+relevance+of+the+primary+findings+of+the+MTA:+success+rates+based+on+severity+of+ADHD+and+ODD+symptoms+at+the+end+of+treatment+&author=JM+Swanson&author=HC+Kraemer&author=SP+Hinshaw&author=LE+Arnold&author=CK+Conners&author=HB+Abikoff&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200102000-00011, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0226,"Vitiello B, Elliott GR, Swanson JM, Arnold LE, Hechtman L, Abikoff H, et al. ",Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD,,2012,,    ,['citation-other']," Vitiello B, Elliott GR, Swanson JM, Arnold LE, Hechtman L, Abikoff H, et al. Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. American Journal of Psychiatry2012; Vol. 169, issue 2:167‐77. [DOI: 10.1176/appi.ajp.2011.10111705; PMC4132884; PUBMED: 21890793]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Blood+pressure+and+heart+rate+over+10+years+in+the+multimodal+treatment+study+of+children+with+ADHD+&author=B+Vitiello&author=GR+Elliott&author=JM+Swanson&author=LE+Arnold&author=L+Hechtman&author=H+Abikoff&publication_year=2012&hl=en']",,, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0227,"Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, et al. ",Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal']," Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(2):188‐96. [DOI: 10.1097/00004583‐200102000‐00013; PUBMED: 11211367]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-200102000-00013', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+dosage+for+children+with+ADHD+over+time+under+controlled+conditions:+lessons+from+the+MTA+&author=B+Vitiello&author=JB+Severe&author=LL+Greenhill&author=LE+Arnold&author=HB+Abikoff&author=OG+Bukstein&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200102000-00013, Jensen 1999 (MTA) {published data only}  ,included,CD012069-bbs2-0114,
CD012069-bib-0228,"Johnson KA, Barry E, Lambert D, Fitzgerald M, McNicholas F, Kirley A, et al. ",Methylphenidate side effect profile is influenced by genetic variation in the attention‐deficit/hyperactivity disorder‐associated CES1 gene, Journal of Child and Adolescent Psychopharmacology ,2013,23,    ,['citation-journal']," Johnson KA, Barry E, Lambert D, Fitzgerald M, McNicholas F, Kirley A, et al. Methylphenidate side effect profile is influenced by genetic variation in the attention‐deficit/hyperactivity disorder‐associated CES1 gene.  Journal of Child and Adolescent Psychopharmacology 2013;23(10):655‐64. [DOI: 10.1089/cap.2013.0032; PUBMED: 24350812]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2013.0032', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+side+effect+profile+is+influenced+by+genetic+variation+in+the+attention‐deficit/hyperactivity+disorder‐associated+CES1+gene+&author=KA+Johnson&author=E+Barry&author=D+Lambert&author=M+Fitzgerald&author=F+McNicholas&author=A+Kirley&publication_year=2013&hl=en']",,https://doi.org/10.1089/cap.2013.0032, Johnson 2013 {published data only}  ,included,CD012069-bbs2-0115,
CD012069-bib-0229,"Jung C, Choi S, Jeong S, Song CJ, Seo W, Chung US, et al. ","Multicenter, open‐label study to evaluate the effects of methylphenidate‐OROS (Concerta®) on cognitive functions in children with attention deficit hyperactivity disorder", Clinical Psychopharmacology and Neuroscience ,2007,5,    ,['citation-journal']," Jung C, Choi S, Jeong S, Song CJ, Seo W, Chung US, et al. Multicenter, open‐label study to evaluate the effects of methylphenidate‐OROS (Concerta®) on cognitive functions in children with attention deficit hyperactivity disorder.  Clinical Psychopharmacology and Neuroscience 2007;5(1):31‐7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Multicenter,+open‐label+study+to+evaluate+the+effects+of+methylphenidate‐OROS+(Concerta®)+on+cognitive+functions+in+children+with+attention+deficit+hyperactivity+disorder+&author=C+Jung&author=S+Choi&author=S+Jeong&author=CJ+Song&author=W+Seo&author=US+Chung&publication_year=2007&hl=en']",,, Jung 2007 {published data only}  ,included,CD012069-bbs2-0116,
CD012069-bib-0230,"Lee JH, Jung CH, Song CJ, Choi SY, Jeong SH, Chung US, et al. ",Multi‐center study for evaluation of efficacy and safety of methylphenidate‐OROS in children with ADHD, European Neuropsychopharmacology ,2007,17,    ,['citation-journal']," Lee JH, Jung CH, Song CJ, Choi SY, Jeong SH, Chung US, et al. Multi‐center study for evaluation of efficacy and safety of methylphenidate‐OROS in children with ADHD.  European Neuropsychopharmacology 2007;17(Suppl 4):S571‐2. [DOI: 10.1016/S0924‐977X(07)70890‐8]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(07)70890-8', 'https://scholar.google.com/scholar_lookup?title=Multi‐center+study+for+evaluation+of+efficacy+and+safety+of+methylphenidate‐OROS+in+children+with+ADHD+&author=JH+Lee&author=CH+Jung&author=CJ+Song&author=SY+Choi&author=SH+Jeong&author=US+Chung&publication_year=2007&hl=en']",,https://doi.org/10.1016/S0924-977X(07)70890-8, Jung 2007 {published data only}  ,included,CD012069-bbs2-0116,
CD012069-bib-0231,"Karabekiroglu K, Yazgan Y M, Dedeoglu C. ",Can we predict short‐term side effects of methylphenidate immediate‐release?, International Journal of Psychiatry in Clinical Practice ,2008,12,    ,['citation-journal']," Karabekiroglu K, Yazgan Y M, Dedeoglu C. Can we predict short‐term side effects of methylphenidate immediate‐release?.  International Journal of Psychiatry in Clinical Practice 2008;12(1):48‐54. [DOI: 10.1080/13651500701435954]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/13651500701435954', 'https://scholar.google.com/scholar_lookup?title=Can+we+predict+short‐term+side+effects+of+methylphenidate+immediate‐release?&author=K+Karabekiroglu&author=YM+Yazgan&author=C+Dedeoglu&publication_year=2008&hl=en']",,https://doi.org/10.1080/13651500701435954, Karabekiroglu 2008 {published data only}  ,included,CD012069-bbs2-0117,
CD012069-bib-0233,,Pulmonary arterial hypertension with methylphenidate OROS initiation, Brown University Child & Adolescent Psychopharmacology Update ,2010,12,   ,['citation-journal'], Pulmonary arterial hypertension with methylphenidate OROS initiation.  Brown University Child & Adolescent Psychopharmacology Update 2010;12(9):8‐8. [DOI: 10.1002/cpu.20123]CENTRAL    ,[''],,, Karaman 2010 {published data only}  ,included,CD012069-bbs2-0118,
CD012069-bib-0232,"Karaman MG, Atalay F, Tufan AE, Erdogan A. ",Pulmonary arterial hypertension in an adolescent treated with methylphenidate, Journal of Child & Adolescent Psychopharmacology ,2010,20,    ,['citation-journal']," Karaman MG, Atalay F, Tufan AE, Erdogan A. Pulmonary arterial hypertension in an adolescent treated with methylphenidate.  Journal of Child & Adolescent Psychopharmacology 2010;20(3):229‐31. [DOI: 10.1089/cap.2009.0095; PUBMED: 20578938]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2009.0095', 'https://scholar.google.com/scholar_lookup?title=Pulmonary+arterial+hypertension+in+an+adolescent+treated+with+methylphenidate&author=MG+Karaman&author=F+Atalay&author=AE+Tufan&author=A+Erdogan&publication_year=2010&hl=en']",,https://doi.org/10.1089/cap.2009.0095, Karaman 2010 {published data only}  ,included,CD012069-bbs2-0118,
CD012069-bib-0234,"Karapinar U, Saglam O, Dursun E, Cetin B, Salman N, Sahan M. ",Sudden hearing loss associated with methylphenidate therapy, European Archives of Otorhinolaryngology ,2014,271,    ,['citation-journal']," Karapinar U, Saglam O, Dursun E, Cetin B, Salman N, Sahan M. Sudden hearing loss associated with methylphenidate therapy.  European Archives of Otorhinolaryngology 2014;271(1):199‐201. [DOI: 10.1007/s00405‐013‐2763‐y; PUBMED: 24141471]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00405-013-2763-y', 'https://scholar.google.com/scholar_lookup?title=Sudden+hearing+loss+associated+with+methylphenidate+therapy&author=U+Karapinar&author=O+Saglam&author=E+Dursun&author=B+Cetin&author=N+Salman&author=M+Sahan&publication_year=2014&hl=en']",,https://doi.org/10.1007/s00405-013-2763-y, Karapinar 2014 {published data only}  ,included,CD012069-bbs2-0119,
CD012069-bib-0235,"Kazanci SY, Tarakcioglu M C, Bulbul L, Saglam N O. ",Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias?, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2015,25,    ,['citation-journal']," Kazanci SY, Tarakcioglu M C, Bulbul L, Saglam N O. Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias?.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2015;25(4):399‐402. [DOI: 10.5455/bcp.20150902042021]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.5455/bcp.20150902042021', 'https://scholar.google.com/scholar_lookup?title=Should+we+continue+methylphenidate+treatment+despite+orofacial+or+extremity+dyskinesias?&author=SY+Kazanci&author=MC+Tarakcioglu&author=L+Bulbul&author=NO+Saglam&publication_year=2015&hl=en']",,https://doi.org/10.5455/bcp.20150902042021, Kazanci 2015 {published data only}  ,included,CD012069-bbs2-0120,
CD012069-bib-0236,"Kemner JE, Starr HL, Bowen DL, Ciccone PL, Lynch JM. ",Greater symptom improvement and response rates with OROS® MPH vs. atomoxetine in children with ADHD, International Journal of Neuropsychopharmacology ,2004,7,    ,['citation-journal']," Kemner JE, Starr HL, Bowen DL, Ciccone PL, Lynch JM. Greater symptom improvement and response rates with OROS® MPH vs. atomoxetine in children with ADHD.  International Journal of Neuropsychopharmacology 2004;7:S273‐4. [DOI: 10.1017/S1461145704004547]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Greater+symptom+improvement+and+response+rates+with+OROS®+MPH+vs.+atomoxetine+in+children+with+ADHD+&author=JE+Kemner&author=HL+Starr&author=DL+Bowen&author=PL+Ciccone&author=JM+Lynch&publication_year=2004&hl=en']",,, Kemner 2005 (FOCUS) {published data only}  ,included,CD012069-bbs2-0121,
CD012069-bib-0237,"Kemner JE, Starr HL, Ciccone PE, Hooper‐Wood CG, Crockett RS. ","Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study", Advances in Therapy ,2005,22,    ,['citation-journal']," Kemner JE, Starr HL, Ciccone PE, Hooper‐Wood CG, Crockett RS. Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study.  Advances in Therapy 2005;22(5):498‐512. [PUBMED: 16418159]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/BF02849870', 'https://scholar.google.com/scholar_lookup?title=Outcomes+of+OROS+methylphenidate+compared+with+atomoxetine+in+children+with+ADHD:+a+multicenter,+randomized+prospective+study+&author=JE+Kemner&author=HL+Starr&author=PE+Ciccone&author=CG+Hooper‐Wood&author=RS+Crockett&publication_year=2005&hl=en']",16418159,https://doi.org/10.1007/BF02849870, Kemner 2005 (FOCUS) {published data only}  ,included,CD012069-bbs2-0121,
CD012069-bib-0238,"Kemner JE, Starr HL, Hooper‐Wood CG, Ciccone PE. ",Greater improvement and response rates with OROS (R) methylphenidate compared with atomoxetine in children with attention‐deficit/hyperactivity disorder, Pharmacotherapy ,2004,24,    ,['citation-journal']," Kemner JE, Starr HL, Hooper‐Wood CG, Ciccone PE. Greater improvement and response rates with OROS (R) methylphenidate compared with atomoxetine in children with attention‐deficit/hyperactivity disorder.  Pharmacotherapy 2004;24(10):1462‐3. [DOI: 10.1592/phco.24.14.1419.43157]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Greater+improvement+and+response+rates+with+OROS+(R)+methylphenidate+compared+with+atomoxetine+in+children+with+attention‐deficit/hyperactivity+disorder+&author=JE+Kemner&author=HL+Starr&author=CG+Hooper‐Wood&author=PE+Ciccone&publication_year=2004&hl=en']",,, Kemner 2005 (FOCUS) {published data only}  ,included,CD012069-bbs2-0121,
CD012069-bib-0239,"Starr HL, Kemner J. ","Multicenter, randomized, open‐label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African‐American children with ADHD", Journal of the National Medical Association ,2005,97,    ,['citation-journal']," Starr HL, Kemner J. Multicenter, randomized, open‐label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African‐American children with ADHD.  Journal of the National Medical Association 2005;97(10 Suppl):11S‐6S. [PMC2640623; PUBMED: 16350601]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Multicenter,+randomized,+open‐label+study+of+OROS+methylphenidate+versus+atomoxetine:+treatment+outcomes+in+African‐American+children+with+ADHD+&author=HL+Starr&author=J+Kemner&publication_year=2005&hl=en']",,, Kemner 2005 (FOCUS) {published data only}  ,included,CD012069-bbs2-0121,
CD012069-bib-0240,"Khajehpiri Z, Mahmoudi‐Gharaei J, Faghihi T, Karimzadeh I, Khalili H, Mohammadi M. ",Adverse reactions of Methylphenidate in children with attention deficit‐hyperactivity disorder: report from a referral center, Journal of Research in Pharmacy Practice ,2014,3,    ,['citation-journal']," Khajehpiri Z, Mahmoudi‐Gharaei J, Faghihi T, Karimzadeh I, Khalili H, Mohammadi M. Adverse reactions of Methylphenidate in children with attention deficit‐hyperactivity disorder: report from a referral center.  Journal of Research in Pharmacy Practice 2014;3(4):130‐6. [DOI: 10.4103/2279‐042X.145389; PMC4262859; PUBMED: 25535621]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Adverse+reactions+of+Methylphenidate+in+children+with+attention+deficit‐hyperactivity+disorder:+report+from+a+referral+center+&author=Z+Khajehpiri&author=J+Mahmoudi‐Gharaei&author=T+Faghihi&author=I+Karimzadeh&author=H+Khalili&author=M+Mohammadi&publication_year=2014&hl=en']",,, Khajehpiri 2014 {published data only}  ,included,CD012069-bbs2-0122,
CD012069-bib-0241,"Khodadust N, Jalali A‐H, Ahmadzad‐Asl M, Khademolreza N, Shirazi E. ","Comparison of two brands of methylphenidate (Stimdate® vs. Ritalin®) in children and adolescents with attention deficit hyperactivity disorder: a double‐blind, randomized clinical trial",,2012,,    ,['citation-other']," Khodadust N, Jalali A‐H, Ahmadzad‐Asl M, Khademolreza N, Shirazi E. Comparison of two brands of methylphenidate (Stimdate® vs. Ritalin®) in children and adolescents with attention deficit hyperactivity disorder: a double‐blind, randomized clinical trial. Iranian Journal of Psychiatry and Behavioral Sciences2012; Vol. 6, issue 1:26‐32. [PMC3939941]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+two+brands+of+methylphenidate+(Stimdate®+vs.+Ritalin®)+in+children+and+adolescents+with+attention+deficit+hyperactivity+disorder:+a+double‐blind,+randomized+clinical+trial+&author=N+Khodadust&author=A‐H+Jalali&author=M+Ahmadzad‐Asl&author=N+Khademolreza&author=E+Shirazi&publication_year=2012&hl=en']",,, Khodadust 2012 {published data only}  ,included,CD012069-bbs2-0123,
CD012069-bib-0242,"Chung I, Han CH, Kim HW, Cho SC. ",The effect of prolonged‐release methylphenidate on the sleep of children with attention‐deficit/hyperactivity disorders, European Neuropsychopharmacology ,2010,20,    ,['citation-journal']," Chung I, Han CH, Kim HW, Cho SC. The effect of prolonged‐release methylphenidate on the sleep of children with attention‐deficit/hyperactivity disorders.  European Neuropsychopharmacology 2010;20(Suppl 3):S624‐5. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(10)70957-3', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+prolonged‐release+methylphenidate+on+the+sleep+of+children+with+attention‐deficit/hyperactivity+disorders+&author=I+Chung&author=CH+Han&author=HW+Kim&author=SC+Cho&publication_year=2010&hl=en']",,https://doi.org/10.1016/S0924-977X(10)70957-3, Kim 2010 {published data only}  ,included,CD012069-bbs2-0124,
CD012069-bib-0243,"Kim HW, Yoon IY, Cho SC, Kim BN, Chung S, Lee H, et al. ",The effect of OROS methylphenidate on the sleep of children with attention‐deficit/hyperactivity disorder, International Clinical Psychopharmacology ,2010,25,    ,['citation-journal']," Kim HW, Yoon IY, Cho SC, Kim BN, Chung S, Lee H, et al. The effect of OROS methylphenidate on the sleep of children with attention‐deficit/hyperactivity disorder.  International Clinical Psychopharmacology 2010;25(2):107‐15. [DOI: 10.1097/YIC.0b013e3283364411; PUBMED: 20093941]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/YIC.0b013e3283364411', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+OROS+methylphenidate+on+the+sleep+of+children+with+attention‐deficit/hyperactivity+disorder+&author=HW+Kim&author=IY+Yoon&author=SC+Cho&author=BN+Kim&author=S+Chung&author=H+Lee&publication_year=2010&hl=en']",,https://doi.org/10.1097/YIC.0b013e3283364411, Kim 2010 {published data only}  ,included,CD012069-bbs2-0124,
CD012069-bib-0244,"Kim BN, Kim YN, Cheong US, Kim JW, Hwang JW, Shin MS, et al. ","Switching from Methylphenidate‐Immediate Release (MPH‐IR) to Methylphenidate‐OROS (OROS‐MPH): a multi‐center, open‐label study in Korea", Clinical Psychopharmacology and Neuroscience ,2011,9,    ,['citation-journal']," Kim BN, Kim YN, Cheong US, Kim JW, Hwang JW, Shin MS, et al. Switching from Methylphenidate‐Immediate Release (MPH‐IR) to Methylphenidate‐OROS (OROS‐MPH): a multi‐center, open‐label study in Korea.  Clinical Psychopharmacology and Neuroscience 2011;9(1):29‐35. [DOI: 10.9758/cpn.2011.9.1.29; PMC3568652; PUBMED: 23430964]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.9758/cpn.2011.9.1.29', 'https://scholar.google.com/scholar_lookup?title=Switching+from+Methylphenidate‐Immediate+Release+(MPH‐IR)+to+Methylphenidate‐OROS+(OROS‐MPH):+a+multi‐center,+open‐label+study+in+Korea+&author=BN+Kim&author=YN+Kim&author=US+Cheong&author=JW+Kim&author=JW+Hwang&author=MS+Shin&publication_year=2011&hl=en']",,https://doi.org/10.9758/cpn.2011.9.1.29, Kim 2011 {published data only}  ,included,CD012069-bbs2-0125,
CD012069-bib-0245,"Kim HW, Kim SO, Shon S, Lee JS, Lee HJ, Choi JH. ",Effect of methylphenidate on height and weight in Korean children and adolescents with attention‐deficit/hyperactivity disorder: a retrospective chart review, Journal of Child and Adolescent Psychopharmacology ,2014,24,    ,['citation-journal']," Kim HW, Kim SO, Shon S, Lee JS, Lee HJ, Choi JH. Effect of methylphenidate on height and weight in Korean children and adolescents with attention‐deficit/hyperactivity disorder: a retrospective chart review.  Journal of Child and Adolescent Psychopharmacology 2014;24(8):448‐53. [DOI: 10.1089/cap.2014.0025; PUBMED: 25285915]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2014.0025', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+on+height+and+weight+in+Korean+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder:+a+retrospective+chart+review+&author=HW+Kim&author=SO+Kim&author=S+Shon&author=JS+Lee&author=HJ+Lee&author=JH+Choi&publication_year=2014&hl=en']",,https://doi.org/10.1089/cap.2014.0025, Kim 2014a {published data only}  ,included,CD012069-bbs2-0126,
CD012069-bib-0246,"Kim Y, Kim B, Chang JS, Kim BN, Cho SC, Hwang JW. ",Parental quality of life and depressive mood following methylphenidate treatment of children with attention‐deficit hyperactivity disorder, Psychiatry and Clinical Neurosciences ,2014,68,    ,['citation-journal']," Kim Y, Kim B, Chang JS, Kim BN, Cho SC, Hwang JW. Parental quality of life and depressive mood following methylphenidate treatment of children with attention‐deficit hyperactivity disorder.  Psychiatry and Clinical Neurosciences 2014;68(7):506‐14. [DOI: 10.1111/pcn.12155; PUBMED: 24417707]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/pcn.12155', 'https://scholar.google.com/scholar_lookup?title=Parental+quality+of+life+and+depressive+mood+following+methylphenidate+treatment+of+children+with+attention‐deficit+hyperactivity+disorder+&author=Y+Kim&author=B+Kim&author=JS+Chang&author=BN+Kim&author=SC+Cho&author=JW+Hwang&publication_year=2014&hl=en']",,https://doi.org/10.1111/pcn.12155, Kim 2014b {published data only}  ,included,CD012069-bbs2-0127,
CD012069-bib-0247,"Kim HJ, Yang J, Lee MS. ",Changes of heart rate variability during methylphenidate treatment in attention‐deficit hyperactivity disorder children: a 12‐week prospective study, Yonsei Medical Journal ,2015,56,    ,['citation-journal']," Kim HJ, Yang J, Lee MS. Changes of heart rate variability during methylphenidate treatment in attention‐deficit hyperactivity disorder children: a 12‐week prospective study.  Yonsei Medical Journal 2015;56(5):1365‐71. [DOI: 10.3349/ymj.2015.56.5.1365; PMC4541668]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3349/ymj.2015.56.5.1365', 'https://scholar.google.com/scholar_lookup?title=Changes+of+heart+rate+variability+during+methylphenidate+treatment+in+attention‐deficit+hyperactivity+disorder+children:+a+12‐week+prospective+study+&author=HJ+Kim&author=J+Yang&author=MS+Lee&publication_year=2015&hl=en']",,https://doi.org/10.3349/ymj.2015.56.5.1365, Kim 2015a {published data only}  ,included,CD012069-bbs2-0128,
CD012069-bib-0248,"Kim E, Cheon KA, Joung YS, Kim JY, Song DH. ",The relationship between symptomatic and functional changes of Korean children and adolescents with attention‐deficit/hyperactivity disorder treated with osmotic‐controlled release oral delivery system‐methylphenidate,,2015,,    ,['citation-other']," Kim E, Cheon KA, Joung YS, Kim JY, Song DH. The relationship between symptomatic and functional changes of Korean children and adolescents with attention‐deficit/hyperactivity disorder treated with osmotic‐controlled release oral delivery system‐methylphenidate. Clinical Neuropharmacology2015; Vol. 38, issue 1:30‐5. [DOI: 10.1097/WNF.0000000000000064; PUBMED: 25580917]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+relationship+between+symptomatic+and+functional+changes+of+Korean+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+treated+with+osmotic‐controlled+release+oral+delivery+system‐methylphenidate+&author=E+Kim&author=KA+Cheon&author=YS+Joung&author=JY+Kim&author=DH+Song&publication_year=2015&hl=en']",,, Kim 2015b {published data only}  ,included,CD012069-bbs2-0129,
CD012069-bib-0249,"Hechtman L, Abikoff H, Klein RG, Weiss G, Respitz C, Kouri J, et al. ",Academic achievement and emotional status of children with ADHD treated with long‐term methylphenidate and multimodal psychosocial treatment, Journal of the American Academy of Child and Adolescent Psychiatry ,2004,43,    ,['citation-journal']," Hechtman L, Abikoff H, Klein RG, Weiss G, Respitz C, Kouri J, et al. Academic achievement and emotional status of children with ADHD treated with long‐term methylphenidate and multimodal psychosocial treatment.  Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(7):812‐9. [DOI: 10.1097/01.chi.0000128796.84202.eb; PUBMED: 15213582]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.chi.0000128796.84202.eb', 'https://scholar.google.com/scholar_lookup?title=Academic+achievement+and+emotional+status+of+children+with+ADHD+treated+with+long‐term+methylphenidate+and+multimodal+psychosocial+treatment+&author=L+Hechtman&author=H+Abikoff&author=RG+Klein&author=G+Weiss&author=C+Respitz&author=J+Kouri&publication_year=2004&hl=en']",,https://doi.org/10.1097/01.chi.0000128796.84202.eb, Klein 2004 {published data only}  ,included,CD012069-bbs2-0130,
CD012069-bib-0250,"Klein RG, Abikoff H, Hechtman L, Weiss G. ",Design and rationale of controlled study of long‐term methylphenidate and multimodal psychosocial treatment in children with ADHD, Journal of the American Academy of Child and Adolescent Psychiatry ,2004,43,    ,['citation-journal']," Klein RG, Abikoff H, Hechtman L, Weiss G. Design and rationale of controlled study of long‐term methylphenidate and multimodal psychosocial treatment in children with ADHD.  Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(7):792‐801. [DOI: 10.1097/01.chi.0000128798.91601.fe; PUBMED: 15213580]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.chi.0000128798.91601.fe', 'https://scholar.google.com/scholar_lookup?title=Design+and+rationale+of+controlled+study+of+long‐term+methylphenidate+and+multimodal+psychosocial+treatment+in+children+with+ADHD+&author=RG+Klein&author=H+Abikoff&author=L+Hechtman&author=G+Weiss&publication_year=2004&hl=en']",,https://doi.org/10.1097/01.chi.0000128798.91601.fe, Klein 2004 {published data only}  ,included,CD012069-bbs2-0130,
CD012069-bib-0251,"Kordon A, Stollhoff K, Niederkirchner K, Mattejat F, Rettig K, Schäuble B. ",Exploring the impact of once‐daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate‐release MPH, Postgraduate Medicine ,2011,123,    ,['citation-journal']," Kordon A, Stollhoff K, Niederkirchner K, Mattejat F, Rettig K, Schäuble B. Exploring the impact of once‐daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate‐release MPH.  Postgraduate Medicine 2011;123(5):27‐38. [DOI: 10.3810/pgm.2011.09.2457; PUBMED: 21904084]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3810/pgm.2011.09.2457', 'https://scholar.google.com/scholar_lookup?title=Exploring+the+impact+of+once‐daily+OROS®+methylphenidate+(MPH)+on+symptoms+and+quality+of+life+in+children+and+adolescents+with+ADHD+transitioning+from+immediate‐release+MPH+&author=A+Kordon&author=K+Stollhoff&author=K+Niederkirchner&author=F+Mattejat&author=K+Rettig&author=B+Schäuble&publication_year=2011&hl=en']",,https://doi.org/10.3810/pgm.2011.09.2457, Kordon 2011 {published data only}  ,included,CD012069-bbs2-0131,
CD012069-bib-0252,"Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer TJ, Biederman J, Wernicke J, et al. ","Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open‐label trial", Journal of the American Academy of Child and Adolescent Psychiatry ,2002,41,    ,['citation-journal']," Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer TJ, Biederman J, Wernicke J, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open‐label trial.  Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(7):776‐84. [DOI: 10.1097/00004583‐200207000‐00008; PUBMED: 12108801]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-200207000-00008', 'https://scholar.google.com/scholar_lookup?title=Atomoxetine+and+methylphenidate+treatment+in+children+with+ADHD:+a+prospective,+randomized,+open‐label+trial+&author=CJ+Kratochvil&author=JH+Heiligenstein&author=R+Dittmann&author=TJ+Spencer&author=J+Biederman&author=J+Wernicke&publication_year=2002&hl=en']",,https://doi.org/10.1097/00004583-200207000-00008, Kratochvil 2002 {published data only}  ,included,CD012069-bbs2-0132,
CD012069-bib-0253,"Kraut AA, Langner I, Lindemann C, Banaschewski T, Petermann U, Petermann F, et al. ",Comorbidities in ADHD children treated with methylphenidate: a database study, BMC Psychiatry ,2013,13,    ,['citation-journal']," Kraut AA, Langner I, Lindemann C, Banaschewski T, Petermann U, Petermann F, et al. Comorbidities in ADHD children treated with methylphenidate: a database study.  BMC Psychiatry 2013;13:11. [DOI: 10.1186/1471‐244X‐13‐11; PMC3544568; PUBMED: 23294623]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1471-244X-13-11', 'https://scholar.google.com/scholar_lookup?title=Comorbidities+in+ADHD+children+treated+with+methylphenidate:+a+database+study&author=AA+Kraut&author=I+Langner&author=C+Lindemann&author=T+Banaschewski&author=U+Petermann&author=F+Petermann&publication_year=2013&hl=en']",,https://doi.org/10.1186/1471-244X-13-11, Kraut 2013 {published data only}  ,included,CD012069-bbs2-0133,
CD012069-bib-0254,"Lahat E, Weiss M, Ben‐Shlomo A, Evans S, Bistritzer T. ",Bone mineral density and turnover in children with attention‐deficit hyperactivity disorder receiving methylphenidate, Journal of Child Neurology ,2000,15,    ,['citation-journal']," Lahat E, Weiss M, Ben‐Shlomo A, Evans S, Bistritzer T. Bone mineral density and turnover in children with attention‐deficit hyperactivity disorder receiving methylphenidate.  Journal of Child Neurology 2000;15(7):436‐9. [DOI: 10.1177/088307380001500702; PUBMED: 10921512]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/088307380001500702', 'https://scholar.google.com/scholar_lookup?title=Bone+mineral+density+and+turnover+in+children+with+attention‐deficit+hyperactivity+disorder+receiving+methylphenidate+&author=E+Lahat&author=M+Weiss&author=A+Ben‐Shlomo&author=S+Evans&author=T+Bistritzer&publication_year=2000&hl=en']",,https://doi.org/10.1177/088307380001500702, Lahat 2000 {published data only}  ,included,CD012069-bbs2-0134,
CD012069-bib-0255,"Lakic A, Kesic A, Dronjak D. ",Tics in children with attention‐deficit/hyperactivity disorder under treatment with the sustained‐release form of methylphenidate,,2012,,    ,['citation-other']," Lakic A, Kesic A, Dronjak D. Tics in children with attention‐deficit/hyperactivity disorder under treatment with the sustained‐release form of methylphenidate. European Neuropsychopharmacology2012; Vol. 22, issue Suppl 2:S420. [DOI: 10.1016/S0924‐977X(12)70658‐2]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Tics+in+children+with+attention‐deficit/hyperactivity+disorder+under+treatment+with+the+sustained‐release+form+of+methylphenidate+&author=A+Lakic&author=A+Kesic&author=D+Dronjak&publication_year=2012&hl=en']",,, Lakic 2012 {published data only}  ,included,CD012069-bbs2-0135,
CD012069-bib-0256,"Lamberti M, Italiano D, Guerriero L, D'Amico G, Siracusano R, Ingrassia M, et al. ",Evaluation of acute cardiovascular effects of immediate‐release methylphenidate in children and adolescents with attention‐deficit hyperactivity disorder, Neuropsychiatric Disease and Treatment ,2015,11,    ,['citation-journal']," Lamberti M, Italiano D, Guerriero L, D'Amico G, Siracusano R, Ingrassia M, et al. Evaluation of acute cardiovascular effects of immediate‐release methylphenidate in children and adolescents with attention‐deficit hyperactivity disorder.  Neuropsychiatric Disease and Treatment 2015;11:1169‐74. [DOI: 10.2147/NDT.S79866; PMC4431494; PUBMED: 26056451]CENTRAL    Google Scholar     ","['', ""https://scholar.google.com/scholar_lookup?title=Evaluation+of+acute+cardiovascular+effects+of+immediate‐release+methylphenidate+in+children+and+adolescents+with+attention‐deficit+hyperactivity+disorder+&author=M+Lamberti&author=D+Italiano&author=L+Guerriero&author=G+D'Amico&author=R+Siracusano&author=M+Ingrassia&publication_year=2015&hl=en""]",,, Lamberti 2015 {published data only}  ,included,CD012069-bbs2-0136,
CD012069-bib-0257,"Langevin R, Ramdé J. ","Attention deficit hyperactivity disorder (ADHD) in children, seasonal photoperiods, nocturnal movements and diurnal agitation", Journal of the Canadian Academy of Child and Adolescent Psychiatry ,2012,21,    ,['citation-journal']," Langevin R, Ramdé J. Attention deficit hyperactivity disorder (ADHD) in children, seasonal photoperiods, nocturnal movements and diurnal agitation.  Journal of the Canadian Academy of Child and Adolescent Psychiatry 2012;21(1):53‐8. [PMC3269251]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Attention+deficit+hyperactivity+disorder+(ADHD)+in+children,+seasonal+photoperiods,+nocturnal+movements+and+diurnal+agitation+&author=R+Langevin&author=J+Ramdé&publication_year=2012&hl=en']",,, Langevin 2012 {published data only}  ,included,CD012069-bbs2-0137,
CD012069-bib-0258,"Larrañaga‐Fragoso P, Noval S, Rivero JC, Boto‐de‐los‐Bueis A. ",The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder, Journal of AAPOS ,2015,19,    ,['citation-journal']," Larrañaga‐Fragoso P, Noval S, Rivero JC, Boto‐de‐los‐Bueis A. The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder.  Journal of AAPOS 2015;19(4):322‐6. [DOI: 10.1016/j.jaapos.2015.04.005; PUBMED: 26235791]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jaapos.2015.04.005', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+methylphenidate+on+refraction+and+anterior+segment+parameters+in+children+with+attention+deficit+hyperactivity+disorder+&author=P+Larrañaga‐Fragoso&author=S+Noval&author=JC+Rivero&author=A+Boto‐de‐los‐Bueis&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.jaapos.2015.04.005, Larrañaga‐Fragoso 2015 {published data only}  ,included,CD012069-bbs2-0138,
CD012069-bib-0259,"Lee SI, Hong SD, Kim S. ",Efficacy and tolerability of OROS methylphenidate in Korean children with AD/HD ‐ Reply,,2007,,    ,['citation-other']," Lee SI, Hong SD, Kim S. Efficacy and tolerability of OROS methylphenidate in Korean children with AD/HD ‐ Reply. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2007; Vol. 31, issue 5:1151‐2. [DOI: 10.1016/j.pnpbp.2007.03.019]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+tolerability+of+OROS+methylphenidate+in+Korean+children+with+AD/HD+‐+Reply+&author=SI+Lee&author=SD+Hong&author=S+Kim&publication_year=2007&hl=en']",,, Lee 2007 {published data only}  ,included,CD012069-bbs2-0139,
CD012069-bib-0260,"Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, et al. ",Efficacy and tolerability of OROS methylphenidate in Korean children with attention‐deficit/hyperactivity disorder, Progress in Neuro‐Psychopharmacology and Biological Psychiatry ,2007,31,    ,['citation-journal']," Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, et al. Efficacy and tolerability of OROS methylphenidate in Korean children with attention‐deficit/hyperactivity disorder.  Progress in Neuro‐Psychopharmacology and Biological Psychiatry 2007;31(1):210‐6. [DOI: 10.1016/j.pnpbp.2006.09.002; PUBMED: 17046131]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.pnpbp.2006.09.002', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+tolerability+of+OROS+methylphenidate+in+Korean+children+with+attention‐deficit/hyperactivity+disorder+&author=SI+Lee&author=SD+Hong&author=SY+Kim&author=EJ+Kim&author=JH+Kim&author=JH+Kim&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.pnpbp.2006.09.002, Lee 2007 {published data only}  ,included,CD012069-bbs2-0139,
CD012069-bib-0261,Pae CU. ,Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention‐deficit/hyperactivity disorder, Progress in Neuro‐Psychopharmacology and Biological Psychiatry ,2007,31,    ,['citation-journal'], Pae CU. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention‐deficit/hyperactivity disorder.  Progress in Neuro‐Psychopharmacology and Biological Psychiatry 2007;31(5):1151‐2. [DOI: 10.1016/j.pnpbp.2007.03.018]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/j.pnpbp.2007.03.018', 'https://scholar.google.com/scholar_lookup?title=Comments+on+efficacy+and+tolerability+of+OROS+methylphenidate+in+Korean+children+with+attention‐deficit/hyperactivity+disorder+&author=CU+Pae&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.pnpbp.2007.03.018, Lee 2007 {published data only}  ,included,CD012069-bbs2-0139,
CD012069-bib-0262,"Lee SH, Song DH, Kim BN, Joung YS, Ha EH, Cheon KA, et al. ",Variability of response time as a predictor of methylphenidate treatment response in Korean children with attention deficit hyperactivity disorder, Yonsei Medical Journal ,2009,50,    ,['citation-journal']," Lee SH, Song DH, Kim BN, Joung YS, Ha EH, Cheon KA, et al. Variability of response time as a predictor of methylphenidate treatment response in Korean children with attention deficit hyperactivity disorder.  Yonsei Medical Journal 2009;50(5):650‐5. [DOI: 10.3349/ymj.2009.50.5.650; PMC2768239; PUBMED: 19881968]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3349/ymj.2009.50.5.650', 'https://scholar.google.com/scholar_lookup?title=Variability+of+response+time+as+a+predictor+of+methylphenidate+treatment+response+in+Korean+children+with+attention+deficit+hyperactivity+disorder+&author=SH+Lee&author=DH+Song&author=BN+Kim&author=YS+Joung&author=EH+Ha&author=KA+Cheon&publication_year=2009&hl=en']",,https://doi.org/10.3349/ymj.2009.50.5.650, Lee 2009 {published data only}  ,included,CD012069-bbs2-0140,
CD012069-bib-0263,"Lee SH, Seo WS, Sung HM, Choi TY, Kim SY, Choi SJ, et al. ",Effect of methylphenidate on sleep parameters in children with ADHD, Psychiatry Investigation ,2012,9,    ,['citation-journal']," Lee SH, Seo WS, Sung HM, Choi TY, Kim SY, Choi SJ, et al. Effect of methylphenidate on sleep parameters in children with ADHD.  Psychiatry Investigation 2012;9(4):384‐90. [DOI: 10.4306/pi.2012.9.4.384; PMC3521116]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4306/pi.2012.9.4.384', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+on+sleep+parameters+in+children+with+ADHD&author=SH+Lee&author=WS+Seo&author=HM+Sung&author=TY+Choi&author=SY+Kim&author=SJ+Choi&publication_year=2012&hl=en']",,https://doi.org/10.4306/pi.2012.9.4.384, Lee 2012 {published data only}  ,included,CD012069-bbs2-0141,
CD012069-bib-0264,"Lee WJ, Lee TA, Pickard AS, Caskey RN, Schumock GT. ",Drugs associated with adverse events in children and adolescents, Pharmacotherapy ,2014,34,    ,['citation-journal']," Lee WJ, Lee TA, Pickard AS, Caskey RN, Schumock GT. Drugs associated with adverse events in children and adolescents.  Pharmacotherapy 2014;34(9):918‐26. [DOI: 10.1002/phar.1455; PUBMED: 24990656]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/phar.1455', 'https://scholar.google.com/scholar_lookup?title=Drugs+associated+with+adverse+events+in+children+and+adolescents&author=WJ+Lee&author=TA+Lee&author=AS+Pickard&author=RN+Caskey&author=GT+Schumock&publication_year=2014&hl=en']",,https://doi.org/10.1002/phar.1455, Lee 2014 {published data only}  ,included,CD012069-bbs2-0142,
CD012069-bib-0265,"Lewis H, Lewis J. ",Safe and effective methylphenidate therapy in a pediatric patient with glaucoma,,2012,,    ,['citation-other']," Lewis H, Lewis J. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma. ADHD Attention Deficit and Hyperactivity Disorders2012; Vol. 4, issue 1:37‐9. [DOI: 10.1007/s12402‐012‐0071‐9; PUBMED: 22311620]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Safe+and+effective+methylphenidate+therapy+in+a+pediatric+patient+with+glaucoma&author=H+Lewis&author=J+Lewis&publication_year=2012&hl=en']",,, Lewis 2012 {published data only}  ,included,CD012069-bbs2-0143,
CD012069-bib-0266,"Li JJ, Li ZW, Wang SZ, Qi FH, Zhao L, Lv H, et al. ",Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder,,2011,,    ,['citation-other']," Li JJ, Li ZW, Wang SZ, Qi FH, Zhao L, Lv H, et al. Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder. Psychopharmacology2011; Vol. 216, issue 4:501‐9. [DOI: 10.1007/s00213‐011‐2238‐z; PUBMED: 21416235]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Ningdong+granule:+a+complementary+and+alternative+therapy+in+the+treatment+of+attention+deficit/hyperactivity+disorder+&author=JJ+Li&author=ZW+Li&author=SZ+Wang&author=FH+Qi&author=L+Zhao&author=H+Lv&publication_year=2011&hl=en']",,, Li 2011 {published data only}  ,included,CD012069-bbs2-0144,
CD012069-bib-0267,,Dexmethylphenidate in youth with ADHD and Tourette's, Brown University Child and Adolescent Psychopharmacology Update ,2010,12,   ,['citation-journal'], Dexmethylphenidate in youth with ADHD and Tourette's.  Brown University Child and Adolescent Psychopharmacology Update 2010;12(11):4‐5. [DOI: 10.1002/cpu.20127]CENTRAL    ,[''],,, Lyon 2010 {published data only}  ,included,CD012069-bbs2-0145,
CD012069-bib-0268,"Lyon GJ, Coffey B, Castellanos XF, Woods D. ",Improving TIC‐related response inhibition: comparing the effects of dexmethylphenidate to placebo in children and adolescents with ADHD and chronic TIC disorders, International Journal of Neuropsychopharmacology ,2008,11,    ,['citation-journal']," Lyon GJ, Coffey B, Castellanos XF, Woods D. Improving TIC‐related response inhibition: comparing the effects of dexmethylphenidate to placebo in children and adolescents with ADHD and chronic TIC disorders.  International Journal of Neuropsychopharmacology 2008;11(Suppl 1):292. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Improving+TIC‐related+response+inhibition:+comparing+the+effects+of+dexmethylphenidate+to+placebo+in+children+and+adolescents+with+ADHD+and+chronic+TIC+disorders+&author=GJ+Lyon&author=B+Coffey&author=XF+Castellanos&author=D+Woods&publication_year=2008&hl=en']",,, Lyon 2010 {published data only}  ,included,CD012069-bbs2-0145,
CD012069-bib-0269,"Lyon GJ, Coffey B, Woods D, Samar S, Conelea C, Bauer CC, et al. ",Improving tic‐related response inhibition: comparing the effects of dexmethylphenidate to no medication in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and chronic tic disorders, Journal of Child and Adolescent Psychopharmacology ,2010,20,    ,['citation-journal']," Lyon GJ, Coffey B, Woods D, Samar S, Conelea C, Bauer CC, et al. Improving tic‐related response inhibition: comparing the effects of dexmethylphenidate to no medication in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and chronic tic disorders.  Journal of Child and Adolescent Psychopharmacology 2010;20(6):537‐8. [DOI: 10.1089/cap.2010.2064]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Improving+tic‐related+response+inhibition:+comparing+the+effects+of+dexmethylphenidate+to+no+medication+in+children+and+adolescents+with+Attention+Deficit+Hyperactivity+Disorder+(ADHD)+and+chronic+tic+disorders+&author=GJ+Lyon&author=B+Coffey&author=D+Woods&author=S+Samar&author=C+Conelea&author=CC+Bauer&publication_year=2010&hl=en']",,, Lyon 2010 {published data only}  ,included,CD012069-bbs2-0145,
CD012069-bib-0270,"Lyon GJ, Samar SM, Conelea C, Trujillo MR, Lipinski CM, Bauer CC, et al. ",Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention‐deficit/hyperactivity disorder and Tourette's disorder, Journal of Child and Adolescent Psychopharmacology ,2010,20,    ,['citation-journal']," Lyon GJ, Samar SM, Conelea C, Trujillo MR, Lipinski CM, Bauer CC, et al. Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention‐deficit/hyperactivity disorder and Tourette's disorder.  Journal of Child and Adolescent Psychopharmacology 2010;20(4):283‐9. [DOI: 10.1089/cap.2010.0032]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2010.0032', ""https://scholar.google.com/scholar_lookup?title=Testing+tic+suppression:+comparing+the+effects+of+dexmethylphenidate+to+no+medication+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+and+Tourette's+disorder+&author=GJ+Lyon&author=SM+Samar&author=C+Conelea&author=MR+Trujillo&author=CM+Lipinski&author=CC+Bauer&publication_year=2010&hl=en""]",,https://doi.org/10.1089/cap.2010.0032, Lyon 2010 {published data only}  ,included,CD012069-bbs2-0145,
CD012069-bib-0272,,Methylphenidate for preschool ADHD, Brown University Child and Adolescent Psychopharmacology Update ,2009,11,   ,['citation-journal'], Methylphenidate for preschool ADHD.  Brown University Child and Adolescent Psychopharmacology Update 2009;11(7):4‐4. [DOI: 10.1002/cpu.20095]CENTRAL    ,[''],,, Maayan 2009 {published data only}  ,included,CD012069-bbs2-0146,
CD012069-bib-0271,"Maayan L, Paykina N, Fried J, Strauss T, Gugga SS, Greenhill L. ",The open‐label treatment of attention‐deficit/hyperactivity disorder in 4‐ and 5‐year‐old children with beaded methylphenidate, Journal of Child and Adolescent Psychopharmacology ,2009,19,    ,['citation-journal']," Maayan L, Paykina N, Fried J, Strauss T, Gugga SS, Greenhill L. The open‐label treatment of attention‐deficit/hyperactivity disorder in 4‐ and 5‐year‐old children with beaded methylphenidate.  Journal of Child and Adolescent Psychopharmacology 2009;19(2):147‐53. [PMC2935832; PUBMED: 19374023]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2008.053', 'https://scholar.google.com/scholar_lookup?title=The+open‐label+treatment+of+attention‐deficit/hyperactivity+disorder+in+4‐+and+5‐year‐old+children+with+beaded+methylphenidate+&author=L+Maayan&author=N+Paykina&author=J+Fried&author=T+Strauss&author=SS+Gugga&author=L+Greenhill&publication_year=2009&hl=en']",,https://doi.org/10.1089/cap.2008.053, Maayan 2009 {published data only}  ,included,CD012069-bbs2-0146,
CD012069-bib-0273,"MacDonald Fredericks E, Kollins SH. ",A pilot study of methylphenidate preference assessment in children diagnosed with attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2005,15,    ,['citation-journal']," MacDonald Fredericks E, Kollins SH. A pilot study of methylphenidate preference assessment in children diagnosed with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2005;15(5):729‐41. [DOI: 10.1089/cap.2005.15.729; PUBMED: 16262590]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2005.15.729', 'https://scholar.google.com/scholar_lookup?title=A+pilot+study+of+methylphenidate+preference+assessment+in+children+diagnosed+with+attention‐deficit/hyperactivity+disorder+&author=E+MacDonaldFredericks&author=SH+Kollins&publication_year=2005&hl=en']",,https://doi.org/10.1089/cap.2005.15.729, MacDonald 2005 {published data only}  ,included,CD012069-bbs2-0147,
CD012069-bib-0274,"Machado A, Cerqueira J, Rodrigues M, Soares‐Fernandes J. ",Is methylphenidate‐induced chorea responsive to chlorpromazine?, Journal of Neuropsychiatry and Clinical Neurosciences ,2010,22,    ,['citation-journal']," Machado A, Cerqueira J, Rodrigues M, Soares‐Fernandes J. Is methylphenidate‐induced chorea responsive to chlorpromazine?.  Journal of Neuropsychiatry and Clinical Neurosciences 2010;22(3):352.e20. [DOI: 10.1176/jnp.2010.22.3.352.e20; PUBMED: 20686158]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1176/jnp.2010.22.3.352.e20', 'https://scholar.google.com/scholar_lookup?title=Is+methylphenidate‐induced+chorea+responsive+to+chlorpromazine?&author=A+Machado&author=J+Cerqueira&author=M+Rodrigues&author=J+Soares‐Fernandes&publication_year=2010&hl=en']",,https://doi.org/10.1176/jnp.2010.22.3.352.e20, Machado 2010 {published data only}  ,included,CD012069-bbs2-0148,
CD012069-bib-0276,Maia CR. ,,Evalution of the Exchange of Immediate Release Methylphenidate for Prolonged Release Methylphenidate in Attention Deficit/Hyperactivity Disorder [Availação da troca do metilfenidato de liberação imediata para o metilfenidato de liberação prolongada no transtorno de déficit de atenção/hiperatividade] [Masters thesis],2009,,   ,['citation-book']," Maia CR. Evalution of the Exchange of Immediate Release Methylphenidate for Prolonged Release Methylphenidate in Attention Deficit/Hyperactivity Disorder [Availação da troca do metilfenidato de liberação imediata para o metilfenidato de liberação prolongada no transtorno de déficit de atenção/hiperatividade] [Masters thesis]. Rio Grande (BZ): The Federal University of Rio Grande, 2009. CENTRAL    ",[''],,, Maia 2008 {published data only}  ,included,CD012069-bbs2-0149,
CD012069-bib-0275,"Maia CR, Matte BC, Ludwig HT, Rohde LA. ",Switching from methylphenidate immediate release to MPH‐SODAS in attention‐deficit/hyperactivity disorder, European Child and Adolescent Psychiatry ,2008,17,    ,['citation-journal']," Maia CR, Matte BC, Ludwig HT, Rohde LA. Switching from methylphenidate immediate release to MPH‐SODAS in attention‐deficit/hyperactivity disorder.  European Child and Adolescent Psychiatry 2008;17(3):133‐42. [DOI: 10.1007/s00787‐007‐0647‐7; PUBMED: 17846812]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-007-0647-7', 'https://scholar.google.com/scholar_lookup?title=Switching+from+methylphenidate+immediate+release+to+MPH‐SODAS+in+attention‐deficit/hyperactivity+disorder+&author=CR+Maia&author=BC+Matte&author=HT+Ludwig&author=LA+Rohde&publication_year=2008&hl=en']",,https://doi.org/10.1007/s00787-007-0647-7, Maia 2008 {published data only}  ,included,CD012069-bbs2-0149,
CD012069-bib-0277,"Man KK, Chan EW, Coghill D, Douglas I, Douglas I, Ip P, et al. ",Methylphenidate and the risk of trauma, Pediatrics ,2015,135,    ,['citation-journal']," Man KK, Chan EW, Coghill D, Douglas I, Douglas I, Ip P, et al. Methylphenidate and the risk of trauma.  Pediatrics 2015;135(1):40‐8. [DOI: 10.1542/peds.2014‐1738; PUBMED: 25511122]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2014-1738', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+the+risk+of+trauma&author=KK+Man&author=EW+Chan&author=D+Coghill&author=I+Douglas&author=I+Douglas&author=P+Ip&publication_year=2015&hl=en']",,https://doi.org/10.1542/peds.2014-1738, Man 2015 {published data only}  ,included,CD012069-bbs2-0150,
CD012069-bib-0278,"Mayes SD, Crites DL, Bixler EO, Humphrey FJ, Mattison RE. ","Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status", Developmental Medicine and Child Neurology ,1994,36,    ,['citation-journal']," Mayes SD, Crites DL, Bixler EO, Humphrey FJ, Mattison RE. Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status.  Developmental Medicine and Child Neurology 1994;36(12):1099‐107. [PUBMED: 7525394]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1469-8749.1994.tb11811.x', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+ADHD:+influence+of+age,+IQ+and+neurodevelopmental+status&author=SD+Mayes&author=DL+Crites&author=EO+Bixler&author=FJ+Humphrey&author=RE+Mattison&publication_year=1994&hl=en']",7525394,https://doi.org/10.1111/j.1469-8749.1994.tb11811.x, Mayes 1994 {published data only}  ,included,CD012069-bbs2-0151,
CD012069-bib-0279,"McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. ","Mortality associated with attention‐deficit hyperactivity disorder: a retrospective cohort study of children, adolescents and young adults using the general practice research database", Drug Safety ,2009,32,    ,['citation-journal']," McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. Mortality associated with attention‐deficit hyperactivity disorder: a retrospective cohort study of children, adolescents and young adults using the general practice research database.  Drug Safety 2009;32(11):1089‐96. [DOI: 10.2165/11317630‐000000000‐00000; PUBMED: 19810780]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2165/11317630-000000000-00000', 'https://scholar.google.com/scholar_lookup?title=Mortality+associated+with+attention‐deficit+hyperactivity+disorder:+a+retrospective+cohort+study+of+children,+adolescents+and+young+adults+using+the+general+practice+research+database+&author=S+McCarthy&author=N+Cranswick&author=L+Potts&author=E+Taylor&author=IC+Wong&publication_year=2009&hl=en']",,https://doi.org/10.2165/11317630-000000000-00000, McCarthy 2009 {published data only}  ,included,CD012069-bbs2-0152,
CD012069-bib-0280,"Loo SK, Bilder R, Cho AL, Sturm A, Cowen J, Welker PW, et al. ","Effects of d‐Methylphenidate, Guanfacine, and their combination on electroencephalogram resting state spectral power in Attention‐Deficit/Hyperactivity Disorder", Journal of the American Academy of Child and Adolescent Psychiatry ,2016,55,    ,['citation-journal']," Loo SK, Bilder R, Cho AL, Sturm A, Cowen J, Welker PW, et al. Effects of d‐Methylphenidate, Guanfacine, and their combination on electroencephalogram resting state spectral power in Attention‐Deficit/Hyperactivity Disorder.  Journal of the American Academy of Child and Adolescent Psychiatry 2016;55(8):674‐82.e1. [DOI: 10.1016/j.jaac.2016.04.020; PMC5003618; PUBMED: 27453081]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jaac.2016.04.020', 'https://scholar.google.com/scholar_lookup?title=Effects+of+d‐Methylphenidate,+Guanfacine,+and+their+combination+on+electroencephalogram+resting+state+spectral+power+in+Attention‐Deficit/Hyperactivity+Disorder+&author=SK+Loo&author=R+Bilder&author=AL+Cho&author=A+Sturm&author=J+Cowen&author=PW+Welker&publication_year=2016&hl=en']",,https://doi.org/10.1016/j.jaac.2016.04.020, McCracken 2016 {published data only}  ,included,CD012069-bbs2-0153,
CD012069-bib-0281,"McCracken JT, McGough JJ, Loo SK, Levitt J, Del'Homme M, Cowen J, et al. ","Combined stimulant and Guanfacine administration in Attention‐Deficit/Hyperactivity Disorder: a controlled, comparative study", Journal of the American Academy of Child and Adolescent Psychiatry ,2016,55,    ,['citation-journal']," McCracken JT, McGough JJ, Loo SK, Levitt J, Del'Homme M, Cowen J, et al. Combined stimulant and Guanfacine administration in Attention‐Deficit/Hyperactivity Disorder: a controlled, comparative study.  Journal of the American Academy of Child and Adolescent Psychiatry 2016;55(8):657‐66.e1. [DOI: 10.1016/j.jaac.2016.05.015; PMC4976782; PUBMED: 27453079]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jaac.2016.05.015', ""https://scholar.google.com/scholar_lookup?title=Combined+stimulant+and+Guanfacine+administration+in+Attention‐Deficit/Hyperactivity+Disorder:+a+controlled,+comparative+study+&author=JT+McCracken&author=JJ+McGough&author=SK+Loo&author=J+Levitt&author=M+Del'Homme&author=J+Cowen&publication_year=2016&hl=en""]",,https://doi.org/10.1016/j.jaac.2016.05.015, McCracken 2016 {published data only}  ,included,CD012069-bbs2-0153,
CD012069-bib-0282,"McLaren JL, Cauble S, Barnett RJ. ",Aripiprazole induced acute dystonia after discontinuation of a stimulant medication, Journal of Clinical Psychopharmacology ,2010,30,    ,['citation-journal']," McLaren JL, Cauble S, Barnett RJ. Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.  Journal of Clinical Psychopharmacology 2010;30(1):77‐8. [DOI: 10.1097/JCP.0b013e3181c92eb2; PUBMED: 20075654]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0b013e3181c92eb2', 'https://scholar.google.com/scholar_lookup?title=Aripiprazole+induced+acute+dystonia+after+discontinuation+of+a+stimulant+medication&author=JL+McLaren&author=S+Cauble&author=RJ+Barnett&publication_year=2010&hl=en']",,https://doi.org/10.1097/JCP.0b013e3181c92eb2, McLaren 2010 {published data only}  ,included,CD012069-bbs2-0154,
CD012069-bib-0283,"Miller‐Horn JW, Kaleyias J, Valencia I, Melvin JJ, Khurana DS, Hardison HH, et al. ",Efficacy and tolerability of ADHD medications in a clinical practice, Journal of Pediatric Neurology ,2008,6,    ,['citation-journal']," Miller‐Horn JW, Kaleyias J, Valencia I, Melvin JJ, Khurana DS, Hardison HH, et al. Efficacy and tolerability of ADHD medications in a clinical practice.  Journal of Pediatric Neurology 2008;6(1):5‐10. [DOI: 10.1055/s‐0035‐1557417]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1055/s-0035-1557417', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+tolerability+of+ADHD+medications+in+a+clinical+practice&author=JW+Miller‐Horn&author=J+Kaleyias&author=I+Valencia&author=JJ+Melvin&author=DS+Khurana&author=HH+Hardison&publication_year=2008&hl=en']",,https://doi.org/10.1055/s-0035-1557417, Miller‐Horn 2008 {published data only}  ,included,CD012069-bbs2-0155,
CD012069-bib-0284,"Mino Y, Aoki S. ",Methylphenidate‐induced psychosis in an adolescent with hyperkinetic disorder, Kawasaki Medical Journal ,1999,25,    ,['citation-journal']," Mino Y, Aoki S. Methylphenidate‐induced psychosis in an adolescent with hyperkinetic disorder.  Kawasaki Medical Journal 1999;25(2):81‐5. [DOI: 10.11482/KMJ25(2)81‐85.1999.pdf]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐induced+psychosis+in+an+adolescent+with+hyperkinetic+disorder&author=Y+Mino&author=S+Aoki&publication_year=1999&hl=en']",,, Mino 1999 {published data only}  ,included,CD012069-bbs2-0156,
CD012069-bib-0285,"Mino Y, Ohara H, Nagamatsu I, Nagamatsu K. ",Methylphenidate psychosis in an adolescent with attention deficit disorder,,1986,,    ,['citation-other']," Mino Y, Ohara H, Nagamatsu I, Nagamatsu K. Methylphenidate psychosis in an adolescent with attention deficit disorder. Japanese Journal of Child and Adolescent Psychiatry1986; Vol. 27, issue 3:178‐87. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+psychosis+in+an+adolescent+with+attention+deficit+disorder&author=Y+Mino&author=H+Ohara&author=I+Nagamatsu&author=K+Nagamatsu&publication_year=1986&hl=en']",,, Mino 1999 {published data only}  ,included,CD012069-bbs2-0156,
CD012069-bib-0286,Mize W. ,Hemoencephalography ‐ a new therapy for attention deficit hyperactivity disorder (ADHD): case report, Journal of Neurotherapy ,2004,8,    ,['citation-journal'], Mize W. Hemoencephalography ‐ a new therapy for attention deficit hyperactivity disorder (ADHD): case report.  Journal of Neurotherapy 2004;8(3):77‐97. [DOI: 10.1300/J184v0803_06]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1300/J184v08n03_06', 'https://scholar.google.com/scholar_lookup?title=Hemoencephalography+‐+a+new+therapy+for+attention+deficit+hyperactivity+disorder+(ADHD):+case+report+&author=W+Mize&publication_year=2004&hl=en']",,https://doi.org/10.1300/J184v08n03_06, Mize 2004 {published data only}  ,included,CD012069-bbs2-0157,
CD012069-bib-0287,"Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S. ",Efficacy of theophylline compared to methylphenidate for the treatment of attention‐deficit hyperactivity disorder in children and adolescents: a pilot double‐blind randomized trial, Journal of Clinical Pharmacy and Therapeutics ,2004,29,    ,['citation-journal']," Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S. Efficacy of theophylline compared to methylphenidate for the treatment of attention‐deficit hyperactivity disorder in children and adolescents: a pilot double‐blind randomized trial.  Journal of Clinical Pharmacy and Therapeutics 2004;29(2):139‐44. [DOI: 10.1111/j.1365‐2710.2004.00545.x; PUBMED: 15068402]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1365-2710.2004.00545.x', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+theophylline+compared+to+methylphenidate+for+the+treatment+of+attention‐deficit+hyperactivity+disorder+in+children+and+adolescents:+a+pilot+double‐blind+randomized+trial+&author=MR+Mohammadi&author=L+Kashani&author=S+Akhondzadeh&author=ES+Izadian&author=S+Ohadinia&publication_year=2004&hl=en']",,https://doi.org/10.1111/j.1365-2710.2004.00545.x, Mohammadi 2004 {published data only}  ,included,CD012069-bbs2-0158,
CD012069-bib-0288,"Mohammadi MR, Akhondzadeh S, Mehr NK, Mohammadi M, Mahintorabi S. ",Comparison of Stimdate with Ritalin in children and adolescents with attention deficit hyperactivity disorder, Iranian Journal of Psychiatry ,2009,4,    ,['citation-journal']," Mohammadi MR, Akhondzadeh S, Mehr NK, Mohammadi M, Mahintorabi S. Comparison of Stimdate with Ritalin in children and adolescents with attention deficit hyperactivity disorder.  Iranian Journal of Psychiatry 2009;4(1):31‐4. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+Stimdate+with+Ritalin+in+children+and+adolescents+with+attention+deficit+hyperactivity+disorder+&author=MR+Mohammadi&author=S+Akhondzadeh&author=NK+Mehr&author=M+Mohammadi&author=S+Mahintorabi&publication_year=2009&hl=en']",,, Mohammadi 2009 {published data only}  ,included,CD012069-bbs2-0159,
CD012069-bib-0289,"Mohammadi MR, Kazemi MR, Zia E, Rezazadeh SA, Tabrizi M, Akhondzadeh S. ","Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐blind trial", Human Psychopharmacology ,2010,25,    ,['citation-journal']," Mohammadi MR, Kazemi MR, Zia E, Rezazadeh SA, Tabrizi M, Akhondzadeh S. Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐blind trial.  Human Psychopharmacology 2010;25(7‐8):560‐5. [DOI: 10.1002/hup.1154; PUBMED: 21312290]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/hup.1154', 'https://scholar.google.com/scholar_lookup?title=Amantadine+versus+methylphenidate+in+children+and+adolescents+with+attention+deficit/hyperactivity+disorder:+a+randomized,+double‐blind+trial+&author=MR+Mohammadi&author=MR+Kazemi&author=E+Zia&author=SA+Rezazadeh&author=M+Tabrizi&author=S+Akhondzadeh&publication_year=2010&hl=en']",,https://doi.org/10.1002/hup.1154, Mohammadi 2010 {published data only}  ,included,CD012069-bbs2-0160,
CD012069-bib-0290,"Mohammadi MR, Mostafavi SA, Keshavarz SA, Eshraghian MR, Hosseinzadeh P, Hosseinzadeh‐Attar MJ, et al. ",Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial, Iranian Journal of Psychiatry ,2012,7,    ,['citation-journal']," Mohammadi MR, Mostafavi SA, Keshavarz SA, Eshraghian MR, Hosseinzadeh P, Hosseinzadeh‐Attar MJ, et al. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial.  Iranian Journal of Psychiatry 2012;7(2):87‐92. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Melatonin+effects+in+methylphenidate+treated+children+with+attention+deficit+hyperactivity+disorder:+a+randomized+double+blind+clinical+trial+&author=MR+Mohammadi&author=SA+Mostafavi&author=SA+Keshavarz&author=MR+Eshraghian&author=P+Hosseinzadeh&author=MJ+Hosseinzadeh‐Attar&publication_year=2012&hl=en']",,, Mohammadi 2012a {published data only}  ,included,CD012069-bbs2-0161,
CD012069-bib-0291,"Mostafavi SA, Mohammadi MR, Hosseinzadeh P, Eshraghian MR, Akhondzadeh S, Hosseinzadeh‐Attar MJ, et al. ","Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co‐administration: through circadian cycle modification or appetite enhancement?", Iranian Journal of Psychiatry ,2012,7,    ,['citation-journal']," Mostafavi SA, Mohammadi MR, Hosseinzadeh P, Eshraghian MR, Akhondzadeh S, Hosseinzadeh‐Attar MJ, et al. Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co‐administration: through circadian cycle modification or appetite enhancement?.  Iranian Journal of Psychiatry 2012;7(3):114‐9. [PMC3488866; PUBMED: 23139692]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Dietary+intake,+growth+and+development+of+children+with+ADHD+in+a+randomized+clinical+trial+of+Ritalin+and+Melatonin+co‐administration:+through+circadian+cycle+modification+or+appetite+enhancement?+&author=SA+Mostafavi&author=MR+Mohammadi&author=P+Hosseinzadeh&author=MR+Eshraghian&author=S+Akhondzadeh&author=MJ+Hosseinzadeh‐Attar&publication_year=2012&hl=en']",,, Mohammadi 2012a {published data only}  ,included,CD012069-bbs2-0161,
CD012069-bib-0292,"Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S. ",Buspirone versus methylphenidate in the treatment of children with attention‐ deficit/ hyperactivity disorder: randomized double‐blind study, Acta Medica Iranica ,2012,50,    ,['citation-journal']," Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S. Buspirone versus methylphenidate in the treatment of children with attention‐ deficit/ hyperactivity disorder: randomized double‐blind study.  Acta Medica Iranica 2012;50(11):723‐8. [PUBMED: 23292622]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Buspirone+versus+methylphenidate+in+the+treatment+of+children+with+attention‐+deficit/+hyperactivity+disorder:+randomized+double‐blind+study+&author=MR+Mohammadi&author=P+Hafezi&author=A+Galeiha&author=R+Hajiaghaee&author=S+Akhondzadeh&publication_year=2012&hl=en']",23292622,, Mohammadi 2012b {published data only}  ,included,CD012069-bbs2-0162,
CD012069-bib-0293,"Montañés Rada F, Martínez Granero MA, Vidal Formoso M, Sanchez Romero S, Andrés Prado MJ. ","Extended release methylphenidate (medikinet®) twice a day, a prospective open trial", Revista de Psiquiatria Infanto‐Juvenil ,2012,29,    ,['citation-journal']," Montañés Rada F, Martínez Granero MA, Vidal Formoso M, Sanchez Romero S, Andrés Prado MJ. Extended release methylphenidate (medikinet®) twice a day, a prospective open trial [Metilfenidato de liberación prolongada 50/50 (medikinet®) dos veces al día, estudio abierto prospectivo].  Revista de Psiquiatria Infanto‐Juvenil 2012;29(1):50‐8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Extended+release+methylphenidate+(medikinet®)+twice+a+day,+a+prospective+open+trial&author=F+MontañésRada&author=MA+MartínezGranero&author=M+VidalFormoso&author=S+SanchezRomero&author=MJ+AndrésPrado&publication_year=2012&hl=en']",,, Montañés‐Rada 2012 {published data only}  ,included,CD012069-bbs2-0163,
CD012069-bib-0294,"Montiel‐Nava C, Peña JA, Espina‐Mariñes G, Ferrer‐Hernandez ME, López‐Rubio A, Puertas‐Sánchez S, et al. ",A pilot study of methylphenidate and parent training in the treatment of children with attention deficit hyperactivity disorder, Revista de Neurologia ,2002,35,    ,['citation-journal']," Montiel‐Nava C, Peña JA, Espina‐Mariñes G, Ferrer‐Hernandez ME, López‐Rubio A, Puertas‐Sánchez S, et al. A pilot study of methylphenidate and parent training in the treatment of children with attention deficit hyperactivity disorder [Estudio piloto de metilfenidato y entrenamiento a padres en el tratamiento de niños con trastorno por déficit de atención‐hiperactividad].  Revista de Neurologia 2002;35(3):201‐5. [PUBMED: 12235578]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+pilot+study+of+methylphenidate+and+parent+training+in+the+treatment+of+children+with+attention+deficit+hyperactivity+disorder+&author=C+Montiel‐Nava&author=JA+Peña&author=G+Espina‐Mariñes&author=ME+Ferrer‐Hernandez&author=A+López‐Rubio&author=S+Puertas‐Sánchez&publication_year=2002&hl=en']",12235578,, Montiel‐Nava 2002 {published data only}  ,included,CD012069-bbs2-0164,
CD012069-bib-0295,"Moungnoi P, Maipang P. ",Long‐term effects of short‐acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health, Journal of the Medical Association of Thailand ,2011,94,    ,['citation-journal']," Moungnoi P, Maipang P. Long‐term effects of short‐acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.  Journal of the Medical Association of Thailand 2011;94(Suppl 3):S158‐63. [PUBMED: 22043770]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Long‐term+effects+of+short‐acting+methylphenidate+on+growth+rates+of+children+with+attention+deficit+hyperactivity+disorder+at+Queen+Sirikit+National+Institute+of+Child+Health+&author=P+Moungnoi&author=P+Maipang&publication_year=2011&hl=en']",22043770,, Moungnoi 2011 {published data only}  ,included,CD012069-bbs2-0165,
CD012069-bib-0296,"Munk K, Gormsen L, Kim WY, Andersen NH. ",Cardiac arrest following a myocardial infarction in a child treated with methylphenidate, Case Reports in Pediatrics ,2015,2015,    ,['citation-journal']," Munk K, Gormsen L, Kim WY, Andersen NH. Cardiac arrest following a myocardial infarction in a child treated with methylphenidate.  Case Reports in Pediatrics 2015;2015:905097. [DOI: 10.1155/2015/905097]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1155/2015/905097', 'https://scholar.google.com/scholar_lookup?title=Cardiac+arrest+following+a+myocardial+infarction+in+a+child+treated+with+methylphenidate&author=K+Munk&author=L+Gormsen&author=WY+Kim&author=NH+Andersen&publication_year=2015&hl=en']",,https://doi.org/10.1155/2015/905097, Munk 2015 {published data only}  ,included,CD012069-bbs2-0166,
CD012069-bib-0297,"Lee MS, Lee SI, Hong SD, Kim JH, Choi J, Joung YS. ","Two different solicitation methods for obtaining information on adverse events associated with methylphenidate in adolescents: a 12‐week multicenter, open‐label study", Journal of Child and Adolescent Psychopharmacology ,2013,23,    ,['citation-journal']," Lee MS, Lee SI, Hong SD, Kim JH, Choi J, Joung YS. Two different solicitation methods for obtaining information on adverse events associated with methylphenidate in adolescents: a 12‐week multicenter, open‐label study.  Journal of Child and Adolescent Psychopharmacology 2013;23(1):22‐7. [DOI: 10.1089/cap.2012.0018; PUBMED: 23347125]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2012.0018', 'https://scholar.google.com/scholar_lookup?title=Two+different+solicitation+methods+for+obtaining+information+on+adverse+events+associated+with+methylphenidate+in+adolescents:+a+12‐week+multicenter,+open‐label+study+&author=MS+Lee&author=SI+Lee&author=SD+Hong&author=JH+Kim&author=J+Choi&author=YS+Joung&publication_year=2013&hl=en']",,https://doi.org/10.1089/cap.2012.0018, Na 2013 {published and unpublished data}  ,included,CD012069-bbs2-0167,
CD012069-bib-0298,"Na KS, Lee SI, Hong SD, Kim JH, Shim SH, Choi J, et al. ",Effect of osmotic‐release oral system methylphenidate on learning skills in adolescents with attention‐deficit/hyperactivity disorder: an open‐label study, International Clinical Psychopharmacology ,2013,28,    ,['citation-journal']," Na KS, Lee SI, Hong SD, Kim JH, Shim SH, Choi J, et al. Effect of osmotic‐release oral system methylphenidate on learning skills in adolescents with attention‐deficit/hyperactivity disorder: an open‐label study.  International Clinical Psychopharmacology 2013;28(4):184‐92. [DOI: 10.1097/YIC.0b013e3283612509; PUBMED: 23587983]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/YIC.0b013e3283612509', 'https://scholar.google.com/scholar_lookup?title=Effect+of+osmotic‐release+oral+system+methylphenidate+on+learning+skills+in+adolescents+with+attention‐deficit/hyperactivity+disorder:+an+open‐label+study+&author=KS+Na&author=SI+Lee&author=SD+Hong&author=JH+Kim&author=SH+Shim&author=J+Choi&publication_year=2013&hl=en']",,https://doi.org/10.1097/YIC.0b013e3283612509, Na 2013 {published and unpublished data}  ,included,CD012069-bbs2-0167,
CD012069-bib-0299,Niederhofer H. ,Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?, Psychiatria Danubina ,2009,21,    ,['citation-journal'], Niederhofer H. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?.  Psychiatria Danubina 2009;21(3):330. [PUBMED: 19794351]CENTRAL    Google Scholar     ,"['', ""https://scholar.google.com/scholar_lookup?title=Atomoxetine+may+improve+methylphenidates'+efficacy+in+treatment+of+ADHD?&author=H+Niederhofer&publication_year=2009&hl=en""]",19794351,, Niederhofer 2009 {published data only}  ,included,CD012069-bbs2-0168,
CD012069-bib-0300,Niederhofer H. ,"Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication]",,,,   ,['citation-other']," Niederhofer H. Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication]. Email to: HB Krogh 31 July 2013. CENTRAL    ",[''],,, Niederhofer 2009 {published data only}  ,included,CD012069-bbs2-0168,
CD012069-bib-0301,Niederhofer H. ,"Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine", Medical Hypotheses ,2011,76,    ,['citation-journal']," Niederhofer H. Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.  Medical Hypotheses 2011;76(5):764‐5. [DOI: 10.1016/j.mehy.2011.02.011; PUBMED: 21397406]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.mehy.2011.02.011', 'https://scholar.google.com/scholar_lookup?title=Combining+carbamazepine,+neuroleptics+and+acetylcholinesterase+inhibitors+with+methylphenidate+only+reduces+adverse+side+effects,+but+is+less+effective+than+a+combination+with+atomoxetine+&author=H+Niederhofer&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.mehy.2011.02.011, Niederhofer 2011 {published data only}  ,included,CD012069-bbs2-0169,
CD012069-bib-0302,Ghanizadeh A. ,"A commentary on ""A young man with acute dilated cardiomyopathy associated with methylphenidate""", Vascular Health and Risk Management ,2009,5,    ,['citation-journal']," Ghanizadeh A. A commentary on ""A young man with acute dilated cardiomyopathy associated with methylphenidate"".  Vascular Health and Risk Management 2009;5(2):525‐6. [DOI: 10.2147/VHRM.S5108]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2147/VHRM.S5108', 'https://scholar.google.com/scholar_lookup?title=A+commentary+on+']",,https://doi.org/10.2147/VHRM.S5108, Nymark 2008 {published data only}  ,included,CD012069-bbs2-0170,
CD012069-bib-0303,"Nymark TB, Hovland A, Bjørnstad H, Nielsen EW. ",A young man with acute dilated cardiomyopathy associated with methylphenidate, Vascular Health and Risk Management ,2008,4,    ,['citation-journal']," Nymark TB, Hovland A, Bjørnstad H, Nielsen EW. A young man with acute dilated cardiomyopathy associated with methylphenidate.  Vascular Health and Risk Management 2008;4(2):477‐9. [PMC2496981; PUBMED: 18561524]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2147/VHRM.S2410', 'https://scholar.google.com/scholar_lookup?title=A+young+man+with+acute+dilated+cardiomyopathy+associated+with+methylphenidate&author=TB+Nymark&author=A+Hovland&author=H+Bjørnstad&author=EW+Nielsen&publication_year=2008&hl=en']",,https://doi.org/10.2147/VHRM.S2410, Nymark 2008 {published data only}  ,included,CD012069-bbs2-0170,
CD012069-bib-0304,"Özcan IT, Toros F, Pekdemir H, Çiçek D, Çamsari A, Yurttaş M, et al. ",The effect of methylphenidate on time domain heart rate variability in the treatment of attention deficit and hyperactivity disorder, Turkish Journal of Child and Adolescent Mental Health ,2004,11,    ,['citation-journal']," Özcan IT, Toros F, Pekdemir H, Çiçek D, Çamsari A, Yurttaş M, et al. The effect of methylphenidate on time domain heart rate variability in the treatment of attention deficit and hyperactivity disorder [Dikkat eksikliği hiperaktivite bozukluğu tedavisinde metilfenidat kullanımının zaman bağımlı kalp hızı değişkenliği üzerine etkisi].  Turkish Journal of Child and Adolescent Mental Health 2004;11(3):117‐22. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+methylphenidate+on+time+domain+heart+rate+variability+in+the+treatment+of+attention+deficit+and+hyperactivity+disorder+&author=IT+Özcan&author=F+Toros&author=H+Pekdemir&author=D+Çiçek&author=A+Çamsari&author=M+Yurttaş&publication_year=2004&hl=en']",,, Özcan 2004 {published data only}  ,included,CD012069-bbs2-0171,
CD012069-bib-0305,"Park S, Kim BN, Kim JW, Shin MS, Cho SC, Kim JH, et al. ",Neurotrophin 3 genotype and emotional adverse effects of osmotic‐release oral system methylphenidate (OROS‐MPH) in children with attention‐deficit/hyperactivity disorder, Journal of Psychopharmacology ,2014,28,    ,['citation-journal']," Park S, Kim BN, Kim JW, Shin MS, Cho SC, Kim JH, et al. Neurotrophin 3 genotype and emotional adverse effects of osmotic‐release oral system methylphenidate (OROS‐MPH) in children with attention‐deficit/hyperactivity disorder.  Journal of Psychopharmacology 2014;28(3):220‐6. [DOI: 10.1177/0269881113480989; PUBMED: 23471121]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/0269881113480989', 'https://scholar.google.com/scholar_lookup?title=Neurotrophin+3+genotype+and+emotional+adverse+effects+of+osmotic‐release+oral+system+methylphenidate+(OROS‐MPH)+in+children+with+attention‐deficit/hyperactivity+disorder+&author=S+Park&author=BN+Kim&author=JW+Kim&author=MS+Shin&author=SC+Cho&author=JH+Kim&publication_year=2014&hl=en']",,https://doi.org/10.1177/0269881113480989, Park 2013 {published data only}  ,included,CD012069-bbs2-0172,
CD012069-bib-0306,"Perera H, Jeewandara KC, Seneviratne S, Guruge C. ",Assessment of outcome of an ADHD treatment program using parent feedback, Sri Lanka Journal of Psychiatry ,2010,1,    ,['citation-journal']," Perera H, Jeewandara KC, Seneviratne S, Guruge C. Assessment of outcome of an ADHD treatment program using parent feedback.  Sri Lanka Journal of Psychiatry 2010;1(2):51‐5. [DOI: 10.4038/sljpsyc.v1i2.2575]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4038/sljpsyc.v1i2.2575', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+outcome+of+an+ADHD+treatment+program+using+parent+feedback&author=H+Perera&author=KC+Jeewandara&author=S+Seneviratne&author=C+Guruge&publication_year=2010&hl=en']",,https://doi.org/10.4038/sljpsyc.v1i2.2575, Perera 2010 {published data only}  ,included,CD012069-bbs2-0173,
CD012069-bib-0307,"Peyre H, Speranza M, Cortese S, Wohl M, Purper‐Ouakil D. ","Do ADHD children with and without child behavior checklist‐dysregulation profile have different clinical characteristics, cognitive features, and treatment outcomes?", Journal of Attention Disorders ,2012,19,    ,['citation-journal']," Peyre H, Speranza M, Cortese S, Wohl M, Purper‐Ouakil D. Do ADHD children with and without child behavior checklist‐dysregulation profile have different clinical characteristics, cognitive features, and treatment outcomes?.  Journal of Attention Disorders 2012;19(1):63‐71. [DOI: 10.1177/1087054712452135; PUBMED: 22837549]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054712452135', 'https://scholar.google.com/scholar_lookup?title=Do+ADHD+children+with+and+without+child+behavior+checklist‐dysregulation+profile+have+different+clinical+characteristics,+cognitive+features,+and+treatment+outcomes?+&author=H+Peyre&author=M+Speranza&author=S+Cortese&author=M+Wohl&author=D+Purper‐Ouakil&publication_year=2012&hl=en']",,https://doi.org/10.1177/1087054712452135, Peyre 2012a {published data only}  ,included,CD012069-bbs2-0174,
CD012069-bib-0308,"Pierce D, Katic A, Buckwalter M, Webster K. ",Single‐ and multiple‐dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic‐release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder, Journal of Clinical Psychopharmacology ,2010,30,    ,['citation-journal']," Pierce D, Katic A, Buckwalter M, Webster K. Single‐ and multiple‐dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic‐release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.  Journal of Clinical Psychopharmacology 2010;30(5):554‐64. [DOI: 10.1097/JCP.0b013e3181f0c2f6; PUBMED: 20814325]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0b013e3181f0c2f6', 'https://scholar.google.com/scholar_lookup?title=Single‐+and+multiple‐dose+pharmacokinetics+of+methylphenidate+administered+as+methylphenidate+transdermal+system+or+osmotic‐release+oral+system+methylphenidate+to+children+and+adolescents+with+attention+deficit+hyperactivity+disorder+&author=D+Pierce&author=A+Katic&author=M+Buckwalter&author=K+Webster&publication_year=2010&hl=en']",,https://doi.org/10.1097/JCP.0b013e3181f0c2f6, Pierce 2010 {published data only}  ,included,CD012069-bbs2-0175,
CD012069-bib-0309,"Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, et al. ",Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention‐deficit/hyperactivity disorder, Archives of General Psychiatry ,2007,64,    ,['citation-journal']," Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, et al. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention‐deficit/hyperactivity disorder.  Archives of General Psychiatry 2007;64(2):218‐24. [DOI: 10.1001/archpsyc.64.2.218; PUBMED: 17283289]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpsyc.64.2.218', 'https://scholar.google.com/scholar_lookup?title=Association+of+the+adrenergic+alpha2A+receptor+gene+with+methylphenidate+improvement+of+inattentive+symptoms+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=G+Polanczyk&author=C+Zeni&author=JP+Genro&author=AP+Guimarães&author=T+Roman&author=MH+Hutz&publication_year=2007&hl=en']",,https://doi.org/10.1001/archpsyc.64.2.218, Polanczyk 2007 {published data only}  ,included,CD012069-bbs2-0176,
CD012069-bib-0310,"Porfirio MC, Giana G, Giovinazzo S, Curatolo P. ",Methylphenidate‐induced visual hallucinations, Neuropediatrics ,2011,42,    ,['citation-journal']," Porfirio MC, Giana G, Giovinazzo S, Curatolo P. Methylphenidate‐induced visual hallucinations.  Neuropediatrics 2011;42(1):30‐1. [DOI: 10.1055/s‐0031‐1275738; PUBMED: 21500140]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1055/s-0031-1275738', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐induced+visual+hallucinations&author=MC+Porfirio&author=G+Giana&author=S+Giovinazzo&author=P+Curatolo&publication_year=2011&hl=en']",,https://doi.org/10.1055/s-0031-1275738, Porfirio 2011 {published data only}  ,included,CD012069-bbs2-0177,
CD012069-bib-0311,"Poulton A, Cowell CT. ",Slowing of growth in height and weight on stimulants: a characteristic pattern, Journal of Paediatrics and Child Health ,2003,39,    ,['citation-journal']," Poulton A, Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern.  Journal of Paediatrics and Child Health 2003;39(3):180‐5. [PUBMED: 12654140]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1046/j.1440-1754.2003.00107.x', 'https://scholar.google.com/scholar_lookup?title=Slowing+of+growth+in+height+and+weight+on+stimulants:+a+characteristic+pattern&author=A+Poulton&author=CT+Cowell&publication_year=2003&hl=en']",12654140,https://doi.org/10.1046/j.1440-1754.2003.00107.x, Poulton 2003 {published data only}  ,included,CD012069-bbs2-0178,
CD012069-bib-0312,"Poulton A, Briody J, McCorquodale T, Melzer E, Herrmann M, Baur LA, et al. ",Weight loss on stimulant medication: how does it affect body composition and bone metabolism? ‐ A prospective longitudinal study, International Journal of Pediatric Endocrinology ,2012,2012,    ,['citation-journal']," Poulton A, Briody J, McCorquodale T, Melzer E, Herrmann M, Baur LA, et al. Weight loss on stimulant medication: how does it affect body composition and bone metabolism? ‐ A prospective longitudinal study.  International Journal of Pediatric Endocrinology 2012;2012(1):30. [DOI: 10.1186/1687‐9856‐2012‐30; PMC3549744; PUBMED: 23216890]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1687-9856-2012-30', 'https://scholar.google.com/scholar_lookup?title=Weight+loss+on+stimulant+medication:+how+does+it+affect+body+composition+and+bone+metabolism?+‐+A+prospective+longitudinal+study+&author=A+Poulton&author=J+Briody&author=T+McCorquodale&author=E+Melzer&author=M+Herrmann&author=LA+Baur&publication_year=2012&hl=en']",,https://doi.org/10.1186/1687-9856-2012-30, Poulton 2012 {published data only}  ,included,CD012069-bbs2-0179,
CD012069-bib-0313,"Poulton A, Evans R, Melzer E, Bui Q. ",Stimulant medication affects growth but not bone age, Archives of Disease in Childhood ,2014,99,    ,['citation-journal']," Poulton A, Evans R, Melzer E, Bui Q. Stimulant medication affects growth but not bone age.  Archives of Disease in Childhood 2014;99(Suppl 1):A4.A5. [DOI: 10.1136/archdischild‐2014‐306237.10]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1136/archdischild-2014-306237.10', 'https://scholar.google.com/scholar_lookup?title=Stimulant+medication+affects+growth+but+not+bone+age&author=A+Poulton&author=R+Evans&author=E+Melzer&author=Q+Bui&publication_year=2014&hl=en']",,https://doi.org/10.1136/archdischild-2014-306237.10, Poulton 2012 {published data only}  ,included,CD012069-bbs2-0179,
CD012069-bib-0314,"Poulton A, Nanan R. ","Differential effects of dexamphetamine and methylphenidate on symptoms of inattention‐overactivity, oppositional‐defiant and weight", Archives of Disease in Childhood ,2014,99,    ,['citation-journal']," Poulton A, Nanan R. Differential effects of dexamphetamine and methylphenidate on symptoms of inattention‐overactivity, oppositional‐defiant and weight.  Archives of Disease in Childhood 2014;99(Suppl 1):A70. [DOI: 10.1136/archdischild‐2014‐306237.167]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1136/archdischild-2014-306237.167', 'https://scholar.google.com/scholar_lookup?title=Differential+effects+of+dexamphetamine+and+methylphenidate+on+symptoms+of+inattention‐overactivity,+oppositional‐defiant+and+weight+&author=A+Poulton&author=R+Nanan&publication_year=2014&hl=en']",,https://doi.org/10.1136/archdischild-2014-306237.167, Poulton 2012 {published data only}  ,included,CD012069-bbs2-0179,
CD012069-bib-0315,"Ramasamy R, Dadhich P, Dhingra A, Lipshultz L. ",Case report: testicular failure possibly associated with chronic use of methylphenidate, F1000Research ,2014,3,    ,['citation-journal']," Ramasamy R, Dadhich P, Dhingra A, Lipshultz L. Case report: testicular failure possibly associated with chronic use of methylphenidate.  F1000Research 2014;3:207. [DOI: 10.12688/f1000research.5163.1; PMC4215747; PUBMED: 25383187]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.12688/f1000research.5163.1', 'https://scholar.google.com/scholar_lookup?title=Case+report:+testicular+failure+possibly+associated+with+chronic+use+of+methylphenidate&author=R+Ramasamy&author=P+Dadhich&author=A+Dhingra&author=L+Lipshultz&publication_year=2014&hl=en']",,https://doi.org/10.12688/f1000research.5163.1, Ramasamy 2014 {published data only}  ,included,CD012069-bbs2-0180,
CD012069-bib-0316,"Rappaport N, Coffey B. ","Psychopharmacology in the school setting: therapeutic challenges in an adolescent with attention deficit hyperactivity disorder, possible bipolar disorder, and other comorbidity", Journal of Child and Adolescent Psychopharmacology ,2004,14,    ,['citation-journal']," Rappaport N, Coffey B. Psychopharmacology in the school setting: therapeutic challenges in an adolescent with attention deficit hyperactivity disorder, possible bipolar disorder, and other comorbidity.  Journal of Child and Adolescent Psychopharmacology 2004;14(1):3‐7. [DOI: 10.1089/104454604773840418; PUBMED: 15142385]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/104454604773840418', 'https://scholar.google.com/scholar_lookup?title=Psychopharmacology+in+the+school+setting:+therapeutic+challenges+in+an+adolescent+with+attention+deficit+hyperactivity+disorder,+possible+bipolar+disorder,+and+other+comorbidity+&author=N+Rappaport&author=B+Coffey&publication_year=2004&hl=en']",,https://doi.org/10.1089/104454604773840418, Rappaport 2004 {published data only}  ,included,CD012069-bbs2-0181,
CD012069-bib-0317,"Rapport MD, Loo S, Isaacs P, Goya S, Denney C, Scanlan S. ",Methylphenidate and attentional training. Comparative effects on behavior and neurocognitive performance in twin girls with attention‐deficit/hyperactivity disorder, Behavior Modification ,1996,20,    ,['citation-journal']," Rapport MD, Loo S, Isaacs P, Goya S, Denney C, Scanlan S. Methylphenidate and attentional training. Comparative effects on behavior and neurocognitive performance in twin girls with attention‐deficit/hyperactivity disorder.  Behavior Modification 1996;20(4):428‐50. [DOI: 10.1177/01454455960204004; PUBMED: 8875814]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/01454455960204004', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+attentional+training.+Comparative+effects+on+behavior+and+neurocognitive+performance+in+twin+girls+with+attention‐deficit/hyperactivity+disorder+&author=MD+Rapport&author=S+Loo&author=P+Isaacs&author=S+Goya&author=C+Denney&author=S+Scanlan&publication_year=1996&hl=en']",,https://doi.org/10.1177/01454455960204004, Rapport 1996 {published data only}  ,included,CD012069-bbs2-0182,
CD012069-bib-0319,,Somatic hallucinations with methylphenidate in a 10‐year‐old boy, Brown University Child and Adolescent Psychopharmacology Update ,2007,9,   ,['citation-journal'], Somatic hallucinations with methylphenidate in a 10‐year‐old boy.  Brown University Child and Adolescent Psychopharmacology Update 2007;9(11):8‐8. [DOI: 10.1002/cpu.20055]CENTRAL    ,[''],,, Rashid 2007 {published data only}  ,included,CD012069-bbs2-0183,
CD012069-bib-0318,"Rashid J, Mitelman S. ",Methylphenidate and somatic hallucinations, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Rashid J, Mitelman S. Methylphenidate and somatic hallucinations.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):945‐6. [DOI: 10.1097/CHI.0b013e318067fd7c; PUBMED: 17667474]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/CHI.0b013e318067fd7c', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+somatic+hallucinations&author=J+Rashid&author=S+Mitelman&publication_year=2007&hl=en']",,https://doi.org/10.1097/CHI.0b013e318067fd7c, Rashid 2007 {published data only}  ,included,CD012069-bbs2-0183,
CD012069-bib-0320,"Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, et al. ",12‐month efficacy and safety of OROS MPH in children and adolescents with attention‐deficit/hyperactivity disorder switched from MPH, European Child and Adolescent Psychiatry ,2005,14,    ,['citation-journal']," Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, et al. 12‐month efficacy and safety of OROS MPH in children and adolescents with attention‐deficit/hyperactivity disorder switched from MPH.  European Child and Adolescent Psychiatry 2005;14(6):305‐9. [DOI: 10.1007/s00787‐005‐0486‐3; PUBMED: 16220214]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-005-0486-3', 'https://scholar.google.com/scholar_lookup?title=12‐month+efficacy+and+safety+of+OROS+MPH+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+switched+from+MPH+&author=P+Hoare&author=H+Remschmidt&author=R+Medori&author=C+Ettrich&author=A+Rothenberger&author=P+Santosh&publication_year=2005&hl=en']",,https://doi.org/10.1007/s00787-005-0486-3, Remschmidt 2005 {published data only}  ,included,CD012069-bbs2-0184,
CD012069-bib-0321,"Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, et al. ",Symptom control in children and adolescents with attention‐deficit/hyperactivity disorder on switching from immediate‐release MPH to OROS® MPH, European Child and Adolescent Psychiatry ,2005,14,    ,['citation-journal']," Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, et al. Symptom control in children and adolescents with attention‐deficit/hyperactivity disorder on switching from immediate‐release MPH to OROS® MPH.  European Child and Adolescent Psychiatry 2005;14(6):297‐304. [DOI: 10.1007/s00787‐005‐0467‐6]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-005-0467-6', 'https://scholar.google.com/scholar_lookup?title=Symptom+control+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+on+switching+from+immediate‐release+MPH+to+OROS®+MPH+&author=H+Remschmidt&author=P+Hoare&author=C+Ettrich&author=A+Rothenberger&author=P+Santosh&author=M+Schmidt&publication_year=2005&hl=en']",,https://doi.org/10.1007/s00787-005-0467-6, Remschmidt 2005 {published data only}  ,included,CD012069-bbs2-0184,
CD012069-bib-0322,"Ririe DG, Ririe KL, Sethna NF, Fox L. ",Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents, Paediatric Anaesthesia ,1997,7,    ,['citation-journal']," Ririe DG, Ririe KL, Sethna NF, Fox L. Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents.  Paediatric Anaesthesia 1997;7(1):69‐72. [PUBMED: 9041578]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1046/j.1460-9592.1997.d01-34.x', 'https://scholar.google.com/scholar_lookup?title=Unexpected+interaction+of+methylphenidate+(Ritalin)+with+anaesthetic+agents&author=DG+Ririe&author=KL+Ririe&author=NF+Sethna&author=L+Fox&publication_year=1997&hl=en']",9041578,https://doi.org/10.1046/j.1460-9592.1997.d01-34.x, Ririe 1997 {published data only}  ,included,CD012069-bbs2-0185,
CD012069-bib-0323,Sabuncuoglu O. ,Risperidone‐to‐methylphenidate switch reaction in children: three cases, Journal of Psychopharmacology ,2007,21,    ,['citation-journal'], Sabuncuoglu O. Risperidone‐to‐methylphenidate switch reaction in children: three cases.  Journal of Psychopharmacology 2007;21(2):216‐9. [DOI: 10.1177/0269881107069466; PUBMED: 17329303]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1177/0269881107069466', 'https://scholar.google.com/scholar_lookup?title=Risperidone‐to‐methylphenidate+switch+reaction+in+children:+three+cases&author=O+Sabuncuoglu&publication_year=2007&hl=en']",,https://doi.org/10.1177/0269881107069466, Sabuncuoglu 2007 {published data only}  ,included,CD012069-bbs2-0186,
CD012069-bib-0324,Sabuncuoglu O. ,Severe adverse events following risperidone‐to‐methylphenidate switch, Brown University Child and Adolescent Psychopharmacology Update ,2007,9,    ,['citation-journal'], Sabuncuoglu O. Severe adverse events following risperidone‐to‐methylphenidate switch.  Brown University Child and Adolescent Psychopharmacology Update 2007;9(5):8‐8. [DOI: 10.1002/cpu.20043]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Severe+adverse+events+following+risperidone‐to‐methylphenidate+switch&author=O+Sabuncuoglu&publication_year=2007&hl=en']",,, Sabuncuoglu 2007 {published data only}  ,included,CD012069-bbs2-0186,
CD012069-bib-0325,"Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salis O. ","Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain‐derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder", International Journal of Psychiatry in Clinical Practice ,2014,18,    ,['citation-journal']," Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salis O. Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain‐derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder.  International Journal of Psychiatry in Clinical Practice 2014;18(4):280‐7. [DOI: 10.3109/13651501.2014.940054; PUBMED: 24994482]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3109/13651501.2014.940054', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+treatment+on+appetite+and+levels+of+leptin,+ghrelin,+adiponectin,+and+brain‐derived+neurotrophic+factor+in+children+and+adolescents+with+attention+deficit+and+hyperactivity+disorder+&author=S+Sahin&author=M+Yuce&author=H+Alacam&author=K+Karabekiroglu&author=GN+Say&author=O+Salis&publication_year=2014&hl=en']",,https://doi.org/10.3109/13651501.2014.940054, Sahin 2014 {published data only}  ,included,CD012069-bbs2-0187,
CD012069-bib-0326,Saieh AC. ,"Methylphenidate: arterial hypertension, a side effect to take into account", Revista Chilena de Pediatria ,2004,75,    ,['citation-journal']," Saieh AC. Methylphenidate: arterial hypertension, a side effect to take into account [Metilfenidato: hipertensión arterial, un efecto a tener en cuenta].  Revista Chilena de Pediatria 2004;75(1):80‐1. [DOI: 10.4067/S0370‐41062004000100014]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate:+arterial+hypertension,+a+side+effect+to+take+into+account&author=AC+Saieh&publication_year=2004&hl=en']",,, Saieh 2004 {published data only}  ,included,CD012069-bbs2-0188,
CD012069-bib-0327,Rostain AL. ,Sleep disturbances and ADHD medications, Current Psychiatry Reports ,2007,9,    ,['citation-journal'], Rostain AL. Sleep disturbances and ADHD medications.  Current Psychiatry Reports 2007;9(5):399‐400. [PUBMED: 17915079]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1007/s11920-007-0051-5', 'https://scholar.google.com/scholar_lookup?title=Sleep+disturbances+and+ADHD+medications&author=AL+Rostain&publication_year=2007&hl=en']",17915079,https://doi.org/10.1007/s11920-007-0051-5, Sangal 2006 {published data only}  ,included,CD012069-bbs2-0189,
CD012069-bib-0328,"Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. ",Effects of atomoxetine and methylphenidate on sleep in children with ADHD, Sleep ,2006,29,    ,['citation-journal']," Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.  Sleep 2006;29(12):1573‐85. [PUBMED: 17252888]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/sleep/29.12.1573', 'https://scholar.google.com/scholar_lookup?title=Effects+of+atomoxetine+and+methylphenidate+on+sleep+in+children+with+ADHD&author=RB+Sangal&author=J+Owens&author=AJ+Allen&author=V+Sutton&author=K+Schuh&author=D+Kelsey&publication_year=2006&hl=en']",17252888,https://doi.org/10.1093/sleep/29.12.1573, Sangal 2006 {published data only}  ,included,CD012069-bbs2-0189,
CD012069-bib-0329,"Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. ",Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study," Child: Care, Health and Development ",2006,32,    ,['citation-journal']," Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.  Child: Care, Health and Development 2006;32(5):575‐83. [DOI: 10.1111/j.1365‐2214.2006.00631.x; PUBMED: 16919137]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1365-2214.2006.00631.x', 'https://scholar.google.com/scholar_lookup?title=Impact+of+comorbid+autism+spectrum+disorders+on+stimulant+response+in+children+with+attention+deficit+hyperactivity+disorder:+a+retrospective+and+prospective+effectiveness+study+&author=PJ+Santosh&author=G+Baird&author=N+Pityaratstian&author=E+Tavare&author=P+Gringras&publication_year=2006&hl=en']",,https://doi.org/10.1111/j.1365-2214.2006.00631.x, Santosh 2006 {published data only}  ,included,CD012069-bbs2-0190,
CD012069-bib-0330,"Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. ",Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication, Pediatrics ,1996,98,    ,['citation-journal']," Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.  Pediatrics 1996;98(4 Pt 1):763‐9. [PUBMED: 8885958]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Predictors+of+weight+loss+in+children+with+attention+deficit+hyperactivity+disorder+treated+with+stimulant+medication+&author=M+Schertz&author=AR+Adesman&author=NE+Alfieri&author=RS+Bienkowski&publication_year=1996&hl=en']",8885958,, Schertz 1996 {published data only}  ,included,CD012069-bbs2-0191,
CD012069-bib-0331,"Schmidt JK, Plück J, von Gontard A. ",Waiver of EEG diagnostics prior to and during methylphenidate therapy: dangerous or justifiable?, Zeitschrift fur Kinder‐ und Jugendpsychiatrie und Psychotherapie ,2002,30,    ,['citation-journal']," Schmidt JK, Plück J, von Gontard A. Waiver of EEG diagnostics prior to and during methylphenidate therapy: dangerous or justifiable? [Verzicht auf eine EEG‐Diagnostik vor Beginn und unter einer Therapie mit Methylphenidat: gefährlich oder gerechtfertigt?].  Zeitschrift fur Kinder‐ und Jugendpsychiatrie und Psychotherapie 2002;30(4):295‐302. [DOI: 10.1024/1422‐4917.30.4.295]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1024/1422-4917.30.4.295', 'https://scholar.google.com/scholar_lookup?title=Waiver+of+EEG+diagnostics+prior+to+and+during+methylphenidate+therapy:+dangerous+or+justifiable?+&author=JK+Schmidt&author=J+Plück&author=A+Gontard&publication_year=2002&hl=en']",,https://doi.org/10.1024/1422-4917.30.4.295, Schmidt 2002 {published data only}  ,included,CD012069-bbs2-0192,
CD012069-bib-0332,"Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Haessler F, Linder M, et al. ","A randomized, rater‐blinded, crossover study comparing the clinical efficacy of Ritalin(®) LA (methylphenidate) treatment in children with attention‐deficit hyperactivity disorder under different breakfast conditions over 2 weeks", Attention Deficit and Hyperactivity Disorders ,2010,2,    ,['citation-journal']," Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Haessler F, Linder M, et al. A randomized, rater‐blinded, crossover study comparing the clinical efficacy of Ritalin(®) LA (methylphenidate) treatment in children with attention‐deficit hyperactivity disorder under different breakfast conditions over 2 weeks.  Attention Deficit and Hyperactivity Disorders 2010;2(3):133‐8. [DOI: 10.1007/s12402‐010‐0031‐1; PUBMED: 21432599]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-010-0031-1', 'https://scholar.google.com/scholar_lookup?title=A+randomized,+rater‐blinded,+crossover+study+comparing+the+clinical+efficacy+of+Ritalin(®)+LA+(methylphenidate)+treatment+in+children+with+attention‐deficit+hyperactivity+disorder+under+different+breakfast+conditions+over+2+weeks+&author=E+Schulz&author=C+Fleischhaker&author=K+Hennighausen&author=P+Heiser&author=F+Haessler&author=M+Linder&publication_year=2010&hl=en']",,https://doi.org/10.1007/s12402-010-0031-1, Schulz 2010 {published data only}  ,included,CD012069-bbs2-0193,
CD012069-bib-0333,Ginsberg DL. ,Priapism due to withdrawal from sustained‐release methylphenidate, Primary Psychiatry ,2004,11,    ,['citation-journal'], Ginsberg DL. Priapism due to withdrawal from sustained‐release methylphenidate.  Primary Psychiatry 2004;11(10):25‐6. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Priapism+due+to+withdrawal+from+sustained‐release+methylphenidate&author=DL+Ginsberg&publication_year=2004&hl=en']",,, Schwartz 2004 {published data only}  ,included,CD012069-bbs2-0194,
CD012069-bib-0334,"Schwartz RH, Rushton HG. ",Stuttering priapism associated with withdrawal from sustained‐release methylphenidate, Journal of Pediatrics ,2004,144,    ,['citation-journal']," Schwartz RH, Rushton HG. Stuttering priapism associated with withdrawal from sustained‐release methylphenidate.  Journal of Pediatrics 2004;144(5):675‐6. [DOI: 10.1016/j.jpeds.2003.12.039; PUBMED: 15127013]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jpeds.2003.12.039', 'https://scholar.google.com/scholar_lookup?title=Stuttering+priapism+associated+with+withdrawal+from+sustained‐release+methylphenidate&author=RH+Schwartz&author=HG+Rushton&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.jpeds.2003.12.039, Schwartz 2004 {published data only}  ,included,CD012069-bbs2-0194,
CD012069-bib-0335,"Shang CY, Pan YL, Lin HY, Huang LW, Gau SS. ","An open‐label, randomized trial of methylphenidate and atomoxetine treatment in children with attention‐deficit/hyperactivity disorder", Journal of Child and Adolescent Psychopharmacology ,2015,25,    ,['citation-journal']," Shang CY, Pan YL, Lin HY, Huang LW, Gau SS. An open‐label, randomized trial of methylphenidate and atomoxetine treatment in children with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2015;25(7):566‐73. [DOI: 10.1089/cap.2015.0035; PUBMED: 26222447]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2015.0035', 'https://scholar.google.com/scholar_lookup?title=An+open‐label,+randomized+trial+of+methylphenidate+and+atomoxetine+treatment+in+children+with+attention‐deficit/hyperactivity+disorder+&author=CY+Shang&author=YL+Pan&author=HY+Lin&author=LW+Huang&author=SS+Gau&publication_year=2015&hl=en']",,https://doi.org/10.1089/cap.2015.0035, Shang 2015 {published data only}  ,included,CD012069-bbs2-0195,
CD012069-bib-0336,"Shibib S, Chalhoub N. ",Stimulant induced psychosis, Child and Adolescent Mental Health ,2009,14,    ,['citation-journal']," Shibib S, Chalhoub N. Stimulant induced psychosis.  Child and Adolescent Mental Health 2009;14(1):20‐3. [DOI: 10.1111/j.1475‐3588.2008.00490.x]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1475-3588.2008.00490.x', 'https://scholar.google.com/scholar_lookup?title=Stimulant+induced+psychosis&author=S+Shibib&author=N+Chalhoub&publication_year=2009&hl=en']",,https://doi.org/10.1111/j.1475-3588.2008.00490.x, Shibib 2009 {published data only}  ,included,CD012069-bbs2-0196,
CD012069-bib-0337,"Shin JY, Roughead EE, Park BJ, Pratt NL. ",Cardiovascular safety of methylphenidate among children and young people with attention‐deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study, BMJ ,2016,353,    ,['citation-journal']," Shin JY, Roughead EE, Park BJ, Pratt NL. Cardiovascular safety of methylphenidate among children and young people with attention‐deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.  BMJ 2016;353:i2550. [DOI: 10.1136/bmj.i2550]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1136/bmj.i2550', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+safety+of+methylphenidate+among+children+and+young+people+with+attention‐deficit/hyperactivity+disorder+(ADHD):+nationwide+self+controlled+case+series+study+&author=JY+Shin&author=EE+Roughead&author=BJ+Park&author=NL+Pratt&publication_year=2016&hl=en']",,https://doi.org/10.1136/bmj.i2550, Shin 2016 {published data only}  ,included,CD012069-bbs2-0197,
CD012069-bib-0338,"Lee MJ, Yang KC, Shyu YC, Yuan SS, Yang CJ, Lee SY, et al. ","Attention‐deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a nationwide population‐based study in Taiwan", Journal of Affective Disorders ,2016,189,    ,['citation-journal']," Lee MJ, Yang KC, Shyu YC, Yuan SS, Yang CJ, Lee SY, et al. Attention‐deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a nationwide population‐based study in Taiwan.  Journal of Affective Disorders 2016;189:110‐7. [DOI: 10.1016/j.jad.2015.09.015; PUBMED: 26433758]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jad.2015.09.015', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit+hyperactivity+disorder,+its+treatment+with+medication+and+the+probability+of+developing+a+depressive+disorder:+a+nationwide+population‐based+study+in+Taiwan+&author=MJ+Lee&author=KC+Yang&author=YC+Shyu&author=SS+Yuan&author=CJ+Yang&author=SY+Lee&publication_year=2016&hl=en']",,https://doi.org/10.1016/j.jad.2015.09.015, Shyu 2015 {published data only}  ,included,CD012069-bbs2-0198,
CD012069-bib-0339,"Shyu YC, Yuan SS, Lee SY, Yang CJ, Yang KC, Lee TL, et al. ","Attention‐deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population‐based study in Taiwan", Schizophrenia Research ,2015,168,    ,['citation-journal']," Shyu YC, Yuan SS, Lee SY, Yang CJ, Yang KC, Lee TL, et al. Attention‐deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population‐based study in Taiwan.  Schizophrenia Research 2015;168(1‐2):161‐7. [DOI: 10.1016/j.schres.2015.08.033; PUBMED: 26363968]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.schres.2015.08.033', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit/hyperactivity+disorder,+methylphenidate+use+and+the+risk+of+developing+schizophrenia+spectrum+disorders:+a+nationwide+population‐based+study+in+Taiwan+&author=YC+Shyu&author=SS+Yuan&author=SY+Lee&author=CJ+Yang&author=KC+Yang&author=TL+Lee&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.schres.2015.08.033, Shyu 2015 {published data only}  ,included,CD012069-bbs2-0198,
CD012069-bib-0340,"Silva R, Tilker HA, Cecil JT, Kowalik S, Khetani V, Faleck H, et al. ",Open‐label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2004,14,    ,['citation-journal']," Silva R, Tilker HA, Cecil JT, Kowalik S, Khetani V, Faleck H, et al. Open‐label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2004;14(4):555‐63. [DOI: 10.1089/cap.2004.14.555; PUBMED: 15662147]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2004.14.555', 'https://scholar.google.com/scholar_lookup?title=Open‐label+study+of+dexmethylphenidate+hydrochloride+in+children+and+adolescents+with+attention+deficit+hyperactivity+disorder+&author=R+Silva&author=HA+Tilker&author=JT+Cecil&author=S+Kowalik&author=V+Khetani&author=H+Faleck&publication_year=2004&hl=en']",,https://doi.org/10.1089/cap.2004.14.555, Silva 2004 {published data only}  ,included,CD012069-bbs2-0199,
CD012069-bib-0341,"Tilker H, Silva R, Cecil J, Kowalik S, Faleck H, Robinson W, et al. ","Open label, pilot study of dexmethylphenidate in children with ADHD", Journal of Child and Adolescent Psychopharmacology ,2002,12,    ,['citation-journal']," Tilker H, Silva R, Cecil J, Kowalik S, Faleck H, Robinson W, et al. Open label, pilot study of dexmethylphenidate in children with ADHD.  Journal of Child and Adolescent Psychopharmacology 2002;12(4):295. [DOI: 10.1089/104454602762599835]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Open+label,+pilot+study+of+dexmethylphenidate+in+children+with+ADHD&author=H+Tilker&author=R+Silva&author=J+Cecil&author=S+Kowalik&author=H+Faleck&author=W+Robinson&publication_year=2002&hl=en']",,, Silva 2004 {published data only}  ,included,CD012069-bbs2-0199,
CD012069-bib-0342,"Sobanski E, Döpfner M, Ose C, Fischer R. ","A non‐interventional study of extended‐release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment", Attention Deficit and Hyperactivity Disorders ,2013,5,    ,['citation-journal']," Sobanski E, Döpfner M, Ose C, Fischer R. A non‐interventional study of extended‐release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment.  Attention Deficit and Hyperactivity Disorders 2013;5(4):387‐95. [DOI: 10.1007/s12402‐013‐0113‐y; PUBMED: 23794192]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-013-0113-y', 'https://scholar.google.com/scholar_lookup?title=A+non‐interventional+study+of+extended‐release+methylphenidate+in+the+routine+treatment+of+adolescents+with+ADHD:+effectiveness,+safety+and+adherence+to+treatment+&author=E+Sobanski&author=M+Döpfner&author=C+Ose&author=R+Fischer&publication_year=2013&hl=en']",,https://doi.org/10.1007/s12402-013-0113-y, Sobanski 2013 {published data only}  ,included,CD012069-bbs2-0200,
CD012069-bib-0343,"Song DH, Choi S, Joung YS, Ha EH, Kim BN, Shin YJ, et al. ",Titrating optimal dose of osmotic‐controlled release oral delivery (OROS)‐methylphenidate and its efficacy and safety in Korean children with ADHD: a multisite open labeled study,,2012,,    ,['citation-other']," Song DH, Choi S, Joung YS, Ha EH, Kim BN, Shin YJ, et al. Titrating optimal dose of osmotic‐controlled release oral delivery (OROS)‐methylphenidate and its efficacy and safety in Korean children with ADHD: a multisite open labeled study. Psychiatry Investigation2012; Vol. 9, issue 3:257‐62. [DOI: 10.4306/pi.2012.9.3.257; PMC3440475]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Titrating+optimal+dose+of+osmotic‐controlled+release+oral+delivery+(OROS)‐methylphenidate+and+its+efficacy+and+safety+in+Korean+children+with+ADHD:+a+multisite+open+labeled+study+&author=DH+Song&author=S+Choi&author=YS+Joung&author=EH+Ha&author=BN+Kim&author=YJ+Shin&publication_year=2012&hl=en']",,, Song 2012 {published data only}  ,included,CD012069-bbs2-0201,
CD012069-bib-0344,"Song DH, Choi S, Joung YS, Kim BN, Ha EH, Shin YJ, et al. ","Titrating optimal dose of OROS‐MPH and its efficacy and safety in Korean children with ADHD: multicenter, open labeled study", International Journal of Neuropsychopharmacology ,2010,13,    ,['citation-journal']," Song DH, Choi S, Joung YS, Kim BN, Ha EH, Shin YJ, et al. Titrating optimal dose of OROS‐MPH and its efficacy and safety in Korean children with ADHD: multicenter, open labeled study.  International Journal of Neuropsychopharmacology 2010;13(Suppl 1):193‐4. [DOI: 10.1017/S1461145710000635]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Titrating+optimal+dose+of+OROS‐MPH+and+its+efficacy+and+safety+in+Korean+children+with+ADHD:+multicenter,+open+labeled+study+&author=DH+Song&author=S+Choi&author=YS+Joung&author=BN+Kim&author=EH+Ha&author=YJ+Shin&publication_year=2010&hl=en']",,, Song 2012 {published data only}  ,included,CD012069-bbs2-0201,
CD012069-bib-0345,"Spencer T, Biederman J, Wright V, Danon M. ",Growth deficits in children treated with desipramine: a controlled study, Journal of the American Academy of Child & Adolescent Psychiatry ,1992,31,    ,['citation-journal']," Spencer T, Biederman J, Wright V, Danon M. Growth deficits in children treated with desipramine: a controlled study.  Journal of the American Academy of Child & Adolescent Psychiatry 1992;31(2):235‐43. [DOI: 10.1097/00004583‐199203000‐00009; PUBMED: 1564024]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199203000-00009', 'https://scholar.google.com/scholar_lookup?title=Growth+deficits+in+children+treated+with+desipramine:+a+controlled+study&author=T+Spencer&author=J+Biederman&author=V+Wright&author=M+Danon&publication_year=1992&hl=en']",,https://doi.org/10.1097/00004583-199203000-00009, Spencer 1992 {published data only}  ,included,CD012069-bbs2-0202,
CD012069-bib-0346,Hechtman L. ,Effects of treatment on the overall functioning of children with ADHD, Journal of the Canadian Academy of Child and Adolescent Psychiatry ,2009,14,    ,['citation-journal'], Hechtman L. Effects of treatment on the overall functioning of children with ADHD.  Journal of the Canadian Academy of Child and Adolescent Psychiatry 2009;14(Suppl 1):10‐5. [PMC2547092]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Effects+of+treatment+on+the+overall+functioning+of+children+with+ADHD&author=L+Hechtman&publication_year=2009&hl=en']",,, Steele 2006 {published data only}  ,included,CD012069-bbs2-0203,
CD012069-bib-0347,"Steele M, Riccardelli R, Binder C. ",The effectiveness of OROS® methylphenidate (Concerta®) vs. usual treatment with immediate‐release methylphenidate (IR MPH) in children aged 6‐12 years with attention deficit hyperactivity disorder (ADHD), International Journal of Neuropsychopharmacology ,2004,7,    ,['citation-journal']," Steele M, Riccardelli R, Binder C. The effectiveness of OROS® methylphenidate (Concerta®) vs. usual treatment with immediate‐release methylphenidate (IR MPH) in children aged 6‐12 years with attention deficit hyperactivity disorder (ADHD).  International Journal of Neuropsychopharmacology 2004;7(Suppl 2):S442. [DOI: 10.1017/S1461145704004547]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effectiveness+of+OROS®+methylphenidate+(Concerta®)+vs.+usual+treatment+with+immediate‐release+methylphenidate+(IR+MPH)+in+children+aged+6‐12+years+with+attention+deficit+hyperactivity+disorder+(ADHD)+&author=M+Steele&author=R+Riccardelli&author=C+Binder&publication_year=2004&hl=en']",,, Steele 2006 {published data only}  ,included,CD012069-bbs2-0203,
CD012069-bib-0348,"Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. ","A randomized, controlled effectiveness trial of OROS‐methylphenidate compared to usual care with immediate‐release methylphenidate in ADHD", Canadian Journal of Clinical Pharmacology ,2006,13,    ,['citation-journal']," Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS‐methylphenidate compared to usual care with immediate‐release methylphenidate in ADHD.  Canadian Journal of Clinical Pharmacology 2006;13(1):e50‐62. [PUBMED: 16456216]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+randomized,+controlled+effectiveness+trial+of+OROS‐methylphenidate+compared+to+usual+care+with+immediate‐release+methylphenidate+in+ADHD+&author=M+Steele&author=M+Weiss&author=J+Swanson&author=J+Wang&author=RS+Prinzo&author=CE+Binder&publication_year=2006&hl=en']",16456216,, Steele 2006 {published data only}  ,included,CD012069-bbs2-0203,
CD012069-bib-0349,"Steele MM, Prinzo R, Binder C. ",Effectiveness of Concerta versus twice or thrice daily IR‐MPH in children with ADHD,,2005,,    ,['citation-other']," Steele MM, Prinzo R, Binder C. Effectiveness of Concerta versus twice or thrice daily IR‐MPH in children with ADHD. 158th Annual Meeting of the American Psychiatric Association; 2005 May 21‐26; Atlanta (GA). 2005. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Concerta+versus+twice+or+thrice+daily+IR‐MPH+in+children+with+ADHD&author=MM+Steele&author=R+Prinzo&author=C+Binder&publication_year=2005&hl=en']",,, Steele 2006 {published data only}  ,included,CD012069-bbs2-0203,
CD012069-bib-0350,"Steele MM, Prinzo R, Binder C. ",Long‐term effectiveness and safety of Concerta in children with ADHD: a six‐month study,,2005,,    ,['citation-other']," Steele MM, Prinzo R, Binder C. Long‐term effectiveness and safety of Concerta in children with ADHD: a six‐month study. 158th Annual Meeting of the American Psychiatric Association; 2005 May 21‐26; Atlanta (GA). 2005. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Long‐term+effectiveness+and+safety+of+Concerta+in+children+with+ADHD:+a+six‐month+study+&author=MM+Steele&author=R+Prinzo&author=C+Binder&publication_year=2005&hl=en']",,, Steele 2006 {published data only}  ,included,CD012069-bbs2-0203,
CD012069-bib-0351,"Stein D, Pat‐Horenczyk R, Blank S, Dagan Y, Barak Y, Gumpel TP. ",Sleep disturbances in adolescents with symptoms of attention‐deficit/hyperactivity disorder, Journal of Learning Disabilities ,2002,35,    ,['citation-journal']," Stein D, Pat‐Horenczyk R, Blank S, Dagan Y, Barak Y, Gumpel TP. Sleep disturbances in adolescents with symptoms of attention‐deficit/hyperactivity disorder.  Journal of Learning Disabilities 2002;35(3):268‐75. [DOI: 10.1177/002221940203500308; PUBMED: 15493323]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/002221940203500308', 'https://scholar.google.com/scholar_lookup?title=Sleep+disturbances+in+adolescents+with+symptoms+of+attention‐deficit/hyperactivity+disorder+&author=D+Stein&author=R+Pat‐Horenczyk&author=S+Blank&author=Y+Dagan&author=Y+Barak&author=TP+Gumpel&publication_year=2002&hl=en']",,https://doi.org/10.1177/002221940203500308, Stein 2002 {published data only}  ,included,CD012069-bbs2-0204,
CD012069-bib-0352,"Stevens JR, George RA, Fusillo S, Stern TA, Wilens TE. ",Plasma methylphenidate concentration in youths treated with high‐dose osmotic release oral system formulation, Journal of Child and Adolescent Psychopharmacology ,2010,20,    ,['citation-journal']," Stevens JR, George RA, Fusillo S, Stern TA, Wilens TE. Plasma methylphenidate concentration in youths treated with high‐dose osmotic release oral system formulation.  Journal of Child and Adolescent Psychopharmacology 2010;20(1):49‐54. [DOI: 10.1089/cap.2008.0128; PUBMED: 20166796]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2008.0128', 'https://scholar.google.com/scholar_lookup?title=Plasma+methylphenidate+concentration+in+youths+treated+with+high‐dose+osmotic+release+oral+system+formulation+&author=JR+Stevens&author=RA+George&author=S+Fusillo&author=TA+Stern&author=TE+Wilens&publication_year=2010&hl=en']",,https://doi.org/10.1089/cap.2008.0128, Stevens 2010 {published data only}  ,included,CD012069-bbs2-0205,
CD012069-bib-0353,"Strandell J, Starr K. ",Reports of suicide related behaviour with methylphenidate and atomoxetine in children and adolescents, Drug Safety ,2007,30,    ,['citation-journal']," Strandell J, Starr K. Reports of suicide related behaviour with methylphenidate and atomoxetine in children and adolescents.  Drug Safety 2007;30(10):919‐90. [DOI: 10.2165/00002018‐200730100‐00105]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2165/00002018-200730100-00105', 'https://scholar.google.com/scholar_lookup?title=Reports+of+suicide+related+behaviour+with+methylphenidate+and+atomoxetine+in+children+and+adolescents+&author=J+Strandell&author=K+Starr&publication_year=2007&hl=en']",,https://doi.org/10.2165/00002018-200730100-00105, Strandell 2007 {published data only}  ,included,CD012069-bbs2-0206,
CD012069-bib-0354,"Su Y, Li H, Chen Y, Fang F, Xu T, Lu H, et al. ",Remission rate and functional outcomes during a 6‐month treatment with Osmotic‐Release Oral‐System methylphenidate in children with attention‐deficit/hyperactivity disorder, Journal of Clinical Psychopharmacology ,2015,35,    ,['citation-journal']," Su Y, Li H, Chen Y, Fang F, Xu T, Lu H, et al. Remission rate and functional outcomes during a 6‐month treatment with Osmotic‐Release Oral‐System methylphenidate in children with attention‐deficit/hyperactivity disorder.  Journal of Clinical Psychopharmacology 2015;35(5):525‐34. [DOI: 10.1097/JCP.0000000000000389; PUBMED: 26267421]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0000000000000389', 'https://scholar.google.com/scholar_lookup?title=Remission+rate+and+functional+outcomes+during+a+6‐month+treatment+with+Osmotic‐Release+Oral‐System+methylphenidate+in+children+with+attention‐deficit/hyperactivity+disorder+&author=Y+Su&author=H+Li&author=Y+Chen&author=F+Fang&author=T+Xu&author=H+Lu&publication_year=2015&hl=en']",,https://doi.org/10.1097/JCP.0000000000000389, Su 2015 {published data only}  ,included,CD012069-bbs2-0207,
CD012069-bib-0355,"Sudarmadji SS, Meliala L, Aziz A. ","Improvement of cognitive function in attention deficit hyperactivity disorder (ADHD) treatment by methylphenidate (MPH) of elementary school students at Bantul District, Yogyakarta Special Regency", Journal of the Neurological Sciences ,2009,285,    ,['citation-journal']," Sudarmadji SS, Meliala L, Aziz A. Improvement of cognitive function in attention deficit hyperactivity disorder (ADHD) treatment by methylphenidate (MPH) of elementary school students at Bantul District, Yogyakarta Special Regency.  Journal of the Neurological Sciences 2009;285(Suppl 1):S236. [DOI: 10.1016/S0022‐510X(09)70898‐6]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0022-510X(09)70898-6', 'https://scholar.google.com/scholar_lookup?title=Improvement+of+cognitive+function+in+attention+deficit+hyperactivity+disorder+(ADHD)+treatment+by+methylphenidate+(MPH)+of+elementary+school+students+at+Bantul+District,+Yogyakarta+Special+Regency+&author=SS+Sudarmadji&author=L+Meliala&author=A+Aziz&publication_year=2009&hl=en']",,https://doi.org/10.1016/S0022-510X(09)70898-6, Sudarmadji 2009 {published data only}  ,included,CD012069-bbs2-0208,
CD012069-bib-0356,"Tang CS, Chou WJ, Cheng AT. ",Osmotic release oral system (OROS) methylphenidate‐induced double incontinence: a case report, Primary Care Companion to the Journal of Clinical Psychiatry ,2010,12,    ,['citation-journal']," Tang CS, Chou WJ, Cheng AT. Osmotic release oral system (OROS) methylphenidate‐induced double incontinence: a case report.  Primary Care Companion to the Journal of Clinical Psychiatry 2010;12(3):PCC.09l00870. [DOI: 10.4088/PCC.09l00870pur; PMC2947529]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4088/PCC.09l00870pur', 'https://scholar.google.com/scholar_lookup?title=Osmotic+release+oral+system+(OROS)+methylphenidate‐induced+double+incontinence:+a+case+report+&author=CS+Tang&author=WJ+Chou&author=AT+Cheng&publication_year=2010&hl=en']",,https://doi.org/10.4088/PCC.09l00870pur, Tang 2010 {published data only}  ,included,CD012069-bbs2-0209,
CD012069-bib-0357,"Tasdelen BI, Karakaya E, Oztop DB. ",Effects of atomoxetine and osmotic release oral system‐methylphenidate on executive functions in patients with combined type attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2015,25,    ,['citation-journal']," Tasdelen BI, Karakaya E, Oztop DB. Effects of atomoxetine and osmotic release oral system‐methylphenidate on executive functions in patients with combined type attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2015;25(6):494‐500. [DOI: 10.1089/cap.2014.0155; PUBMED: 26218871]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2014.0155', 'https://scholar.google.com/scholar_lookup?title=Effects+of+atomoxetine+and+osmotic+release+oral+system‐methylphenidate+on+executive+functions+in+patients+with+combined+type+attention‐deficit/hyperactivity+disorder+&author=BI+Tasdelen&author=E+Karakaya&author=DB+Oztop&publication_year=2015&hl=en']",,https://doi.org/10.1089/cap.2014.0155, Tasdelen 2015 {published data only}  ,included,CD012069-bbs2-0210,
CD012069-bib-0358,"Tekin U, Soyata AZ, Oflaz S. ",Acute focal dystonic reaction after acute methylphenidate treatment in an adolescent patient, Journal of Clinical Psychopharmacology ,2015,35,    ,['citation-journal']," Tekin U, Soyata AZ, Oflaz S. Acute focal dystonic reaction after acute methylphenidate treatment in an adolescent patient.  Journal of Clinical Psychopharmacology 2015;35(2):209‐11. [DOI: 10.1097/JCP.0000000000000266; PUBMED: 25607477]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/JCP.0000000000000266', 'https://scholar.google.com/scholar_lookup?title=Acute+focal+dystonic+reaction+after+acute+methylphenidate+treatment+in+an+adolescent+patient+&author=U+Tekin&author=AZ+Soyata&author=S+Oflaz&publication_year=2015&hl=en']",,https://doi.org/10.1097/JCP.0000000000000266, Tekin 2015 {published data only}  ,included,CD012069-bbs2-0211,
CD012069-bib-0359,"Thorell LB, Dahlström K. ",Children's self‐reports on perceived effects on taking stimulant medication for ADHD, Journal of Attention Disorders ,2009,12,    ,['citation-journal']," Thorell LB, Dahlström K. Children's self‐reports on perceived effects on taking stimulant medication for ADHD.  Journal of Attention Disorders 2009;12(5):460‐8. [DOI: 10.1177/1087054708320430; PUBMED: 18685139]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054708320430', ""https://scholar.google.com/scholar_lookup?title=Children's+self‐reports+on+perceived+effects+on+taking+stimulant+medication+for+ADHD&author=LB+Thorell&author=K+Dahlström&publication_year=2009&hl=en""]",,https://doi.org/10.1177/1087054708320430, Thorell 2009 {published data only}  ,included,CD012069-bbs2-0212,
CD012069-bib-0360,"Tomás Vila M, Izquierdo Quevedo FJ, Cerdán Vera MT, Fernández A, Artás Figueres M, Revert Gomas M. ",Visual hallucinations caused by methylphenidate, Anales de Pediatria ,2010,72,    ,['citation-journal']," Tomás Vila M, Izquierdo Quevedo FJ, Cerdán Vera MT, Fernández A, Artás Figueres M, Revert Gomas M. Visual hallucinations caused by methylphenidate.  Anales de Pediatria 2010;72(3):229‐30. [DOI: 10.1016/j.anpedi.2009.10.013; PUBMED: 20097145]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.anpedi.2009.10.013', 'https://scholar.google.com/scholar_lookup?title=Visual+hallucinations+caused+by+methylphenidate&author=M+TomásVila&author=FJ+IzquierdoQuevedo&author=MT+CerdánVera&author=A+Fernández&author=M+ArtásFigueres&author=M+RevertGomas&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.anpedi.2009.10.013, Tomás Vila 2010a {published data only}  ,included,CD012069-bbs2-0213,
CD012069-bib-0361,"Tomás Vila M, Aleu Pérez‐Gramunt M, Beseler Soto B, Benac Prefasi M, Pantoja Martínez J, Pitarch Castellano I. ",Methylphenidate and sleep: results of a multicentre study on a population of children with attention deficit hyperactivity disorder, Anales de Pediatria ,2010,73,    ,['citation-journal']," Tomás Vila M, Aleu Pérez‐Gramunt M, Beseler Soto B, Benac Prefasi M, Pantoja Martínez J, Pitarch Castellano I. Methylphenidate and sleep: results of a multicentre study on a population of children with attention deficit hyperactivity disorder.  Anales de Pediatria 2010;73(2):78‐83. [DOI: 10.1016/j.anpedi.2010.05.013; PUBMED: 20605120]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.anpedi.2010.05.013', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+sleep:+results+of+a+multicentre+study+on+a+population+of+children+with+attention+deficit+hyperactivity+disorder+&author=M+TomásVila&author=M+AleuPérez‐Gramunt&author=B+BeselerSoto&author=M+BenacPrefasi&author=J+PantojaMartínez&author=I+PitarchCastellano&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.anpedi.2010.05.013, Tomás Vila 2010b {published data only}  ,included,CD012069-bbs2-0214,
CD012069-bib-0362,Trugman JM. ,Cerebral arteritis and oral methylphenidate, Lancet ,1988,1,    ,['citation-journal'], Trugman JM. Cerebral arteritis and oral methylphenidate.  Lancet 1988;1(8585):584‐5. [PUBMED: 2894511]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/S0140-6736(88)91372-4', 'https://scholar.google.com/scholar_lookup?title=Cerebral+arteritis+and+oral+methylphenidate&author=JM+Trugman&publication_year=1988&hl=en']",2894511,https://doi.org/10.1016/S0140-6736(88)91372-4, Trugman 1988 {published data only}  ,included,CD012069-bbs2-0215,
CD012069-bib-0363,"Tzang RF, Wang YC, Yeh CB, Hsu CD, Liang HY, Yang PC, et al. ",Naturalistic exploration of the effect of osmotic release oral system‐methylphenidate on remission rate and functional improvement in Taiwanese children with attention‐deficit‐hyperactivity disorder,,2012,,    ,['citation-other']," Tzang RF, Wang YC, Yeh CB, Hsu CD, Liang HY, Yang PC, et al. Naturalistic exploration of the effect of osmotic release oral system‐methylphenidate on remission rate and functional improvement in Taiwanese children with attention‐deficit‐hyperactivity disorder. Psychiatry and Clinical Neurosciences2012; Vol. 66, issue 1:53‐63. [DOI: 10.1111/j.1440‐1819.2011.02289.x; PUBMED: 22250610]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Naturalistic+exploration+of+the+effect+of+osmotic+release+oral+system‐methylphenidate+on+remission+rate+and+functional+improvement+in+Taiwanese+children+with+attention‐deficit‐hyperactivity+disorder+&author=RF+Tzang&author=YC+Wang&author=CB+Yeh&author=CD+Hsu&author=HY+Liang&author=PC+Yang&publication_year=2012&hl=en']",,, Tzang 2012 {published data only}  ,included,CD012069-bbs2-0216,
CD012069-bib-0364,"Tølløfsrud C, Hoel T. ",A young man with acute dilated cardiomyopathy, Tidsskrift for Den Norske Laegeforening ,2006,126,    ,['citation-journal']," Tølløfsrud C, Hoel T. A young man with acute dilated cardiomyopathy.  Tidsskrift for Den Norske Laegeforening 2006;126(10):1338‐9. [PUBMED: 16715575]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+young+man+with+acute+dilated+cardiomyopathy&author=C+Tølløfsrud&author=T+Hoel&publication_year=2006&hl=en']",16715575,, Tølløfsrud 2006 {published data only}  ,included,CD012069-bbs2-0217,
CD012069-bib-0365,Valdizan Uson JR. ,Diagnostic and therapeutic electroclinical correlation with immediate action methylphenidate in ADHD, Revista Espanola de Pediatria ,2004,60,    ,['citation-journal'], Valdizan Uson JR. Diagnostic and therapeutic electroclinical correlation with immediate action methylphenidate in ADHD [Correlación electrónica diagnóstica y terapéutica con metilfeniato de acción inmediata en TDAH].  Revista Espanola de Pediatria 2004;60(3):181‐7. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Diagnostic+and+therapeutic+electroclinical+correlation+with+immediate+action+methylphenidate+in+ADHD+&author=JR+ValdizanUson&publication_year=2004&hl=en']",,, Valdizán Usón 2004 {published data only}  ,included,CD012069-bbs2-0218,
CD012069-bib-0367,Valdizán Uson JR. ,Methylphenidate in children and adolescents with attention‐deficit/ hyperactivity disorder: The DIHANA Study, Acta Pediatrica Espanola ,2013,71,    ,['citation-journal'], Valdizán Uson JR. Methylphenidate in children and adolescents with attention‐deficit/ hyperactivity disorder: The DIHANA Study.  Acta Pediatrica Espanola 2013;71(3):67‐76. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+in+children+and+adolescents+with+attention‐deficit/+hyperactivity+disorder:+The+DIHANA+Study+&author=JR+ValdizánUson&publication_year=2013&hl=en']",,, Valdizán Usón 2013 {published data only}  ,included,CD012069-bbs2-0219,
CD012069-bib-0366,"Valdizán Uson JR, Cánovas‐Martínez A, De Lucas‐Taracena MT, Díaz‐Atienza F, Eddy‐Ives LS, Fernandez‐Jaen A, et al. ",Response to methylphenidate by adult and pediatric patients with attention‐deficit/hyperactivity disorder: the Spanish multicenter DIHANA study, Neuropsychiatric Disease and Treatment ,2013,9,    ,['citation-journal']," Valdizán Uson JR, Cánovas‐Martínez A, De Lucas‐Taracena MT, Díaz‐Atienza F, Eddy‐Ives LS, Fernandez‐Jaen A, et al. Response to methylphenidate by adult and pediatric patients with attention‐deficit/hyperactivity disorder: the Spanish multicenter DIHANA study.  Neuropsychiatric Disease and Treatment 2013;9:211‐8. [DOI: 10.2147/NDT.S35836; PMC3573811]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2147/NDT.S35836', 'https://scholar.google.com/scholar_lookup?title=Response+to+methylphenidate+by+adult+and+pediatric+patients+with+attention‐deficit/hyperactivity+disorder:+the+Spanish+multicenter+DIHANA+study+&author=JR+ValdizánUson&author=A+Cánovas‐Martínez&author=MT+Lucas‐Taracena&author=F+Díaz‐Atienza&author=LS+Eddy‐Ives&author=A+Fernandez‐Jaen&publication_year=2013&hl=en']",,https://doi.org/10.2147/NDT.S35836, Valdizán Usón 2013 {published data only}  ,included,CD012069-bbs2-0219,
CD012069-bib-0368,"Van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. ","Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?", European Child and Adolescent Psychiatry ,2007,16,    ,['citation-journal']," Van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?.  European Child and Adolescent Psychiatry 2007;16(1):48‐57. [DOI: 10.1007/s00787‐006‐0574‐z; PUBMED: 16972117]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-006-0574-z', 'https://scholar.google.com/scholar_lookup?title=Does+brief,+clinically+based,+intensive+multimodal+behavior+therapy+enhance+the+effects+of+methylphenidate+in+children+with+ADHD?+&author=S+Oord&author=PJ+Prins&author=J+Oosterlaan&author=PM+Emmelkamp&publication_year=2007&hl=en']",,https://doi.org/10.1007/s00787-006-0574-z, Van der Oord 2007 {published data only}  ,included,CD012069-bbs2-0220,
CD012069-bib-0369,"Varley CK, Vincent J, Varley P, Calderon R. ",Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications, Comprehensive Psychiatry ,2001,42,    ,['citation-journal']," Varley CK, Vincent J, Varley P, Calderon R. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.  Comprehensive Psychiatry 2001;42(3):228‐33. [DOI: 10.1053/comp.2001.23145; PUBMED: 11349243]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1053/comp.2001.23145', 'https://scholar.google.com/scholar_lookup?title=Emergence+of+tics+in+children+with+attention+deficit+hyperactivity+disorder+treated+with+stimulant+medications+&author=CK+Varley&author=J+Vincent&author=P+Varley&author=R+Calderon&publication_year=2001&hl=en']",,https://doi.org/10.1053/comp.2001.23145, Varley 2001 {published data only}  ,included,CD012069-bbs2-0221,
CD012069-bib-0370,"Vashi NA, Souza A, Cohen N, Franklin B, Cohen DE. ",Allergic contact dermatitis caused by methylphenidate, Contact Dermatitis ,2011,65,    ,['citation-journal']," Vashi NA, Souza A, Cohen N, Franklin B, Cohen DE. Allergic contact dermatitis caused by methylphenidate.  Contact Dermatitis 2011;65(3):183‐85. [DOI: 10.1111/j.1600‐0536.2011.01949.x; PUBMED: 21827513]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1600-0536.2011.01949.x', 'https://scholar.google.com/scholar_lookup?title=Allergic+contact+dermatitis+caused+by+methylphenidate&author=NA+Vashi&author=A+Souza&author=N+Cohen&author=B+Franklin&author=DE+Cohen&publication_year=2011&hl=en']",,https://doi.org/10.1111/j.1600-0536.2011.01949.x, Vashi 2011 {published data only}  ,included,CD012069-bbs2-0222,
CD012069-bib-0371,"Verret C, Gardiner P, Béliveau L. ",Fitness level and gross motor performance of children with attention‐deficit hyperactivity disorder, Adapted Physical Activity Quarterly ,2010,27,    ,['citation-journal']," Verret C, Gardiner P, Béliveau L. Fitness level and gross motor performance of children with attention‐deficit hyperactivity disorder.  Adapted Physical Activity Quarterly 2010;27(4):337‐51. [PUBMED: 20956839]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1123/apaq.27.4.337', 'https://scholar.google.com/scholar_lookup?title=Fitness+level+and+gross+motor+performance+of+children+with+attention‐deficit+hyperactivity+disorder+&author=C+Verret&author=P+Gardiner&author=L+Béliveau&publication_year=2010&hl=en']",20956839,https://doi.org/10.1123/apaq.27.4.337, Verret 2010 {published data only}  ,included,CD012069-bbs2-0223,
CD012069-bib-0372,"Vincent J, Varley CK, Leger P. ",Effects of methylphenidate on early adolescent growth, American Journal of Psychiatry ,1990,147,    ,['citation-journal']," Vincent J, Varley CK, Leger P. Effects of methylphenidate on early adolescent growth.  American Journal of Psychiatry 1990;147(4):501‐2. [DOI: 10.1176/ajp.147.4.501; PUBMED: 2316739]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+on+early+adolescent+growth&author=J+Vincent&author=CK+Varley&author=P+Leger&publication_year=1990&hl=en']",,, Vincent 1990 {published data only}  ,included,CD012069-bbs2-0224,
CD012069-bib-0373,"Walitza S, Werner B, Romanos M, Warnke A, Gerlach M, Stopper H. ",Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?, Environmental Health Perspectives ,2007,115,    ,['citation-journal']," Walitza S, Werner B, Romanos M, Warnke A, Gerlach M, Stopper H. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?.  Environmental Health Perspectives 2007;115(6):936‐40. [DOI: 10.1289/ehp.9866; PMC1892117]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1289/ehp.9866', 'https://scholar.google.com/scholar_lookup?title=Does+methylphenidate+cause+a+cytogenetic+effect+in+children+with+attention+deficit+hyperactivity+disorder?+&author=S+Walitza&author=B+Werner&author=M+Romanos&author=A+Warnke&author=M+Gerlach&author=H+Stopper&publication_year=2007&hl=en']",,https://doi.org/10.1289/ehp.9866, Walitza 2007 {published data only}  ,included,CD012069-bbs2-0225,
CD012069-bib-0374,"Stopper H, Kampf K, Romanos M, Warnke A, Walitza S, Gerlach M. ",Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?, International Journal of Neuropsychopharmacology ,2008,11,    ,['citation-journal']," Stopper H, Kampf K, Romanos M, Warnke A, Walitza S, Gerlach M. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?.  International Journal of Neuropsychopharmacology 2008;11:290. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Does+methylphenidate+cause+a+cytogenetic+effect+in+children+with+attention+deficit+hyperactivity+disorder?+&author=H+Stopper&author=K+Kampf&author=M+Romanos&author=A+Warnke&author=S+Walitza&author=M+Gerlach&publication_year=2008&hl=en']",,, Walitza 2009 {published data only}  ,included,CD012069-bbs2-0226,
CD012069-bib-0375,"Walitza S, Kampf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, et al. ",No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy, Toxicology Letters ,2009,184,    ,['citation-journal']," Walitza S, Kampf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, et al. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.  Toxicology Letters 2009;184(1):38‐43. [DOI: 10.1016/j.toxlet.2008.10.011]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.toxlet.2008.10.011', 'https://scholar.google.com/scholar_lookup?title=No+elevated+genomic+damage+in+children+and+adolescents+with+attention+deficit/hyperactivity+disorder+after+methylphenidate+therapy+&author=S+Walitza&author=K+Kampf&author=N+Artamonov&author=M+Romanos&author=R+GnanaOli&author=S+Wirth&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.toxlet.2008.10.011, Walitza 2009 {published data only}  ,included,CD012069-bbs2-0226,
CD012069-bib-0376,"Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, et al. ","Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial", Australian and New Zealand Journal of Psychiatry ,2007,41,    ,['citation-journal']," Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, et al. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial.  Australian and New Zealand Journal of Psychiatry 2007;41(3):222‐30. [DOI: 10.1080/00048670601057767; PUBMED: 17464703]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/00048670601057767', 'https://scholar.google.com/scholar_lookup?title=Atomoxetine+versus+methylphenidate+in+paediatric+outpatients+with+attention+deficit+hyperactivity+disorder:+a+randomized,+double‐blind+comparison+trial+&author=Y+Wang&author=Y+Zheng&author=Y+Du&author=DH+Song&author=YJ+Shin&author=SC+Cho&publication_year=2007&hl=en']",,https://doi.org/10.1080/00048670601057767, Wang 2007 {published data only}  ,included,CD012069-bbs2-0227,
CD012069-bib-0377,"Wang LJ, Hsiao CC, Huang YS, Chiang YL, Ree SC, Chen YC, et al. ",Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate, Psychoneuroendocrinology ,2011,36,    ,['citation-journal']," Wang LJ, Hsiao CC, Huang YS, Chiang YL, Ree SC, Chen YC, et al. Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.  Psychoneuroendocrinology 2011;36(8):1209‐16. [DOI: 10.1016/j.psyneuen.2011.02.014; PUBMED: 21411231]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.psyneuen.2011.02.014', 'https://scholar.google.com/scholar_lookup?title=Association+of+salivary+dehydroepiandrosterone+levels+and+symptoms+in+patients+with+attention+deficit+hyperactivity+disorder+during+six+months+of+treatment+with+methylphenidate+&author=LJ+Wang&author=CC+Hsiao&author=YS+Huang&author=YL+Chiang&author=SC+Ree&author=YC+Chen&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.psyneuen.2011.02.014, Wang 2011 {published data only}  ,included,CD012069-bbs2-0228,
CD012069-bib-0378,"Wang LJ, Huang YS, Chiang YL, Hsiao CC, Shang ZY, Chen CK. ",Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow‐up study for 6 months, BMC Psychiatry ,2011,11,    ,['citation-journal']," Wang LJ, Huang YS, Chiang YL, Hsiao CC, Shang ZY, Chen CK. Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow‐up study for 6 months.  BMC Psychiatry 2011;11:65. [DOI: 10.1186/1471‐244X‐11‐65; PMC3111344; PUBMED: 21504587]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1471-244X-11-65', 'https://scholar.google.com/scholar_lookup?title=Clinical+symptoms+and+performance+on+the+Continuous+Performance+Test+in+children+with+attention+deficit+hyperactivity+disorder+between+subtypes:+a+natural+follow‐up+study+for+6+months+&author=LJ+Wang&author=YS+Huang&author=YL+Chiang&author=CC+Hsiao&author=ZY+Shang&author=CK+Chen&publication_year=2011&hl=en']",,https://doi.org/10.1186/1471-244X-11-65, Wang 2011 {published data only}  ,included,CD012069-bbs2-0228,
CD012069-bib-0379,"Wang LJ, Huang YS, Hsiao CC, Chiang YL, Wu CC, Shang ZY, et al. ","Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder", World Journal of Biological Psychiatry ,2011,12,    ,['citation-journal']," Wang LJ, Huang YS, Hsiao CC, Chiang YL, Wu CC, Shang ZY, et al. Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder.  World Journal of Biological Psychiatry 2011;12(2):99‐109. [DOI: 10.3109/15622975.2010.512090; PUBMED: 20822373]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3109/15622975.2010.512090', 'https://scholar.google.com/scholar_lookup?title=Salivary+dehydroepiandrosterone,+but+not+cortisol,+is+associated+with+attention+deficit+hyperactivity+disorder+&author=LJ+Wang&author=YS+Huang&author=CC+Hsiao&author=YL+Chiang&author=CC+Wu&author=ZY+Shang&publication_year=2011&hl=en']",,https://doi.org/10.3109/15622975.2010.512090, Wang 2011 {published data only}  ,included,CD012069-bbs2-0228,
CD012069-bib-0380,"Wang LJ, Wu CC, Lee SY, Tsai YF. ",Salivary neurosteroid levels and behavioural profiles of children with attention‐deficit/hyperactivity disorder during six months of methylphenidate treatment, Journal of Child and Adolescent Psychopharmacology ,2014,24,    ,['citation-journal']," Wang LJ, Wu CC, Lee SY, Tsai YF. Salivary neurosteroid levels and behavioural profiles of children with attention‐deficit/hyperactivity disorder during six months of methylphenidate treatment.  Journal of Child and Adolescent Psychopharmacology 2014;24(6):336‐40. [DOI: 10.1089/cap.2013.0122; PUBMED: 24956271]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2013.0122', 'https://scholar.google.com/scholar_lookup?title=Salivary+neurosteroid+levels+and+behavioural+profiles+of+children+with+attention‐deficit/hyperactivity+disorder+during+six+months+of+methylphenidate+treatment+&author=LJ+Wang&author=CC+Wu&author=SY+Lee&author=YF+Tsai&publication_year=2014&hl=en']",,https://doi.org/10.1089/cap.2013.0122, Wang 2011 {published data only}  ,included,CD012069-bbs2-0228,
CD012069-bib-0381,"Warshaw EM, Squires L, Li Y, Civil R, Paller AS. ","Methylphenidate transdermal system: a multisite, open‐label study of dermal reactions in pediatric patients diagnosed with ADHD", Primary Care Companion to the Journal of Clinical Psychiatry ,2010,12,    ,['citation-journal']," Warshaw EM, Squires L, Li Y, Civil R, Paller AS. Methylphenidate transdermal system: a multisite, open‐label study of dermal reactions in pediatric patients diagnosed with ADHD.  Primary Care Companion to the Journal of Clinical Psychiatry 2010;12(6):e1‐e9. [DOI: 10.4088/PCC.10m00996pur; NCT00434213; PMC3067997; PUBMED: 21494336]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4088/PCC.10m00996pur', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+transdermal+system:+a+multisite,+open‐label+study+of+dermal+reactions+in+pediatric+patients+diagnosed+with+ADHD+&author=EM+Warshaw&author=L+Squires&author=Y+Li&author=R+Civil&author=AS+Paller&publication_year=2010&hl=en']",,https://doi.org/10.4088/PCC.10m00996pur, Warshaw 2010 {published data only}  ,included,CD012069-bbs2-0229,
CD012069-bib-0382,"Weber P, Bubl R, Lütschg J. ",Side effects of methylphenidate in children. Prevalence and associated factors, Monatsschrift Kinderheilkunde ,2003,151,    ,['citation-journal']," Weber P, Bubl R, Lütschg J. Side effects of methylphenidate in children. Prevalence and associated factors [Nebenwirkungen einer Methylphenidat‐Therapie bei Schulkindern].  Monatsschrift Kinderheilkunde 2003;151(4):399‐404. [DOI: 10.1007/s00112‐002‐0590‐0]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00112-002-0590-0', 'https://scholar.google.com/scholar_lookup?title=Side+effects+of+methylphenidate+in+children.+Prevalence+and+associated+factors&author=P+Weber&author=R+Bubl&author=J+Lütschg&publication_year=2003&hl=en']",,https://doi.org/10.1007/s00112-002-0590-0, Weber 2003 {published data only}  ,included,CD012069-bbs2-0230,
CD012069-bib-0383,"Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, et al. ","Once‐daily multilayer‐release methylphenidate in a double‐blind, crossover comparison to immediate‐release methylphenidate in children with attention‐deficit/hyperactivity disorder", Journal of Child and Adolescent Psychopharmacology ,2007,17,    ,['citation-journal']," Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, et al. Once‐daily multilayer‐release methylphenidate in a double‐blind, crossover comparison to immediate‐release methylphenidate in children with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2007;17(5):675‐88. [DOI: 10.1089/cap.2006.0101; PUBMED: 17979587]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2006.0101', 'https://scholar.google.com/scholar_lookup?title=Once‐daily+multilayer‐release+methylphenidate+in+a+double‐blind,+crossover+comparison+to+immediate‐release+methylphenidate+in+children+with+attention‐deficit/hyperactivity+disorder+&author=M+Weiss&author=L+Hechtman&author=A+Turgay&author=U+Jain&author=D+Quinn&author=TS+Ahmed&publication_year=2007&hl=en']",,https://doi.org/10.1089/cap.2006.0101, Weiss 2007 {published data only}  ,included,CD012069-bbs2-0231,
CD012069-bib-0384,"Wigal SB, Gupta S, Heverin E, Starr HL. ",Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2011,21,    ,['citation-journal']," Wigal SB, Gupta S, Heverin E, Starr HL. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2011;21(3):255‐63. [DOI: 10.1089/cap.2010.0083; PUBMED: 21663428]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2010.0083', 'https://scholar.google.com/scholar_lookup?title=Pharmacokinetics+and+therapeutic+effect+of+OROS+methylphenidate+under+different+breakfast+conditions+in+children+with+attention‐deficit/hyperactivity+disorder+&author=SB+Wigal&author=S+Gupta&author=E+Heverin&author=HL+Starr&publication_year=2011&hl=en']",,https://doi.org/10.1089/cap.2010.0083, Wigal 2011 {published data only}  ,included,CD012069-bbs2-0232,
CD012069-bib-0385,,Liquid version of methylphenidate shows efficacy in school trial, Brown University Child and Adolescent Psychopharmacology Update ,2013,15,   ,['citation-journal'], Liquid version of methylphenidate shows efficacy in school trial.  Brown University Child and Adolescent Psychopharmacology Update 2013;15(3):1‐3. [DOI: 10.1002/cpu.20183/epdf]CENTRAL    ,[''],,, Wigal 2013 {published data only}  ,included,CD012069-bbs2-0233,
CD012069-bib-0386,"Wigal S, Childress A, Belden H, Berry S. ","NWP06, an extended‐release oral suspension of methylphenidate, improved attention‐deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study", Journal of Child and Adolescent Psychopharmacology ,2013,23,    ,['citation-journal']," Wigal S, Childress A, Belden H, Berry S. NWP06, an extended‐release oral suspension of methylphenidate, improved attention‐deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.  Journal of Child and Adolescent Psychopharmacology 2013;23(1):3‐10. [DOI: 10.1089/cap.2012.0073; PMC3696913]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2012.0073', 'https://scholar.google.com/scholar_lookup?title=NWP06,+an+extended‐release+oral+suspension+of+methylphenidate,+improved+attention‐deficit/hyperactivity+disorder+symptoms+compared+with+placebo+in+a+laboratory+classroom+study+&author=S+Wigal&author=A+Childress&author=H+Belden&author=S+Berry&publication_year=2013&hl=en']",,https://doi.org/10.1089/cap.2012.0073, Wigal 2013 {published data only}  ,included,CD012069-bbs2-0233,
CD012069-bib-0387,"Wigal SB, Nordbrock E, Adjei AL, Childress A, Kupper RJ, Greenhill L. ","Efficacy of methylphenidate hydrochloride extended‐release capsules (Aptensio XRTM) in children and adolescents with attention‐deficit/hyperactivity disorder: a phase III, randomized, double‐blind study", CNS Drugs ,2015,29,    ,['citation-journal']," Wigal SB, Nordbrock E, Adjei AL, Childress A, Kupper RJ, Greenhill L. Efficacy of methylphenidate hydrochloride extended‐release capsules (Aptensio XRTM) in children and adolescents with attention‐deficit/hyperactivity disorder: a phase III, randomized, double‐blind study.  CNS Drugs 2015;29(4):331‐40. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s40263-015-0241-3', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+methylphenidate+hydrochloride+extended‐release+capsules+(Aptensio+XRTM)+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder:+a+phase+III,+randomized,+double‐blind+study+&author=SB+Wigal&author=E+Nordbrock&author=AL+Adjei&author=A+Childress&author=RJ+Kupper&author=L+Greenhill&publication_year=2015&hl=en']",,https://doi.org/10.1007/s40263-015-0241-3, Wigal 2015 {published data only}  ,included,CD012069-bbs2-0234,
CD012069-bib-0388,"Wiguna T, Guerrero AP, Wibisono S, Sastroasmoro S. ","Effect of 12‐week administration of 20‐mg long‐acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school‐age children in Indonesia: a study using 1H Magnetic Resonance Spectroscopy (MRS)",,2012,,    ,['citation-other']," Wiguna T, Guerrero AP, Wibisono S, Sastroasmoro S. Effect of 12‐week administration of 20‐mg long‐acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school‐age children in Indonesia: a study using 1H Magnetic Resonance Spectroscopy (MRS). Clinical Neuropharmacology. T. Wiguna, Child and Adolescent Psychiatry Division, Department of Psychiatry, University of Indonesia, Jl. Salemba Raya 4, Jakarta 10430, Indonesia. E‐mail: [email protected]: Lippincott Williams and Wilkins (530 Walnut Street,P O Box 327, Philadelphia PA 19106‐3621, United States), 2012; Vol. 35, issue 2:81‐5. [DOI: 10.1097/WNF.0b013e3182452572; PUBMED: 22318191]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effect+of+12‐week+administration+of+20‐mg+long‐acting+methylphenidate+on+Glu/Cr,+NAA/Cr,+Cho/Cr,+and+mI/Cr+ratios+in+the+prefrontal+cortices+of+school‐age+children+in+Indonesia:+a+study+using+1H+Magnetic+Resonance+Spectroscopy+(MRS)+&author=T+Wiguna&author=AP+Guerrero&author=S+Wibisono&author=S+Sastroasmoro&publication_year=2012&hl=en']",,, Wiguna 2012 {published data only}  ,included,CD012069-bbs2-0235,
CD012069-bib-0389,Biederman J. ,"Evaluation of once‐daily OROS methylphenidate in children with attention‐deficit/hyperactivity disorder: effects on sleep, appetite, and tics", European Neuropsychopharmacology ,2003,13,    ,['citation-journal']," Biederman J. Evaluation of once‐daily OROS methylphenidate in children with attention‐deficit/hyperactivity disorder: effects on sleep, appetite, and tics.  European Neuropsychopharmacology 2003;13(Suppl 4):S447‐8. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(03)92350-9', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+once‐daily+OROS+methylphenidate+in+children+with+attention‐deficit/hyperactivity+disorder:+effects+on+sleep,+appetite,+and+tics+&author=J+Biederman&publication_year=2003&hl=en']",,https://doi.org/10.1016/S0924-977X(03)92350-9, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0390,Biederman J. ,Treatment of attention‐deficit/hyperactivity disorder with the once‐daily OROS formulation of methylphenidate: effect on growth in children, European Neuropsychopharmacology ,2003,13,    ,['citation-journal'], Biederman J. Treatment of attention‐deficit/hyperactivity disorder with the once‐daily OROS formulation of methylphenidate: effect on growth in children.  European Neuropsychopharmacology 2003;13(Suppl 4):S448‐9. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Treatment+of+attention‐deficit/hyperactivity+disorder+with+the+once‐daily+OROS+formulation+of+methylphenidate:+effect+on+growth+in+children+&author=J+Biederman&publication_year=2003&hl=en']",,, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0391,"Faraone SV, Biederman J, Zimmerman B. ","An analysis of patient adherence to treatment during a 1‐year, open‐label study of OROS methylphenidate in children with ADHD", Journal of Attention Disorders ,2007,11,    ,['citation-journal']," Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1‐year, open‐label study of OROS methylphenidate in children with ADHD.  Journal of Attention Disorders 2007;11(2):157‐66. [DOI: 10.1177/1087054706295663; PUBMED: 17494833]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054706295663', 'https://scholar.google.com/scholar_lookup?title=An+analysis+of+patient+adherence+to+treatment+during+a+1‐year,+open‐label+study+of+OROS+methylphenidate+in+children+with+ADHD+&author=SV+Faraone&author=J+Biederman&author=B+Zimmerman&publication_year=2007&hl=en']",,https://doi.org/10.1177/1087054706295663, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0392,"Lerner MA, Spencer T. ",Analysis of growth in children with ADHD during long‐term therapy with once‐daily OROS® methylphenidate,,2004,,    ,['citation-other']," Lerner MA, Spencer T. Analysis of growth in children with ADHD during long‐term therapy with once‐daily OROS® methylphenidate. Pediatric Academic Societies' Annual Meeting; 2004 May 1‐4; San Francisco (CA). 2004; Vol. 55. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Analysis+of+growth+in+children+with+ADHD+during+long‐term+therapy+with+once‐daily+OROS®+methylphenidate+&author=MA+Lerner&author=T+Spencer&publication_year=2004&hl=en']",,, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0393,"Palumbo DR, Starr HL. ",Once‐daily OROS methylphenidate: Impact on tics in children with attention deficit hyperactivity disorder, Annals of Neurology ,2003,54,    ,['citation-journal']," Palumbo DR, Starr HL. Once‐daily OROS methylphenidate: Impact on tics in children with attention deficit hyperactivity disorder.  Annals of Neurology 2003;54(Suppl 7):S27. [DOI: 10.1002/ana.5049/epdf]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Once‐daily+OROS+methylphenidate:+Impact+on+tics+in+children+with+attention+deficit+hyperactivity+disorder+&author=DR+Palumbo&author=HL+Starr&publication_year=2003&hl=en']",,, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0394,"Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B, Concerta Study Group. ",Does prolonged therapy with a long‐acting stimulant suppress growth in children with ADHD?, Journal of the American Academy of Child and Adolescent Psychiatry ,2006,45,    ,['citation-journal']," Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B, Concerta Study Group. Does prolonged therapy with a long‐acting stimulant suppress growth in children with ADHD?.  Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(5):527‐37. [DOI: 10.1097/01.chi.0000205710.01690.d4; PUBMED: 16670649]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.chi.0000205710.01690.d4', 'https://scholar.google.com/scholar_lookup?title=Does+prolonged+therapy+with+a+long‐acting+stimulant+suppress+growth+in+children+with+ADHD?+&author=TJ+Spencer&author=SV+Faraone&author=J+Biederman&author=M+Lerner&author=KM+Cooper&author=B+Zimmerman&publication_year=2006&hl=en']",,https://doi.org/10.1097/01.chi.0000205710.01690.d4, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0395,"Spencer TJ, Faraone SV, Lerner M, Cooper KM, Zimmerman B. ",Effect of long‐term treatment with stimulant medication on growth? Drs. Spencer et al. Reply, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Spencer TJ, Faraone SV, Lerner M, Cooper KM, Zimmerman B. Effect of long‐term treatment with stimulant medication on growth? Drs. Spencer et al. Reply.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(3):306. [DOI: 10.1097/chi.0b013e31802ed960]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/chi.0b013e31802ed960', 'https://scholar.google.com/scholar_lookup?title=Effect+of+long‐term+treatment+with+stimulant+medication+on+growth?+Drs.+Spencer+et+al.+Reply+&author=TJ+Spencer&author=SV+Faraone&author=M+Lerner&author=KM+Cooper&author=B+Zimmerman&publication_year=2007&hl=en']",,https://doi.org/10.1097/chi.0b013e31802ed960, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0396,"Wigal SB, Wilens TE, Wolraich M, Lerner M. ","Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention‐deficit/hyperactivity disorder: 2‐year, open‐label study results", Pediatrics ,2007,120,    ,['citation-journal']," Wigal SB, Wilens TE, Wolraich M, Lerner M. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention‐deficit/hyperactivity disorder: 2‐year, open‐label study results.  Pediatrics 2007;120(1):e120‐8. [DOI: 10.1542/peds.2006‐1402]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2006-1402', 'https://scholar.google.com/scholar_lookup?title=Hematologic+and+blood+biochemistry+monitoring+during+methylphenidate+treatment+in+children+with+attention‐deficit/hyperactivity+disorder:+2‐year,+open‐label+study+results+&author=SB+Wigal&author=TE+Wilens&author=M+Wolraich&author=M+Lerner&publication_year=2007&hl=en']",,https://doi.org/10.1542/peds.2006-1402, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0397,"Wilens T, Biederman J, Lerner M, Concerta Study Group. ",Effects of once‐daily osmotic‐release methylphenidate on blood pressure and heart rate in children with attention‐deficit/hyperactivity disorder: results from a one‐year follow‐up study, Journal of Clinical Psychopharmacology ,2004,24,    ,['citation-journal']," Wilens T, Biederman J, Lerner M, Concerta Study Group. Effects of once‐daily osmotic‐release methylphenidate on blood pressure and heart rate in children with attention‐deficit/hyperactivity disorder: results from a one‐year follow‐up study.  Journal of Clinical Psychopharmacology 2004;24(1):36‐41. [DOI: 10.1097/01.jcp.0000106223.36344.df; PUBMED: 14709945]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.jcp.0000106223.36344.df', 'https://scholar.google.com/scholar_lookup?title=Effects+of+once‐daily+osmotic‐release+methylphenidate+on+blood+pressure+and+heart+rate+in+children+with+attention‐deficit/hyperactivity+disorder:+results+from+a+one‐year+follow‐up+study+&author=T+Wilens&author=J+Biederman&author=M+Lerner&publication_year=2004&hl=en']",,https://doi.org/10.1097/01.jcp.0000106223.36344.df, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0398,"Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ",ADHD treatment with once‐daily OROS methylphenidate: final results from a long‐term open‐label study, Journal of the American Academy of Child and Adolescent Psychiatry ,2005,44,    ,['citation-journal']," Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once‐daily OROS methylphenidate: final results from a long‐term open‐label study.  Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(10):1015‐23. [DOI: 10.1097/01.chi.0000173291.28688.e7; PUBMED: 16175106]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.chi.0000173291.28688.e7', 'https://scholar.google.com/scholar_lookup?title=ADHD+treatment+with+once‐daily+OROS+methylphenidate:+final+results+from+a+long‐term+open‐label+study+&author=T+Wilens&author=K+McBurnett&author=M+Stein&author=M+Lerner&author=T+Spencer&author=M+Wolraich&publication_year=2005&hl=en']",,https://doi.org/10.1097/01.chi.0000173291.28688.e7, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0399,"Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ",ADHD treatment with once‐daily OROS methylphenidate: final results from a long‐term open‐label study: erratum, Journal of the American Academy of Child and Adolescent Psychiatry ,2006,45,    ,['citation-journal']," Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once‐daily OROS methylphenidate: final results from a long‐term open‐label study: erratum.  Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(5):632. [DOI: 10.1097/00004583‐200605000‐00020]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=ADHD+treatment+with+once‐daily+OROS+methylphenidate:+final+results+from+a+long‐term+open‐label+study:+erratum+&author=T+Wilens&author=K+McBurnett&author=M+Stein&author=M+Lerner&author=T+Spencer&author=M+Wolraich&publication_year=2006&hl=en']",,, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0400,"Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, et al. ",ADHD treatment with once‐daily OROS methylphenidate: interim 12‐month results from a long‐term open‐label study, Journal of the American Academy of Child and Adolescent Psychiatry ,2003,42,    ,['citation-journal']," Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, et al. ADHD treatment with once‐daily OROS methylphenidate: interim 12‐month results from a long‐term open‐label study.  Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(4):424‐33. [DOI: 10.1097/01.CHI.0000046814.95464.7D; PUBMED: 12649629]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.CHI.0000046814.95464.7D', 'https://scholar.google.com/scholar_lookup?title=ADHD+treatment+with+once‐daily+OROS+methylphenidate:+interim+12‐month+results+from+a+long‐term+open‐label+study+&author=T+Wilens&author=W+Pelham&author=M+Stein&author=CK+Conners&author=H+Abikoff&author=M+Atkins&publication_year=2003&hl=en']",,https://doi.org/10.1097/01.CHI.0000046814.95464.7D, Wilens 2005 {published data only}  ,included,CD012069-bbs2-0236,
CD012069-bib-0405,,Oral system methylphenidate for teen ADHD, Brown University Child and Adolescent Psychopharmacology Update ,2006,8,   ,['citation-journal'], Oral system methylphenidate for teen ADHD.  Brown University Child and Adolescent Psychopharmacology Update 2006;8(3):4‐5. [DOI: 10.1002/cpu.20015]CENTRAL    ,[''],,, Wilens 2006 {published data only}  ,included,CD012069-bbs2-0237,
CD012069-bib-0401,Biederman J. ,Effectiveness and safety of the once‐daily OROS formulation of methylphenidate in adolescents with attention‐deficit/hyperactivity disorder, European Neuropsychopharmacology ,2003,13,    ,['citation-journal'], Biederman J. Effectiveness and safety of the once‐daily OROS formulation of methylphenidate in adolescents with attention‐deficit/hyperactivity disorder.  European Neuropsychopharmacology 2003;13(Suppl 4):S448. CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/S0924-977X(03)92351-0', 'https://scholar.google.com/scholar_lookup?title=Effectiveness+and+safety+of+the+once‐daily+OROS+formulation+of+methylphenidate+in+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=J+Biederman&publication_year=2003&hl=en']",,https://doi.org/10.1016/S0924-977X(03)92351-0, Wilens 2006 {published data only}  ,included,CD012069-bbs2-0237,
CD012069-bib-0402,Greenhill LL. ,Safety and efficacy of OROS MPH in adolescents with ADHD,,2003,,    ,['citation-other'], Greenhill LL. Safety and efficacy of OROS MPH in adolescents with ADHD. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17‐22; San Francisco (CA). 2003. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+OROS+MPH+in+adolescents+with+ADHD&author=LL+Greenhill&publication_year=2003&hl=en']",,, Wilens 2006 {published data only}  ,included,CD012069-bbs2-0237,
CD012069-bib-0403,"McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, et al. ",Once‐daily OROS methylphenidate is safe and well tolerated in adolescents with attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2006,16,    ,['citation-journal']," McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, et al. Once‐daily OROS methylphenidate is safe and well tolerated in adolescents with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2006;16(3):351‐6. [DOI: 10.1089/cap.2006.16.351; PUBMED: 16768642]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2006.16.351', 'https://scholar.google.com/scholar_lookup?title=Once‐daily+OROS+methylphenidate+is+safe+and+well+tolerated+in+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=JJ+McGough&author=K+McBurnett&author=O+Bukstein&author=TE+Wilens&author=L+Greenhill&author=M+Lerner&publication_year=2006&hl=en']",,https://doi.org/10.1089/cap.2006.16.351, Wilens 2006 {published data only}  ,included,CD012069-bbs2-0237,
CD012069-bib-0404,"Newcorn JH, Stein MA, Cooper KM. ","Dose‐response characteristics in adolescents with attention‐deficit/hyperactivity disorder treated with OROS methylphenidate in a 4‐week, open‐label, dose‐titration study", Journal of Child and Adolescent Psychopharmacology ,2010,20,    ,['citation-journal']," Newcorn JH, Stein MA, Cooper KM. Dose‐response characteristics in adolescents with attention‐deficit/hyperactivity disorder treated with OROS methylphenidate in a 4‐week, open‐label, dose‐titration study.  Journal of Child and Adolescent Psychopharmacology 2010;20(3):187‐96. [DOI: 10.1089/cap.2009.0102; PUBMED: 20578931]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2009.0102', 'https://scholar.google.com/scholar_lookup?title=Dose‐response+characteristics+in+adolescents+with+attention‐deficit/hyperactivity+disorder+treated+with+OROS+methylphenidate+in+a+4‐week,+open‐label,+dose‐titration+study+&author=JH+Newcorn&author=MA+Stein&author=KM+Cooper&publication_year=2010&hl=en']",,https://doi.org/10.1089/cap.2009.0102, Wilens 2006 {published data only}  ,included,CD012069-bbs2-0237,
CD012069-bib-0406,"Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, et al. ",Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention‐deficit/hyperactivity disorder, Archives of Pediatrics and Adolescent Medicine ,2006,160,    ,['citation-journal']," Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention‐deficit/hyperactivity disorder.  Archives of Pediatrics and Adolescent Medicine 2006;160(1):82‐90. [DOI: 10.1001/archpedi.160.1.82; PUBMED: 16389216]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpedi.160.1.82', 'https://scholar.google.com/scholar_lookup?title=Multisite+controlled+study+of+OROS+methylphenidate+in+the+treatment+of+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=TE+Wilens&author=K+McBurnett&author=O+Bukstein&author=J+McGough&author=L+Greenhill&author=M+Lerner&publication_year=2006&hl=en']",,https://doi.org/10.1001/archpedi.160.1.82, Wilens 2006 {published data only}  ,included,CD012069-bbs2-0237,
CD012069-bib-0407,"López FA, Landgraf JM, Wilens TE. ",Quality of life and parent satisfaction with the methylphenidate transdermal system, European Neuropsychopharmacology ,2008,18,    ,['citation-journal']," López FA, Landgraf JM, Wilens TE. Quality of life and parent satisfaction with the methylphenidate transdermal system.  European Neuropsychopharmacology 2008;18(Suppl 4):S562. [DOI: 10.1016/S0924‐977X(08)70856‐3]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(08)70856-3', 'https://scholar.google.com/scholar_lookup?title=Quality+of+life+and+parent+satisfaction+with+the+methylphenidate+transdermal+system&author=FA+López&author=JM+Landgraf&author=TE+Wilens&publication_year=2008&hl=en']",,https://doi.org/10.1016/S0924-977X(08)70856-3, Wilens 2008 {published data only}  ,included,CD012069-bbs2-0238,
CD012069-bib-0408,"López FA, Wilens TE, Wigal SB, Turnbow JM. ",Effects of variable wear times on transdermal methylphenidate in attention‐deficit/hyperactivity disorder, European Neuropsychopharmacology ,2008,18,    ,['citation-journal']," López FA, Wilens TE, Wigal SB, Turnbow JM. Effects of variable wear times on transdermal methylphenidate in attention‐deficit/hyperactivity disorder.  European Neuropsychopharmacology 2008;18(Suppl 4):S561‐2. [DOI: 10.1016/S0924‐977X(08)70855‐1]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-977X(08)70855-1', 'https://scholar.google.com/scholar_lookup?title=Effects+of+variable+wear+times+on+transdermal+methylphenidate+in+attention‐deficit/hyperactivity+disorder+&author=FA+López&author=TE+Wilens&author=SB+Wigal&author=JM+Turnbow&publication_year=2008&hl=en']",,https://doi.org/10.1016/S0924-977X(08)70855-1, Wilens 2008 {published data only}  ,included,CD012069-bbs2-0238,
CD012069-bib-0409,"Manos M, Frazier TW, Landgraf JM, Weiss M, Hodgkins P. ",HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system, Current Medical Research and Opinion ,2009,25,    ,['citation-journal']," Manos M, Frazier TW, Landgraf JM, Weiss M, Hodgkins P. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.  Current Medical Research and Opinion 2009;25(12):3001‐10. [DOI: 19849639; PUBMED: 10.1185/03007990903388797]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1185/03007990903388797', 'https://scholar.google.com/scholar_lookup?title=HRQL+and+medication+satisfaction+in+children+with+ADHD+treated+with+the+methylphenidate+transdermal+system+&author=M+Manos&author=TW+Frazier&author=JM+Landgraf&author=M+Weiss&author=P+Hodgkins&publication_year=2009&hl=en']",,https://doi.org/10.1185/03007990903388797, Wilens 2008 {published data only}  ,included,CD012069-bbs2-0238,
CD012069-bib-0410,"Wilens TE, Boellner SW, López FA, Turnbow JM, Wigal SB, Childress AC, et al. ",Varying the wear time of the methylphenidate transdermal system in children with attention‐deficit/hyperactivity disorder, Journal of the American Academy of Child and Adolescent Psychiatry ,2008,47,    ,['citation-journal']," Wilens TE, Boellner SW, López FA, Turnbow JM, Wigal SB, Childress AC, et al. Varying the wear time of the methylphenidate transdermal system in children with attention‐deficit/hyperactivity disorder.  Journal of the American Academy of Child and Adolescent Psychiatry 2008;47(6):700‐8. [DOI: 10.1097/CHI.0b013e31816bffdf; PUBMED: 18434918]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/CHI.0b013e31816bffdf', 'https://scholar.google.com/scholar_lookup?title=Varying+the+wear+time+of+the+methylphenidate+transdermal+system+in+children+with+attention‐deficit/hyperactivity+disorder+&author=TE+Wilens&author=SW+Boellner&author=FA+López&author=JM+Turnbow&author=SB+Wigal&author=AC+Childress&publication_year=2008&hl=en']",,https://doi.org/10.1097/CHI.0b013e31816bffdf, Wilens 2008 {published data only}  ,included,CD012069-bbs2-0238,
CD012069-bib-0411,"Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, et al. ",Misinterpreting emotional expressions in attention‐deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects, Biological Psychiatry ,2008,63,    ,['citation-journal']," Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, et al. Misinterpreting emotional expressions in attention‐deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.  Biological Psychiatry 2008;63(10):917‐26. [DOI: 10.1016/j.biopsych.2007.11.022; PUBMED: 18272140]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.biopsych.2007.11.022', 'https://scholar.google.com/scholar_lookup?title=Misinterpreting+emotional+expressions+in+attention‐deficit/hyperactivity+disorder:+evidence+for+a+neural+marker+and+stimulant+effects+&author=LM+Williams&author=DF+Hermens&author=D+Palmer&author=M+Kohn&author=S+Clarke&author=H+Keage&publication_year=2008&hl=en']",,https://doi.org/10.1016/j.biopsych.2007.11.022, Williams 2008 {published data only}  ,included,CD012069-bbs2-0239,
CD012069-bib-0412,,Resolution of enuresis with stimulant treatment of ADHD, Brown University Child and Adolescent Psychopharmacology Update ,2011,13,   ,['citation-journal'], Resolution of enuresis with stimulant treatment of ADHD.  Brown University Child and Adolescent Psychopharmacology Update 2011;13(6):8‐8. [DOI: 10.1002/cpu.20141]CENTRAL    ,[''],,, Williamson 2011 {published data only}  ,included,CD012069-bbs2-0240,
CD012069-bib-0413,"Williamson LB, Gower M, Ulzen T. ",Clinical case rounds in child and adolescent psychiatry: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series, Journal of the Canadian Academy of Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Williamson LB, Gower M, Ulzen T. Clinical case rounds in child and adolescent psychiatry: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series.  Journal of the Canadian Academy of Child and Adolescent Psychiatry 2011;20(1):53‐5. [PMC3024723]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Clinical+case+rounds+in+child+and+adolescent+psychiatry:+enuresis+and+ADHD+in+older+children+and+an+adolescent+treated+with+stimulant+medication:+a+case+series+&author=LB+Williamson&author=M+Gower&author=T+Ulzen&publication_year=2011&hl=en']",,, Williamson 2011 {published data only}  ,included,CD012069-bbs2-0240,
CD012069-bib-0414,"Winsberg BG, Kupietz SS, Sverg J, Hungund BL, Young NL. ",Methylphenidate oral dose plasma concentrations and behavioral response in children, Psychopharmacology ,1982,76,    ,['citation-journal']," Winsberg BG, Kupietz SS, Sverg J, Hungund BL, Young NL. Methylphenidate oral dose plasma concentrations and behavioral response in children.  Psychopharmacology 1982;76(4):329‐32. [PUBMED: 6812106]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/BF00449120', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+oral+dose+plasma+concentrations+and+behavioral+response+in+children&author=BG+Winsberg&author=SS+Kupietz&author=J+Sverg&author=BL+Hungund&author=NL+Young&publication_year=1982&hl=en']",6812106,https://doi.org/10.1007/BF00449120, Winsberg 1982 {published data only}  ,included,CD012069-bbs2-0241,
CD012069-bib-0415,"Winterstein AG, Gerhard T, Shuster J, Saidi A. ",Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD, Pediatrics ,2009,124,    ,['citation-journal']," Winterstein AG, Gerhard T, Shuster J, Saidi A. Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.  Pediatrics 2009;124(1):e75‐80. [DOI: 10.1542/peds.2008‐3138; PMC3856396; PUBMED: 19564272]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2008-3138', 'https://scholar.google.com/scholar_lookup?title=Cardiac+safety+of+methylphenidate+versus+amphetamine+salts+in+the+treatment+of+ADHD&author=AG+Winterstein&author=T+Gerhard&author=J+Shuster&author=A+Saidi&publication_year=2009&hl=en']",,https://doi.org/10.1542/peds.2008-3138, Winterstein 2009 {published data only}  ,included,CD012069-bbs2-0242,
CD012069-bib-0416,"Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, et al. ",Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database, Annals of Pharmacotherapy ,2008,42,    ,['citation-journal']," Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, et al. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.  Annals of Pharmacotherapy 2008;42(1):24‐31. [DOI: 10.1345/aph.1K143; PUBMED: 18042808]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1345/aph.1K143', 'https://scholar.google.com/scholar_lookup?title=Utilization+of+pharmacologic+treatment+in+youths+with+attention+deficit/hyperactivity+disorder+in+Medicaid+database+&author=AG+Winterstein&author=T+Gerhard&author=J+Shuster&author=J+Zito&author=M+Johnson&author=H+Liu&publication_year=2008&hl=en']",,https://doi.org/10.1345/aph.1K143, Winterstein 2009 {published data only}  ,included,CD012069-bbs2-0242,
CD012069-bib-0417,"Witt KL, Shelby MD, Itchon RN, Faircloth M, Kissling GE, Chrisman AK, et al. ",Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD, Journal of the American Academy of Child and Adolescent Psychiatry ,2008,47,    ,['citation-journal']," Witt KL, Shelby MD, Itchon RN, Faircloth M, Kissling GE, Chrisman AK, et al. Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.  Journal of the American Academy of Child and Adolescent Psychiatry 2008;47(12):1375‐83. [DOI: 10.1097/CHI.0b013e3181893620; PMC2807376; PUBMED: 18978633]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/CHI.0b013e3181893620', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+amphetamine+do+not+induce+cytogenetic+damage+in+lymphocytes+of+children+with+ADHD+&author=KL+Witt&author=MD+Shelby&author=RN+Itchon&author=M+Faircloth&author=GE+Kissling&author=AK+Chrisman&publication_year=2008&hl=en']",,https://doi.org/10.1097/CHI.0b013e3181893620, Witt 2008 {published data only}  ,included,CD012069-bbs2-0243,
CD012069-bib-0418,"Woolley JB, Heyman I. ",Dexamphetamine for obsessive‐compulsive disorder, American Journal of Psychiatry ,2003,160,    ,['citation-journal']," Woolley JB, Heyman I. Dexamphetamine for obsessive‐compulsive disorder.  American Journal of Psychiatry 2003;160(1):183. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1176/appi.ajp.160.1.183', 'https://scholar.google.com/scholar_lookup?title=Dexamphetamine+for+obsessive‐compulsive+disorder&author=JB+Woolley&author=I+Heyman&publication_year=2003&hl=en']",,https://doi.org/10.1176/appi.ajp.160.1.183, Woolley 2003 {published data only}  ,included,CD012069-bbs2-0244,
CD012069-bib-0419,"Yalcin O, Aslan AA, Sari BA, Turkbay T. ",Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases,,2012,,    ,['citation-other']," Yalcin O, Aslan AA, Sari BA, Turkbay T. Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases. Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology]2012; Vol. 22, issue 3:278‐82. [DOI: 10.5455/bcp.20120731061626]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Possible+methylphenidate+related+hoarseness+and+disturbances+of+voice+quality:+two+pediatric+cases+&author=O+Yalcin&author=AA+Aslan&author=BA+Sari&author=T+Turkbay&publication_year=2012&hl=en']",,, Yalcin 2012 {published data only}  ,included,CD012069-bbs2-0245,
CD012069-bib-0420,"Yalcin O, Iseri E, Bukan N, Ercin U. ",Effects of long acting methylphenidate on ghrelin levels in male children with attention deficit hyperactivity disorder: an open label trial, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2014,24,    ,['citation-journal']," Yalcin O, Iseri E, Bukan N, Ercin U. Effects of long acting methylphenidate on ghrelin levels in male children with attention deficit hyperactivity disorder: an open label trial.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2014;24(2):146‐57. [DOI: 10.5455/bcp.20130708042604]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.5455/bcp.20130708042604', 'https://scholar.google.com/scholar_lookup?title=Effects+of+long+acting+methylphenidate+on+ghrelin+levels+in+male+children+with+attention+deficit+hyperactivity+disorder:+an+open+label+trial+&author=O+Yalcin&author=E+Iseri&author=N+Bukan&author=U+Ercin&publication_year=2014&hl=en']",,https://doi.org/10.5455/bcp.20130708042604, Yalcin 2014 {published data only}  ,included,CD012069-bbs2-0246,
CD012069-bib-0421,"Yang P, Chung LC, Chen CS, Chen CC. ",Rapid improvement in academic grades following methylphenidate treatment in attention‐deficit hyperactivity disorder, Psychiatry and Clinical Neurosciences ,2004,58,    ,['citation-journal']," Yang P, Chung LC, Chen CS, Chen CC. Rapid improvement in academic grades following methylphenidate treatment in attention‐deficit hyperactivity disorder.  Psychiatry and Clinical Neurosciences 2004;58(1):37‐41. [PUBMED: 14678455]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1440-1819.2004.01190.x', 'https://scholar.google.com/scholar_lookup?title=Rapid+improvement+in+academic+grades+following+methylphenidate+treatment+in+attention‐deficit+hyperactivity+disorder+&author=P+Yang&author=LC+Chung&author=CS+Chen&author=CC+Chen&publication_year=2004&hl=en']",14678455,https://doi.org/10.1111/j.1440-1819.2004.01190.x, Yang 2004 {published data only}  ,included,CD012069-bbs2-0247,
CD012069-bib-0422,"Yang L, Cao Q, Shuai L, Li H, Chan RC, Wang Y. ",Comparative study of OROS‐MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial,,2012,,    ,['citation-other']," Yang L, Cao Q, Shuai L, Li H, Chan RC, Wang Y. Comparative study of OROS‐MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial. International Journal of Neuropsychopharmacology2012; Vol. 15, issue 1:15‐26. [DOI: 10.1017/S1461145711001490; PUBMED: 22017969]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparative+study+of+OROS‐MPH+and+atomoxetine+on+executive+function+improvement+in+ADHD:+a+randomized+controlled+trial+&author=L+Yang&author=Q+Cao&author=L+Shuai&author=H+Li&author=RC+Chan&author=Y+Wang&publication_year=2012&hl=en']",,, Yang 2012 {published data only}  ,included,CD012069-bbs2-0248,
CD012069-bib-0423,"Yatsuga C, Toyohisa D, Fujisawa TX, Nishitani S, Shinohara K, Matsuura N, et al. ",No association between catechol‐O‐methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children, Brain and Development ,2014,36,    ,['citation-journal']," Yatsuga C, Toyohisa D, Fujisawa TX, Nishitani S, Shinohara K, Matsuura N, et al. No association between catechol‐O‐methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children.  Brain and Development 2014;36(7):620‐5. [DOI: 10.1016/j.braindev.2013.08.006; PUBMED: 24035255]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.braindev.2013.08.006', 'https://scholar.google.com/scholar_lookup?title=No+association+between+catechol‐O‐methyltransferase+(COMT)+genotype+and+attention+deficit+hyperactivity+disorder+(ADHD)+in+Japanese+children+&author=C+Yatsuga&author=D+Toyohisa&author=TX+Fujisawa&author=S+Nishitani&author=K+Shinohara&author=N+Matsuura&publication_year=2014&hl=en']",,https://doi.org/10.1016/j.braindev.2013.08.006, Yatsuga 2014 {published data only}  ,included,CD012069-bbs2-0249,
CD012069-bib-0424,"Yildiz Öç Ö, Ağaoğlu B, Karakaya I, Şişmanlar ŞG, Çakin Memik N. ",Efficiency and tolerability of OROS‐methylphenidate in Turkish children and adolescents with attention‐deficit/hyperactivity disorder, Anadolu Psikiyatri Dergisi ,2010,11,    ,['citation-journal']," Yildiz Öç Ö, Ağaoğlu B, Karakaya I, Şişmanlar ŞG, Çakin Memik N. Efficiency and tolerability of OROS‐methylphenidate in Turkish children and adolescents with attention‐deficit/hyperactivity disorder.  Anadolu Psikiyatri Dergisi 2010;11(1):44‐50. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Efficiency+and+tolerability+of+OROS‐methylphenidate+in+Turkish+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=Ö+YildizÖç&author=B+Ağaoğlu&author=I+Karakaya&author=ŞG+Şişmanlar&author=N+ÇakinMemik&publication_year=2010&hl=en']",,, Yildiz 2010 {published data only}  ,included,CD012069-bbs2-0250,
CD012069-bib-0425,"Yildiz Ö, Şişmanlar ŞG, Memik NÇ, Karakaya I, Ağaoğlu B. ","Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions", Child Psychiatry and Human Development ,2011,42,    ,['citation-journal']," Yildiz Ö, Şişmanlar ŞG, Memik NÇ, Karakaya I, Ağaoğlu B. Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.  Child Psychiatry and Human Development 2011;42(3):257‐69. [DOI: 10.1007/s10578‐010‐0212‐3; PUBMED: 21165694]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s10578-010-0212-3', 'https://scholar.google.com/scholar_lookup?title=Atomoxetine+and+methylphenidate+treatment+in+children+with+ADHD:+the+efficacy,+tolerability+and+effects+on+executive+functions+&author=Ö+Yildiz&author=ŞG+Şişmanlar&author=NÇ+Memik&author=I+Karakaya&author=B+Ağaoğlu&publication_year=2011&hl=en']",,https://doi.org/10.1007/s10578-010-0212-3, Yildiz 2011 {published data only}  ,included,CD012069-bbs2-0251,
CD012069-bib-0426,,Methylphenidate‐induced orofacial and extremity dyskinesia, Brown University Child and Adolescent Psychopharmacology Update ,2012,14,   ,['citation-journal'], Methylphenidate‐induced orofacial and extremity dyskinesia.  Brown University Child and Adolescent Psychopharmacology Update 2012;14(8):7‐7. [DOI: 10.1002/cpu.20169]CENTRAL    ,[''],,, Yilmaz 2013 {published data only}  ,included,CD012069-bbs2-0252,
CD012069-bib-0427,"Yilmaz AE, Donmez A, Orun E, Tas T, Isik B, Sonmez FM. ",Methylphenidate‐induced acute orofacial and extremity dyskinesia, Journal of Child Neurology ,2013,28,    ,['citation-journal']," Yilmaz AE, Donmez A, Orun E, Tas T, Isik B, Sonmez FM. Methylphenidate‐induced acute orofacial and extremity dyskinesia.  Journal of Child Neurology 2013;28(6):778‐80. [DOI: 10.1177/0883073812449905; PUBMED: 22791547]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/0883073812449905', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐induced+acute+orofacial+and+extremity+dyskinesia&author=AE+Yilmaz&author=A+Donmez&author=E+Orun&author=T+Tas&author=B+Isik&author=FM+Sonmez&publication_year=2013&hl=en']",,https://doi.org/10.1177/0883073812449905, Yilmaz 2013 {published data only}  ,included,CD012069-bbs2-0252,
CD012069-bib-0428,"Yu ZJ, Parker‐Kotler C, Tran K, Weller RA, Weller EB. ",Peripheral vasculopathy associated with psychostimulant treatment in children with attention‐deficit/hyperactivity disorder, Current Psychiatry Reports ,2010,12,    ,['citation-journal']," Yu ZJ, Parker‐Kotler C, Tran K, Weller RA, Weller EB. Peripheral vasculopathy associated with psychostimulant treatment in children with attention‐deficit/hyperactivity disorder.  Current Psychiatry Reports 2010;12(2):111‐5. [DOI: 10.1007/s11920‐010‐0093‐y; PUBMED: 20425295]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s11920-010-0093-y', 'https://scholar.google.com/scholar_lookup?title=Peripheral+vasculopathy+associated+with+psychostimulant+treatment+in+children+with+attention‐deficit/hyperactivity+disorder+&author=ZJ+Yu&author=C+Parker‐Kotler&author=K+Tran&author=RA+Weller&author=EB+Weller&publication_year=2010&hl=en']",,https://doi.org/10.1007/s11920-010-0093-y, Yu 2010 {published data only}  ,included,CD012069-bbs2-0253,
CD012069-bib-0429,"Zarinara AR, Mohammadi MR, Hazrati N, Tabrizi M, Rezazadeh SA, Rezaie F, et al. ","Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial", Human Psychopharmacology ,2010,25,    ,['citation-journal']," Zarinara AR, Mohammadi MR, Hazrati N, Tabrizi M, Rezazadeh SA, Rezaie F, et al. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial.  Human Psychopharmacology 2010;25(7‐8):530‐5. [DOI: 10.1002/hup.1148; PUBMED: 20860068]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/hup.1148', 'https://scholar.google.com/scholar_lookup?title=Venlafaxine+versus+methylphenidate+in+pediatric+outpatients+with+attention+deficit+hyperactivity+disorder:+a+randomized,+double‐blind+comparison+trial+&author=AR+Zarinara&author=MR+Mohammadi&author=N+Hazrati&author=M+Tabrizi&author=SA+Rezazadeh&author=F+Rezaie&publication_year=2010&hl=en']",,https://doi.org/10.1002/hup.1148, Zarinara 2010 {published data only}  ,included,CD012069-bbs2-0254,
CD012069-bib-0430,"Zelnik N, Terkel‐Dawer R. ",The clinical profile of children with ADHD that require OROS‐methylphenidate combined with shorter‐acting formulations, ADHD Attention Deficit and Hyperactivity Disorders ,2015,7,    ,['citation-journal']," Zelnik N, Terkel‐Dawer R. The clinical profile of children with ADHD that require OROS‐methylphenidate combined with shorter‐acting formulations.  ADHD Attention Deficit and Hyperactivity Disorders 2015;7(4):313‐8. [DOI: 10.1007/s12402‐015‐0168‐z; PUBMED: 25838111]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-015-0168-z', 'https://scholar.google.com/scholar_lookup?title=The+clinical+profile+of+children+with+ADHD+that+require+OROS‐methylphenidate+combined+with+shorter‐acting+formulations+&author=N+Zelnik&author=R+Terkel‐Dawer&publication_year=2015&hl=en']",,https://doi.org/10.1007/s12402-015-0168-z, Zelnik 2015 {published data only}  ,included,CD012069-bbs2-0255,
CD012069-bib-0431,"Zeni CP, Guimarães AP, Polanczyk GV, Genro JP, Roman T, Hutz MH, et al. ",No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorder," American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics ",2007,144B,    ,['citation-journal']," Zeni CP, Guimarães AP, Polanczyk GV, Genro JP, Roman T, Hutz MH, et al. No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorder.  American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2007;144B(3):391‐4. [DOI: 10.1002/ajmg.b.30474; PUBMED: 17171656]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/ajmg.b.30474', 'https://scholar.google.com/scholar_lookup?title=No+significant+association+between+response+to+methylphenidate+and+genes+of+the+dopaminergic+and+serotonergic+systems+in+a+sample+of+Brazilian+children+with+attention‐deficit/hyperactivity+disorder+&author=CP+Zeni&author=AP+Guimarães&author=GV+Polanczyk&author=JP+Genro&author=T+Roman&author=MH+Hutz&publication_year=2007&hl=en']",,https://doi.org/10.1002/ajmg.b.30474, Zeni 2007 {published data only}  ,included,CD012069-bbs2-0256,
CD012069-bib-0432,"Zhang H, Du M, Zhuang S. ",Impact of long‐term treatment of methylphenidate on height and weight of school age children with ADHD, Neuropediatrics ,2010,41,    ,['citation-journal']," Zhang H, Du M, Zhuang S. Impact of long‐term treatment of methylphenidate on height and weight of school age children with ADHD.  Neuropediatrics 2010;41(2):55‐9. [DOI: 10.1055/s‐0030‐1261893; PUBMED: 20799150]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1055/s-0030-1261893', 'https://scholar.google.com/scholar_lookup?title=Impact+of+long‐term+treatment+of+methylphenidate+on+height+and+weight+of+school+age+children+with+ADHD+&author=H+Zhang&author=M+Du&author=S+Zhuang&publication_year=2010&hl=en']",,https://doi.org/10.1055/s-0030-1261893, Zhang 2010 {published data only}  ,included,CD012069-bbs2-0257,
CD012069-bib-0433,"Zheng Y, Wang YF, Qin J, Wang LW, Zou LP, Jin XM, et al. ","Prospective, naturalistic study of open‐label OROS methylphenidate treatment in Chinese school‐aged children with attention‐deficit/hyperactivity disorder", Chinese Medical Journal ,2011,124,    ,['citation-journal']," Zheng Y, Wang YF, Qin J, Wang LW, Zou LP, Jin XM, et al. Prospective, naturalistic study of open‐label OROS methylphenidate treatment in Chinese school‐aged children with attention‐deficit/hyperactivity disorder.  Chinese Medical Journal 2011;124(20):3269‐74. [PUBMED: 22088519]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Prospective,+naturalistic+study+of+open‐label+OROS+methylphenidate+treatment+in+Chinese+school‐aged+children+with+attention‐deficit/hyperactivity+disorder+&author=Y+Zheng&author=YF+Wang&author=J+Qin&author=LW+Wang&author=LP+Zou&author=XM+Jin&publication_year=2011&hl=en']",22088519,, Zheng 2011 {published data only}  ,included,CD012069-bbs2-0258,
CD012069-bib-0434,"Zheng Y, Liang JM, Gao HY, Yang ZW, Jia FJ, Liang YZ, et al. ","An open‐label, self‐control, prospective study on cognitive function, academic performance, and tolerability of osmotic‐release oral system methylphenidate in children with attention‐deficit hyperactivity disorder", Chinese Medical Journal ,2015,128,    ,['citation-journal']," Zheng Y, Liang JM, Gao HY, Yang ZW, Jia FJ, Liang YZ, et al. An open‐label, self‐control, prospective study on cognitive function, academic performance, and tolerability of osmotic‐release oral system methylphenidate in children with attention‐deficit hyperactivity disorder.  Chinese Medical Journal 2015;128(22):2988‐97. [DOI: 10.4103/0366‐6999.168948; PMC4795269; PUBMED: 26608976]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.4103/0366-6999.168948', 'https://scholar.google.com/scholar_lookup?title=An+open‐label,+self‐control,+prospective+study+on+cognitive+function,+academic+performance,+and+tolerability+of+osmotic‐release+oral+system+methylphenidate+in+children+with+attention‐deficit+hyperactivity+disorder+&author=Y+Zheng&author=JM+Liang&author=HY+Gao&author=ZW+Yang&author=FJ+Jia&author=YZ+Liang&publication_year=2015&hl=en']",,https://doi.org/10.4103/0366-6999.168948, Zheng 2015 {published data only}  ,included,CD012069-bbs2-0259,
CD012069-bib-0435,"Bart O, Podoly T, Bar‐Haim Y. ",A preliminary study on the effect of methylphenidate on motor performance in children with comorbid DCD and ADHD, Research in Developmental Disabilities ,2010,31,    ,['citation-journal']," Bart O, Podoly T, Bar‐Haim Y. A preliminary study on the effect of methylphenidate on motor performance in children with comorbid DCD and ADHD.  Research in Developmental Disabilities 2010;31(6):1443‐7. [DOI: 10.1016/j.ridd.2010.06.014; PUBMED: 20650602]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ridd.2010.06.014', 'https://scholar.google.com/scholar_lookup?title=A+preliminary+study+on+the+effect+of+methylphenidate+on+motor+performance+in+children+with+comorbid+DCD+and+ADHD+&author=O+Bart&author=T+Podoly&author=Y+Bar‐Haim&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.ridd.2010.06.014, Bart 2010 {published data only}  ,excluded,CD012069-bbs2-0260," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0436,"Beauchaine TP, Gartner Joseph. ","A linear growth curve analysis of inpatient treatment response by conduct‐disordered, ADHD, and comorbid preadolescents", Aggressive Behavior ,2003,29,    ,['citation-journal']," Beauchaine TP, Gartner Joseph. A linear growth curve analysis of inpatient treatment response by conduct‐disordered, ADHD, and comorbid preadolescents.  Aggressive Behavior 2003;29(5):440‐56. [DOI: 10.1002/ab.10066]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/ab.10066', 'https://scholar.google.com/scholar_lookup?title=A+linear+growth+curve+analysis+of+inpatient+treatment+response+by+conduct‐disordered,+ADHD,+and+comorbid+preadolescents+&author=TP+Beauchaine&author=Joseph+Gartner&publication_year=2003&hl=en']",,https://doi.org/10.1002/ab.10066, Beauchaine 2003 {published data only}  ,excluded,CD012069-bbs2-0261," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0437,"Becker A, Roessner V, Breuer D, Döpfner M, Rothenberger A. ",Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD, European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Becker A, Roessner V, Breuer D, Döpfner M, Rothenberger A. Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD.  European Child and Adolescent Psychiatry 2011;20(Suppl 2):S267‐75. [DOI: 10.1007/s00787‐011‐0204‐2; PMC3180591; PUBMED: 21901415]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0204-2', 'https://scholar.google.com/scholar_lookup?title=Relationship+between+quality+of+life+and+psychopathological+profile:+data+from+an+observational+study+in+children+with+ADHD+&author=A+Becker&author=V+Roessner&author=D+Breuer&author=M+Döpfner&author=A+Rothenberger&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-011-0204-2, Becker 2011 {published data only}  ,excluded,CD012069-bbs2-0262," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0438,Beery SH. ,,"Behavioral Disinhibition, Anxiety, and Response to Methylphenidate and Behavior Management in Children with Attention Deficit Hyperactivity Disorder [PhD thesis]",1994,,   ,['citation-book']," Beery SH. Behavioral Disinhibition, Anxiety, and Response to Methylphenidate and Behavior Management in Children with Attention Deficit Hyperactivity Disorder [PhD thesis]. Miami (FL): University of Miami, 1994. CENTRAL    ",[''],,, Beery 1994 {published data only}  ,excluded,CD012069-bbs2-0263," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0439,Benamor L. ,H‐Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder, Neuropsychiatric Disease and Treatment ,2014,10,    ,['citation-journal'], Benamor L. H‐Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder.  Neuropsychiatric Disease and Treatment 2014;10:47‐54. [DOI: 10.2147/NDT.S52338; PMC3901735]CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=H‐Magnetic+resonance+spectroscopy+study+of+stimulant+medication+effect+on+brain+metabolites+in+French+Canadian+children+with+attention+deficit+hyperactivity+disorder+&author=L+Benamor&publication_year=2014&hl=en']",,, Benamor 2014 {published data only}  ,excluded,CD012069-bbs2-0264," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0440,"Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. ",Pharmacotherapy of attention‐deficit/hyperactivity disorder reduces risk for substance use disorder, Pediatrics ,1999,104,    ,['citation-journal']," Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention‐deficit/hyperactivity disorder reduces risk for substance use disorder.  Pediatrics 1999;104(2):e20. [PUBMED: 10429138]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.104.2.e20', 'https://scholar.google.com/scholar_lookup?title=Pharmacotherapy+of+attention‐deficit/hyperactivity+disorder+reduces+risk+for+substance+use+disorder+&author=J+Biederman&author=T+Wilens&author=E+Mick&author=T+Spencer&author=SV+Faraone&publication_year=1999&hl=en']",10429138,https://doi.org/10.1542/peds.104.2.e20, Biederman 1999 {published data only}  ,excluded,CD012069-bbs2-0265, Not possible to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0441,"Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. ",Do stimulants protect against psychiatric disorders in youth with ADHD? A 10‐year follow‐up study, Pediatrics ,2009,124,    ,['citation-journal']," Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10‐year follow‐up study.  Pediatrics 2009;124(1):71‐8. [DOI: 10.1542/peds.2008‐3347; 10.1542/peds.2008‐3347; PUBMED: 19564285]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2008-3347', 'https://scholar.google.com/scholar_lookup?title=Do+stimulants+protect+against+psychiatric+disorders+in+youth+with+ADHD?+A+10‐year+follow‐up+study+&author=J+Biederman&author=MC+Monuteaux&author=T+Spencer&author=TE+Wilens&author=SV+Faraone&publication_year=2009&hl=en']",,https://doi.org/10.1542/peds.2008-3347, Biederman 2009 {published data only}  ,excluded,CD012069-bbs2-0266," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0442,"Bohane L, Young M, Rowlandson P. ",Medication in attention deficit hyperactivity disorder and ADHD with Autistic Spectrum Disorder (ASD), Procedia ‐ Social and Behavioral Sciences ,2010,5,    ,['citation-journal']," Bohane L, Young M, Rowlandson P. Medication in attention deficit hyperactivity disorder and ADHD with Autistic Spectrum Disorder (ASD).  Procedia ‐ Social and Behavioral Sciences 2010;5:655‐9. [DOI: 10.1016/j.sbspro.2010.07.160]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.sbspro.2010.07.160', 'https://scholar.google.com/scholar_lookup?title=Medication+in+attention+deficit+hyperactivity+disorder+and+ADHD+with+Autistic+Spectrum+Disorder+(ASD)+&author=L+Bohane&author=M+Young&author=P+Rowlandson&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.sbspro.2010.07.160, Bohane 2010 {published data only}  ,excluded,CD012069-bbs2-0267," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0443,"Brossard‐Racine M, Shevell M, Snider L, Bélanger SA, Majnemer A. ",Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication, Research in Developmental Disabilities ,2012,33,    ,['citation-journal']," Brossard‐Racine M, Shevell M, Snider L, Bélanger SA, Majnemer A. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.  Research in Developmental Disabilities 2012;33(6):2080‐7. [DOI: 10.1016/j.ridd.2012.06.003; PUBMED: 22796639]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ridd.2012.06.003', 'https://scholar.google.com/scholar_lookup?title=Motor+skills+of+children+newly+diagnosed+with+Attention+Deficit+Hyperactivity+Disorder+prior+to+and+following+treatment+with+stimulant+medication+&author=M+Brossard‐Racine&author=M+Shevell&author=L+Snider&author=SA+Bélanger&author=A+Majnemer&publication_year=2012&hl=en']",,https://doi.org/10.1016/j.ridd.2012.06.003, Brossard‐Racine 2012 {published data only}  ,excluded,CD012069-bbs2-0268," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0444,"Byrne JM, Bawden HN, DeWolfe NA, Beattie TL. ",Clinical assessment of psychopharmacological treatment of preschoolers with ADHD, Journal of Clinical and Experimental Neuropsychology ,1998,20,    ,['citation-journal']," Byrne JM, Bawden HN, DeWolfe NA, Beattie TL. Clinical assessment of psychopharmacological treatment of preschoolers with ADHD.  Journal of Clinical and Experimental Neuropsychology 1998;20(5):613‐27. [DOI: 10.1076/jcen.20.5.613.1121; PUBMED: 10079039]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1076/jcen.20.5.613.1121', 'https://scholar.google.com/scholar_lookup?title=Clinical+assessment+of+psychopharmacological+treatment+of+preschoolers+with+ADHD&author=JM+Byrne&author=HN+Bawden&author=NA+DeWolfe&author=TL+Beattie&publication_year=1998&hl=en']",,https://doi.org/10.1076/jcen.20.5.613.1121, Byrne 1998 {published data only}  ,excluded,CD012069-bbs2-0269, No data on adverse events 
CD012069-bib-0445,"Casat CD, Pearson DA, Van Davelaar MJ, Cherek DR, Van‐Davelaar MJ. ",Methylphenidate effects on a laboratory aggression measure in children with ADHD, Psychopharmacology Bulletin ,1995,31,    ,['citation-journal']," Casat CD, Pearson DA, Van Davelaar MJ, Cherek DR, Van‐Davelaar MJ. Methylphenidate effects on a laboratory aggression measure in children with ADHD.  Psychopharmacology Bulletin 1995;31(2):353‐6. [PUBMED: 7491391]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+effects+on+a+laboratory+aggression+measure+in+children+with+ADHD&author=CD+Casat&author=DA+Pearson&author=MJ+Davelaar&author=DR+Cherek&author=MJ+Van‐Davelaar&publication_year=1995&hl=en']",7491391,, Casat 1995 {published data only}  ,excluded,CD012069-bbs2-0270," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0446,"Cavadas M, Pereira LD, Mattos P. ",Effects of methylphenidate in auditory processing evaluation of children and adolescents with attention deficit hyperactivity disorder, Arquivos de Neuro‐Psiquiatria ,2007,65,    ,['citation-journal']," Cavadas M, Pereira LD, Mattos P. Effects of methylphenidate in auditory processing evaluation of children and adolescents with attention deficit hyperactivity disorder [Efeito do metilfenidato no processamento auditivo em crianças e adolescentes com transtorno do deficit de atenção/hiperatividade].  Arquivos de Neuro‐Psiquiatria 2007;65(1):138‐43. [DOI: 10.1590/S0004‐282X2007000100028; PUBMED: 17420844]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1590/S0004-282X2007000100028', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+in+auditory+processing+evaluation+of+children+and+adolescents+with+attention+deficit+hyperactivity+disorder+&author=M+Cavadas&author=LD+Pereira&author=P+Mattos&publication_year=2007&hl=en']",,https://doi.org/10.1590/S0004-282X2007000100028, Cavadas 2007 {published data only}  ,excluded,CD012069-bbs2-0271, No data on adverse events 
CD012069-bib-0447,"Chambers NA, Pascoe E, Kaplanian S, Forsyth I. ",Ingestion of stimulant medications does not alter bispectral index or clinical depth of anesthesia at 1 MAC sevoflurane in children, Paediatric Anaesthesia ,2012,22,    ,['citation-journal']," Chambers NA, Pascoe E, Kaplanian S, Forsyth I. Ingestion of stimulant medications does not alter bispectral index or clinical depth of anesthesia at 1 MAC sevoflurane in children.  Paediatric Anaesthesia 2012;22(4):341‐4. [DOI: 10.1111/j.1460‐9592.2011.03717.x; PUBMED: 21988202]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1460-9592.2011.03717.x', 'https://scholar.google.com/scholar_lookup?title=Ingestion+of+stimulant+medications+does+not+alter+bispectral+index+or+clinical+depth+of+anesthesia+at+1+MAC+sevoflurane+in+children+&author=NA+Chambers&author=E+Pascoe&author=S+Kaplanian&author=I+Forsyth&publication_year=2012&hl=en']",,https://doi.org/10.1111/j.1460-9592.2011.03717.x, Chambers 2012 {published data only}  ,excluded,CD012069-bbs2-0272," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0448,"Chavez H, Ozolins D, Losek JD. ",Hypoglycemia and propranolol in pediatric behavioral disorders, Pediatrics ,1999,103,    ,['citation-journal']," Chavez H, Ozolins D, Losek JD. Hypoglycemia and propranolol in pediatric behavioral disorders.  Pediatrics 1999;103(6 Pt 1):1290‐2. [PUBMED: 10353945]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.103.6.1290', 'https://scholar.google.com/scholar_lookup?title=Hypoglycemia+and+propranolol+in+pediatric+behavioral+disorders&author=H+Chavez&author=D+Ozolins&author=JD+Losek&publication_year=1999&hl=en']",10353945,https://doi.org/10.1542/peds.103.6.1290, Chavez 1999 {published data only}  ,excluded,CD012069-bbs2-0273," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0449,"Chelonis JJ, Johnson TA, Ferguson SA, Kubacak B, Edwards M, Paule M. ",Effects of methylphenidate on motivation in children with attention‐deficit/hyperactivity disorder, Neurotoxicology and Teratology ,2010,32,    ,['citation-journal']," Chelonis JJ, Johnson TA, Ferguson SA, Kubacak B, Edwards M, Paule M. Effects of methylphenidate on motivation in children with attention‐deficit/hyperactivity disorder.  Neurotoxicology and Teratology 2010;32(4):504. [DOI: 10.1016/j.ntt.2010.04.031]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ntt.2010.04.031', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+on+motivation+in+children+with+attention‐deficit/hyperactivity+disorder+&author=JJ+Chelonis&author=TA+Johnson&author=SA+Ferguson&author=B+Kubacak&author=M+Edwards&author=M+Paule&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.ntt.2010.04.031, Chelonis 2010 {published data only}  ,excluded,CD012069-bbs2-0274, Lack of relevant outcome measures 
CD012069-bib-0450,"Chelonis JJ, Johnson TA, Ferguson SA, Berry KJ, Kubacak B, Edwards MC, et al. ",Effect of methylphenidate on motivation in children with attention‐deficit/hyperactivity disorder, Experimental and Clinical Psychopharmacology ,2011,19,    ,['citation-journal']," Chelonis JJ, Johnson TA, Ferguson SA, Berry KJ, Kubacak B, Edwards MC, et al. Effect of methylphenidate on motivation in children with attention‐deficit/hyperactivity disorder.  Experimental and Clinical Psychopharmacology 2011;19(2):145‐53. [DOI: 10.1037/a0022794; PUBMED: 21463072]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1037/a0022794', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+on+motivation+in+children+with+attention‐deficit/hyperactivity+disorder+&author=JJ+Chelonis&author=TA+Johnson&author=SA+Ferguson&author=KJ+Berry&author=B+Kubacak&author=MC+Edwards&publication_year=2011&hl=en']",,https://doi.org/10.1037/a0022794, Chelonis 2011 {published data only}  ,excluded,CD012069-bbs2-0275," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0451,"Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Clarke DC, Croft R J. ",Effects of stimulant medications on children with attention‐deficit/hyperactivity disorder and excessive beta activity in their EEG, Clinical Neurophysiology ,2003,114,    ,['citation-journal']," Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Clarke DC, Croft R J. Effects of stimulant medications on children with attention‐deficit/hyperactivity disorder and excessive beta activity in their EEG.  Clinical Neurophysiology 2003;114(9):1729‐37. [PUBMED: 12948803]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S1388-2457(03)00112-3', 'https://scholar.google.com/scholar_lookup?title=Effects+of+stimulant+medications+on+children+with+attention‐deficit/hyperactivity+disorder+and+excessive+beta+activity+in+their+EEG+&author=AR+Clarke&author=RJ+Barry&author=R+McCarthy&author=M+Selikowitz&author=DC+Clarke&author=RJ+Croft&publication_year=2003&hl=en']",12948803,https://doi.org/10.1016/S1388-2457(03)00112-3, Clarke 2003 {published data only}  ,excluded,CD012069-bbs2-0276," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0452,"Conzelmann A, Gerdes AB, Mucha RF, Weyers P, Lesch KP, Bähne CG, et al. ",Autonomic hypoactivity in boys with attention‐deficit/hyperactivity disorder and the influence of methylphenidate, World Journal of Biological Psychiatry ,2014,15,    ,['citation-journal']," Conzelmann A, Gerdes AB, Mucha RF, Weyers P, Lesch KP, Bähne CG, et al. Autonomic hypoactivity in boys with attention‐deficit/hyperactivity disorder and the influence of methylphenidate.  World Journal of Biological Psychiatry 2014;15(1):56‐65. [DOI: 10.3109/15622975.2013.829584; PUBMED: 24410179]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3109/15622975.2013.829584', 'https://scholar.google.com/scholar_lookup?title=Autonomic+hypoactivity+in+boys+with+attention‐deficit/hyperactivity+disorder+and+the+influence+of+methylphenidate+&author=A+Conzelmann&author=AB+Gerdes&author=RF+Mucha&author=P+Weyers&author=KP+Lesch&author=CG+Bähne&publication_year=2014&hl=en']",,https://doi.org/10.3109/15622975.2013.829584, Conzelmann 2014 {published data only}  ,excluded,CD012069-bbs2-0277," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0454,Cooper WO. ,E‐mail regarding your study 'ADHD drugs and serious cardiovascular events in children and young adults',,,,   ,['citation-other'], Cooper WO. E‐mail regarding your study 'ADHD drugs and serious cardiovascular events in children and young adults'. Email to: M Holmskov 10 September 2014. CENTRAL    ,[''],,, Cooper 2011 {published data only}  ,excluded,CD012069-bbs2-0278," Unable to obtain the disaggregated data on children receiving methylphenidate, either from the publication or through personal email correspondence with the study authors  "
CD012069-bib-0453,"Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, et al. ",ADHD drugs and serious cardiovascular events in children and young adults, New England Journal of Medicine ,2011,365,    ,['citation-journal']," Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, et al. ADHD drugs and serious cardiovascular events in children and young adults.  New England Journal of Medicine 2011;365(20):1896‐904. [DOI: 10.1056/NEJMoa1110212]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa1110212', 'https://scholar.google.com/scholar_lookup?title=ADHD+drugs+and+serious+cardiovascular+events+in+children+and+young+adults&author=WO+Cooper&author=LA+Habel&author=CM+Sox&author=KA+Chan&author=PG+Arbogast&author=TC+Cheetham&publication_year=2011&hl=en']",,https://doi.org/10.1056/NEJMoa1110212, Cooper 2011 {published data only}  ,excluded,CD012069-bbs2-0278," Unable to obtain the disaggregated data on children receiving methylphenidate, either from the publication or through personal email correspondence with the study authors  "
CD012069-bib-0455,"DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, et al. ",Methylphenidate improves response inhibition but not reflection‐impulsivity in children with attention deficit hyperactivity disorder (ADHD), Psychopharmacology ,2009,202,    ,['citation-journal']," DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, et al. Methylphenidate improves response inhibition but not reflection‐impulsivity in children with attention deficit hyperactivity disorder (ADHD).  Psychopharmacology 2009;202(1‐3):531‐9. [DOI: 10.1007/s00213‐008‐1337‐y; PMC2704617; PUBMED: 18818905]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00213-008-1383-5', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+improves+response+inhibition+but+not+reflection‐impulsivity+in+children+with+attention+deficit+hyperactivity+disorder+(ADHD)+&author=EE+DeVito&author=AD+Blackwell&author=L+Clark&author=L+Kent&author=AM+Dezsery&author=DC+Turner&publication_year=2009&hl=en']",,https://doi.org/10.1007/s00213-008-1383-5, DeVito 2009 {published data only}  ,excluded,CD012069-bbs2-0279," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0456,"De Zeeuw P, Mandl RC, Hulshoff Pol HE, van Engeland H, Durston S. ",Decreased frontostriatal microstructural organization in attention deficit/hyperactivity disorder,,2012,,    ,['citation-other']," De Zeeuw P, Mandl RC, Hulshoff Pol HE, van Engeland H, Durston S. Decreased frontostriatal microstructural organization in attention deficit/hyperactivity disorder. Human Brain Mapping2012; Vol. 33, issue 8:1941‐51. [DOI: 10.1002/hbm.21335; PUBMED: 21826757]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Decreased+frontostriatal+microstructural+organization+in+attention+deficit/hyperactivity+disorder+&author=P+Zeeuw&author=RC+Mandl&author=HE+HulshoffPol&author=H+Engeland&author=S+Durston&publication_year=2012&hl=en']",,, De Zeeuw 2012 {published data only}  ,excluded,CD012069-bbs2-0280," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0457,"Drtílková I, Misurec J, Náhunek K. ",The paradox effect of psychostimulants in the treatment of the child hyperkinetic syndrome, Activitas Nervosa Superior ,1990,32,    ,['citation-journal']," Drtílková I, Misurec J, Náhunek K. The paradox effect of psychostimulants in the treatment of the child hyperkinetic syndrome.  Activitas Nervosa Superior 1990;32(4):302‐3. [PUBMED: 1982036]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+paradox+effect+of+psychostimulants+in+the+treatment+of+the+child+hyperkinetic+syndrome+&author=I+Drtílková&author=J+Misurec&author=K+Náhunek&publication_year=1990&hl=en']",1982036,, Drtílková 1990 {published data only}  ,excluded,CD012069-bbs2-0281," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0458,"Epstein JN, Langberg JM, Lichtenstein PK, Altaye M, Brinkman WB, House K, et al. ",Attention‐deficit/hyperactivity disorder outcomes for children treated in community‐based pediatric settings, Archives of Pediatrics & Adolescent Medicine ,2010,164,    ,['citation-journal']," Epstein JN, Langberg JM, Lichtenstein PK, Altaye M, Brinkman WB, House K, et al. Attention‐deficit/hyperactivity disorder outcomes for children treated in community‐based pediatric settings.  Archives of Pediatrics & Adolescent Medicine 2010;164(2):160‐5. [DOI: 10.1001/archpediatrics.2009.263; PUBMED: 20124145]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archpediatrics.2009.263', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit/hyperactivity+disorder+outcomes+for+children+treated+in+community‐based+pediatric+settings+&author=JN+Epstein&author=JM+Langberg&author=PK+Lichtenstein&author=M+Altaye&author=WB+Brinkman&author=K+House&publication_year=2010&hl=en']",,https://doi.org/10.1001/archpediatrics.2009.263, Epstein 2010 {published data only}  ,excluded,CD012069-bbs2-0282," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0459,"Faraone SV, Biederman J, Zimmerman B. ","An analysis of patient adherence to treatment during a 1‐year, open‐label study of OROS methylphenidate in children with ADHD", Journal of Attention Disorders ,2007,11,    ,['citation-journal']," Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1‐year, open‐label study of OROS methylphenidate in children with ADHD.  Journal of Attention Disorders 2007;11(2):157‐66. [DOI: 10.1177/1087054706295663; PUBMED: 17494833]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054706295663', 'https://scholar.google.com/scholar_lookup?title=An+analysis+of+patient+adherence+to+treatment+during+a+1‐year,+open‐label+study+of+OROS+methylphenidate+in+children+with+ADHD+&author=SV+Faraone&author=J+Biederman&author=B+Zimmerman&publication_year=2007&hl=en']",,https://doi.org/10.1177/1087054706295663, Faraone 2007b {published data only}  ,excluded,CD012069-bbs2-0283, No data on adverse events 
CD012069-bib-0460,"Fegert JM, Hebebrand J, Kommission Entwicklungspsychopharmakologie der drei Fachgesellschaften. ",Statement to questionable cardiac risks of application of stimulants, Zeitschrift für Kinder‐ und Jugendpsychiatrie und Psychotherapie ,2006,34,    ,['citation-journal']," Fegert JM, Hebebrand J, Kommission Entwicklungspsychopharmakologie der drei Fachgesellschaften. Statement to questionable cardiac risks of application of stimulants [Stellungnahme zu fraglichen kardialen Risiken der Stimulanziengabe].  Zeitschrift für Kinder‐ und Jugendpsychiatrie und Psychotherapie 2006;34(4):295‐97. [DOI: 10.1024/1422‐4917.34.4.295]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1024/1422-4917.34.4.295', 'https://scholar.google.com/scholar_lookup?title=Statement+to+questionable+cardiac+risks+of+application+of+stimulants&author=JM+Fegert&author=J+Hebebrand&author=Fachgesellschaften+KommissionEntwicklungspsychopharmakologiederdrei&publication_year=2006&hl=en']",,https://doi.org/10.1024/1422-4917.34.4.295, Fegert 2006 {published data only}  ,excluded,CD012069-bbs2-0284, No data on adverse events 
CD012069-bib-0461,"Foodman A, McPhillips K. ",ADD and soft signs, Journal of the American Academy of Child and Adolescent Psychiatry ,1996,35,    ,['citation-journal']," Foodman A, McPhillips K. ADD and soft signs.  Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(7):841‐2. [PUBMED: 8768341]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199607000-00007', 'https://scholar.google.com/scholar_lookup?title=ADD+and+soft+signs&author=A+Foodman&author=K+McPhillips&publication_year=1996&hl=en']",8768341,https://doi.org/10.1097/00004583-199607000-00007, Foodman 1996 {published data only}  ,excluded,CD012069-bbs2-0285," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0462,Frank Y. ,Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder, Clinical EEG ,1993,24,    ,['citation-journal'], Frank Y. Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder.  Clinical EEG 1993;24(1):19‐24. [PUBMED: 8420693]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1177/155005949302400106', 'https://scholar.google.com/scholar_lookup?title=Visual+event+related+potentials+after+methylphenidate+and+sodium+valproate+in+children+with+attention+deficit+hyperactivity+disorder+&author=Y+Frank&publication_year=1993&hl=en']",8420693,https://doi.org/10.1177/155005949302400106, Frank 1993 {published data only}  ,excluded,CD012069-bbs2-0286," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0463,"Funk JB, Chessare JB, Weaver MT, Exley AR. ","Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate", Pediatrics ,1993,91,    ,['citation-journal']," Funk JB, Chessare JB, Weaver MT, Exley AR. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate.  Pediatrics 1993;91(4):816‐9. [PUBMED: 8464673]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Attention+deficit+hyperactivity+disorder,+creativity,+and+the+effects+of+methylphenidate&author=JB+Funk&author=JB+Chessare&author=MT+Weaver&author=AR+Exley&publication_year=1993&hl=en']",8464673,, Funk 1993 {published data only}  ,excluded,CD012069-bbs2-0287," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0464,"Gau SS, Chiu CD, Shang CY, Cheng AT, Soong WT. ",Executive function in adolescence among children with attention‐deficit/hyperactivity disorder in Taiwan, Journal of Developmental and Behavioral Pediatrics ,2009,30,    ,['citation-journal']," Gau SS, Chiu CD, Shang CY, Cheng AT, Soong WT. Executive function in adolescence among children with attention‐deficit/hyperactivity disorder in Taiwan.  Journal of Developmental and Behavioral Pediatrics 2009;30(6):525‐34. [DOI: 10.1097/DBP.0b013e3181c21c97; PUBMED: 19884851]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/DBP.0b013e3181c21c97', 'https://scholar.google.com/scholar_lookup?title=Executive+function+in+adolescence+among+children+with+attention‐deficit/hyperactivity+disorder+in+Taiwan+&author=SS+Gau&author=CD+Chiu&author=CY+Shang&author=AT+Cheng&author=WT+Soong&publication_year=2009&hl=en']",,https://doi.org/10.1097/DBP.0b013e3181c21c97, Gau 2009 {published data only}  ,excluded,CD012069-bbs2-0288," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0465,"Gimpel GA, Collett BR, Veeder MA, Gifford JA, Sneddon P, Bushman B, et al. ",Effects of stimulant medication on cognitive performance of children with ADHD, Clinical Pediatrics ,2005,44,    ,['citation-journal']," Gimpel GA, Collett BR, Veeder MA, Gifford JA, Sneddon P, Bushman B, et al. Effects of stimulant medication on cognitive performance of children with ADHD.  Clinical Pediatrics 2005;44(5):405‐11. [DOI: 10.1177/000992280504400504; PUBMED: 15965546]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/000992280504400504', 'https://scholar.google.com/scholar_lookup?title=Effects+of+stimulant+medication+on+cognitive+performance+of+children+with+ADHD&author=GA+Gimpel&author=BR+Collett&author=MA+Veeder&author=JA+Gifford&author=P+Sneddon&author=B+Bushman&publication_year=2005&hl=en']",,https://doi.org/10.1177/000992280504400504, Gimpel 2005 {published data only}  ,excluded,CD012069-bbs2-0289," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0466,"Glenngård AH, Hjelmgren J, Thomsen P H, Tvedten T, Prtz C. ","Eliciting patient preferences for ADHD treatment using Discrete Choice Experiment in Sweden, Norway and Denmark", Journal of Mental Health Policy and Economics ,2011,14,    ,['citation-journal']," Glenngård AH, Hjelmgren J, Thomsen P H, Tvedten T, Prtz C. Eliciting patient preferences for ADHD treatment using Discrete Choice Experiment in Sweden, Norway and Denmark.  Journal of Mental Health Policy and Economics 2011;14(Suppl 1):S8‐9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Eliciting+patient+preferences+for+ADHD+treatment+using+Discrete+Choice+Experiment+in+Sweden,+Norway+and+Denmark+&author=AH+Glenngård&author=J+Hjelmgren&author=PH+Thomsen&author=T+Tvedten&author=C+Prtz&publication_year=2011&hl=en']",,, Glenngård 2013 {published data only}  ,excluded,CD012069-bbs2-0290," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0467,"Glenngård AH, Hjelmgren J, Thomsen PH, Tvedten T. ","Patient preferences and willingness‐to‐pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway", Nordic Journal of Psychiatry ,2013,67,    ,['citation-journal']," Glenngård AH, Hjelmgren J, Thomsen PH, Tvedten T. Patient preferences and willingness‐to‐pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway.  Nordic Journal of Psychiatry 2013;67(5):351‐9. [DOI: 10.3109/08039488.2012.748825; PUBMED: 23245636]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3109/08039488.2012.748825', 'https://scholar.google.com/scholar_lookup?title=Patient+preferences+and+willingness‐to‐pay+for+ADHD+treatment+with+stimulants+using+discrete+choice+experiment+(DCE)+in+Sweden,+Denmark+and+Norway+&author=AH+Glenngård&author=J+Hjelmgren&author=PH+Thomsen&author=T+Tvedten&publication_year=2013&hl=en']",,https://doi.org/10.3109/08039488.2012.748825, Glenngård 2013 {published data only}  ,excluded,CD012069-bbs2-0290," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0468,"Gormez V, Avery B, Mann H. ",An additional mid‐afternoon dose of immediate release methylphenidate (MPH‐IR) with Concerta XL provides better symptom control in children and adolescents with attention deficit/hyperactivity disorder (ADHD), European Psychiatry ,2012,27,    ,['citation-journal']," Gormez V, Avery B, Mann H. An additional mid‐afternoon dose of immediate release methylphenidate (MPH‐IR) with Concerta XL provides better symptom control in children and adolescents with attention deficit/hyperactivity disorder (ADHD).  European Psychiatry 2012;27(Suppl 1):1. [DOI: 10.1016/S0924‐9338(12)74460‐7]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0924-9338(12)74460-7', 'https://scholar.google.com/scholar_lookup?title=An+additional+mid‐afternoon+dose+of+immediate+release+methylphenidate+(MPH‐IR)+with+Concerta+XL+provides+better+symptom+control+in+children+and+adolescents+with+attention+deficit/hyperactivity+disorder+(ADHD)+&author=V+Gormez&author=B+Avery&author=H+Mann&publication_year=2012&hl=en']",,https://doi.org/10.1016/S0924-9338(12)74460-7, Gormez 2012 {published data only}  ,excluded,CD012069-bbs2-0291," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0469,"Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan NH, Olfson M, et al. ",Sudden death and use of stimulant medications in youths, American Journal of Psychiatry ,2009,166,    ,['citation-journal']," Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan NH, Olfson M, et al. Sudden death and use of stimulant medications in youths.  American Journal of Psychiatry 2009;166(9):992‐1001. [DOI: 10.1176/appi.ajp.2009.09040472; PUBMED: 19528194]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1176/appi.ajp.2009.09040472', 'https://scholar.google.com/scholar_lookup?title=Sudden+death+and+use+of+stimulant+medications+in+youths&author=MS+Gould&author=BT+Walsh&author=JL+Munfakh&author=M+Kleinman&author=NH+Duan&author=M+Olfson&publication_year=2009&hl=en']",,https://doi.org/10.1176/appi.ajp.2009.09040472, Gould 2009 {published data only}  ,excluded,CD012069-bbs2-0292, No ADHD diagnosis 
CD012069-bib-0470,"Gould MS, Walsh BT, Munfakh JL, et al. ",Study finds link between stimulants and sudden unexplained death in young people, Brown University Psychopharmacology Update ,2009,20,    ,['citation-journal']," Gould MS, Walsh BT, Munfakh JL, et al. Study finds link between stimulants and sudden unexplained death in young people.  Brown University Psychopharmacology Update 2009;20(12):1,1‐5,6. [DOI: 10.1002/pu.20105]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Study+finds+link+between+stimulants+and+sudden+unexplained+death+in+young+people&author=MS+Gould&author=BT+Walsh&author=JL+Munfakh&publication_year=2009&hl=en']",,, Gould 2009 {published data only}  ,excluded,CD012069-bbs2-0292, No ADHD diagnosis 
CD012069-bib-0471,Kuehn BM. ,Stimulant use linked to sudden death in children without heart problems, JAMA: Journal of the American Medical Association ,2009,302,    ,['citation-journal'], Kuehn BM. Stimulant use linked to sudden death in children without heart problems.  JAMA: Journal of the American Medical Association 2009;302(6):613‐4. [DOI: 10.1001/jama.2009.1115; PUBMED: 19671894]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1001/jama.2009.1115', 'https://scholar.google.com/scholar_lookup?title=Stimulant+use+linked+to+sudden+death+in+children+without+heart+problems&author=BM+Kuehn&publication_year=2009&hl=en']",,https://doi.org/10.1001/jama.2009.1115, Gould 2009 {published data only}  ,excluded,CD012069-bbs2-0292, No ADHD diagnosis 
CD012069-bib-0472,Uhl D. ,Stimulant therapy: sudden death cases under methylphenidate, Deutsche Apotheker Zeitung ,2009,26,    ,['citation-journal'], Uhl D. Stimulant therapy: sudden death cases under methylphenidate [Plötzliche Todesfälle unter Methylphenidat].  Deutsche Apotheker Zeitung 2009;26:46‐8. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Stimulant+therapy:+sudden+death+cases+under+methylphenidate&author=D+Uhl&publication_year=2009&hl=en']",,, Gould 2009 {published data only}  ,excluded,CD012069-bbs2-0292, No ADHD diagnosis 
CD012069-bib-0473,"Gualtieri CT, Hicks RE. ",Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity, Psychiatric Clinics of North America ,1985,8,    ,['citation-journal']," Gualtieri CT, Hicks RE. Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity.  Psychiatric Clinics of North America 1985;8(4):875‐92. [PUBMED: 2867534]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0193-953X(18)30661-0', 'https://scholar.google.com/scholar_lookup?title=Neuropharmacology+of+methylphenidate+and+a+neural+substrate+for+childhood+hyperactivity&author=CT+Gualtieri&author=RE+Hicks&publication_year=1985&hl=en']",2867534,https://doi.org/10.1016/S0193-953X(18)30661-0, Gualtieri 1985 {published data only}  ,excluded,CD012069-bbs2-0293," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0474,"Guimarães AP, Zeni C, Polanczyk G, Genro JP, Roman T, Rohde LA, et al. ",MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder, International Journal of Neuropsychopharmacology ,2009,12,    ,['citation-journal']," Guimarães AP, Zeni C, Polanczyk G, Genro JP, Roman T, Rohde LA, et al. MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder.  International Journal of Neuropsychopharmacology 2009;12(5):709‐14. [DOI: 10.1017/S1461145709000212; PUBMED: 19309535]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1017/S1461145709000212', 'https://scholar.google.com/scholar_lookup?title=MAOA+is+associated+with+methylphenidate+improvement+of+oppositional+symptoms+in+boys+with+attention+deficit+hyperactivity+disorder+&author=AP+Guimarães&author=C+Zeni&author=G+Polanczyk&author=JP+Genro&author=T+Roman&author=LA+Rohde&publication_year=2009&hl=en']",,https://doi.org/10.1017/S1461145709000212, Guimarães 2009 {published data only}  ,excluded,CD012069-bbs2-0294," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0475,"Gurkan CK, Yurumez E, Akca OF, Bilgic A, Turkoglu S, Kilic BG, et al. ",The effect of treatment on multiple symptom domains and quality of life in children and adolescents with ADHD: A 3‐year follow‐up study, European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Gurkan CK, Yurumez E, Akca OF, Bilgic A, Turkoglu S, Kilic BG, et al. The effect of treatment on multiple symptom domains and quality of life in children and adolescents with ADHD: A 3‐year follow‐up study.  European Child and Adolescent Psychiatry 2011;20(Suppl 1):S170. [DOI: 10.1007/s00787‐011‐0181‐5]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+treatment+on+multiple+symptom+domains+and+quality+of+life+in+children+and+adolescents+with+ADHD:+A+3‐year+follow‐up+study+&author=CK+Gurkan&author=E+Yurumez&author=OF+Akca&author=A+Bilgic&author=S+Turkoglu&author=BG+Kilic&publication_year=2011&hl=en']",,, Gurkan 2011 {published data only}  ,excluded,CD012069-bbs2-0295," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0476,"Hautmann C, Rothenberger A, Döpfner M. ",An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified‐release methylphenidate, BMC Psychiatry ,2013,13,    ,['citation-journal']," Hautmann C, Rothenberger A, Döpfner M. An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified‐release methylphenidate.  BMC Psychiatry 2013;13:219. [DOI: 10.1186/1471‐244X‐13‐219; PMC3846116; PUBMED: 24004962]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1471-244X-13-219', 'https://scholar.google.com/scholar_lookup?title=An+observational+study+of+response+heterogeneity+in+children+with+attention+deficit+hyperactivity+disorder+following+treatment+switch+to+modified‐release+methylphenidate+&author=C+Hautmann&author=A+Rothenberger&author=M+Döpfner&publication_year=2013&hl=en']",,https://doi.org/10.1186/1471-244X-13-219, Hautmann 2013 {published data only}  ,excluded,CD012069-bbs2-0296," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0477,"Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M. ",Reported paediatric adverse drug reactions in the UK 2000‐2009, British Journal of Clinical Pharmacology ,2012,73,    ,['citation-journal']," Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M. Reported paediatric adverse drug reactions in the UK 2000‐2009.  British Journal of Clinical Pharmacology 2012;73(3):437‐46. [DOI: 10.1111/j.1365‐2125.2011.04113.x; PMC3370348; PUBMED: 21988288]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1365-2125.2011.04113.x', 'https://scholar.google.com/scholar_lookup?title=Reported+paediatric+adverse+drug+reactions+in+the+UK+2000‐2009&author=DB+Hawcutt&author=P+Mainie&author=A+Riordan&author=RL+Smyth&author=M+Pirmohamed&publication_year=2012&hl=en']",,https://doi.org/10.1111/j.1365-2125.2011.04113.x, Hawcutt 2012 {published data only}  ,excluded,CD012069-bbs2-0297," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0478,"Hawk LW, Yartz AR, Pelham WE, Lock TM. ",The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention‐deficit hyperactivity disorder, Psychopharmacology ,2003,165,    ,['citation-journal']," Hawk LW, Yartz AR, Pelham WE, Lock TM. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention‐deficit hyperactivity disorder.  Psychopharmacology 2003;165(2):118‐27. [DOI: 10.1007/s00213‐002‐1235‐7; PUBMED: 12417963]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00213-002-1235-7', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+methylphenidate+on+prepulse+inhibition+during+attended+and+ignored+prestimuli+among+boys+with+attention‐deficit+hyperactivity+disorder+&author=LW+Hawk&author=AR+Yartz&author=WE+Pelham&author=TM+Lock&publication_year=2003&hl=en']",,https://doi.org/10.1007/s00213-002-1235-7, Hawk 2003 {published data only}  ,excluded,CD012069-bbs2-0298," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0479,"Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier PM, Hebebrand J, et al. ","Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate", European Child and Adolescent Psychiatry ,2004,13,    ,['citation-journal']," Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier PM, Hebebrand J, et al. Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate.  European Child and Adolescent Psychiatry 2004;13(2):100‐4. [DOI: 10.1007/s00787‐004‐0365‐3; PUBMED: 15103535]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Objective+measurement+of+hyperactivity,+impulsivity,+and+inattention+in+children+with+hyperkinetic+disorders+before+and+after+treatment+with+methylphenidate+&author=P+Heiser&author=J+Frey&author=J+Smidt&author=C+Sommerlad&author=PM+Wehmeier&author=J+Hebebrand&publication_year=2004&hl=en']",,, Heiser 2004 {published data only}  ,excluded,CD012069-bbs2-0299," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0480,"Hidas A, Noy AF, Birman N, Shapira J, Matot I, Steinberg D, et al. ","Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD",,2011,,    ,['citation-other']," Hidas A, Noy AF, Birman N, Shapira J, Matot I, Steinberg D, et al. Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD. Archives of Oral Biology2011; Vol. 56, issue 10:1137‐41. [DOI: 10.1016/j.archoralbio.2011.03.018; PUBMED: 21514566]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Oral+health+status,+salivary+flow+rate+and+salivary+quality+in+children,+adolescents+and+young+adults+with+ADHD+&author=A+Hidas&author=AF+Noy&author=N+Birman&author=J+Shapira&author=I+Matot&author=D+Steinberg&publication_year=2011&hl=en']",,, Hidas 2011 {published data only}  ,excluded,CD012069-bbs2-0300," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0481,"Hood J, Baird G, Rankin PM, Isaacs E. ",Immediate effects of methylphenidate on cognitive attention skills of children with attention‐deficit‐hyperactivity disorder, Developmental Medicine and Child Neurology ,2005,47,    ,['citation-journal']," Hood J, Baird G, Rankin PM, Isaacs E. Immediate effects of methylphenidate on cognitive attention skills of children with attention‐deficit‐hyperactivity disorder.  Developmental Medicine and Child Neurology 2005;47(6):408‐14. [DOI: 10.1111/j.1469‐8749.2005.tb01162.x/pdf]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1017/S0012162205000794', 'https://scholar.google.com/scholar_lookup?title=Immediate+effects+of+methylphenidate+on+cognitive+attention+skills+of+children+with+attention‐deficit‐hyperactivity+disorder+&author=J+Hood&author=G+Baird&author=PM+Rankin&author=E+Isaacs&publication_year=2005&hl=en']",,https://doi.org/10.1017/S0012162205000794, Hood 2005 {published data only}  ,excluded,CD012069-bbs2-0301," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0482,"Hoza B, Pelham WE, Sams SE, Carlson C. ",An examination of the 'dosage' effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children, Behavior Modification ,1992,16,    ,['citation-journal']," Hoza B, Pelham WE, Sams SE, Carlson C. An examination of the 'dosage' effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children.  Behavior Modification 1992;16(2):164‐92. [DOI: 10.1177/01454455920162002; PUBMED: 1580892]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/01454455920162002', ""https://scholar.google.com/scholar_lookup?title=An+examination+of+the+'dosage'+effects+of+both+behavior+therapy+and+methylphenidate+on+the+classroom+performance+of+two+ADHD+children+&author=B+Hoza&author=WE+Pelham&author=SE+Sams&author=C+Carlson&publication_year=1992&hl=en""]",,https://doi.org/10.1177/01454455920162002, Hoza 1992 {published data only}  ,excluded,CD012069-bbs2-0302," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0483,"Hwang J, Kim B, Kim Y, Yoo H. ",Methylphenidate‐osmotic release oral delivery system reduces parenting stress in parents of children and adolescents with ADHD in Korea,,2012,,    ,['citation-other']," Hwang J, Kim B, Kim Y, Yoo H. Methylphenidate‐osmotic release oral delivery system reduces parenting stress in parents of children and adolescents with ADHD in Korea. European Neuropsychopharmacology2012; Vol. 22, issue Suppl 2:S415. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐osmotic+release+oral+delivery+system+reduces+parenting+stress+in+parents+of+children+and+adolescents+with+ADHD+in+Korea+&author=J+Hwang&author=B+Kim&author=Y+Kim&author=H+Yoo&publication_year=2012&hl=en']",,, Hwang 2012 {published data only}  ,excluded,CD012069-bbs2-0303," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0484,"Jonkman LM, Kemner C, Verbaten MN, van Engeland H, Camfferman G, Buitelaar JK, et al. ","Attentional capacity, a probe ERP study: differences between children with attention‐deficit hyperactivity disorder and normal control children and effects of methylphenidate", Psychophysiology ,2000,37,    ,['citation-journal']," Jonkman LM, Kemner C, Verbaten MN, van Engeland H, Camfferman G, Buitelaar JK, et al. Attentional capacity, a probe ERP study: differences between children with attention‐deficit hyperactivity disorder and normal control children and effects of methylphenidate.  Psychophysiology 2000;37(3):334‐46. [PUBMED: 10860411]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/1469-8986.3730334', 'https://scholar.google.com/scholar_lookup?title=Attentional+capacity,+a+probe+ERP+study:+differences+between+children+with+attention‐deficit+hyperactivity+disorder+and+normal+control+children+and+effects+of+methylphenidate+&author=LM+Jonkman&author=C+Kemner&author=MN+Verbaten&author=H+Engeland&author=G+Camfferman&author=JK+Buitelaar&publication_year=2000&hl=en']",10860411,https://doi.org/10.1111/1469-8986.3730334, Jonkman 1999 {published data only}  ,excluded,CD012069-bbs2-0304," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0485,"Jonkman LM, Kemner C, Verbaten MN, van Engeland H, Kenemans JL, Camfferman G, et al. ","Perceptual and response interference in children with attention‐deficit hyperactivity disorder, and the effects of methylphenidate", Psychophysiology ,1999,36,    ,['citation-journal']," Jonkman LM, Kemner C, Verbaten MN, van Engeland H, Kenemans JL, Camfferman G, et al. Perceptual and response interference in children with attention‐deficit hyperactivity disorder, and the effects of methylphenidate.  Psychophysiology 1999;36(4):419‐29. [DOI: 10.1111/1469‐8986.3640419]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/1469-8986.3640419', 'https://scholar.google.com/scholar_lookup?title=Perceptual+and+response+interference+in+children+with+attention‐deficit+hyperactivity+disorder,+and+the+effects+of+methylphenidate+&author=LM+Jonkman&author=C+Kemner&author=MN+Verbaten&author=H+Engeland&author=JL+Kenemans&author=G+Camfferman&publication_year=1999&hl=en']",,https://doi.org/10.1111/1469-8986.3640419, Jonkman 1999 {published data only}  ,excluded,CD012069-bbs2-0304," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0486,"Kerdar MS, Scheuerpflug P, Srdinko P, Wewetzer C, Warnke A, Romanos M. ",Quantitative effect of treatment with methylphenidate on EEG ‐ a pilot study, Z Kinder Jugendpsychiatr Psychother ,2007,35,    ,['citation-journal']," Kerdar MS, Scheuerpflug P, Srdinko P, Wewetzer C, Warnke A, Romanos M. Quantitative effect of treatment with methylphenidate on EEG ‐ a pilot study [EEG‐Veränderungen unter Methylphenidat ‐ eine Pilotstudie].  Z Kinder Jugendpsychiatr Psychother 2007;35(4):247‐55; quiz 255‐6. [DOI: 10.1024/1422‐4917.35.4.247; PUBMED: 17970368]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Quantitative+effect+of+treatment+with+methylphenidate+on+EEG+‐+a+pilot+study&author=MS+Kerdar&author=P+Scheuerpflug&author=P+Srdinko&author=C+Wewetzer&author=A+Warnke&author=M+Romanos&publication_year=2007&hl=en']",,, Kerdar 2007 {published data only}  ,excluded,CD012069-bbs2-0305," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0487,"Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, et al. ",Catechol‐O‐methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children, American Journal of Medical Genetics ,2008,147B,    ,['citation-journal']," Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, et al. Catechol‐O‐methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.  American Journal of Medical Genetics 2008;147B(8):1431‐5. [DOI: 10.1002/ajmg.b.30704; PUBMED: 18214865]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Catechol‐O‐methyltransferase+Val158Met+polymorphism+is+associated+with+methylphenidate+response+in+ADHD+children+&author=E+Kereszturi&author=Z+Tarnok&author=E+Bognar&author=K+Lakatos&author=L+Farkas&author=J+Gadoros&publication_year=2008&hl=en']",,, Kereszturi 2008 {published data only}  ,excluded,CD012069-bbs2-0306," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0488,"Keulers EH, Hendriksen JG, Feron FJ, Wassenberg R, Wuisman‐Frerker MG, Jolles J, et al. ",Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial, European Journal of Paediatric Neurology ,2007,11,    ,['citation-journal']," Keulers EH, Hendriksen JG, Feron FJ, Wassenberg R, Wuisman‐Frerker MG, Jolles J, et al. Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial.  European Journal of Paediatric Neurology 2007;11(1):21‐8. [DOI: 10.1016/j.ejpn.2006.10.002; PUBMED: 17169593]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ejpn.2006.10.002', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+improves+reading+performance+in+children+with+attention+deficit+hyperactivity+disorder+and+comorbid+dyslexia:+an+unblinded+clinical+trial+&author=EH+Keulers&author=JG+Hendriksen&author=FJ+Feron&author=R+Wassenberg&author=MG+Wuisman‐Frerker&author=J+Jolles&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.ejpn.2006.10.002, Keulers 2007 {published data only}  ,excluded,CD012069-bbs2-0307," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0489,"Klein C, Fischer B, Fischer B, Hartnegg K. ",Effects of methylphenidate on saccadic responses in patients with ADHD, Experimental Brain Research ,2002,145,    ,['citation-journal']," Klein C, Fischer B, Fischer B, Hartnegg K. Effects of methylphenidate on saccadic responses in patients with ADHD.  Experimental Brain Research 2002;145(1):121‐5. [DOI: 10.1007/s00221‐002‐1105‐x; PUBMED: 12070751]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00221-002-1105-x', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+on+saccadic+responses+in+patients+with+ADHD&author=C+Klein&author=B+Fischer&author=B+Fischer&author=K+Hartnegg&publication_year=2002&hl=en']",,https://doi.org/10.1007/s00221-002-1105-x, Klein 2002 {published data only}  ,excluded,CD012069-bbs2-0308," No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0490,"Kramer AF, Cepeda NJ, Cepeda ML. ",Methylphenidate effects on task‐switching performance in attention‐deficit/hyperactivity disorder, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal']," Kramer AF, Cepeda NJ, Cepeda ML. Methylphenidate effects on task‐switching performance in attention‐deficit/hyperactivity disorder.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(11):1277‐84. [DOI: 10.1097/00004583‐200111000‐00007; PUBMED: 11699801]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-200111000-00007', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+effects+on+task‐switching+performance+in+attention‐deficit/hyperactivity+disorder+&author=AF+Kramer&author=NJ+Cepeda&author=ML+Cepeda&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200111000-00007, Kramer 2001 {published data only}  ,excluded,CD012069-bbs2-0309," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0491,"Lajoie G, Anderson V, Anderson P, Tucker AR, Robertson IH, Manly T. ",Effects of methylphenidate on attention skills in children with attention deficit/hyperactivity disorder, Brain Impairment ,2005,6,    ,['citation-journal']," Lajoie G, Anderson V, Anderson P, Tucker AR, Robertson IH, Manly T. Effects of methylphenidate on attention skills in children with attention deficit/hyperactivity disorder.  Brain Impairment 2005;6(1):21‐32. [DOI: 10.1375/brim.6.1.21.65479]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1375/brim.6.1.21.65479', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+on+attention+skills+in+children+with+attention+deficit/hyperactivity+disorder+&author=G+Lajoie&author=V+Anderson&author=P+Anderson&author=AR+Tucker&author=IH+Robertson&author=T+Manly&publication_year=2005&hl=en']",,https://doi.org/10.1375/brim.6.1.21.65479, Lajoie 2005 {published data only}  ,excluded,CD012069-bbs2-0310," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0492,"Lawrence CA, Barry RJ, Clarke AR, Johnstone SJ, McCarthy R, Selikowitz M, et al. ",Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task, Psychopharmacology ,2005,183,    ,['citation-journal']," Lawrence CA, Barry RJ, Clarke AR, Johnstone SJ, McCarthy R, Selikowitz M, et al. Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task.  Psychopharmacology 2005;183(1):81‐91. [DOI: 10.1007/s00213‐005‐0144‐y; PUBMED: 16160877]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00213-005-0144-y', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+effects+in+attention+deficit/hyperactivity+disorder:+electrodermal+and+ERP+measures+during+a+continuous+performance+task+&author=CA+Lawrence&author=RJ+Barry&author=AR+Clarke&author=SJ+Johnstone&author=R+McCarthy&author=M+Selikowitz&publication_year=2005&hl=en']",,https://doi.org/10.1007/s00213-005-0144-y, Lawrence 2005 {published data only}  ,excluded,CD012069-bbs2-0311," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0493,"Matier K, Halperin JM, Sharma V, Newcorn JH, Sathaye N. ",Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms, Journal of the American Academy of Child and Adolescent Psychiatry ,1992,31,    ,['citation-journal']," Matier K, Halperin JM, Sharma V, Newcorn JH, Sathaye N. Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms.  Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(2):219‐25. [DOI: 10.1097/00004583‐199203000‐00007; PUBMED: 1564022]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-199203000-00007', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+response+in+aggressive+and+nonaggressive+ADHD+children:+distinctions+on+laboratory+measures+of+symptoms+&author=K+Matier&author=JM+Halperin&author=V+Sharma&author=JH+Newcorn&author=N+Sathaye&publication_year=1992&hl=en']",,https://doi.org/10.1097/00004583-199203000-00007, Matier 1992 {published data only}  ,excluded,CD012069-bbs2-0312," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0494,"Mayes SD, Bixler EO. ",Reliability of global impressions for assessing methylphenidate effects in children with attention‐deficit hyperactivity disorder, Perceptual and Motor Skills ,1993,77,    ,['citation-journal']," Mayes SD, Bixler EO. Reliability of global impressions for assessing methylphenidate effects in children with attention‐deficit hyperactivity disorder.  Perceptual and Motor Skills 1993;77(3 Pt 2):1215‐8. [DOI: 10.2466/pms.1993.77.3f.1215; PUBMED: 8170770]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2466/pms.1993.77.3f.1215', 'https://scholar.google.com/scholar_lookup?title=Reliability+of+global+impressions+for+assessing+methylphenidate+effects+in+children+with+attention‐deficit+hyperactivity+disorder+&author=SD+Mayes&author=EO+Bixler&publication_year=1993&hl=en']",,https://doi.org/10.2466/pms.1993.77.3f.1215, Mayes 1993 {published data only}  ,excluded,CD012069-bbs2-0313," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0495,"Miller LG, Kraft IA. ",Application of actigraphy in the clinical setting: use in children with attention‐deficit hyperactivity disorder, Pharmacotherapy ,1994,14,    ,['citation-journal']," Miller LG, Kraft IA. Application of actigraphy in the clinical setting: use in children with attention‐deficit hyperactivity disorder.  Pharmacotherapy 1994;14(2):219‐23. [PUBMED: 8197043]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Application+of+actigraphy+in+the+clinical+setting:+use+in+children+with+attention‐deficit+hyperactivity+disorder+&author=LG+Miller&author=IA+Kraft&publication_year=1994&hl=en']",8197043,, Miller 1994 {published data only}  ,excluded,CD012069-bbs2-0314," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0496,"Miller DC, Kavcic V, Leslie JE. ",ERP changes induced by methylphenidate in boys with attention‐deficit hyperactivity disorder,,1996,,    ,['citation-other']," Miller DC, Kavcic V, Leslie JE. ERP changes induced by methylphenidate in boys with attention‐deficit hyperactivity disorder. Journal of Attention Disorders1996; Vol. 1, issue 2:95‐113. [DOI: 10.1177/108705479600100203]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=ERP+changes+induced+by+methylphenidate+in+boys+with+attention‐deficit+hyperactivity+disorder+&author=DC+Miller&author=V+Kavcic&author=JE+Leslie&publication_year=1996&hl=en']",,, Miller 1996 {published data only}  ,excluded,CD012069-bbs2-0315," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0497,"Miranda A, Jarque S, Rosel J. ",Treatment of children with ADHD: psychopedagogical program at school versus psychostimulant medication, Psicothema ,2006,18,    ,['citation-journal']," Miranda A, Jarque S, Rosel J. Treatment of children with ADHD: psychopedagogical program at school versus psychostimulant medication.  Psicothema 2006;18(3):335‐41. [PUBMED: 17296053]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Treatment+of+children+with+ADHD:+psychopedagogical+program+at+school+versus+psychostimulant+medication+&author=A+Miranda&author=S+Jarque&author=J+Rosel&publication_year=2006&hl=en']",17296053,, Miranda 2006 {published data only}  ,excluded,CD012069-bbs2-0316," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0498,"Monden Y, Dan H, Nagashima M, Dan I, Kyutoku Y, Okamoto M, et al. ",Clinically‐oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS,,2012,,    ,['citation-other']," Monden Y, Dan H, Nagashima M, Dan I, Kyutoku Y, Okamoto M, et al. Clinically‐oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS. Clinical Neurophysiology2012; Vol. 123, issue 6:1147‐57. [DOI: 10.1016/j.clinph.2011.10.006; PUBMED: 22088661]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Clinically‐oriented+monitoring+of+acute+effects+of+methylphenidate+on+cerebral+hemodynamics+in+ADHD+children+using+fNIRS+&author=Y+Monden&author=H+Dan&author=M+Nagashima&author=I+Dan&author=Y+Kyutoku&author=M+Okamoto&publication_year=2012&hl=en']",,, Monden 2012a {published data only}  ,excluded,CD012069-bbs2-0317," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0499,"Monden Y, Dan H, Nagashima M, Dan I, Tsuzuki D, Kyutoku Y, et al. ",Right prefrontal activation as a neuro‐functional biomarker for monitoring acute effects of methylphenidate in ADHD children: an fNIRS study, NeuroImage: Clinical ,2012,1,    ,['citation-journal']," Monden Y, Dan H, Nagashima M, Dan I, Tsuzuki D, Kyutoku Y, et al. Right prefrontal activation as a neuro‐functional biomarker for monitoring acute effects of methylphenidate in ADHD children: an fNIRS study.  NeuroImage: Clinical 2012;1(1):131‐40. [DOI: 10.1016/j.nicl.2012.10.001; PMC3757725; PUBMED: 24179746]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.nicl.2012.10.001', 'https://scholar.google.com/scholar_lookup?title=Right+prefrontal+activation+as+a+neuro‐functional+biomarker+for+monitoring+acute+effects+of+methylphenidate+in+ADHD+children:+an+fNIRS+study+&author=Y+Monden&author=H+Dan&author=M+Nagashima&author=I+Dan&author=D+Tsuzuki&author=Y+Kyutoku&publication_year=2012&hl=en']",,https://doi.org/10.1016/j.nicl.2012.10.001, Monden 2012b {published data only}  ,excluded,CD012069-bbs2-0318," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0500,"Nahshoni E, Golubchik P, Glazer J, Sever J, Strasberg B, Imbar S, et al. ","Late potentials in the signal‐averaged electrocardiogram in pre‐pubertal children with ADHD, before and after methylphenidate treatment", European Child and Adolescent Psychiatry ,2012,21,    ,['citation-journal']," Nahshoni E, Golubchik P, Glazer J, Sever J, Strasberg B, Imbar S, et al. Late potentials in the signal‐averaged electrocardiogram in pre‐pubertal children with ADHD, before and after methylphenidate treatment.  European Child and Adolescent Psychiatry 2012;21(2):75‐8. [DOI: 10.1007/s00787‐011‐0233‐x; PUBMED: 22160611]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-011-0233-x', 'https://scholar.google.com/scholar_lookup?title=Late+potentials+in+the+signal‐averaged+electrocardiogram+in+pre‐pubertal+children+with+ADHD,+before+and+after+methylphenidate+treatment+&author=E+Nahshoni&author=P+Golubchik&author=J+Glazer&author=J+Sever&author=B+Strasberg&author=S+Imbar&publication_year=2012&hl=en']",,https://doi.org/10.1007/s00787-011-0233-x, Nahshoni 2012 {published data only}  ,excluded,CD012069-bbs2-0319," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0501,"Neef NA, Bicard DF, Endo S, Coury DL, Aman MG. ",Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder, Journal of Applied Behavior Analysis ,2005,38,    ,['citation-journal']," Neef NA, Bicard DF, Endo S, Coury DL, Aman MG. Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder.  Journal of Applied Behavior Analysis 2005;38(2):135‐46. [DOI: 10.1901/jaba.2005.116‐02; PMC1226151]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1901/jaba.2005.116-02', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+pharmacological+treatment+of+impulsivity+in+children+with+attention+deficit+hyperactivity+disorder+&author=NA+Neef&author=DF+Bicard&author=S+Endo&author=DL+Coury&author=MG+Aman&publication_year=2005&hl=en']",,https://doi.org/10.1901/jaba.2005.116-02, Neef 2005 {published data only}  ,excluded,CD012069-bbs2-0320," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0502,"Negrao BL, Bipath P, van der Westhuizen D, Viljoen M. ",Autonomic correlates at rest and during evoked attention in children with attention‐deficit/hyperactivity disorder and effects of methylphenidate, Neuropsychobiology ,2011,63,    ,['citation-journal']," Negrao BL, Bipath P, van der Westhuizen D, Viljoen M. Autonomic correlates at rest and during evoked attention in children with attention‐deficit/hyperactivity disorder and effects of methylphenidate.  Neuropsychobiology 2011;63(2):82‐91. [DOI: 10.1159/000317548; PUBMED: 21178382]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1159/000317548', 'https://scholar.google.com/scholar_lookup?title=Autonomic+correlates+at+rest+and+during+evoked+attention+in+children+with+attention‐deficit/hyperactivity+disorder+and+effects+of+methylphenidate+&author=BL+Negrao&author=P+Bipath&author=D+Westhuizen&author=M+Viljoen&publication_year=2011&hl=en']",,https://doi.org/10.1159/000317548, Negrao 2011 {published data only}  ,excluded,CD012069-bbs2-0321," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0503,"Nigg JT, Swanson JM, Hinshaw SP. ","Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents", Neuropsychologia ,1996,35,    ,['citation-journal']," Nigg JT, Swanson JM, Hinshaw SP. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents.  Neuropsychologia 1996;35(2):165‐76. [PUBMED: 9025120]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0028-3932(96)00070-X', 'https://scholar.google.com/scholar_lookup?title=Covert+visual+spatial+attention+in+boys+with+attention+deficit+hyperactivity+disorder:+lateral+effects,+methylphenidate+response+and+results+for+parents+&author=JT+Nigg&author=JM+Swanson&author=SP+Hinshaw&publication_year=1996&hl=en']",9025120,https://doi.org/10.1016/S0028-3932(96)00070-X, Nigg 1996 {published data only}  ,excluded,CD012069-bbs2-0322," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0504,"Nikles CJ, Clavarino AM, Del‐Mar CB. ",Using n‐of‐1 trials as a clinical tool to improve prescribing, British Journal of General Practice ,2005,55,    ,['citation-journal']," Nikles CJ, Clavarino AM, Del‐Mar CB. Using n‐of‐1 trials as a clinical tool to improve prescribing.  British Journal of General Practice 2005;55(512):175‐80. [PMC1463086]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Using+n‐of‐1+trials+as+a+clinical+tool+to+improve+prescribing+&author=CJ+Nikles&author=AM+Clavarino&author=CB+Del‐Mar&publication_year=2005&hl=en']",,, Nikles 2005 {published data only}  ,excluded,CD012069-bbs2-0323," No relevant outcome measures (experimental, neurocognitive or functional). The paper investigates the patients' satisfaction with N‐of‐1 trials  "
CD012069-bib-0505,"Nolan EE, Gadow KD, Sprafkin J. ",Stimulant medication withdrawal during long‐term therapy in children with comorbid attention‐deficit hyperactivity disorder and chronic multiple tic disorder, Pediatrics ,1999,103,    ,['citation-journal']," Nolan EE, Gadow KD, Sprafkin J. Stimulant medication withdrawal during long‐term therapy in children with comorbid attention‐deficit hyperactivity disorder and chronic multiple tic disorder.  Pediatrics 1999;103(4 Pt 1):730‐7. [PUBMED: 10103294]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.103.4.730', 'https://scholar.google.com/scholar_lookup?title=Stimulant+medication+withdrawal+during+long‐term+therapy+in+children+with+comorbid+attention‐deficit+hyperactivity+disorder+and+chronic+multiple+tic+disorder+&author=EE+Nolan&author=KD+Gadow&author=J+Sprafkin&publication_year=1999&hl=en']",10103294,https://doi.org/10.1542/peds.103.4.730, Nolan 1999 {published data only}  ,excluded,CD012069-bbs2-0324, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0506,"Ohashi K, Vitaliano G, Polcari A, Teicher MH. ",Unraveling the nature of hyperactivity in children with attention‐deficit/hyperactivity disorder, Archives of General Psychiatry ,2010,67,    ,['citation-journal']," Ohashi K, Vitaliano G, Polcari A, Teicher MH. Unraveling the nature of hyperactivity in children with attention‐deficit/hyperactivity disorder.  Archives of General Psychiatry 2010;67(4):388‐96. [DOI: 10.1001/archgenpsychiatry.2010.28; PUBMED: 20368514]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1001/archgenpsychiatry.2010.28', 'https://scholar.google.com/scholar_lookup?title=Unraveling+the+nature+of+hyperactivity+in+children+with+attention‐deficit/hyperactivity+disorder+&author=K+Ohashi&author=G+Vitaliano&author=A+Polcari&author=MH+Teicher&publication_year=2010&hl=en']",,https://doi.org/10.1001/archgenpsychiatry.2010.28, Ohashi 2010 {published data only}  ,excluded,CD012069-bbs2-0325," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0507,"Orgill A, Serfontein S. ",Behavioural and cognitive effects of stimulant and non stimulant drugs in childhood attention deficit disorder, European Neuropsychopharmacology ,1996,6,    ,['citation-journal']," Orgill A, Serfontein S. Behavioural and cognitive effects of stimulant and non stimulant drugs in childhood attention deficit disorder.  European Neuropsychopharmacology 1996;6(Suppl 3):56. [DOI: 10.1016/0924‐977X(96)87562‐6]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0924-977X(96)87562-6', 'https://scholar.google.com/scholar_lookup?title=Behavioural+and+cognitive+effects+of+stimulant+and+non+stimulant+drugs+in+childhood+attention+deficit+disorder+&author=A+Orgill&author=S+Serfontein&publication_year=1996&hl=en']",,https://doi.org/10.1016/0924-977X(96)87562-6, Orgill 1996 {published data only}  ,excluded,CD012069-bbs2-0326," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0508,Overcash SJ. ,"The effect of ROSHI protocol and cranial electrotherapy stimulation on a nine‐year‐old anxious, dyslexic male with attention deficit disorder: a case study", Journal of Neurotherapy ,2005,9,    ,['citation-journal']," Overcash SJ. The effect of ROSHI protocol and cranial electrotherapy stimulation on a nine‐year‐old anxious, dyslexic male with attention deficit disorder: a case study.  Journal of Neurotherapy 2005;9(2):63‐77. [DOI: 10.1300/J184v09n02_05]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1300/J184v09n02_05', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+ROSHI+protocol+and+cranial+electrotherapy+stimulation+on+a+nine‐year‐old+anxious,+dyslexic+male+with+attention+deficit+disorder:+a+case+study+&author=SJ+Overcash&publication_year=2005&hl=en']",,https://doi.org/10.1300/J184v09n02_05, Overcash 2005 {published data only}  ,excluded,CD012069-bbs2-0327," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0509,"Ozdag MF, Yorbik O, Ulas UH, Hamamcioglu K, Vural O. ",Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder, International Journal of Pediatric Otorhinolaryngology ,2004,68,    ,['citation-journal']," Ozdag MF, Yorbik O, Ulas UH, Hamamcioglu K, Vural O. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.  International Journal of Pediatric Otorhinolaryngology 2004;68(10):1267‐72. [DOI: 10.1016/j.ijporl.2004.04.023; PUBMED: 15364497]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ijporl.2004.04.023', 'https://scholar.google.com/scholar_lookup?title=Effect+of+methylphenidate+on+auditory+event+related+potential+in+boys+with+attention+deficit+hyperactivity+disorder+&author=MF+Ozdag&author=O+Yorbik&author=UH+Ulas&author=K+Hamamcioglu&author=O+Vural&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.ijporl.2004.04.023, Ozdag 2004 {published data only}  ,excluded,CD012069-bbs2-0328," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0510,"Palomino MD, Martín‐Calero MJ, Marques G. ",Involvement of community pharmacists on attention‐deficit/hyperactivity disorder patients. A pilot study, Pharmaceutical Care España ,2012,14,    ,['citation-journal']," Palomino MD, Martín‐Calero MJ, Marques G. Involvement of community pharmacists on attention‐deficit/hyperactivity disorder patients. A pilot study [Implicación del farmacéutico comunitario en la dispensación a pacientes con trastorno por déficit de atención e hiperactividad. Un estudio piloto].  Pharmaceutical Care España 2012;14(5):183‐92. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Involvement+of+community+pharmacists+on+attention‐deficit/hyperactivity+disorder+patients.+A+pilot+study+&author=MD+Palomino&author=MJ+Martín‐Calero&author=G+Marques&publication_year=2012&hl=en']",,, Palomino 2012 {published data only}  ,excluded,CD012069-bbs2-0329, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0511,"Park MH, Kim JW, Yang YH, Hong SB, Park S, Kang H, et al. ",Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention‐deficit/hyperactivity disorder,,2012,,    ,['citation-other']," Park MH, Kim JW, Yang YH, Hong SB, Park S, Kang H, et al. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention‐deficit/hyperactivity disorder. Neuroscience Letters2012; Vol. 514, issue 2:159‐63. [DOI: 10.1016/j.neulet.2012.02.079; PUBMED: 22405810]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Regional+brain+perfusion+before+and+after+treatment+with+methylphenidate+may+be+associated+with+the+G1287A+polymorphism+of+the+norepinephrine+transporter+gene+in+children+with+attention‐deficit/hyperactivity+disorder+&author=MH+Park&author=JW+Kim&author=YH+Yang&author=SB+Hong&author=S+Park&author=H+Kang&publication_year=2012&hl=en']",,, Park 2012 {published data only}  ,excluded,CD012069-bbs2-0330," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0512,"Pelham WE, Milich R, Walker JL. ",Effects of continuous and partial reinforcement and methylphenidate on learning in children with Attention Deficit Disorder, Journal of Abnormal Psychology ,1986,95,    ,['citation-journal']," Pelham WE, Milich R, Walker JL. Effects of continuous and partial reinforcement and methylphenidate on learning in children with Attention Deficit Disorder.  Journal of Abnormal Psychology 1986;95(4):319‐25. [PUBMED: 3805493]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1037/0021-843X.95.4.319', 'https://scholar.google.com/scholar_lookup?title=Effects+of+continuous+and+partial+reinforcement+and+methylphenidate+on+learning+in+children+with+Attention+Deficit+Disorder+&author=WE+Pelham&author=R+Milich&author=JL+Walker&publication_year=1986&hl=en']",3805493,https://doi.org/10.1037/0021-843X.95.4.319, Pelham 1986 {published data only}  ,excluded,CD012069-bbs2-0331," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0513,"Pelham WE, Waschbusch DA, Hoza B, Gnagy EM, Greiner AR, Sams SE, et al. ","Music and video as distractors for boys with ADHD in the classroom: comparison with controls, individual differences, and medication effects",,2011,,    ,['citation-other']," Pelham WE, Waschbusch DA, Hoza B, Gnagy EM, Greiner AR, Sams SE, et al. Music and video as distractors for boys with ADHD in the classroom: comparison with controls, individual differences, and medication effects. Journal of Abnormal Child Psychology2011; Vol. 39, issue 8:1085‐98. [DOI: 10.1007/s10802‐011‐9529‐z; PUBMED: 21695447]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Music+and+video+as+distractors+for+boys+with+ADHD+in+the+classroom:+comparison+with+controls,+individual+differences,+and+medication+effects+&author=WE+Pelham&author=DA+Waschbusch&author=B+Hoza&author=EM+Gnagy&author=AR+Greiner&author=SE+Sams&publication_year=2011&hl=en']",,, Pelham 2011 {published data only}  ,excluded,CD012069-bbs2-0332," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0514,"Perera H, Jeewandara KC, Seneviratne S, Guruge C. ","Combined ω3 and ω6 supplementation in children with attention‐deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double‐blind, placebo‐controlled study",,2012,,    ,['citation-other']," Perera H, Jeewandara KC, Seneviratne S, Guruge C. Combined ω3 and ω6 supplementation in children with attention‐deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double‐blind, placebo‐controlled study. Journal of Child Neurology2012; Vol. 27, issue 6:747‐53. [DOI: 10.1177/0883073811435243; PUBMED: 22596014]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Combined+ω3+and+ω6+supplementation+in+children+with+attention‐deficit+hyperactivity+disorder+(ADHD)+refractory+to+methylphenidate+treatment:+a+double‐blind,+placebo‐controlled+study+&author=H+Perera&author=KC+Jeewandara&author=S+Seneviratne&author=C+Guruge&publication_year=2012&hl=en']",,, Perera 2012 {published data only}  ,excluded,CD012069-bbs2-0333," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0515,"Pierce D, Dixon CM, Wigal SB, McGough JJ. ",Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study, Journal of Child and Adolescent Psychopharmacology ,2008,18,    ,['citation-journal']," Pierce D, Dixon CM, Wigal SB, McGough JJ. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.  Journal of Child and Adolescent Psychopharmacology 2008;18(4):355‐64. [DOI: 10.1089/cap.2007.0148; PUBMED: 18759645]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2007.0148', 'https://scholar.google.com/scholar_lookup?title=Pharmacokinetics+of+methylphenidate+transdermal+system+(MTS):+results+from+a+laboratory+classroom+study+&author=D+Pierce&author=CM+Dixon&author=SB+Wigal&author=JJ+McGough&publication_year=2008&hl=en']",,https://doi.org/10.1089/cap.2007.0148, Pierce 2008 {published data only}  ,excluded,CD012069-bbs2-0334," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0516,"Poulton AS, Melzer E, Tait PR, Garnett SP, Cowell Chris, Baur LA, et al. ",Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder, Medical Journal of Australia ,2013,198,    ,['citation-journal']," Poulton AS, Melzer E, Tait PR, Garnett SP, Cowell Chris, Baur LA, et al. Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder.  Medical Journal of Australia 2013;198(1):29‐32. [PUBMED: 23330767]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.5694/mja12.10931', 'https://scholar.google.com/scholar_lookup?title=Growth+and+pubertal+development+of+adolescent+boys+on+stimulant+medication+for+attention+deficit+hyperactivity+disorder+&author=AS+Poulton&author=E+Melzer&author=PR+Tait&author=SP+Garnett&author=Chris+Cowell&author=LA+Baur&publication_year=2013&hl=en']",23330767,https://doi.org/10.5694/mja12.10931, Poulton 2013 {published data only}  ,excluded,CD012069-bbs2-0335, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0517,"Prehn‐Kristensen A, Krauel K, Hinrichs H, Fischer J, Malecki U, Schuetze H, et al. ",Methylphenidate does not improve interference control during a working memory task in young patients with attention‐deficit hyperactivity disorder, Brain Research ,2011,1388,    ,['citation-journal']," Prehn‐Kristensen A, Krauel K, Hinrichs H, Fischer J, Malecki U, Schuetze H, et al. Methylphenidate does not improve interference control during a working memory task in young patients with attention‐deficit hyperactivity disorder.  Brain Research 2011;1388:56‐68. [DOI: 10.1016/j.brainres.2011.02.075; PUBMED: 21385569]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.brainres.2011.02.075', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+does+not+improve+interference+control+during+a+working+memory+task+in+young+patients+with+attention‐deficit+hyperactivity+disorder+&author=A+Prehn‐Kristensen&author=K+Krauel&author=H+Hinrichs&author=J+Fischer&author=U+Malecki&author=H+Schuetze&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.brainres.2011.02.075, Prehn‐Kristensen 2011 {published data only}  ,excluded,CD012069-bbs2-0336," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0518,"Rapport MD, DuPaul GJ, Smith NF. ",Rate‐dependency and hyperactivity: methylphenidate effects on operant responding," Pharmacology, Biochemistry, and Behavior ",1985,23,    ,['citation-journal']," Rapport MD, DuPaul GJ, Smith NF. Rate‐dependency and hyperactivity: methylphenidate effects on operant responding.  Pharmacology, Biochemistry, and Behavior 1985;23(1):77‐83. [PUBMED: 4034622]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0091-3057(85)90133-9', 'https://scholar.google.com/scholar_lookup?title=Rate‐dependency+and+hyperactivity:+methylphenidate+effects+on+operant+responding&author=MD+Rapport&author=GJ+DuPaul&author=NF+Smith&publication_year=1985&hl=en']",4034622,https://doi.org/10.1016/0091-3057(85)90133-9, Rapport 1985 {published data only}  ,excluded,CD012069-bbs2-0337," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0519,"Rhodes SM, Coghill DR, Matthews K. ","Methylphenidate restores visual memory, but not working memory function in attention deficit‐hyperkinetic disorder", Psychopharmacology ,2004,175,    ,['citation-journal']," Rhodes SM, Coghill DR, Matthews K. Methylphenidate restores visual memory, but not working memory function in attention deficit‐hyperkinetic disorder.  Psychopharmacology 2004;175(3):319‐30. [DOI: 10.1007/s00213‐004‐1833‐7; PUBMED: 15138760]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00213-004-1833-7', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+restores+visual+memory,+but+not+working+memory+function+in+attention+deficit‐hyperkinetic+disorder+&author=SM+Rhodes&author=DR+Coghill&author=K+Matthews&publication_year=2004&hl=en']",,https://doi.org/10.1007/s00213-004-1833-7, Rhodes 2004 {published data only}  ,excluded,CD012069-bbs2-0338," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0520,"Rhodes SM, Coghill DR, Matthews K. ",Acute neuropsychological effects of methylphenidate in stimulant drug‐naïve boys with ADHD II‐‐broader executive and non‐executive domains," Journal of Child Psychology and Psychiatry, and Allied Disciplines ",2006,47,    ,['citation-journal']," Rhodes SM, Coghill DR, Matthews K. Acute neuropsychological effects of methylphenidate in stimulant drug‐naïve boys with ADHD II‐‐broader executive and non‐executive domains.  Journal of Child Psychology and Psychiatry, and Allied Disciplines 2006;47(11):1184‐94. [DOI: 10.1111/j.1469‐7610.2006.01633.x; PUBMED: 17076758]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1469-7610.2006.01633.x', 'https://scholar.google.com/scholar_lookup?title=Acute+neuropsychological+effects+of+methylphenidate+in+stimulant+drug‐naïve+boys+with+ADHD+II‐‐broader+executive+and+non‐executive+domains+&author=SM+Rhodes&author=DR+Coghill&author=K+Matthews&publication_year=2006&hl=en']",,https://doi.org/10.1111/j.1469-7610.2006.01633.x, Rhodes 2006 {published data only}  ,excluded,CD012069-bbs2-0339," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0521,"Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH. ",Dopamine transporter gene and response to methylphenidate in attention‐deficit/hyperactivity disorder, Pharmacogenetics ,2002,12,    ,['citation-journal']," Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH. Dopamine transporter gene and response to methylphenidate in attention‐deficit/hyperactivity disorder.  Pharmacogenetics 2002;12(6):497‐9. [PUBMED: 12172219]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00008571-200208000-00011', 'https://scholar.google.com/scholar_lookup?title=Dopamine+transporter+gene+and+response+to+methylphenidate+in+attention‐deficit/hyperactivity+disorder+&author=T+Roman&author=C+Szobot&author=S+Martins&author=J+Biederman&author=LA+Rohde&author=MH+Hutz&publication_year=2002&hl=en']",12172219,https://doi.org/10.1097/00008571-200208000-00011, Roman 2002 {published data only}  ,excluded,CD012069-bbs2-0340," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0522,"Rubia K, Halari R, Cubillo AI, Taylor ET. ",Methylphenidate modulates inferior and orbitofrontal brain activation in ADHD during sustained attention and reward,,2009,,    ,['citation-other']," Rubia K, Halari R, Cubillo AI, Taylor ET. Methylphenidate modulates inferior and orbitofrontal brain activation in ADHD during sustained attention and reward. European Neuropsychopharmacology2009; Vol. 19, issue Suppl 3:S304‐5. [DOI: 10.1016/S0924‐977X(09)70452‐3]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+modulates+inferior+and+orbitofrontal+brain+activation+in+ADHD+during+sustained+attention+and+reward+&author=K+Rubia&author=R+Halari&author=AI+Cubillo&author=ET+Taylor&publication_year=2009&hl=en']",,, Rubia 2009 {published data only}  ,excluded,CD012069-bbs2-0341," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0523,"Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E. ",Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication‐naïve children with ADHD during a rewarded continuous performance task, Neuropharmacology ,2009,57,    ,['citation-journal']," Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication‐naïve children with ADHD during a rewarded continuous performance task.  Neuropharmacology 2009;57(7‐8):640‐52. [DOI: 10.1016/j.neuropharm.2009.08.013; PUBMED: 19715709]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.neuropharm.2009.08.013', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+normalises+activation+and+functional+connectivity+deficits+in+attention+and+motivation+networks+in+medication‐naïve+children+with+ADHD+during+a+rewarded+continuous+performance+task+&author=K+Rubia&author=R+Halari&author=A+Cubillo&author=AM+Mohammad&author=M+Brammer&author=E+Taylor&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.neuropharm.2009.08.013, Rubia 2009a {published data only}  ,excluded,CD012069-bbs2-0342," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0524,"Rubio B, Hernández S, Verche E, Martín R, González‐Pérez P. ",A pilot study: differential effects of methylphenidate‐OROS on working memory and attention functions in children with attention‐deficit/hyperactivity disorder with and without behavioural comorbidities, Attention Deficit and Hyperactivity Disorders ,2011,3,    ,['citation-journal']," Rubio B, Hernández S, Verche E, Martín R, González‐Pérez P. A pilot study: differential effects of methylphenidate‐OROS on working memory and attention functions in children with attention‐deficit/hyperactivity disorder with and without behavioural comorbidities.  Attention Deficit and Hyperactivity Disorders 2011;3(1):13‐20. [DOI: 10.1007/s12402‐010‐0035‐x; PUBMED: 21432614]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s12402-010-0035-x', 'https://scholar.google.com/scholar_lookup?title=A+pilot+study:+differential+effects+of+methylphenidate‐OROS+on+working+memory+and+attention+functions+in+children+with+attention‐deficit/hyperactivity+disorder+with+and+without+behavioural+comorbidities+&author=B+Rubio&author=S+Hernández&author=E+Verche&author=R+Martín&author=P+González‐Pérez&publication_year=2011&hl=en']",,https://doi.org/10.1007/s12402-010-0035-x, Rubio 2011 {published data only}  ,excluded,CD012069-bbs2-0343," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0525,"Schecklmann M, Schaldecker M, Aucktor S, Brast J, Kirchgässner K, Muhlberger A, et al. ",Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD, Journal of Psychiatric Research ,2011,45,    ,['citation-journal']," Schecklmann M, Schaldecker M, Aucktor S, Brast J, Kirchgässner K, Muhlberger A, et al. Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD.  Journal of Psychiatric Research 2011;45(11):1463‐70. [DOI: 10.1016/j.jpsychires.2011.05.011; PUBMED: 21689828]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jpsychires.2011.05.011', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylphenidate+on+olfaction+and+frontal+and+temporal+brain+oxygenation+in+children+with+ADHD+&author=M+Schecklmann&author=M+Schaldecker&author=S+Aucktor&author=J+Brast&author=K+Kirchgässner&author=A+Muhlberger&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jpsychires.2011.05.011, Schecklmann 2011 {published data only}  ,excluded,CD012069-bbs2-0344," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0526,"Scheres A, Oosterlaan J, Swanson J, Morein‐Zamir S, Meiran N, Schut H, et al. ",The effect of methylphenidate on three forms of response inhibition in boys with AD/HD, Journal of Abnormal Child Psychology ,2003,31,    ,['citation-journal']," Scheres A, Oosterlaan J, Swanson J, Morein‐Zamir S, Meiran N, Schut H, et al. The effect of methylphenidate on three forms of response inhibition in boys with AD/HD.  Journal of Abnormal Child Psychology 2003;31(1):105‐20. [PUBMED: 12597703]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1023/A:1021729501230', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+methylphenidate+on+three+forms+of+response+inhibition+in+boys+with+AD/HD&author=A+Scheres&author=J+Oosterlaan&author=J+Swanson&author=S+Morein‐Zamir&author=N+Meiran&author=H+Schut&publication_year=2003&hl=en']",12597703,https://doi.org/10.1023/A:1021729501230, Scheres 2003 {published data only}  ,excluded,CD012069-bbs2-0345," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0527,"Scheres A, Oosterlaan J, Sergeant JA. ",Speed of inhibition predicts teacher‐rated medication response in boys with attention deficit hyperactivity disorder," International Journal of Disability, Development and Education ",2006,53,    ,['citation-journal']," Scheres A, Oosterlaan J, Sergeant JA. Speed of inhibition predicts teacher‐rated medication response in boys with attention deficit hyperactivity disorder.  International Journal of Disability, Development and Education 2006;53(1):93‐109. [DOI: 10.1080/10349120500510107]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/10349120500510107', 'https://scholar.google.com/scholar_lookup?title=Speed+of+inhibition+predicts+teacher‐rated+medication+response+in+boys+with+attention+deficit+hyperactivity+disorder+&author=A+Scheres&author=J+Oosterlaan&author=JA+Sergeant&publication_year=2006&hl=en']",,https://doi.org/10.1080/10349120500510107, Scheres 2006 {published data only}  ,excluded,CD012069-bbs2-0346," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0528,"Schmiedeler S, Schwenck C, Schneider W. ",The mental process of negating values in children with ADHD and effects of medical treatment, Kindheit und Entwicklung ,2009,18,    ,['citation-journal']," Schmiedeler S, Schwenck C, Schneider W. The mental process of negating values in children with ADHD and effects of medical treatment [Die Verarbeitung von Negationen bei Kindern mit ADHS und der Einfluss medikamentöser Behandlung].  Kindheit und Entwicklung 2009;18(3):137‐43. [DOI: 10.1026/0942‐5403.18.3.137]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1026/0942-5403.18.3.137', 'https://scholar.google.com/scholar_lookup?title=The+mental+process+of+negating+values+in+children+with+ADHD+and+effects+of+medical+treatment+&author=S+Schmiedeler&author=C+Schwenck&author=W+Schneider&publication_year=2009&hl=en']",,https://doi.org/10.1026/0942-5403.18.3.137, Schmiedeler 2009 {published data only}  ,excluded,CD012069-bbs2-0347," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0529,"Shafritz KM, Marchione KE, Gore JC, Shaywitz SE, Shaywitz BA. ",The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder, American Journal of Psychiatry ,2004,161,    ,['citation-journal']," Shafritz KM, Marchione KE, Gore JC, Shaywitz SE, Shaywitz BA. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.  American Journal of Psychiatry 2004;161(11):1990‐7. [DOI: 10.1176/appi.ajp.161.11.1990]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1176/appi.ajp.161.11.1990', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+methylphenidate+on+neural+systems+of+attention+in+attention+deficit+hyperactivity+disorder+&author=KM+Shafritz&author=KE+Marchione&author=JC+Gore&author=SE+Shaywitz&author=BA+Shaywitz&publication_year=2004&hl=en']",,https://doi.org/10.1176/appi.ajp.161.11.1990, Shafritz 2004 {published data only}  ,excluded,CD012069-bbs2-0348," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0530,"Shaywitz SE, Hunt RD, Jatlow P. ","Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate", Pediatrics ,1982,69,    ,['citation-journal']," Shaywitz SE, Hunt RD, Jatlow P. Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate.  Pediatrics 1982;69(6):688‐94. [PUBMED: 7079034]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Psychopharmacology+of+attention+deficit+disorder:+pharmacokinetic,+neuroendocrine,+and+behavioral+measures+following+acute+and+chronic+treatment+with+methylphenidate+&author=SE+Shaywitz&author=RD+Hunt&author=P+Jatlow&publication_year=1982&hl=en']",7079034,, Shaywitz 1982 {published data only}  ,excluded,CD012069-bbs2-0349," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0531,"Sheppard DM, Bradshaw JL, Mattingly JB, Lee P. ",Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder," Journal of Neurology, Neurosurgery and Psychiatry ",1999,66,    ,['citation-journal']," Sheppard DM, Bradshaw JL, Mattingly JB, Lee P. Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder.  Journal of Neurology, Neurosurgery and Psychiatry 1999;66(1):57‐63. [PMC1736185; PUBMED: 9886453]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1136/jnnp.66.1.57', 'https://scholar.google.com/scholar_lookup?title=Effects+of+stimulant+medication+on+the+lateralisation+of+line+bisection+judgements+of+children+with+attention+deficit+hyperactivity+disorder+&author=DM+Sheppard&author=JL+Bradshaw&author=JB+Mattingly&author=P+Lee&publication_year=1999&hl=en']",,https://doi.org/10.1136/jnnp.66.1.57, Sheppard 1999 {published data only}  ,excluded,CD012069-bbs2-0350," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0532,"Snyder AM, Maruff P, Pietrzak RH, Cromer JR, Snyder PJ. ",Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD), Child Neuropsychology ,2008,14,    ,['citation-journal']," Snyder AM, Maruff P, Pietrzak RH, Cromer JR, Snyder PJ. Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD).  Child Neuropsychology 2008;14(3):211‐26. [DOI: 10.1080/09297040701220005; PUBMED: 17852127]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/09297040701220005', 'https://scholar.google.com/scholar_lookup?title=Effect+of+treatment+with+stimulant+medication+on+nonverbal+executive+function+and+visuomotor+speed+in+children+with+attention+deficit/hyperactivity+disorder+(ADHD)+&author=AM+Snyder&author=P+Maruff&author=RH+Pietrzak&author=JR+Cromer&author=PJ+Snyder&publication_year=2008&hl=en']",,https://doi.org/10.1080/09297040701220005, Snyder 2008 {published data only}  ,excluded,CD012069-bbs2-0351, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0533,"Solanto MV, Wender EH. ",Does methylphenidate constrict cognitive functioning?, Journal of the American Academy of Child and Adolescent Psychiatry ,1989,28,    ,['citation-journal']," Solanto MV, Wender EH. Does methylphenidate constrict cognitive functioning?.  Journal of the American Academy of Child and Adolescent Psychiatry 1989;28(6):897‐902. [DOI: 10.1097/00004583‐198911000‐00014; PUBMED: 2808260]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00004583-198911000-00014', 'https://scholar.google.com/scholar_lookup?title=Does+methylphenidate+constrict+cognitive+functioning?&author=MV+Solanto&author=EH+Wender&publication_year=1989&hl=en']",,https://doi.org/10.1097/00004583-198911000-00014, Solanto 1989 {published data only}  ,excluded,CD012069-bbs2-0352," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0534,"Spivak B, Vered Y, Yoran‐Hegesh R, Graft E, Averbuch E, Vinokurow S, et al. ",The influence of three months of methylphenidate treatment on platelet‐poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder, Human Psychopharmacology ,2001,16,    ,['citation-journal']," Spivak B, Vered Y, Yoran‐Hegesh R, Graft E, Averbuch E, Vinokurow S, et al. The influence of three months of methylphenidate treatment on platelet‐poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder.  Human Psychopharmacology 2001;16(4):333‐7. [DOI: 10.1002/hup.298; PUBMED: 12404569]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1002/hup.298', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+three+months+of+methylphenidate+treatment+on+platelet‐poor+plasma+biogenic+amine+levels+in+boys+with+attention+deficit+hyperactivity+disorder+&author=B+Spivak&author=Y+Vered&author=R+Yoran‐Hegesh&author=E+Graft&author=E+Averbuch&author=S+Vinokurow&publication_year=2001&hl=en']",,https://doi.org/10.1002/hup.298, Spivak 2001 {published data only}  ,excluded,CD012069-bbs2-0353," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0535,Jerome L. ,Can methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?, Journal of Child and Adolescent Psychopharmacology ,2001,11,    ,['citation-journal'], Jerome L. Can methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?.  Journal of Child and Adolescent Psychopharmacology 2001;11(1):109. [DOI: 10.1089/104454601750143564; PUBMED: 11322740]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1089/104454601750143564', 'https://scholar.google.com/scholar_lookup?title=Can+methylphenidate+facilitate+sleep+in+children+with+attention+deficit+hyperactivity+disorder?+&author=L+Jerome&publication_year=2001&hl=en']",,https://doi.org/10.1089/104454601750143564, Stein 1999 {published data only}  ,excluded,CD012069-bbs2-0354, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0536,Stein MA. ,Unravelling sleep problems in treated and untreated children with ADHD, Journal of Child and Adolescent Psychopharmacology ,1999,9,    ,['citation-journal'], Stein MA. Unravelling sleep problems in treated and untreated children with ADHD.  Journal of Child and Adolescent Psychopharmacology 1999;9(3):157‐68. [DOI: 10.1089/cap.1999.9.157; PUBMED: 10521009]CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1089/cap.1999.9.157', 'https://scholar.google.com/scholar_lookup?title=Unravelling+sleep+problems+in+treated+and+untreated+children+with+ADHD&author=MA+Stein&publication_year=1999&hl=en']",,https://doi.org/10.1089/cap.1999.9.157, Stein 1999 {published data only}  ,excluded,CD012069-bbs2-0354, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0537,"Syrigou‐Papavasiliou A, Lycaki H, LeWitt PA, Verma NP, Spivak D, Chayasirisobhon S. ",Dose‐response effects of chronic methylphenidate administration on late event‐related potentials in attention deficit disorder, Clinical Electroencephalography ,1988,19,    ,['citation-journal']," Syrigou‐Papavasiliou A, Lycaki H, LeWitt PA, Verma NP, Spivak D, Chayasirisobhon S. Dose‐response effects of chronic methylphenidate administration on late event‐related potentials in attention deficit disorder.  Clinical Electroencephalography 1988;19(3):129‐33. [DOI: 10.1177/155005948801900306]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/155005948801900306', 'https://scholar.google.com/scholar_lookup?title=Dose‐response+effects+of+chronic+methylphenidate+administration+on+late+event‐related+potentials+in+attention+deficit+disorder+&author=A+Syrigou‐Papavasiliou&author=H+Lycaki&author=PA+LeWitt&author=NP+Verma&author=D+Spivak&author=S+Chayasirisobhon&publication_year=1988&hl=en']",,https://doi.org/10.1177/155005948801900306, Syrigou‐Papavasiliou 1988 {published data only}  ,excluded,CD012069-bbs2-0355," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0538,"Tabori‐Kraft J, Sørensen M, Kærgaard M, Dalsgaard S, Thomsen PH. ",Is OPTAx[TM] useful for monitoring the effect of stimulants on hyperactivity and inattention?, European Child and Adolescent Psychiatry ,2007,16,    ,['citation-journal']," Tabori‐Kraft J, Sørensen M, Kærgaard M, Dalsgaard S, Thomsen PH. Is OPTAx[TM] useful for monitoring the effect of stimulants on hyperactivity and inattention?.  European Child and Adolescent Psychiatry 2007;16(5):347‐51. [DOI: 10.1007/s00787‐006‐0571‐2]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1007/s00787-006-0571-2', 'https://scholar.google.com/scholar_lookup?title=Is+OPTAx[TM]+useful+for+monitoring+the+effect+of+stimulants+on+hyperactivity+and+inattention?&author=J+Tabori‐Kraft&author=M+Sørensen&author=M+Kærgaard&author=S+Dalsgaard&author=PH+Thomsen&publication_year=2007&hl=en']",,https://doi.org/10.1007/s00787-006-0571-2, Tabori‐Kraft 2007 {published data only}  ,excluded,CD012069-bbs2-0356," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0539,"Tamm L, Carlson CL. ",Task demands interact with the single and combined effects of medication and contingencies on children with ADHD, Journal of Attention Disorders ,2007,10,    ,['citation-journal']," Tamm L, Carlson CL. Task demands interact with the single and combined effects of medication and contingencies on children with ADHD.  Journal of Attention Disorders 2007;10(4):372‐80. [DOI: 10.1177/1087054706289946; PUBMED: 17449836]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/1087054706289946', 'https://scholar.google.com/scholar_lookup?title=Task+demands+interact+with+the+single+and+combined+effects+of+medication+and+contingencies+on+children+with+ADHD+&author=L+Tamm&author=CL+Carlson&publication_year=2007&hl=en']",,https://doi.org/10.1177/1087054706289946, Tamm 2007 {published data only}  ,excluded,CD012069-bbs2-0357," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0540,Tillery KL. ,,A Double‐Blind Study of the Central Auditory Processing and Auditory Continuous Test Performances of Children with Attention Deficit Hyperactivity Disorder and Central Auditory Processing Disorder Under Ritalin and Placebo Conditions [PhD thesis],1998,,   ,['citation-book']," Tillery KL. A Double‐Blind Study of the Central Auditory Processing and Auditory Continuous Test Performances of Children with Attention Deficit Hyperactivity Disorder and Central Auditory Processing Disorder Under Ritalin and Placebo Conditions [PhD thesis]. Buffalo (NY): University of Buffalo, The State University of New York, 1998. CENTRAL    ",[''],,, Tillery 1998 {published data only}  ,excluded,CD012069-bbs2-0358," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0541,"Taam MA, De Boissieu P, Dukic S, Herlem E, Trenque T. ",Hallucinations: a case/noncase study in the French Pharmacovigilance Database, Pharmacoepidemiology and Drug Safety ,2013,22,    ,['citation-journal']," Taam MA, De Boissieu P, Dukic S, Herlem E, Trenque T. Hallucinations: a case/noncase study in the French Pharmacovigilance Database.  Pharmacoepidemiology and Drug Safety 2013;22(Suppl 1):315‐6. [DOI: 10.1002/pds.3512]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Hallucinations:+a+case/noncase+study+in+the+French+Pharmacovigilance+Database&author=MA+Taam&author=P+Boissieu&author=S+Dukic&author=E+Herlem&author=T+Trenque&publication_year=2013&hl=en']",,, Trenque 2009 {published data only}  ,excluded,CD012069-bbs2-0359, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0544,Trenque T. ,Methylphenidate off‐label use, Drug Safety ,2012,35,    ,['citation-journal'], Trenque T. Methylphenidate off‐label use.  Drug Safety 2012;35(10):891. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+off‐label+use&author=T+Trenque&publication_year=2012&hl=en']",,, Trenque 2009 {published data only}  ,excluded,CD012069-bbs2-0359, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0542,"Trenque T, Herlem E, Germain M L. ",Spontaneous reporting with methylphenidate: insufficient data, Drug Safety ,2009,32,    ,['citation-journal']," Trenque T, Herlem E, Germain M L. Spontaneous reporting with methylphenidate: insufficient data.  Drug Safety 2009;32(10):983. [DOI: 10.2165/11316660‐000000000‐00000]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Spontaneous+reporting+with+methylphenidate:+insufficient+data&author=T+Trenque&author=E+Herlem&author=ML+Germain&publication_year=2009&hl=en']",,, Trenque 2009 {published data only}  ,excluded,CD012069-bbs2-0359, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0543,"Trenque T, Maura G, Herlem E. ",Spontaneous reporting with methylphenidate: off‐label use in growth?,,2012,,    ,['citation-other']," Trenque T, Maura G, Herlem E. Spontaneous reporting with methylphenidate: off‐label use in growth?. Fundamental and Clinical Pharmacology. 2012; Vol. 26:105. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Spontaneous+reporting+with+methylphenidate:+off‐label+use+in+growth?&author=T+Trenque&author=G+Maura&author=E+Herlem&publication_year=2012&hl=en']",,, Trenque 2009 {published data only}  ,excluded,CD012069-bbs2-0359, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0545,"Vance AL, Luk ES, Costin J, Tonge BJ, Pantelis C. ",Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more, Australian and New Zealand Journal of Psychiatry ,1999,33,    ,['citation-journal']," Vance AL, Luk ES, Costin J, Tonge BJ, Pantelis C. Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.  Australian and New Zealand Journal of Psychiatry 1999;33(3):399‐406. [DOI: 10.1046/j.1440‐1614.1999.00575.x]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1046/j.1440-1614.1999.00575.x', 'https://scholar.google.com/scholar_lookup?title=Attention+deficit+hyperactivity+disorder:+anxiety+phenomena+in+children+treated+with+psychostimulant+medication+for+6+months+or+more+&author=AL+Vance&author=ES+Luk&author=J+Costin&author=BJ+Tonge&author=C+Pantelis&publication_year=1999&hl=en']",,https://doi.org/10.1046/j.1440-1614.1999.00575.x, Vance 1999 {published data only}  ,excluded,CD012069-bbs2-0360, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0546,"Van der Meere JJ, Shalev RS, Borger N, Wiersema JR. ","Methylphenidate, interstimulus interval, and reaction time performance of children with attention deficit/hyperactivity disorder: a pilot study", Child Neuropsychology ,2009,15,    ,['citation-journal']," Van der Meere JJ, Shalev RS, Borger N, Wiersema JR. Methylphenidate, interstimulus interval, and reaction time performance of children with attention deficit/hyperactivity disorder: a pilot study.  Child Neuropsychology 2009;15(6):554‐66. [DOI: 10.1080/09297040902758803; PUBMED: 19296298]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/09297040902758803', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate,+interstimulus+interval,+and+reaction+time+performance+of+children+with+attention+deficit/hyperactivity+disorder:+a+pilot+study+&author=JJ+Meere&author=RS+Shalev&author=N+Borger&author=JR+Wiersema&publication_year=2009&hl=en']",,https://doi.org/10.1080/09297040902758803, Van der Meere 2009 {published data only}  ,excluded,CD012069-bbs2-0361," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0547,"Van der Oord S, Geurts HM, Prins PJ, Emmelkamp PM, Oosterlaan J. ",Prepotent response inhibition predicts treatment outcome in attention deficit/hyperactivity disorder, Child Neuropsychology ,2012,18,    ,['citation-journal']," Van der Oord S, Geurts HM, Prins PJ, Emmelkamp PM, Oosterlaan J. Prepotent response inhibition predicts treatment outcome in attention deficit/hyperactivity disorder.  Child Neuropsychology 2012;18(1):50‐61. [DOI: 10.1080/09297049.2011.559159; PUBMED: 21819279]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/09297049.2011.559159', 'https://scholar.google.com/scholar_lookup?title=Prepotent+response+inhibition+predicts+treatment+outcome+in+attention+deficit/hyperactivity+disorder+&author=S+Oord&author=HM+Geurts&author=PJ+Prins&author=PM+Emmelkamp&author=J+Oosterlaan&publication_year=2012&hl=en']",,https://doi.org/10.1080/09297049.2011.559159, Van der Oord 2012 {published data only}  ,excluded,CD012069-bbs2-0362," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0548,"Vickers JN, Rodrigues ST, Brown LN. ",Gaze pursuit and arm control of adolescent males diagnosed with attention deficit hyperactivity disorder (ADHD) and normal controls: evidence of a dissociation in processing visual information of short and long duration, Journal of Sports Sciences ,2002,20,    ,['citation-journal']," Vickers JN, Rodrigues ST, Brown LN. Gaze pursuit and arm control of adolescent males diagnosed with attention deficit hyperactivity disorder (ADHD) and normal controls: evidence of a dissociation in processing visual information of short and long duration.  Journal of Sports Sciences 2002;20(3):201‐16. [DOI: 10.1080/026404102317284763]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/026404102317284763', 'https://scholar.google.com/scholar_lookup?title=Gaze+pursuit+and+arm+control+of+adolescent+males+diagnosed+with+attention+deficit+hyperactivity+disorder+(ADHD)+and+normal+controls:+evidence+of+a+dissociation+in+processing+visual+information+of+short+and+long+duration+&author=JN+Vickers&author=ST+Rodrigues&author=LN+Brown&publication_year=2002&hl=en']",,https://doi.org/10.1080/026404102317284763, Vickers 2002 {published data only}  ,excluded,CD012069-bbs2-0363," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0549,"Vogt C, Williams T. ","Early identification of stimulant treatment responders, partial responders and non‐responders using objective measures in children and adolescents with hyperkinetic disorder",,2011,,    ,['citation-other']," Vogt C, Williams T. Early identification of stimulant treatment responders, partial responders and non‐responders using objective measures in children and adolescents with hyperkinetic disorder. Child and Adolescent Mental Health2011; Vol. 16, issue 3:144‐9. [DOI: 10.1111/j.1475‐3588.2010.00593.x]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Early+identification+of+stimulant+treatment+responders,+partial+responders+and+non‐responders+using+objective+measures+in+children+and+adolescents+with+hyperkinetic+disorder+&author=C+Vogt&author=T+Williams&publication_year=2011&hl=en']",,, Vogt 2011 {published data only}  ,excluded,CD012069-bbs2-0364," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0550,"Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. ",Cardiac safety of central nervous system stimulants in children and adolescents with attention‐deficit/hyperactivity disorder, Pediatrics ,2007,120,    ,['citation-journal']," Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. Cardiac safety of central nervous system stimulants in children and adolescents with attention‐deficit/hyperactivity disorder.  Pediatrics 2007;120(6):e1494‐501. [DOI: 10.1542/peds.2007‐0675; PUBMED: 18055666]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2007-0675', 'https://scholar.google.com/scholar_lookup?title=Cardiac+safety+of+central+nervous+system+stimulants+in+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=AG+Winterstein&author=T+Gerhard&author=J+Shuster&author=M+Johnson&author=JM+Zito&author=A+Saidi&publication_year=2007&hl=en']",,https://doi.org/10.1542/peds.2007-0675, Winterstein 2007 {published data only}  ,excluded,CD012069-bbs2-0365, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0551,"Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, et al. ",Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study,,2012,,    ,['citation-other']," Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, et al. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ2012; Vol. 345:e4627. [DOI: 10.1136/bmj.e4627]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+safety+of+central+nervous+system+stimulants+in+children+and+adolescents:+population+based+cohort+study+&author=AG+Winterstein&author=T+Gerhard&author=P+Kubilis&author=A+Saidi&author=S+Linden&author=S+Crystal&publication_year=2012&hl=en']",,, Winterstein 2012 {published data only}  ,excluded,CD012069-bbs2-0366, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0552,"Wong CG, Stevens MC. ",The effects of stimulant medication on working memory functional connectivity in attention‐deficit/hyperactivity disorder,,2012,,    ,['citation-other']," Wong CG, Stevens MC. The effects of stimulant medication on working memory functional connectivity in attention‐deficit/hyperactivity disorder. Biological Psychiatry2012; Vol. 71, issue 5:458‐66. [DOI: 10.1016/j.biopsych.2011.11.011; PMC4120250; PUBMED: 22209640]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+stimulant+medication+on+working+memory+functional+connectivity+in+attention‐deficit/hyperactivity+disorder+&author=CG+Wong&author=MC+Stevens&publication_year=2012&hl=en']",,, Wong 2012 {published data only}  ,excluded,CD012069-bbs2-0367," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0553,"Yeh CB, Huang WS, Lo MC, Chang CJ, Ma KH, Shyu JF. ",The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging,,2012,,    ,['citation-other']," Yeh CB, Huang WS, Lo MC, Chang CJ, Ma KH, Shyu JF. The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging. European Journal of Paediatric Neurology2012; Vol. 16, issue 6:613‐8. [DOI: 10.1016/j.ejpn.2012.02.007; PUBMED: 22417719]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+rCBF+brain+mapping+in+adolescent+ADHD+comorbid+developmental+coordination+disorder+and+its+changes+after+MPH+challenging+&author=CB+Yeh&author=WS+Huang&author=MC+Lo&author=CJ+Chang&author=KH+Ma&author=JF+Shyu&publication_year=2012&hl=en']",,, Yeh 2012 {published data only}  ,excluded,CD012069-bbs2-0368," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0554,"Zachor DA, Roberts AW, Hodgens JB, Isaacs JS, Merrick J. ",Effects of long‐term psychostimulant medication on growth of children with ADHD, Research in Developmental Disabilities ,2006,27,    ,['citation-journal']," Zachor DA, Roberts AW, Hodgens JB, Isaacs JS, Merrick J. Effects of long‐term psychostimulant medication on growth of children with ADHD.  Research in Developmental Disabilities 2006;27(2):162‐74. [DOI: 10.1016/j.ridd.2004.12.004; PUBMED: 15955659]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.ridd.2004.12.004', 'https://scholar.google.com/scholar_lookup?title=Effects+of+long‐term+psychostimulant+medication+on+growth+of+children+with+ADHD&author=DA+Zachor&author=AW+Roberts&author=JB+Hodgens&author=JS+Isaacs&author=J+Merrick&publication_year=2006&hl=en']",,https://doi.org/10.1016/j.ridd.2004.12.004, Zachor 2006 {published data only}  ,excluded,CD012069-bbs2-0369, Unable to obtain the disaggregated data for the methylphenidate group 
CD012069-bib-0555,"Zalsman G, Pumeranz O, Peretz G, Ben‐Dor DH, Dekel S, Horesh N, et al. ",Attention patterns in children with attention deficit disorder with or without hyperactivity, Scientific World Journal ,2003,3,    ,['citation-journal']," Zalsman G, Pumeranz O, Peretz G, Ben‐Dor DH, Dekel S, Horesh N, et al. Attention patterns in children with attention deficit disorder with or without hyperactivity.  Scientific World Journal 2003;3:1093‐107. [DOI: 10.1100/tsw.2003.94; PUBMED: 14625396]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1100/tsw.2003.94', 'https://scholar.google.com/scholar_lookup?title=Attention+patterns+in+children+with+attention+deficit+disorder+with+or+without+hyperactivity&author=G+Zalsman&author=O+Pumeranz&author=G+Peretz&author=DH+Ben‐Dor&author=S+Dekel&author=N+Horesh&publication_year=2003&hl=en']",,https://doi.org/10.1100/tsw.2003.94, Zalsman 2003 {published data only}  ,excluded,CD012069-bbs2-0370," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0556,"Zang YF, Jin Z, Weng XC, Zhang L, Zeng YW, Yang L, et al. ",Functional MRI in attention‐deficit hyperactivity disorder: evidence for hypofrontality, Brain and Development ,2005,27,    ,['citation-journal']," Zang YF, Jin Z, Weng XC, Zhang L, Zeng YW, Yang L, et al. Functional MRI in attention‐deficit hyperactivity disorder: evidence for hypofrontality.  Brain and Development 2005;27(8):544‐50. [DOI: 10.1016/j.braindev.2004.11.009; PUBMED: 15876503]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.braindev.2004.11.009', 'https://scholar.google.com/scholar_lookup?title=Functional+MRI+in+attention‐deficit+hyperactivity+disorder:+evidence+for+hypofrontality&author=YF+Zang&author=Z+Jin&author=XC+Weng&author=L+Zhang&author=YW+Zeng&author=L+Yang&publication_year=2005&hl=en']",,https://doi.org/10.1016/j.braindev.2004.11.009, Zang 2005 {published data only}  ,excluded,CD012069-bbs2-0371," No relevant outcome (experimental, neurocognitive or functional). No data on adverse events  "
CD012069-bib-0589,"Aagaard L, Hansen EH. ","Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs", BMC Clinical Pharmacology ,2009,9,    ,['citation-journal']," Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.  BMC Clinical Pharmacology 2009;9:4. [DOI: 10.1186/1472‐6904‐9‐4]    Link to article     Google Scholar     ","['https://doi.org/10.1186/1472-6904-9-4', 'https://scholar.google.com/scholar_lookup?title=Information+about+ADRs+explored+by+pharmacovigilance+approaches:+a+qualitative+review+of+studies+on+antibiotics,+SSRIs+and+NSAIDs+&author=L+Aagaard&author=EH+Hansen&publication_year=2009&hl=en']",,https://doi.org/10.1186/1472-6904-9-4, Aagaard 2009 ,additional,CD012069-bbs2-0395,
CD012069-bib-0590,"Aagaard L, Hansen EH. ",Adverse drug reactions reported for systemic antibacterials in Danish children over a decade, British Journal of Clinical Pharmacology ,2010,70,    ,['citation-journal']," Aagaard L, Hansen EH. Adverse drug reactions reported for systemic antibacterials in Danish children over a decade.  British Journal of Clinical Pharmacology 2010;70(5):765‐8. [DOI: 10.1111/j.1365‐2125.2010.03732.x; PMC2997318]    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1365-2125.2010.03732.x', 'https://scholar.google.com/scholar_lookup?title=Adverse+drug+reactions+reported+for+systemic+antibacterials+in+Danish+children+over+a+decade+&author=L+Aagaard&author=EH+Hansen&publication_year=2010&hl=en']",,https://doi.org/10.1111/j.1365-2125.2010.03732.x, Aagaard 2010a ,additional,CD012069-bbs2-0396,
CD012069-bib-0591,"Aagaard L, Christensen A, Hansen EH. ",Information about adverse drug reactions reported in children: a qualitative review of empirical studies, British Journal of Clinical Pharmacology ,2010,70,    ,['citation-journal']," Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of empirical studies.  British Journal of Clinical Pharmacology 2010;70(4):481‐91. [DOI: 10.1111/j.1365‐2125.2010.03682.x; PMC2950983]    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1365-2125.2010.03682.x', 'https://scholar.google.com/scholar_lookup?title=Information+about+adverse+drug+reactions+reported+in+children:+a+qualitative+review+of+empirical+studies+&author=L+Aagaard&author=A+Christensen&author=EH+Hansen&publication_year=2010&hl=en']",,https://doi.org/10.1111/j.1365-2125.2010.03682.x, Aagaard 2010b ,additional,CD012069-bbs2-0397,
CD012069-bib-0592,"Aagaard L, Hansen EH. ",The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies,,2011,,    ,['citation-other']," Aagaard L, Hansen EH. The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies. Neuropsychiatric Disease and Treatment2011; Vol. 7:729‐44.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+occurrence+of+adverse+drug+reactions+reported+for+attention+deficit+hyperactivity+disorder+(ADHD)+medications+in+the+pediatric+population:+a+qualitative+review+of+empirical+studies+&author=L+Aagaard&author=EH+Hansen&publication_year=2011&hl=en'],,, Aagaard 2011 ,additional,CD012069-bbs2-0398,
CD012069-bib-0593,"Subcommittee on Attention‐Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ","ADHD: clinical practice guideline for the diagnosis, evaluation, and the treatment of attention‐deficit/hyperactivity disorder in children and adolescents", Pediatrics ,2011,128,    ,['citation-journal']," Subcommittee on Attention‐Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and the treatment of attention‐deficit/hyperactivity disorder in children and adolescents.  Pediatrics 2011;128(5):1077‐22. [DOI: 10.1542/peds.2011‐2654; PMC4500647; PUBMED: 2200306]    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=ADHD:+clinical+practice+guideline+for+the+diagnosis,+evaluation,+and+the+treatment+of+attention‐deficit/hyperactivity+disorder+in+children+and+adolescents+&author=M+Wolraich&author=L+Brown&author=RT+Brown&author=G+DuPaul&author=M+Earls&author=HM+Feldman&publication_year=2011&hl=en']",,, AAP 2011 ,additional,CD012069-bbs2-0399,
CD012069-bib-0594,Abali O. ,Possible inclusion of 'Methylphenidate induced hallucinations: case report' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 6 November 2013.   ,['citation-other'], Abali O. Possible inclusion of 'Methylphenidate induced hallucinations: case report' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 6 November 2013.    ,[],,, Abali 2013 [pers comm] ,additional,CD012069-bbs2-0400,
CD012069-bib-0595,"Adler LD, Nierenberg AA. ",Review of medication adherence in children and adults with ADHD, Postgraduate Medicine ,2010,122,    ,['citation-journal']," Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD.  Postgraduate Medicine 2010;122(1):184‐91. [DOI: 10.3810/pgm.2010.01.2112]    Link to article     Google Scholar     ","['https://doi.org/10.3810/pgm.2010.01.2112', 'https://scholar.google.com/scholar_lookup?title=Review+of+medication+adherence+in+children+and+adults+with+ADHD&author=LD+Adler&author=AA+Nierenberg&publication_year=2010&hl=en']",,https://doi.org/10.3810/pgm.2010.01.2112, Adler 2010 ,additional,CD012069-bbs2-0401,
CD012069-bib-0596,Adrian N. ,Questions regarding your article 'Explosive outbursts associated with methylphenidate' [personal communication],,,,. Email to: HB Krogh 24 October 2013.   ,['citation-other'], Adrian N. Questions regarding your article 'Explosive outbursts associated with methylphenidate' [personal communication]. Email to: HB Krogh 24 October 2013.    ,[],,, Adrian 2013 [pers comm] ,additional,CD012069-bbs2-0402,
CD012069-bib-0597,Aguilera‐Albesa S. ,Inclusion of 'Alucinaciones tras la introducción de metilfenidato en dosis bajas' in a systematic review [personal communication],,,,. Email to: EL Ramstad 1 July 2013.   ,['citation-other'], Aguilera‐Albesa S. Inclusion of 'Alucinaciones tras la introducción de metilfenidato en dosis bajas' in a systematic review [personal communication]. Email to: EL Ramstad 1 July 2013.    ,[],,, Aguilera‐Albesa 2013 [pers comm] ,additional,CD012069-bbs2-0403,
CD012069-bib-0598,"Akinbami LJ, Liu X, Pastor PN, Reuben CA. ","Attention deficit hyperactivity disorder among children aged 5‐17 years in the United States, 1998–2009",,2011,,    ,['citation-other']," Akinbami LJ, Liu X, Pastor PN, Reuben CA. Attention deficit hyperactivity disorder among children aged 5‐17 years in the United States, 1998–2009. NCHS Data Brief2011; Vol. 70:1‐8. [PUBMED: 22142479]    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Attention+deficit+hyperactivity+disorder+among+children+aged+5‐17+years+in+the+United+States,+1998–2009+&author=LJ+Akinbami&author=X+Liu&author=PN+Pastor&author=CA+Reuben&publication_year=2011&hl=en']",22142479,, Akinbami 2011 ,additional,CD012069-bbs2-0404,
CD012069-bib-0599,Alpaslan AH. ,Supplemental data [personal communication],,,,. Email to: MJ Kielsholm 22 April 2016.   ,['citation-other'], Alpaslan AH. Supplemental data [personal communication]. Email to: MJ Kielsholm 22 April 2016.    ,[],,, Alpaslan 2016 [pers comm] ,additional,CD012069-bbs2-0405,
CD012069-bib-0600,Aman M. ,Questions regarding the TOSCA study [personal communication],,,,. Email to: EL Ramstad 28 June 2013.   ,['citation-other'], Aman M. Questions regarding the TOSCA study [personal communication]. Email to: EL Ramstad 28 June 2013.    ,[],,, Aman 2013 [pers comm] ,additional,CD012069-bbs2-0406,
CD012069-bib-0601,"Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck‐Ytter Y, et al. ",GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck‐Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.  Journal of Clinical Epidemiology 2013;66(7):719‐25. [DOI: 10.1016/j.jclinepi.2012.03.013]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2012.03.013', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+14.+Going+from+evidence+to+recommendations:+the+significance+and+presentation+of+recommendations+&author=J+Andrews&author=G+Guyatt&author=AD+Oxman&author=P+Alderson&author=P+Dahm&author=Y+Falck‐Ytter&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jclinepi.2012.03.013, Andrews 2013a ,additional,CD012069-bbs2-0407,
CD012069-bib-0602,"Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. ",GRADE guidelines: 15. Going from evidence to recommendation ‐ determinants of a recommendation's direction and strength, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation ‐ determinants of a recommendation's direction and strength.  Journal of Clinical Epidemiology 2013;66(7):726‐35. [DOI: 10.1016/j.jclinepi.2013.02.003]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2013.02.003', ""https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+15.+Going+from+evidence+to+recommendation+‐+determinants+of+a+recommendation's+direction+and+strength+&author=JC+Andrews&author=HJ+Schünemann&author=AD+Oxman&author=K+Pottie&author=JJ+Meerpohl&author=PA+Coello&publication_year=2013&hl=en""]",,https://doi.org/10.1016/j.jclinepi.2013.02.003, Andrews 2013b ,additional,CD012069-bbs2-0408,
CD012069-bib-0603,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders (DSM‐III),1980,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐III). 3rd Edition. Washington (DC): American Psychiatric Association, 1980.    ",[],,, APA 1980 ,additional,CD012069-bbs2-0409,
CD012069-bib-0604,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders (DSM III‐R),1987,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM III‐R). 3rd Edition. Washington (DC): American Psychiatric Association, 1987.    ",[],,, APA 1987 ,additional,CD012069-bbs2-0410,
CD012069-bib-0605,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV),1994,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV). 4th Edition. Washington (DC): American Psychiatric Association, 1994.    ",[],,, APA 1994 ,additional,CD012069-bbs2-0411,
CD012069-bib-0606,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders: Text revision (DSM‐IV‐TR),2000,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Text revision (DSM‐IV‐TR). 4th Edition. Washington (DC): American Psychiatric Association, 2000.    ",[],,, APA 2000 ,additional,CD012069-bbs2-0412,
CD012069-bib-0607,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders (DSM‐5),2013,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Washington (DC): American Psychiatric Association, 2013.    ",[],,, APA 2013 ,additional,CD012069-bbs2-0413,
CD012069-bib-0608,Arneja J. ,Questions regarding your study 'Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder' [personal communication],,,,. Email to: SS Nielsen 2 July 2016.   ,['citation-other'], Arneja J. Questions regarding your study 'Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder' [personal communication]. Email to: SS Nielsen 2 July 2016.    ,[],,, Arneja 2016 [pers comm] ,additional,CD012069-bbs2-0414,
CD012069-bib-0609,Arnold LE. ,Questions regarding a study of yours ‐ inclusion in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 20 September 2013.   ,['citation-other'], Arnold LE. Questions regarding a study of yours ‐ inclusion in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 20 September 2013.    ,[],,, Arnold 2013 [pers comm] ,additional,CD012069-bbs2-0415,
CD012069-bib-0610,Arnold L. ,"Questions regarding your study 'A double‐blind, placebo‐controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder' [personal communication]",,,,. Email to: HB Krogh 17 october 2013.   ,['citation-other']," Arnold L. Questions regarding your study 'A double‐blind, placebo‐controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder' [personal communication]. Email to: HB Krogh 17 october 2013.    ",[],,, Arnold 2013b [pers comm] ,additional,CD012069-bbs2-0416,
CD012069-bib-0611,"Arnsten AF, Dudley AG. ",Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder, Behavioral and Brain Functions ,2005,1,    ,['citation-journal']," Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.  Behavioral and Brain Functions 2005;1(1):2. [DOI: doi:10.1186/1744‐9081‐1‐2; PMC1143775; PUBMED: 15916700]    Link to article     Google Scholar     ","['https://doi.org/10.1186/1744-9081-1-2', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+improves+prefrontal+cortical+cognitive+function+through+α2+adrenoceptor+and+dopamine+D1+receptor+actions:+relevance+to+therapeutic+effects+in+Attention+Deficit+Hyperactivity+Disorder+&author=AF+Arnsten&author=AG+Dudley&publication_year=2005&hl=en']",,https://doi.org/10.1186/1744-9081-1-2, Arnsten 2005 ,additional,CD012069-bbs2-0417,
CD012069-bib-0612,Artul S. ,Supplemental data [personal communication],,,,. Email to: SS Nielsen 16 August 2016.   ,['citation-other'], Artul S. Supplemental data [personal communication]. Email to: SS Nielsen 16 August 2016.    ,[],,, Artul 2016 [pers comm] ,additional,CD012069-bbs2-0418,
CD012069-bib-0613,Arun P. ,Methylphenidate and suicidal ideation IQ [personal communication],,,,. Email to: M Holmskov 1 September 2014.   ,['citation-other'], Arun P. Methylphenidate and suicidal ideation IQ [personal communication]. Email to: M Holmskov 1 September 2014.    ,[],,, Arun 2014 [pers comm] ,additional,CD012069-bbs2-0419,
CD012069-bib-0614,Ashkenasi A. ,Questions regarding your study 'Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder' [personal communication],,,,. Email to: HB Krogh 11 September 2013.   ,['citation-other'], Ashkenasi A. Questions regarding your study 'Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder' [personal communication]. Email to: HB Krogh 11 September 2013.    ,[],,, Ashkenasi 2013 [pers comm] ,additional,CD012069-bbs2-0420,
CD012069-bib-0615,"Bachmann CJ, Wiljlaars LP, Kalverdijk LJ, Burcu M, Glaeske G, Schuiling‐Veninga CCM, et al. ","Trends in ADHD medication use in children and adolescents in five western countries, 2005‐2012", European Neuropsychopharmacology ,2017,27,    ,['citation-journal']," Bachmann CJ, Wiljlaars LP, Kalverdijk LJ, Burcu M, Glaeske G, Schuiling‐Veninga CCM, et al. Trends in ADHD medication use in children and adolescents in five western countries, 2005‐2012.  European Neuropsychopharmacology 2017;27(5):484‐93. [DOI: 10.1016/j.euroneuro.2017.03.002; PUBMED: 28336088]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.euroneuro.2017.03.002', 'https://scholar.google.com/scholar_lookup?title=Trends+in+ADHD+medication+use+in+children+and+adolescents+in+five+western+countries,+2005‐2012+&author=CJ+Bachmann&author=LP+Wiljlaars&author=LJ+Kalverdijk&author=M+Burcu&author=G+Glaeske&author=CCM+Schuiling‐Veninga&publication_year=2017&hl=en']",,https://doi.org/10.1016/j.euroneuro.2017.03.002, Bachmann 2017 ,additional,CD012069-bbs2-0421,
CD012069-bib-0616,"Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. ",GRADE guidelines: 3. Rating the quality of evidence, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence.  Journal of Clinical Epidemiology 2011;64(4):401‐6. [DOI: 10.1016/j.jclinepi.2010.07.015]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2010.07.015', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+3.+Rating+the+quality+of+evidence&author=H+Balshem&author=M+Helfand&author=HJ+Schünemann&author=AD+Oxman&author=R+Kunz&author=J+Brozek&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2010.07.015, Balshem 2011 ,additional,CD012069-bbs2-0422,
CD012069-bib-0617,Barker MJ. ,Inclusion of one of your studies in a Cochrane systematic review [personal communication],,,,". Emails to: EL Ramstad (22 October, 6 December 2013) 6 December 2013.   ",['citation-other']," Barker MJ. Inclusion of one of your studies in a Cochrane systematic review [personal communication]. Emails to: EL Ramstad (22 October, 6 December 2013) 6 December 2013.    ",[],,, Barker 2013 [pers comm] ,additional,CD012069-bbs2-0423,
CD012069-bib-0618,Barkley RA. ,A review of stimulant drug research with hyperactive children, Journal of Child Psychology and Psychiatry ,1977,18,    ,['citation-journal'], Barkley RA. A review of stimulant drug research with hyperactive children.  Journal of Child Psychology and Psychiatry 1977;18(2):137‐65. [DOI: 10.1111/j.1469‐7610.1977.tb00425.x]    Link to article     Google Scholar     ,"['https://doi.org/10.1111/j.1469-7610.1977.tb00425.x', 'https://scholar.google.com/scholar_lookup?title=A+review+of+stimulant+drug+research+with+hyperactive+children&author=RA+Barkley&publication_year=1977&hl=en']",,https://doi.org/10.1111/j.1469-7610.1977.tb00425.x, Barkley 1977 ,additional,CD012069-bbs2-0424,
CD012069-bib-0619,"Barkley RA, McMurray MB, Edelbrock CS, Robbins K. ","Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo‐controlled evaluation", Pediatrics ,1990,86,    ,['citation-journal']," Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo‐controlled evaluation.  Pediatrics 1990;86(2):184‐192. [PUBMED: 2196520]    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Side+effects+of+methylphenidate+in+children+with+attention+deficit+hyperactivity+disorder:+a+systemic,+placebo‐controlled+evaluation+&author=RA+Barkley&author=MB+McMurray&author=CS+Edelbrock&author=K+Robbins&publication_year=1990&hl=en']",2196520,, Barkley 1990 ,additional,CD012069-bbs2-0425,
CD012069-bib-0620,"Benson K, Hartz AJ. ","A comparison of observational studies and randomized, controlled trials", New England Journal of Medicine ,2000,342,    ,['citation-journal']," Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials.  New England Journal of Medicine 2000;342(25):1878‐86. [DOI: 10.1056/NEJM200006223422506]    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJM200006223422506', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+observational+studies+and+randomized,+controlled+trials&author=K+Benson&author=AJ+Hartz&publication_year=2000&hl=en']",,https://doi.org/10.1056/NEJM200006223422506, Benson 2000 ,additional,CD012069-bbs2-0426,
CD012069-bib-0621,Bereket A. ,"'Height, weight, IGF‐I, IGFBP‐3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder' questions [personal communication]",,,,. Email to: T Nilausen 6 January 2014.   ,['citation-other']," Bereket A. 'Height, weight, IGF‐I, IGFBP‐3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder' questions [personal communication]. Email to: T Nilausen 6 January 2014.    ",[],,, Bereket 2014 [pers comm] ,additional,CD012069-bbs2-0427,
CD012069-bib-0622,"Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. ",Cognitive and behavioral outcomes of school‐aged children who were born preterm: a meta‐analysis, Journal of the American Medical Association ,2002,288,    ,['citation-journal']," Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school‐aged children who were born preterm: a meta‐analysis.  Journal of the American Medical Association 2002;288(6):728‐37. [PUBMED: 12169077]    Link to article     Google Scholar     ","['https://doi.org/10.1001/jama.288.6.728', 'https://scholar.google.com/scholar_lookup?title=Cognitive+and+behavioral+outcomes+of+school‐aged+children+who+were+born+preterm:+a+meta‐analysis+&author=AT+Bhutta&author=MA+Cleves&author=PH+Casey&author=MM+Cradock&author=KJ+Anand&publication_year=2002&hl=en']",12169077,https://doi.org/10.1001/jama.288.6.728, Bhutta 2002 ,additional,CD012069-bbs2-0428,
CD012069-bib-0623,Biederman J. ,Pharmacotherapy for attention‐deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow‐up of youths with and without ADHD, Journal of Clinical Psychiatry ,2003,64,    ,['citation-journal'], Biederman J. Pharmacotherapy for attention‐deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow‐up of youths with and without ADHD.  Journal of Clinical Psychiatry 2003;64(Suppl 11):3‐8. [PUBMED: 14529323]    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Pharmacotherapy+for+attention‐deficit/hyperactivity+disorder+(ADHD)+decreases+the+risk+for+substance+abuse:+findings+from+a+longitudinal+follow‐up+of+youths+with+and+without+ADHD+&author=J+Biederman&publication_year=2003&hl=en'],14529323,, Biederman 2003 ,additional,CD012069-bbs2-0429,
CD012069-bib-0624,"Bjarnadottir GD, Haraldsson HM, Rafnar BO, et al. ",Prevalent intravenous abuse of methylphenidate among treatment‐seeking patients with substance abuse disorders: a descriptive population‐based study, Journal of Addiction Medicine ,2015,9,    ,['citation-journal']," Bjarnadottir GD, Haraldsson HM, Rafnar BO, et al. Prevalent intravenous abuse of methylphenidate among treatment‐seeking patients with substance abuse disorders: a descriptive population‐based study.  Journal of Addiction Medicine 2015;9(3):188‐94. [DOI: doi:10.1097/ADM.0000000000000115]    Link to article     Google Scholar     ","['https://doi.org/10.1097/ADM.0000000000000115', 'https://scholar.google.com/scholar_lookup?title=Prevalent+intravenous+abuse+of+methylphenidate+among+treatment‐seeking+patients+with+substance+abuse+disorders:+a+descriptive+population‐based+study+&author=GD+Bjarnadottir&author=HM+Haraldsson&author=BO+Rafnar&publication_year=2015&hl=en']",,https://doi.org/10.1097/ADM.0000000000000115, Bjarnadottir 2015 ,additional,CD012069-bbs2-0430,
CD012069-bib-0625,BNF. ,Methylphenidate hydrochloride: indications and dose,,,,; www.medicinescomplete.com/mc/bnfc/2011/PHP2479‐methylphenidate‐hydrochloride.htm]   ,['citation-other'], BNF. Methylphenidate hydrochloride: indications and dose. British National Formulary (accessed 9 February 2017). [DOI: 10.18578/BNF.995526496; www.medicinescomplete.com/mc/bnfc/2011/PHP2479‐methylphenidate‐hydrochloride.htm]    ,[],,, BNF 2018 ,additional,CD012069-bbs2-0431,
CD012069-bib-0626,"Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, et al. ",GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence.  Journal of Clinical Epidemiology 2013;66(2):140‐50. [DOI: 10.1016/j.jclinepi.2012.04.012]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2012.04.012', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+10.+Considering+resource+use+and+rating+the+quality+of+economic+evidence+&author=M+Brunetti&author=I+Shemilt&author=S+Pregno&author=L+Vale&author=AD+Oxman&author=J+Lord&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jclinepi.2012.04.012, Brunetti 2013 ,additional,CD012069-bbs2-0432,
CD012069-bib-0627,"Bruni O, Ottaviano S, Guidetti V, Romoli M, Innocenzi M, Cortesi F, et al. ",The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence, Journal of Sleep Research ,1996,5,    ,['citation-journal']," Bruni O, Ottaviano S, Guidetti V, Romoli M, Innocenzi M, Cortesi F, et al. The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence.  Journal of Sleep Research 1996;5(4):251‐61. [PUBMED: 9065877]    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1365-2869.1996.00251.x', 'https://scholar.google.com/scholar_lookup?title=The+Sleep+Disturbance+Scale+for+Children+(SDSC).+Construction+and+validation+of+an+instrument+to+evaluate+sleep+disturbances+in+childhood+and+adolescence+&author=O+Bruni&author=S+Ottaviano&author=V+Guidetti&author=M+Romoli&author=M+Innocenzi&author=F+Cortesi&publication_year=1996&hl=en']",9065877,https://doi.org/10.1111/j.1365-2869.1996.00251.x, Bruni 1996 ,additional,CD012069-bbs2-0433,
CD012069-bib-0628,Buchmann J. ,Questions regarding your study 'Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate' [personal communication],,,,. Email to: FL Magnusson 3 June 2014.   ,['citation-other'], Buchmann J. Questions regarding your study 'Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate' [personal communication]. Email to: FL Magnusson 3 June 2014.    ,[],,, Buchmann 2014 [pers comm] ,additional,CD012069-bbs2-0434,
CD012069-bib-0629,"Burnett A, Davey CG, Wood SJ, Wilson‐Ching M, Molloy C, Cheong JLY, et al. ",Extremely preterm birth and adolescent mental health in a geographical cohort born in the 1990s, Psychological Medicine ,2014,44,    ,['citation-journal']," Burnett A, Davey CG, Wood SJ, Wilson‐Ching M, Molloy C, Cheong JLY, et al. Extremely preterm birth and adolescent mental health in a geographical cohort born in the 1990s.  Psychological Medicine 2014;44(7):1533‐44. [DOI: 10.1017/S0033291713002158]    Link to article     Google Scholar     ","['https://doi.org/10.1017/S0033291713002158', 'https://scholar.google.com/scholar_lookup?title=Extremely+preterm+birth+and+adolescent+mental+health+in+a+geographical+cohort+born+in+the+1990s+&author=A+Burnett&author=CG+Davey&author=SJ+Wood&author=M+Wilson‐Ching&author=C+Molloy&author=JLY+Cheong&publication_year=2014&hl=en']",,https://doi.org/10.1017/S0033291713002158, Burnett 2014 ,additional,CD012069-bbs2-0435,
CD012069-bib-0630,"Bushe CJ, Savill NC. ",Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta‐analysis of atomoxetine and methylphenidate comparator clinical trials, Child and Adolescent Psychiatry and Mental Health ,2013,7,    ,['citation-journal']," Bushe CJ, Savill NC. Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta‐analysis of atomoxetine and methylphenidate comparator clinical trials.  Child and Adolescent Psychiatry and Mental Health 2013;7(1):19. [DOI: 10.1186/1753‐2000‐7‐19; PMC3691607]    Link to article     Google Scholar     ","['https://doi.org/10.1186/1753-2000-7-19', 'https://scholar.google.com/scholar_lookup?title=Suicide+related+events+and+attention+deficit+hyperactivity+disorder+treatments+in+children+and+adolescents:+a+meta‐analysis+of+atomoxetine+and+methylphenidate+comparator+clinical+trials+&author=CJ+Bushe&author=NC+Savill&publication_year=2013&hl=en']",,https://doi.org/10.1186/1753-2000-7-19, Bushe 2013 ,additional,CD012069-bbs2-0436,
CD012069-bib-0631,Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). ,,Canadian ADHD Practice Guidelines,2011,3rd Edition,.   ,['citation-book']," Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD Practice Guidelines. Vol. 3rd Edition, Toronto (ON): CADDRA, 2011.    ",[],,, CADDRA 2011 ,additional,CD012069-bbs2-0437,
CD012069-bib-0632,"Cairns R, Daniels B, Wood DA, Brett J. ","ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004‐2014", Medical Journal of Australia ,2016,204,    ,['citation-journal']," Cairns R, Daniels B, Wood DA, Brett J. ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004‐2014.  Medical Journal of Australia 2016;204(4):154. [PUBMED: 26937669]    Link to article     Google Scholar     ","['https://doi.org/10.5694/mja15.00791', 'https://scholar.google.com/scholar_lookup?title=ADHD+medication+overdose+and+misuse:+the+NSW+Poisons+Information+Centre+experience,+2004‐2014+&author=R+Cairns&author=B+Daniels&author=DA+Wood&author=J+Brett&publication_year=2016&hl=en']",26937669,https://doi.org/10.5694/mja15.00791, Cairns 2014 ,additional,CD012069-bbs2-0438,
CD012069-bib-0633,"Castellanos FX, Sonuga‐Barke EJS, Milham MP, Tannock R. ",Characterizing cognition in ADHD: beyond executive dysfunction, Trends in Cognitive Sciences ,2006,10,    ,['citation-journal']," Castellanos FX, Sonuga‐Barke EJS, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction.  Trends in Cognitive Sciences 2006;10(3):117‐23. [DOI: 10.1016/j.tics.2006.01.011]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.tics.2006.01.011', 'https://scholar.google.com/scholar_lookup?title=Characterizing+cognition+in+ADHD:+beyond+executive+dysfunction&author=FX+Castellanos&author=EJS+Sonuga‐Barke&author=MP+Milham&author=R+Tannock&publication_year=2006&hl=en']",,https://doi.org/10.1016/j.tics.2006.01.011, Castellanos 2006 ,additional,CD012069-bbs2-0439,
CD012069-bib-0634,Castro‐Manglano P. ,Questions regarding your study 'Long‐term effects of medication for ADHD in weight and height in children and adolescents' [personal communication],,,,. Email to: SS Nielsen 3 June 2016.   ,['citation-other'], Castro‐Manglano P. Questions regarding your study 'Long‐term effects of medication for ADHD in weight and height in children and adolescents' [personal communication]. Email to: SS Nielsen 3 June 2016.    ,[],,, Castro‐Manglano 2016 [pers comm] ,additional,CD012069-bbs2-0440,
CD012069-bib-0635,Centers for Disease Control and Prevention (CDC). ,"QuickStats: percentage of children aged 5‐17 years with diagnosed attention deficit/hyperactivity disorder (ADHD), by poverty status and sex – National Health Interview Survey, 2011–2014",,2015,,"; Vol. 64, issue 40:1156. [PUBMED: 26469562]   ",['citation-other']," Centers for Disease Control and Prevention (CDC). QuickStats: percentage of children aged 5‐17 years with diagnosed attention deficit/hyperactivity disorder (ADHD), by poverty status and sex – National Health Interview Survey, 2011–2014. Morbidity and Mortality Weekly Report2015; Vol. 64, issue 40:1156. [PUBMED: 26469562]    ",[],26469562,, CDC 2015 ,additional,CD012069-bbs2-0441,
CD012069-bib-0636,"Chang Z, Lichtenstein P, Larsson H. ",The effects of childhood ADHD symptoms on early‐onset substance use: a Swedish twin study, Journal of Abnormal Child Psychology ,2012,40,    ,['citation-journal']," Chang Z, Lichtenstein P, Larsson H. The effects of childhood ADHD symptoms on early‐onset substance use: a Swedish twin study.  Journal of Abnormal Child Psychology 2012;40(3):425‐35. [DOI: 10.1007/s10802‐011‐9575‐6; PUBMED: 21947618]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s10802-011-9575-6', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+childhood+ADHD+symptoms+on+early‐onset+substance+use:+a+Swedish+twin+study+&author=Z+Chang&author=P+Lichtenstein&author=H+Larsson&publication_year=2012&hl=en']",,https://doi.org/10.1007/s10802-011-9575-6, Chang 2012 ,additional,CD012069-bbs2-0442,
CD012069-bib-0637,"Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H. ","Serious transport accidents in adults with ADHD, and the effect of medication: a population based study", JAMA Psychiatry ,2014,71,    ,['citation-journal']," Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H. Serious transport accidents in adults with ADHD, and the effect of medication: a population based study.  JAMA Psychiatry 2014;71(3):319‐25. [DOI: 10.1001/jamapsychiatry.2013.4174]    Link to article     Google Scholar     ","['https://doi.org/10.1001/jamapsychiatry.2013.4174', ""https://scholar.google.com/scholar_lookup?title=Serious+transport+accidents+in+adults+with+ADHD,+and+the+effect+of+medication:+a+population+based+study+&author=Z+Chang&author=P+Lichtenstein&author=BM+D'Onofrio&author=A+Sjölander&author=H+Larsson&publication_year=2014&hl=en""]",,https://doi.org/10.1001/jamapsychiatry.2013.4174, Chang 2014a ,additional,CD012069-bbs2-0443,
CD012069-bib-0638,"Chang Z, Lichtenstein P, Hallder L, D'Onofrio B, Serlachius E, Fazel S, Långström N, Larsson H. ",Stimulant ADHD medication and risk for substance abuse, Journal of Child Psychology and Psychiatry ,2014,55,    ,['citation-journal']," Chang Z, Lichtenstein P, Hallder L, D'Onofrio B, Serlachius E, Fazel S, Långström N, Larsson H. Stimulant ADHD medication and risk for substance abuse.  Journal of Child Psychology and Psychiatry 2014;55(8):878‐85. [DOI: 10.1111/jcpp.12164]    Link to article     Google Scholar     ","['https://doi.org/10.1111/jcpp.12164', ""https://scholar.google.com/scholar_lookup?title=Stimulant+ADHD+medication+and+risk+for+substance+abuse&author=Z+Chang&author=P+Lichtenstein&author=L+Hallder&author=B+D'Onofrio&author=E+Serlachius&author=S+Fazel&author=N+Långström&author=H+Larsson&publication_year=2014&hl=en""]",,https://doi.org/10.1111/jcpp.12164, Chang 2014b ,additional,CD012069-bbs2-0444,
CD012069-bib-0639,"Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H, D'Onofrio BM. ",Associations between medication use for attention‐deficit/hyperactivity disorder and risk of motor vehicle crashes, JAMA Psychiatry ,2017,74,    ,['citation-journal']," Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H, D'Onofrio BM. Associations between medication use for attention‐deficit/hyperactivity disorder and risk of motor vehicle crashes.  JAMA Psychiatry 2017;74(6):597‐603. [DOI: 10.1001/jamapsychiatry.2017.0659]    Link to article     Google Scholar     ","['https://doi.org/10.1001/jamapsychiatry.2017.0659', ""https://scholar.google.com/scholar_lookup?title=Associations+between+medication+use+for+attention‐deficit/hyperactivity+disorder+and+risk+of+motor+vehicle+crashes+&author=Z+Chang&author=PD+Quinn&author=K+Hur&author=RD+Gibbons&author=A+Sjölander&author=H+Larsson&author=BM+D'Onofrio&publication_year=2017&hl=en""]",,https://doi.org/10.1001/jamapsychiatry.2017.0659, Chang 2017 ,additional,CD012069-bbs2-0445,
CD012069-bib-0640,"Charach A, Carson P, Fox S, Ali MU, Beckett J, Lim CG. ",Interventions for preschool children at high risk for ADHD: a comparative effectiveness review, Pediatrics ,2013,131,    ,['citation-journal']," Charach A, Carson P, Fox S, Ali MU, Beckett J, Lim CG. Interventions for preschool children at high risk for ADHD: a comparative effectiveness review.  Pediatrics 2013;131(5):e1584–604. [DOI: 10.1542/peds.2012‐0974; PUBMED: 23545375]    Link to article     Google Scholar     ","['https://doi.org/10.1542/peds.2012-0974', 'https://scholar.google.com/scholar_lookup?title=Interventions+for+preschool+children+at+high+risk+for+ADHD:+a+comparative+effectiveness+review+&author=A+Charach&author=P+Carson&author=S+Fox&author=MU+Ali&author=J+Beckett&author=CG+Lim&publication_year=2013&hl=en']",,https://doi.org/10.1542/peds.2012-0974, Charach 2013 ,additional,CD012069-bbs2-0446,
CD012069-bib-0641,"Chen Qi, Sjölander A, Runeson B, D'Onofrio BM, Lichtenstein P, Larsson H. ",Drug treatment for attention‐deficit/hyperactivity disorder and suicidal behaviour: register based study, BMJ ,2014,348,    ,['citation-journal']," Chen Qi, Sjölander A, Runeson B, D'Onofrio BM, Lichtenstein P, Larsson H. Drug treatment for attention‐deficit/hyperactivity disorder and suicidal behaviour: register based study.  BMJ 2014;348:g3769.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.g3769', ""https://scholar.google.com/scholar_lookup?title=Drug+treatment+for+attention‐deficit/hyperactivity+disorder+and+suicidal+behaviour:+register+based+study+&author=Qi+Chen&author=A+Sjölander&author=B+Runeson&author=BM+D'Onofrio&author=P+Lichtenstein&author=H+Larsson&publication_year=2014&hl=en""]",,https://doi.org/10.1136/bmj.g3769, Chen 2014 ,additional,CD012069-bbs2-0447,
CD012069-bib-0642,"Chervin RD, Hedger K, Dillon JE, Pituch KJ. ","Pediatric Sleep Questionnaire (PSQ): validity and reliability of scales for sleep‐disordered breathing, snoring, sleepiness, and behavioral problems", Sleep Medicine ,2000,1,    ,['citation-journal']," Chervin RD, Hedger K, Dillon JE, Pituch KJ. Pediatric Sleep Questionnaire (PSQ): validity and reliability of scales for sleep‐disordered breathing, snoring, sleepiness, and behavioral problems.  Sleep Medicine 2000;1(1):21‐32. [PUBMED: 10733617]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S1389-9457(99)00009-X', 'https://scholar.google.com/scholar_lookup?title=Pediatric+Sleep+Questionnaire+(PSQ):+validity+and+reliability+of+scales+for+sleep‐disordered+breathing,+snoring,+sleepiness,+and+behavioral+problems+&author=RD+Chervin&author=K+Hedger&author=JE+Dillon&author=KJ+Pituch&publication_year=2000&hl=en']",10733617,https://doi.org/10.1016/S1389-9457(99)00009-X, Chervin 2000 ,additional,CD012069-bbs2-0448,
CD012069-bib-0643,Chou WJ. ,Remission in children and adolescents further information [personal communication],,,,. Email to: T Nilausen 7 February 2014.   ,['citation-other'], Chou WJ. Remission in children and adolescents further information [personal communication]. Email to: T Nilausen 7 February 2014.    ,[],,, Chou 2014 [pers comm] ,additional,CD012069-bbs2-0449,
CD012069-bib-0644,Cockcroft K. ,Regarding your study 'Sleep and daytime sleepiness in methylphenidate medicated and un‐medicated children with attention‐deficit/hyperactivity disorder (ADHD)' [personal communication],,,,". Emails to: EL Ramstad (8 October 2013, 27 January 2014) 27 January 2014.   ",['citation-other']," Cockcroft K. Regarding your study 'Sleep and daytime sleepiness in methylphenidate medicated and un‐medicated children with attention‐deficit/hyperactivity disorder (ADHD)' [personal communication]. Emails to: EL Ramstad (8 October 2013, 27 January 2014) 27 January 2014.    ",[],,, Cockcroft 2014 [pers comm] ,additional,CD012069-bbs2-0450,
CD012069-bib-0645,Cohen HA. ,Questions regarding your study 'Fixed drug eruption of the scrotum due to methylphenidate' [personal communication],,,,. Email to: HB Krogh 12 July 2013.   ,['citation-other'], Cohen HA. Questions regarding your study 'Fixed drug eruption of the scrotum due to methylphenidate' [personal communication]. Email to: HB Krogh 12 July 2013.    ,[],,, Cohen 2013 [pers comm] ,additional,CD012069-bbs2-0451,
CD012069-bib-0646,"Cole TJ, Flegal KM, Nicholls D, Jackson AA. ",Body mass index cut offs to define thinness in children and adolescents: international survey, BMJ ,2007,335,    ,['citation-journal']," Cole TJ, Flegal KM, Nicholls D, Jackson AA. Body mass index cut offs to define thinness in children and adolescents: international survey.  BMJ 2007;335(7612):194‐7. [DOI: 10.1136/bmj.39238.399444.55]    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.39238.399444.55', 'https://scholar.google.com/scholar_lookup?title=Body+mass+index+cut+offs+to+define+thinness+in+children+and+adolescents:+international+survey+&author=TJ+Cole&author=KM+Flegal&author=D+Nicholls&author=AA+Jackson&publication_year=2007&hl=en']",,https://doi.org/10.1136/bmj.39238.399444.55, Cole 2007 ,additional,CD012069-bbs2-0452,
CD012069-bib-0647,BioStat. ,Comprehensive Meta Analysis,,,,. www.meta‐analysis.com (accessed 9 February 2018).   ,['citation-other'], BioStat. Comprehensive Meta Analysis. www.meta‐analysis.com (accessed 9 February 2018).    ,[],,, Comprehensive Meta Analysis ,additional,CD012069-bbs2-0453,
CD012069-bib-0648,Confino‐Cohen R. ,Questions regarding your case report 'Successful desensitization of methylphenidate‐induced rash' [personal communication],,,,. Email to: HB Krogh 17 November 2013.   ,['citation-other'], Confino‐Cohen R. Questions regarding your case report 'Successful desensitization of methylphenidate‐induced rash' [personal communication]. Email to: HB Krogh 17 November 2013.    ,[],,, Confino‐Cohen 2013 [pers comm] ,additional,CD012069-bbs2-0454,
CD012069-bib-0649,Corrigall R. ,Questions regarding your case report 'Methylphenidate euphoria' [personal communication],,,,. Email to: HB Krogh 22 October 2013.   ,['citation-other'], Corrigall R. Questions regarding your case report 'Methylphenidate euphoria' [personal communication]. Email to: HB Krogh 22 October 2013.    ,[],,, Corrigall 2013 [pers comm] ,additional,CD012069-bbs2-0455,
CD012069-bib-0650,"Cortese S, Moreira‐Maia CR, St. Fleur D, Morcillo‐Peñalver C, Rohde LA, Faraone SV. ",Association between ADHD and obesity: a systematic review and meta‐analysis, American Journal of Psychiatry ,2016,173,    ,['citation-journal']," Cortese S, Moreira‐Maia CR, St. Fleur D, Morcillo‐Peñalver C, Rohde LA, Faraone SV. Association between ADHD and obesity: a systematic review and meta‐analysis.  American Journal of Psychiatry 2016;173(1):34‐43. [DOI: 10.1176/appi.ajp.2015.15020266]    Link to article     Google Scholar     ","['https://doi.org/10.1176/appi.ajp.2015.15020266', 'https://scholar.google.com/scholar_lookup?title=Association+between+ADHD+and+obesity:+a+systematic+review+and+meta‐analysis&author=S+Cortese&author=CR+Moreira‐Maia&author=D+St.Fleur&author=C+Morcillo‐Peñalver&author=LA+Rohde&author=SV+Faraone&publication_year=2016&hl=en']",,https://doi.org/10.1176/appi.ajp.2015.15020266, Cortese 2016 ,additional,CD012069-bbs2-0456,
CD012069-bib-0651,"Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. ",Impact of methylphenidate delivery profiles on driving performance of adolescents with attention‐deficit/hyperactivity disorder: a pilot study, Journal of the American Academy of Child and Adolescent Psychiatry ,2004,43,    ,['citation-journal']," Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention‐deficit/hyperactivity disorder: a pilot study.  Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(3):269‐75. [PUBMED: 15076259]    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004583-200403000-00007', 'https://scholar.google.com/scholar_lookup?title=Impact+of+methylphenidate+delivery+profiles+on+driving+performance+of+adolescents+with+attention‐deficit/hyperactivity+disorder:+a+pilot+study+&author=DJ+Cox&author=RL+Merkel&author=JK+Penberthy&author=B+Kovatchev&author=CS+Hankin&publication_year=2004&hl=en']",15076259,https://doi.org/10.1097/00004583-200403000-00007, Cox 2004 ,additional,CD012069-bbs2-0457,
CD012069-bib-0652,Coşkun M. ,Questions regarding four of your case reports/series [personal communication],,,,. Email to: EL Ramstad 2 August 2013.   ,['citation-other'], Coşkun M. Questions regarding four of your case reports/series [personal communication]. Email to: EL Ramstad 2 August 2013.    ,[],,, Coşkun 2013 [pers comm] ,additional,CD012069-bbs2-0458,
CD012069-bib-0653,Coşkun M. ,Questions regarding four of your case reports/series [personal communication],,,,. Email to: EL Ramstad 2 August 2013.   ,['citation-other'], Coşkun M. Questions regarding four of your case reports/series [personal communication]. Email to: EL Ramstad 2 August 2013.    ,[],,, Coşkun 2013b [pers comm] ,additional,CD012069-bbs2-0459,
CD012069-bib-0654,Coşkun M. ,Questions regarding four of your case reports/series [personal communication],,,,. Email to: EL Ramstad 2 August 2013.   ,['citation-other'], Coşkun M. Questions regarding four of your case reports/series [personal communication]. Email to: EL Ramstad 2 August 2013.    ,[],,, Coşkun 2013c [pers comm] ,additional,CD012069-bbs2-0460,
CD012069-bib-0655,Coşkun M. ,Questions regarding four of your case reports/series [personal communication],,,,. Email to: EL Ramstad 2 August 2013.   ,['citation-other'], Coşkun M. Questions regarding four of your case reports/series [personal communication]. Email to: EL Ramstad 2 August 2013.    ,[],,, Coşkun 2013d [pers comm] ,additional,CD012069-bbs2-0461,
CD012069-bib-0656,Curatolo P. ,Possible inclusion of 'Methylphenidate‐induced visual hallucinations' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 4 October 2013.   ,['citation-other'], Curatolo P. Possible inclusion of 'Methylphenidate‐induced visual hallucinations' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 4 October 2013.    ,[],,, Curatolo 2013 [pers comm] ,additional,CD012069-bbs2-0462,
CD012069-bib-0657,"Curtin F, Elbourne D, Altman DG. ",Meta‐analysis combining parallel and cross‐over clinical trials. III: The issue of carry over, Statistics in Medicine ,2002,21,    ,['citation-journal']," Curtin F, Elbourne D, Altman DG. Meta‐analysis combining parallel and cross‐over clinical trials. III: The issue of carry over.  Statistics in Medicine 2002;21(15):2161‐73.    Link to article     Google Scholar     ","['https://doi.org/10.1002/sim.1207', 'https://scholar.google.com/scholar_lookup?title=Meta‐analysis+combining+parallel+and+cross‐over+clinical+trials.+III:+The+issue+of+carry+over+&author=F+Curtin&author=D+Elbourne&author=DG+Altman&publication_year=2002&hl=en']",,https://doi.org/10.1002/sim.1207, Curtin 2002 ,additional,CD012069-bbs2-0463,
CD012069-bib-0658,"Czamara D, Tiesler CM, Kohlböck G, Berdel D, Hoffmann B, Bauer CP, et al. ","Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies", PLOS ONE ,2013,8,    ,['citation-journal']," Czamara D, Tiesler CM, Kohlböck G, Berdel D, Hoffmann B, Bauer CP, et al. Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies.  PLOS ONE 2013;8(5):e63859. [DOI: 10.1371/journal.pone.0063859]    Link to article     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0063859', 'https://scholar.google.com/scholar_lookup?title=Children+with+ADHD+symptoms+have+a+higher+risk+for+reading,+spelling+and+math+difficulties+in+the+GINIplus+and+LISAplus+cohort+studies+&author=D+Czamara&author=CM+Tiesler&author=G+Kohlböck&author=D+Berdel&author=B+Hoffmann&author=CP+Bauer&publication_year=2013&hl=en']",,https://doi.org/10.1371/journal.pone.0063859, Czamara 2013 ,additional,CD012069-bbs2-0464,
CD012069-bib-0659,Dahlgren J. ,Questions regarding 'Overweight and obese children with diagnosed attention deficit hyperactivity disorder have a favourable weight loss with methylphenidate ‐ one year data' [personal communication],,,,. Email to: EL Ramstad 29 August 2013.   ,['citation-other'], Dahlgren J. Questions regarding 'Overweight and obese children with diagnosed attention deficit hyperactivity disorder have a favourable weight loss with methylphenidate ‐ one year data' [personal communication]. Email to: EL Ramstad 29 August 2013.    ,[],,, Dahlgren 2013 [pers comm] ,additional,CD012069-bbs2-0465,
CD012069-bib-0660,"Dalsgaard S, Leckman JF, Mortensen PB, Nielsen HS, Simonsen M. ",Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study, Lancet Psychiatry ,2015,2,    ,['citation-journal']," Dalsgaard S, Leckman JF, Mortensen PB, Nielsen HS, Simonsen M. Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.  Lancet Psychiatry 2015;2(8):702‐9. [DOI: 10.1016/S2215‐0366(15)00271‐0]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S2215-0366(15)00271-0', 'https://scholar.google.com/scholar_lookup?title=Effect+of+drugs+on+the+risk+of+injuries+in+children+with+attention+deficit+hyperactivity+disorder:+a+prospective+cohort+study+&author=S+Dalsgaard&author=JF+Leckman&author=PB+Mortensen&author=HS+Nielsen&author=M+Simonsen&publication_year=2015&hl=en']",,https://doi.org/10.1016/S2215-0366(15)00271-0, Dalsgaard 2015a ,additional,CD012069-bbs2-0466,
CD012069-bib-0661,"Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. ","Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study", Lancet ,2015,385,    ,['citation-journal']," Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.  Lancet 2015;385(9983):2190‐6. [DOI: 10.1016/S0140‐6736(14)61684‐6]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(14)61684-6', 'https://scholar.google.com/scholar_lookup?title=Mortality+in+children,+adolescents,+and+adults+with+attention+deficit+hyperactivity+disorder:+a+nationwide+cohort+study+&author=S+Dalsgaard&author=SD+Østergaard&author=JF+Leckman&author=PB+Mortensen&author=MG+Pedersen&publication_year=2015&hl=en']",,https://doi.org/10.1016/S0140-6736(14)61684-6, Dalsgaard 2015b ,additional,CD012069-bbs2-0467,
CD012069-bib-0662,Danish Health and Medicines Authority. ,Produktresuméer–human,,,,. www.produktresume.dk/docushare/dsweb/View/Collection‐96 Accessed 2 May 2017.   ,['citation-other'], Danish Health and Medicines Authority. Produktresuméer–human. www.produktresume.dk/docushare/dsweb/View/Collection‐96 Accessed 2 May 2017.    ,[],,, Danish Health and Medicines Authority 2017 ,additional,CD012069-bbs2-0468,
CD012069-bib-0663,Davari‐Ashtiani R. ,Buspirone versus methylphenidate additional data [personal communication],,,,. Email to: T Nilausen 1 January 2014.   ,['citation-other'], Davari‐Ashtiani R. Buspirone versus methylphenidate additional data [personal communication]. Email to: T Nilausen 1 January 2014.    ,[],,, Davari‐Ashtiani 2014 [pers comm] ,additional,CD012069-bbs2-0469,
CD012069-bib-0664,"De Vries TW, van Roon EN. ",Low quality of reporting adverse drug reactions in paediatric randomised controlled trials, Archives of Disease in Childhood ,2010,95,    ,['citation-journal']," De Vries TW, van Roon EN. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials.  Archives of Disease in Childhood 2010;95(12):1023‐6. [DOI: 10.1136/adc.2009.175562; PUBMED: 20551194]    Link to article     Google Scholar     ","['https://doi.org/10.1136/adc.2009.175562', 'https://scholar.google.com/scholar_lookup?title=Low+quality+of+reporting+adverse+drug+reactions+in+paediatric+randomised+controlled+trials+&author=TW+Vries&author=EN+Roon&publication_year=2010&hl=en']",,https://doi.org/10.1136/adc.2009.175562, De Vries 2010 ,additional,CD012069-bbs2-0470,
CD012069-bib-0665,DeSoysa R. ,Questions regarding your abstract 'Use of methylphenidate for attention‐deficit‐hyperactivity disorder in childhood' [personal communication],,,,. Email to: HB Krogh 30 December 2013.   ,['citation-other'], DeSoysa R. Questions regarding your abstract 'Use of methylphenidate for attention‐deficit‐hyperactivity disorder in childhood' [personal communication]. Email to: HB Krogh 30 December 2013.    ,[],,, DeSoysa 2013 [pers comm] ,additional,CD012069-bbs2-0471,
CD012069-bib-0666,Dodangi N. ,Questions regarding your abstract 'Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD' [personal communication],,,,. Email to: TD Nilausen 2 November 2013.   ,['citation-other'], Dodangi N. Questions regarding your abstract 'Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD' [personal communication]. Email to: TD Nilausen 2 November 2013.    ,[],,, Dodangi 2013 [pers comm] ,additional,CD012069-bbs2-0472,
CD012069-bib-0667,"Egger M, Davey Smith G, Schneider M, Minder C. ","Bias in meta‐analysis detected by a simple, graphical test", BMJ ,1997,315,    ,['citation-journal']," Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test.  BMJ 1997;315(7109):629‐34. [DOI: 10.1136/bmj.315.7109.629; PUBMED: 9310563]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.315.7109.629', 'https://www.ncbi.nlm.nih.gov/pubmed/9310563', 'https://scholar.google.com/scholar_lookup?title=Bias+in+meta‐analysis+detected+by+a+simple,+graphical+test&author=M+Egger&author=G+DaveySmith&author=M+Schneider&author=C+Minder&publication_year=1997&hl=en']",9310563,https://doi.org/10.1136/bmj.315.7109.629, Egger 1997 ,additional,CD012069-bbs2-0473,
CD012069-bib-0668,"Elgen SK, Sommerfelt K, Leversen KT, Markestad T. ",Minor neurodevelopmental impairments are associated with increased occurrence of ADHD symptoms in children born extremely preterm, European Child and Adolescent Psychiatry ,2015,24,    ,['citation-journal']," Elgen SK, Sommerfelt K, Leversen KT, Markestad T. Minor neurodevelopmental impairments are associated with increased occurrence of ADHD symptoms in children born extremely preterm.  European Child and Adolescent Psychiatry 2015;24(4):463‐70. [DOI: 1007/s00787‐014‐0597‐9]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00787-014-0597-9', 'https://scholar.google.com/scholar_lookup?title=Minor+neurodevelopmental+impairments+are+associated+with+increased+occurrence+of+ADHD+symptoms+in+children+born+extremely+preterm+&author=SK+Elgen&author=K+Sommerfelt&author=KT+Leversen&author=T+Markestad&publication_year=2015&hl=en']",,https://doi.org/10.1007/s00787-014-0597-9, Elgen 2015 ,additional,CD012069-bbs2-0474,
CD012069-bib-0669,European Medicines Agency. ,Guideline on multiplicity issues in clinical trials,,2017,,.   ,['citation-other'], European Medicines Agency. Guideline on multiplicity issues in clinical trials. Committee for Human Medicinal products (CHMP)2017.    ,[],,, EMA 2017 ,additional,CD012069-bbs2-0475,
CD012069-bib-0670,"Engert V, Pruessner JC. ",Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate, Current Neuropharmacology ,2008,6,    ,['citation-journal']," Engert V, Pruessner JC. Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.  Current Neuropharmacology 2008;6(4):322‐8. [DOI: 10.2174/157015908787386069]    Link to article     Google Scholar     ","['https://doi.org/10.2174/157015908787386069', 'https://scholar.google.com/scholar_lookup?title=Dopaminergic+and+noradrenergic+contributions+to+functionality+in+ADHD:+the+role+of+methylphenidate+&author=V+Engert&author=JC+Pruessner&publication_year=2008&hl=en']",,https://doi.org/10.2174/157015908787386069, Engert 2008 ,additional,CD012069-bbs2-0476,
CD012069-bib-0671,"Erskine HE, Norman RE, Ferrari AJ, Chan GC, Copeland WE, Whiteford HA, et al. ",Long‐term outcomes of attention‐deficit/hyperactivity disorder and conduct disorder: a systematic review and meta‐analysis, Journal of the American Academy of Child and Adolescent Psychiatry ,2016,55,    ,['citation-journal']," Erskine HE, Norman RE, Ferrari AJ, Chan GC, Copeland WE, Whiteford HA, et al. Long‐term outcomes of attention‐deficit/hyperactivity disorder and conduct disorder: a systematic review and meta‐analysis.  Journal of the American Academy of Child and Adolescent Psychiatry 2016;55(10):841–50. [doi: 10.1016/j.jaac.2016.06.016; PUBMED: 27663939]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jaac.2016.06.016', 'https://scholar.google.com/scholar_lookup?title=Long‐term+outcomes+of+attention‐deficit/hyperactivity+disorder+and+conduct+disorder:+a+systematic+review+and+meta‐analysis+&author=HE+Erskine&author=RE+Norman&author=AJ+Ferrari&author=GC+Chan&author=WE+Copeland&author=HA+Whiteford&publication_year=2016&hl=en']",,https://doi.org/10.1016/j.jaac.2016.06.016, Erskine 2016 ,additional,CD012069-bbs2-0477,
CD012069-bib-0672,"Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, et al. ",Dose‐response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD, Experimental and Clinical Psychopharmacology ,2001,9,    ,['citation-journal']," Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, et al. Dose‐response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD.  Experimental and Clinical Psychopharmacology 2001;9(2):163‐75. [PUBMED: 11518092]    Link to article     Google Scholar     ","['https://doi.org/10.1037/1064-1297.9.2.163', 'https://scholar.google.com/scholar_lookup?title=Dose‐response+effects+of+methylphenidate+on+ecologically+valid+measures+of+academic+performance+and+classroom+behavior+in+adolescents+with+ADHD+&author=SW+Evans&author=WE+Pelham&author=BH+Smith&author=O+Bukstein&author=EM+Gnagy&author=AR+Greiner&publication_year=2001&hl=en']",11518092,https://doi.org/10.1037/1064-1297.9.2.163, Evans 2001 ,additional,CD012069-bbs2-0478,
CD012069-bib-0673,"Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al. ",Attention‐deficit/hyperactivity disorder in adults: an overview, Biological Psychiatry ,2000,48,    ,['citation-journal']," Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al. Attention‐deficit/hyperactivity disorder in adults: an overview.  Biological Psychiatry 2000;48(1):9‐20. [PUBMED: 10913503]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0006-3223(00)00889-1', 'https://scholar.google.com/scholar_lookup?title=Attention‐deficit/hyperactivity+disorder+in+adults:+an+overview&author=SV+Faraone&author=J+Biederman&author=T+Spencer&author=T+Wilens&author=LJ+Seidman&author=E+Mick&publication_year=2000&hl=en']",10913503,https://doi.org/10.1016/S0006-3223(00)00889-1, Faraone 2000 ,additional,CD012069-bbs2-0479,
CD012069-bib-0674,"Faraone SV, Biederman J, Roe C. ",Comparative efficacy of Adderall and methylphenidate in attention‐deficit/hyperactivity disorder: a meta‐analysis., Journal of Clinical Psychopharmacology ,2002,22,    ,['citation-journal']," Faraone SV, Biederman J, Roe C. Comparative efficacy of Adderall and methylphenidate in attention‐deficit/hyperactivity disorder: a meta‐analysis..  Journal of Clinical Psychopharmacology 2002;22(5):468–73.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004714-200210000-00005', 'https://scholar.google.com/scholar_lookup?title=Comparative+efficacy+of+Adderall+and+methylphenidate+in+attention‐deficit/hyperactivity+disorder:+a+meta‐analysis.+&author=SV+Faraone&author=J+Biederman&author=C+Roe&publication_year=2002&hl=en']",,https://doi.org/10.1097/00004714-200210000-00005, Faraone 2002 ,additional,CD012069-bbs2-0480,
CD012069-bib-0675,"Faraone S V, Biederman J, Spencer TJ, Aleardi M. ",Comparing the efficacy of medications for A DHD using meta‐analysis, Medscape General Medicine ,2006,8,    ,['citation-journal']," Faraone S V, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for A DHD using meta‐analysis.  Medscape General Medicine 2006;8(4):4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Comparing+the+efficacy+of+medications+for+A+DHD+using+meta‐analysis&author=SV+Faraone&author=J+Biederman&author=TJ+Spencer&author=M+Aleardi&publication_year=2006&hl=en'],,, Faraone 2006 ,additional,CD012069-bbs2-0481,
CD012069-bib-0676,"Faraone SV, Glatt SJ. ",A comparison of the efficacy of medications for adult attention‐deficit/hyperactivity disorder using meta‐analysis of effect sizes, Journal of Clinical Psychiatry ,2010,71,    ,['citation-journal']," Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention‐deficit/hyperactivity disorder using meta‐analysis of effect sizes.  Journal of Clinical Psychiatry 2010;71(6):754‐63.    Link to article     Google Scholar     ","['https://doi.org/10.4088/JCP.08m04902pur', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+the+efficacy+of+medications+for+adult+attention‐deficit/hyperactivity+disorder+using+meta‐analysis+of+effect+sizes+&author=SV+Faraone&author=SJ+Glatt&publication_year=2010&hl=en']",,https://doi.org/10.4088/JCP.08m04902pur, Faraone 2010 ,additional,CD012069-bbs2-0482,
CD012069-bib-0677,Fernández‐Fernámdez MA. ,Interest in including 'Infantile psychosis secondary to methylphenidate' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 5 April 2013.   ,['citation-other'], Fernández‐Fernámdez MA. Interest in including 'Infantile psychosis secondary to methylphenidate' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 5 April 2013.    ,[],,, Fernández‐Fernámdez 2013b [pers comm] ,additional,CD012069-bbs2-0483,
CD012069-bib-0678,Fernández‐Fernández MA. ,Cardiovascular side effects questions on diagnosis and IQ,,,,. Email to: E Ramstad 4 August 2013.   ,['citation-other'], Fernández‐Fernández MA. Cardiovascular side effects questions on diagnosis and IQ. Email to: E Ramstad 4 August 2013.    ,[],,, Fernández‐Fernández 2013 [pers comm] ,additional,CD012069-bbs2-0484,
CD012069-bib-0679,Fischer R. ,AW: Cochrane review on MPH,,,,. Email to: OJ Storebø 14 June 2013.   ,['citation-other'], Fischer R. AW: Cochrane review on MPH. Email to: OJ Storebø 14 June 2013.    ,[],,, Fischer 2013 [pers comm] ,additional,CD012069-bbs2-0485,
CD012069-bib-0680,"Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CHD, Ramos‐Quiroga JA, et al. International Multicentre persistent ADHD CollaboraTion. ","The genetics of attention deficit/hyperactivity disorder in adults, a review", Molecular Psychiatry ,2012,17,    ,['citation-journal']," Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CHD, Ramos‐Quiroga JA, et al. International Multicentre persistent ADHD CollaboraTion. The genetics of attention deficit/hyperactivity disorder in adults, a review.  Molecular Psychiatry 2012;17(10):960‐87.    Link to article     Google Scholar     ","['https://doi.org/10.1038/mp.2011.138', 'https://scholar.google.com/scholar_lookup?title=The+genetics+of+attention+deficit/hyperactivity+disorder+in+adults,+a+review&author=B+Franke&author=SV+Faraone&author=P+Asherson&author=J+Buitelaar&author=CHD+Bau&author=JA+Ramos‐Quiroga&publication_year=2012&hl=en']",,https://doi.org/10.1038/mp.2011.138, Franke 2012 ,additional,CD012069-bbs2-0486,
CD012069-bib-0681,"Frauger E, Amaslidou D, Spadari M, Allaria‐Lapierre V, Braunstein D, Sciortino V, et al. ",Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence, European Addiction Research ,2016,22,    ,['citation-journal']," Frauger E, Amaslidou D, Spadari M, Allaria‐Lapierre V, Braunstein D, Sciortino V, et al. Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence.  European Addiction Research 2016;22(3):119‐26. [DOI: 10.1159/000439273; PUBMED: 26491869]    Link to article     Google Scholar     ","['https://doi.org/10.1159/000439273', 'https://scholar.google.com/scholar_lookup?title=Patterns+of+methylphenidate+use+and+assessment+of+its+abuse+among+the+general+population+and+individuals+with+drug+dependence+&author=E+Frauger&author=D+Amaslidou&author=M+Spadari&author=V+Allaria‐Lapierre&author=D+Braunstein&author=V+Sciortino&publication_year=2016&hl=en']",,https://doi.org/10.1159/000439273, Frauger 2016 ,additional,CD012069-bbs2-0487,
CD012069-bib-0682,Gadow KD. ,Regarding your study 'Efficacy of methylphenidate for attention‐deficit hyperactivity disorder in children with tic disorder' [personal communication],,,,. Email to: KD Gadow 11 March 2013.   ,['citation-other'], Gadow KD. Regarding your study 'Efficacy of methylphenidate for attention‐deficit hyperactivity disorder in children with tic disorder' [personal communication]. Email to: KD Gadow 11 March 2013.    ,[],,, Gadow 2013 [pers comm] ,additional,CD012069-bbs2-0488,
CD012069-bib-0683,"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group. ",The CARE Guidelines: Consensus‐based Clinical Case Reporting Guideline Development, Global Advances in Health and Medicine ,2013,2,    ,['citation-journal']," Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group. The CARE Guidelines: Consensus‐based Clinical Case Reporting Guideline Development.  Global Advances in Health and Medicine 2013;2(5):38‐43. [doi: 10.7453/gahmj.2013.008. PMID: 2441669]    Link to article     Google Scholar     ","['https://doi.org/10.7453/gahmj.2013.008', 'https://scholar.google.com/scholar_lookup?title=The+CARE+Guidelines:+Consensus‐based+Clinical+Case+Reporting+Guideline+Development&author=JJ+Gagnier&author=G+Kienle&author=DG+Altman&author=D+Moher&author=H+Sox&author=D+Riley&publication_year=2013&hl=en']",,https://doi.org/10.7453/gahmj.2013.008, Gagnier 2013 ,additional,CD012069-bbs2-0489,
CD012069-bib-0684,Galland B. ,Regarding your study [personal communication],,,,. Email to: M Holmskov 14 August 2014.   ,['citation-other'], Galland B. Regarding your study [personal communication]. Email to: M Holmskov 14 August 2014.    ,[],,, Galland 2014 [pers comm] ,additional,CD012069-bbs2-0490,
CD012069-bib-0685,"Garattini S, Jakobsen JC, Wetterslev J, Bertelé V, Banzi R, Rath A, et al. ",Evidence‐based clinical practice: overview of threats to the validity of evidence and how to minimise them, European Journal of Internal Medicine ,2016,32,    ,['citation-journal']," Garattini S, Jakobsen JC, Wetterslev J, Bertelé V, Banzi R, Rath A, et al. Evidence‐based clinical practice: overview of threats to the validity of evidence and how to minimise them.  European Journal of Internal Medicine 2016;32:13‐21. [DOI: 10.1016/j.ejim.2016.03.020; PUBMED: 27160381]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.ejim.2016.03.020', 'https://scholar.google.com/scholar_lookup?title=Evidence‐based+clinical+practice:+overview+of+threats+to+the+validity+of+evidence+and+how+to+minimise+them+&author=S+Garattini&author=JC+Jakobsen&author=J+Wetterslev&author=V+Bertelé&author=R+Banzi&author=A+Rath&publication_year=2016&hl=en']",,https://doi.org/10.1016/j.ejim.2016.03.020, Garattini 2016 ,additional,CD012069-bbs2-0491,
CD012069-bib-0686,Gau S. ,"Questions regarding your study 'An open‐label, randomized, active‐ controlled equivalent trial of osmotic release oral system methylphenidate in children with attention‐deficit/hyperactivity disorder in Taiwan' [personal communication]",,,,. Email to: HB Krogh 9 October 2013.   ,['citation-other']," Gau S. Questions regarding your study 'An open‐label, randomized, active‐ controlled equivalent trial of osmotic release oral system methylphenidate in children with attention‐deficit/hyperactivity disorder in Taiwan' [personal communication]. Email to: HB Krogh 9 October 2013.    ",[],,, Gau 2013 [pers comm] ,additional,CD012069-bbs2-0492,
CD012069-bib-0687,Gau CS. ,Possible inclusion of 'The influence of using methylphenidate on the coming up of psychiatric disorders in children with ADHD' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 22 October 2013.   ,['citation-other'], Gau CS. Possible inclusion of 'The influence of using methylphenidate on the coming up of psychiatric disorders in children with ADHD' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 22 October 2013.    ,[],,, Gau 2013b [pers comm] ,additional,CD012069-bbs2-0493,
CD012069-bib-0688,Ghanizadeh A. ,"Questions regarding 'Insomnia, night terror, and depression related to clonidine in attention‐deficit/hyperactivity disorder' [personal communication]",,,,. Email to: EL Ramstad 4 July 2013.   ,['citation-other']," Ghanizadeh A. Questions regarding 'Insomnia, night terror, and depression related to clonidine in attention‐deficit/hyperactivity disorder' [personal communication]. Email to: EL Ramstad 4 July 2013.    ",[],,, Ghanizadeh 2013 [pers comm] ,additional,CD012069-bbs2-0494,
CD012069-bib-0689,Ghanizadeh A. ,Questions regarding your study 'Nortriptyline for treating enuresis in ADHD‐‐a randomized double‐blind controlled clinical trial' [personal communication],,,,. Email to: FL Magnusson 20 June 2014.   ,['citation-other'], Ghanizadeh A. Questions regarding your study 'Nortriptyline for treating enuresis in ADHD‐‐a randomized double‐blind controlled clinical trial' [personal communication]. Email to: FL Magnusson 20 June 2014.    ,[],,, Ghanizadeh 2014 [pers comm] ,additional,CD012069-bbs2-0495,
CD012069-bib-0690,"Gluud LL, Thorlund K, Gluud C, Woods L, Harris R, Sterne JA. ",Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses, Annals of Internal Medicine ,2008,149,    ,['citation-journal']," Gluud LL, Thorlund K, Gluud C, Woods L, Harris R, Sterne JA. Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses.  Annals of Internal Medicine 2008;149(3):219.    Link to article     Google Scholar     ","['https://doi.org/10.7326/0003-4819-149-3-200808050-00023', 'https://scholar.google.com/scholar_lookup?title=Correction:+reported+methodologic+quality+and+discrepancies+between+large+and+small+randomized+trials+in+meta‐analyses+&author=LL+Gluud&author=K+Thorlund&author=C+Gluud&author=L+Woods&author=R+Harris&author=JA+Sterne&publication_year=2008&hl=en']",,https://doi.org/10.7326/0003-4819-149-3-200808050-00023, Gluud 2008 ,additional,CD012069-bbs2-0496,
CD012069-bib-0691,"Golder S, Loke YK, Bland M. ",Meta‐analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview, PLOS Medicine ,2011,8,    ,['citation-journal']," Golder S, Loke YK, Bland M. Meta‐analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.  PLOS Medicine 2011;8(5):e1001026. [DOI: 10.1371/journal.pmed.1001026]    Link to article     Google Scholar     ","['https://doi.org/10.1371/journal.pmed.1001026', 'https://scholar.google.com/scholar_lookup?title=Meta‐analyses+of+adverse+effects+data+derived+from+randomised+controlled+trials+as+compared+to+observational+studies:+methodological+overview+&author=S+Golder&author=YK+Loke&author=M+Bland&publication_year=2011&hl=en']",,https://doi.org/10.1371/journal.pmed.1001026, Golder 2011 ,additional,CD012069-bbs2-0497,
CD012069-bib-0692,"Goyette CH, Conners CK, Ulrich RF. ",Normative data on revised Conners Parent and Teacher Rating Scales, Journal of Abnormal Child Psychology ,1978,6,    ,['citation-journal']," Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating Scales.  Journal of Abnormal Child Psychology 1978;6(2):221‐36. [PUBMED: 670589]    Link to article     Google Scholar     ","['https://doi.org/10.1007/BF00919127', 'https://scholar.google.com/scholar_lookup?title=Normative+data+on+revised+Conners+Parent+and+Teacher+Rating+Scales&author=CH+Goyette&author=CK+Conners&author=RF+Ulrich&publication_year=1978&hl=en']",670589,https://doi.org/10.1007/BF00919127, Goyette 1978 ,additional,CD012069-bbs2-0498,
CD012069-bib-0693,Gracious B. ,Questions regarding your study 'Atrioventricular nodal re‐entrant tachycardia associated with stimulant treatment' [personal communication],,,,. Email to: HB Krogh 1 October 2013.   ,['citation-other'], Gracious B. Questions regarding your study 'Atrioventricular nodal re‐entrant tachycardia associated with stimulant treatment' [personal communication]. Email to: HB Krogh 1 October 2013.    ,[],,, Gracious 2013 [pers comm] ,additional,CD012069-bbs2-0499,
CD012069-bib-0694,"McMaster University (developed by Evidence Prime, Inc.).. ",GRADEpro GDT,,2015,,.   ,['citation-other']," McMaster University (developed by Evidence Prime, Inc.).. GRADEpro GDT. Version accessed prior to 12 March 2018. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.)., 2015.    ",[],,, GRADEpro GDT 2015 [Computer program] ,additional,CD012069-bbs2-0500,
CD012069-bib-0695,"Graham J, Banaschewski T, Buitelaar J, et al. ",European guidelines on managing adverse effects of medication for ADHD, European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Graham J, Banaschewski T, Buitelaar J, et al. European guidelines on managing adverse effects of medication for ADHD.  European Child and Adolescent Psychiatry 2011;20(1):17‐37. [DOI: doi:10.1007/s00787‐010‐0140‐6.]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00787-010-0140-6', 'https://scholar.google.com/scholar_lookup?title=European+guidelines+on+managing+adverse+effects+of+medication+for+ADHD&author=J+Graham&author=T+Banaschewski&author=J+Buitelaar&publication_year=2011&hl=en']",,https://doi.org/10.1007/s00787-010-0140-6, Graham 2011 ,additional,CD012069-bbs2-0501,
CD012069-bib-0696,Grcevich S. ,Questions regarding your study 'Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder' [personal communication],,,,. Email to: HB Krogh 18 October 2013.   ,['citation-other'], Grcevich S. Questions regarding your study 'Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder' [personal communication]. Email to: HB Krogh 18 October 2013.    ,[],,, Grcevich 2013 [pers comm] ,additional,CD012069-bbs2-0502,
CD012069-bib-0697,Green T. ,Possible inclusion of 'Effect of methylphenidate on neurocognitive functioning in velocardiofacial syndrome: a randomized placebo‐controlled trial' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 1 November 2013.   ,['citation-other'], Green T. Possible inclusion of 'Effect of methylphenidate on neurocognitive functioning in velocardiofacial syndrome: a randomized placebo‐controlled trial' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 1 November 2013.    ,[],,, Green 2013 [pers comm] ,additional,CD012069-bbs2-0503,
CD012069-bib-0698,"Greenhill LL, Vitiello B, Fisher P, Levine J, Davies M, Abikoff H, et al. ",Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology,,2004,,    ,['citation-other']," Greenhill LL, Vitiello B, Fisher P, Levine J, Davies M, Abikoff H, et al. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry2004; Vol. 43, issue 12:1488‐96. [DOI: 10.1097/01.chi.0000142668.29191.13; PUBMED: 15564818]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Comparison+of+increasingly+detailed+elicitation+methods+for+the+assessment+of+adverse+events+in+pediatric+psychopharmacology+&author=LL+Greenhill&author=B+Vitiello&author=P+Fisher&author=J+Levine&author=M+Davies&author=H+Abikoff&publication_year=2004&hl=en'],,, Greenhill 2004 ,additional,CD012069-bbs2-0504,
CD012069-bib-0699,"Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. ",Efficacy and safety of immediate‐release methylphenidate treatment for preschoolers with ADHD, Journal of the American Academy of Child and Adolescent Psychiatry ,2006,45,    ,['citation-journal']," Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate‐release methylphenidate treatment for preschoolers with ADHD.  Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(11):1284‐93. [DOI: 10.1097/01.chi.0000235077.32661.61]    Link to article     Google Scholar     ","['https://doi.org/10.1097/01.chi.0000235077.32661.61', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+immediate‐release+methylphenidate+treatment+for+preschoolers+with+ADHD+&author=L+Greenhill&author=S+Kollins&author=H+Abikoff&author=J+McCracken&author=M+Riddle&author=J+Swanson&publication_year=2006&hl=en']",,https://doi.org/10.1097/01.chi.0000235077.32661.61, Greenhill 2006 ,additional,CD012069-bbs2-0505,
CD012069-bib-0700,Grossman N. ,Questions regarding your study 'Methylphenidate and idiopathic thrombocytopenic purpura‐‐is there an association?' [personal communication],,,,. Email to: HB Krogh 12 July 2013.   ,['citation-other'], Grossman N. Questions regarding your study 'Methylphenidate and idiopathic thrombocytopenic purpura‐‐is there an association?' [personal communication]. Email to: HB Krogh 12 July 2013.    ,[],,, Grossman 2013 [pers comm] ,additional,CD012069-bbs2-0506,
CD012069-bib-0701,Gualtieri C. ,Questions regarding your study 'Tryptophan antagonism of stimulant‐induced tics' [personal communication],,,,. Email to: HB Krogh 13 September 2013.   ,['citation-other'], Gualtieri C. Questions regarding your study 'Tryptophan antagonism of stimulant‐induced tics' [personal communication]. Email to: HB Krogh 13 September 2013.    ,[],,, Gualtieri 2013 [pers comm] ,additional,CD012069-bbs2-0507,
CD012069-bib-0702,Guerreiro MM. ,Inclusion of 'Attention deficit disorder: treatment with methylphenidate' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 4 December 2013.   ,['citation-other'], Guerreiro MM. Inclusion of 'Attention deficit disorder: treatment with methylphenidate' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 4 December 2013.    ,[],,, Guerreiro 2013 [pers comm] ,additional,CD012069-bbs2-0508,
CD012069-bib-0703,"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. ",GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables.  Journal of Clinical Epidemiology 2011;64(4):383–94. [DOI: 10.1016/j.jclinepi.2010.04.026]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2010.04.026', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+1.+Introduction‐GRADE+evidence+profiles+and+summary+of+findings+tables+&author=G+Guyatt&author=AD+Oxman&author=EA+Akl&author=R+Kunz&author=G+Vist&author=J+Brozek&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2010.04.026, Guyatt 2011a ,additional,CD012069-bbs2-0509,
CD012069-bib-0704,"Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. ",GRADE guidelines: 2. Framing the question and deciding on important outcomes, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes.  Journal of Clinical Epidemiology 2011;64(4):395–400.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2010.09.012', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+2.+Framing+the+question+and+deciding+on+important+outcomes&author=GH+Guyatt&author=AD+Oxman&author=R+Kunz&author=D+Atkins&author=J+Brozek&author=G+Vist&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2010.09.012, Guyatt 2011b ,additional,CD012069-bbs2-0510,
CD012069-bib-0705,"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso‐Coello P, et al. ",GRADE guidelines: 4. Rating the quality of evidence‐ study limitations (risk of bias), Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso‐Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence‐ study limitations (risk of bias).  Journal of Clinical Epidemiology 2011;64(4):407–15. [DOI: 10.1016/j.jclinepi.2010.07.017]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2010.07.017', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+4.+Rating+the+quality+of+evidence‐+study+limitations+(risk+of+bias)&author=GH+Guyatt&author=AD+Oxman&author=G+Vist&author=R+Kunz&author=J+Brozek&author=P+Alonso‐Coello&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2010.07.017, Guyatt 2011c ,additional,CD012069-bbs2-0511,
CD012069-bib-0706,"Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. ",GRADE guidelines 6. Rating the quality of evidence ‐ imprecision, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence ‐ imprecision.  Journal of Clinical Epidemiology 2011;64(12):1283–93. [DOI: 10.1016/j.jclinepi.2011.01.012]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2011.01.012', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines+6.+Rating+the+quality+of+evidence+‐+imprecision&author=GH+Guyatt&author=AD+Oxman&author=R+Kunz&author=J+Brozek&author=P+Alonso‐Coello&author=D+Rind&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2011.01.012, Guyatt 2011d ,additional,CD012069-bbs2-0512,
CD012069-bib-0707,"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. ",GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency.  Journal of Clinical Epidemiology 2011;64(12):1294–302. [DOI: 10.1016/j.jclinepi.2011.03.017]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2011.03.017', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+7.+Rating+the+quality+of+evidence+‐+inconsistency&author=GH+Guyatt&author=AD+Oxman&author=R+Kunz&author=J+Woodcock&author=J+Brozek&author=M+Helfand&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2011.03.017, Guyatt 2011e ,additional,CD012069-bbs2-0513,
CD012069-bib-0708,"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. ",GRADE guidelines: 8. Rating the quality of evidence ‐ indirectness, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence ‐ indirectness.  Journal of Clinical Epidemiology 2011;64(12):1303–10. [DOI: 10.1016/j.jclinepi.2011.04.014]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2011.04.014', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+8.+Rating+the+quality+of+evidence+‐+indirectness&author=GH+Guyatt&author=AD+Oxman&author=R+Kunz&author=J+Woodcock&author=J+Brozek&author=M+Helfand&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2011.04.014, Guyatt 2011f ,additional,CD012069-bbs2-0514,
CD012069-bib-0709,"Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso‐Coello P, et al. ",GRADE guidelines: 9. Rating up the quality of evidence, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso‐Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence.  Journal of Clinical Epidemiology 2011;64(12):1311–6. [DOI: 10.1016/j.jclinepi.2011.06.004]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2011.06.004', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+9.+Rating+up+the+quality+of+evidence&author=GH+Guyatt&author=AD+Oxman&author=S+Sultan&author=P+Glasziou&author=EA+Akl&author=P+Alonso‐Coello&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.jclinepi.2011.06.004, Guyatt 2011g ,additional,CD012069-bbs2-0515,
CD012069-bib-0710,"Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso‐Coello P, et al. ",GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso‐Coello P, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.  Journal of Clinical Epidemiology 2013;66(2):151–7. [DOI: 10.1016/j.jclinepi.2012.01.006]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2012.01.006', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+11.+Making+an+overall+rating+of+confidence+in+effect+estimates+for+a+single+outcome+and+for+all+outcomes+&author=G+Guyatt&author=AD+Oxman&author=S+Sultan&author=J+Brozek&author=P+Glasziou&author=P+Alonso‐Coello&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jclinepi.2012.01.006, Guyatt 2013a ,additional,CD012069-bbs2-0516,
CD012069-bib-0711,"Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. ",GRADE guidelines: 12. Preparing summary of findings tables ‐ binary outcomes, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE guidelines: 12. Preparing summary of findings tables ‐ binary outcomes.  Journal of Clinical Epidemiology 2013;66(2):158–72. [DOI: 10.1016/j.jclinepi.2012.01.012]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2012.01.012', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+12.+Preparing+summary+of+findings+tables+‐+binary+outcomes&author=GH+Guyatt&author=AD+Oxman&author=N+Santesso&author=M+Helfand&author=G+Vist&author=R+Kunz&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jclinepi.2012.01.012, Guyatt 2013b ,additional,CD012069-bbs2-0517,
CD012069-bib-0712,"Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al. ",GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles ‐ continuous outcomes, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles ‐ continuous outcomes.  Journal of Clinical Epidemiology 2013;66(2):173–83. [DOI: 10.1016/j.jclinepi.2012.08.001]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2012.08.001', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+13.+Preparing+summary+of+findings+tables+and+evidence+profiles+‐+continuous+outcomes+&author=GH+Guyatt&author=K+Thorlund&author=AD+Oxman&author=SD+Walter&author=D+Patrick&author=TA+Furukawa&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jclinepi.2012.08.001, Guyatt 2013c ,additional,CD012069-bbs2-0518,
CD012069-bib-0713,"Habel LA, Cooper WO, Sox CM. ",ADHD medications and risk of serious cardiovascular events in young and middle‐aged adults, JAMA ,2011,306,    ,['citation-journal']," Habel LA, Cooper WO, Sox CM. ADHD medications and risk of serious cardiovascular events in young and middle‐aged adults.  JAMA 2011;306(224):2673‐83.    Link to article     Google Scholar     ","['https://doi.org/10.1001/jama.2011.1830', 'https://scholar.google.com/scholar_lookup?title=ADHD+medications+and+risk+of+serious+cardiovascular+events+in+young+and+middle‐aged+adults+&author=LA+Habel&author=WO+Cooper&author=CM+Sox&publication_year=2011&hl=en']",,https://doi.org/10.1001/jama.2011.1830, Habel 2011 ,additional,CD012069-bbs2-0519,
CD012069-bib-0714,Halevy A. ,Questions regarding 'Methylphenidate induction of complex visual hallucinations' [personal communication],,,,. Email to: EL Ramstad 5 August 2013.   ,['citation-other'], Halevy A. Questions regarding 'Methylphenidate induction of complex visual hallucinations' [personal communication]. Email to: EL Ramstad 5 August 2013.    ,[],,, Halevy 2013 [pers comm] ,additional,CD012069-bbs2-0520,
CD012069-bib-0715,"Halperin JM, Gittelman R, Klein DF, Rudel RG. ",Reading‐disabled hyperactive children: a distinct subgroup of attention deficit disorder with hyperactivity?, Journal of Abnormal Child Psychology ,1984,12,    ,['citation-journal']," Halperin JM, Gittelman R, Klein DF, Rudel RG. Reading‐disabled hyperactive children: a distinct subgroup of attention deficit disorder with hyperactivity?.  Journal of Abnormal Child Psychology 1984;12(1):1‐14. [PUBMED: 6715686]    Link to article     Google Scholar     ","['https://doi.org/10.1007/BF00913458', 'https://scholar.google.com/scholar_lookup?title=Reading‐disabled+hyperactive+children:+a+distinct+subgroup+of+attention+deficit+disorder+with+hyperactivity?+&author=JM+Halperin&author=R+Gittelman&author=DF+Klein&author=RG+Rudel&publication_year=1984&hl=en']",6715686,https://doi.org/10.1007/BF00913458, Halperin 1984 ,additional,CD012069-bbs2-0521,
CD012069-bib-0716,Hannan EL. ,Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations, JACC Cardiovascular Interventions ,2008,1,    ,['citation-journal'], Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.  JACC Cardiovascular Interventions 2008;1(3):211‐7. [DOI: 10.1016/j.jcin.2008.01.008]    Link to article     Google Scholar     ,"['https://doi.org/10.1016/j.jcin.2008.01.008', 'https://scholar.google.com/scholar_lookup?title=Randomized+clinical+trials+and+observational+studies:+guidelines+for+assessing+respective+strengths+and+limitations+&author=EL+Hannan&publication_year=2008&hl=en']",,https://doi.org/10.1016/j.jcin.2008.01.008, Hannan 2008 ,additional,CD012069-bbs2-0522,
CD012069-bib-0717,"Hanwella R, Senanayake Mi, De Silva V. ",Comparative efficacy and acceptability of methylphenidate andatomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta‐analysis, BMC Psychiatry ,2011,11,    ,['citation-journal']," Hanwella R, Senanayake Mi, De Silva V. Comparative efficacy and acceptability of methylphenidate andatomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta‐analysis.  BMC Psychiatry 2011;11(1):176.    Link to article     Google Scholar     ","['https://doi.org/10.1186/1471-244X-11-176', 'https://scholar.google.com/scholar_lookup?title=Comparative+efficacy+and+acceptability+of+methylphenidate+andatomoxetine+in+treatment+of+attention+deficit+hyperactivity+disorder+in+children+and+adolescents:+a+meta‐analysis+&author=R+Hanwella&author=Mi+Senanayake&author=V+Silva&publication_year=2011&hl=en']",,https://doi.org/10.1186/1471-244X-11-176, Hanwella 2011 ,additional,CD012069-bbs2-0523,
CD012069-bib-0718,Harsanyi Z. ,"Questions regarding your study 'Once‐daily multilayer‐release methylphenidate in a double‐blind, crossover comparison to immediate‐release methylphenidate in children with attention‐deficit/hyperactivity disorder' [personal communication]",,,,. Email to: HB Krogh 27 August 2013.   ,['citation-other']," Harsanyi Z. Questions regarding your study 'Once‐daily multilayer‐release methylphenidate in a double‐blind, crossover comparison to immediate‐release methylphenidate in children with attention‐deficit/hyperactivity disorder' [personal communication]. Email to: HB Krogh 27 August 2013.    ",[],,, Harsanyi 2013 [pers comm] ,additional,CD012069-bbs2-0524,
CD012069-bib-0719,"Heal DJ, Pierce DM. ",Methylphenidate and its isomers: their role in the treatment of attention‐deficit hyperactivity disorder using a transdermal delivery system, CNS Drugs ,2006,20,    ,['citation-journal']," Heal DJ, Pierce DM. Methylphenidate and its isomers: their role in the treatment of attention‐deficit hyperactivity disorder using a transdermal delivery system.  CNS Drugs 2006;20(9):713‐38. [PUBMED: 16953648]    Link to article     Google Scholar     ","['https://doi.org/10.2165/00023210-200620090-00002', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+and+its+isomers:+their+role+in+the+treatment+of+attention‐deficit+hyperactivity+disorder+using+a+transdermal+delivery+system+&author=DJ+Heal&author=DM+Pierce&publication_year=2006&hl=en']",16953648,https://doi.org/10.2165/00023210-200620090-00002, Heal 2006 ,additional,CD012069-bbs2-0525,
CD012069-bib-0720,Hechtman L. ,'Treatment of ADHD in patients unresponsive to methylphenidate' [personal communication],,,,. Email to: HB Krogh 7 August 2013.   ,['citation-other'], Hechtman L. 'Treatment of ADHD in patients unresponsive to methylphenidate' [personal communication]. Email to: HB Krogh 7 August 2013.    ,[],,, Hechtman 2013 [pers comm] ,additional,CD012069-bbs2-0526,
CD012069-bib-0721,"Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, et al. ",Cardiovascular safety of ADHD medications: rationale for and design of an investigator‐initiated observational study, Pharmacoepidemiology and Drug Safety ,2010,19,    ,['citation-journal']," Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, et al. Cardiovascular safety of ADHD medications: rationale for and design of an investigator‐initiated observational study.  Pharmacoepidemiology and Drug Safety 2010;19(9):934‐41. [DOI: 10.1002/pds.1992; PUBMED: 20623519]    Link to article     Google Scholar     ","['https://doi.org/10.1002/pds.1992', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+safety+of+ADHD+medications:+rationale+for+and+design+of+an+investigator‐initiated+observational+study+&author=S+Hennessy&author=H+Schelleman&author=GW+Daniel&author=WB+Bilker&author=SE+Kimmel&author=J+Guevara&publication_year=2010&hl=en']",,https://doi.org/10.1002/pds.1992, Hennessy 2010 ,additional,CD012069-bbs2-0527,
CD012069-bib-0722,Heyman I. ,Questions regarding your case report 'Dexamphetamine for obsessive‐ compulsive disorder' [personal communication],,,,. Email to: HB Krogh 27 October 2013.   ,['citation-other'], Heyman I. Questions regarding your case report 'Dexamphetamine for obsessive‐ compulsive disorder' [personal communication]. Email to: HB Krogh 27 October 2013.    ,[],,, Heyman 2013 [pers comm] ,additional,CD012069-bbs2-0528,
CD012069-bib-0723,"Higgins JPT, Green S (editors). ","Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from www.cochrane‐handbook.org.   ,['citation-other']," Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.    ",[],,, Higgins 2011 ,additional,CD012069-bbs2-0529,
CD012069-bib-0724,"Hodgkins P, Montejano L, Sasané R, Huse D. ",Risk of injury associated with attention‐deficit/hyperactivity disorder in adults enrolled in employer‐sponsored health plans: a retrospective analysis, Primary Care Companion for CNS Disorders ,2011,13,    ,['citation-journal']," Hodgkins P, Montejano L, Sasané R, Huse D. Risk of injury associated with attention‐deficit/hyperactivity disorder in adults enrolled in employer‐sponsored health plans: a retrospective analysis.  Primary Care Companion for CNS Disorders 2011;13(2):PCC.10m01031. [DOI: 10.4088/PCC.10m01031; PMC3184594; PUBMED: 21977357]    Link to article     Google Scholar     ","['https://doi.org/10.4088/PCC.10m01031', 'https://scholar.google.com/scholar_lookup?title=Risk+of+injury+associated+with+attention‐deficit/hyperactivity+disorder+in+adults+enrolled+in+employer‐sponsored+health+plans:+a+retrospective+analysis+&author=P+Hodgkins&author=L+Montejano&author=R+Sasané&author=D+Huse&publication_year=2011&hl=en']",,https://doi.org/10.4088/PCC.10m01031, Hodgkins 2011 ,additional,CD012069-bbs2-0530,
CD012069-bib-0725,"Hodgkins P, Setyawan J, Mitra D, Davis K, Quintera J, Fridman M, et al. ","Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns", European Journal of Pediatrics ,2013,172,    ,['citation-journal']," Hodgkins P, Setyawan J, Mitra D, Davis K, Quintera J, Fridman M, et al. Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns.  European Journal of Pediatrics 2013;172(7):895‐906. [DOI: 10.1007/s00431‐013‐1969‐8; PMC3701791; PUBMED: 23440479]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00431-013-1969-8', 'https://scholar.google.com/scholar_lookup?title=Management+of+ADHD+in+children+across+Europe:+patient+demographics,+physician+characteristics+and+treatment+patterns+&author=P+Hodgkins&author=J+Setyawan&author=D+Mitra&author=K+Davis&author=J+Quintera&author=M+Fridman&publication_year=2013&hl=en']",,https://doi.org/10.1007/s00431-013-1969-8, Hodgkins 2013 ,additional,CD012069-bbs2-0531,
CD012069-bib-0726,Hollis C. ,Questions regarding your case report 'Acute dyskinesia on starting methylphenidate after risperidone withdrawal' [personal communication],,,,. Email to: HB Krogh 9 October 2013.   ,['citation-other'], Hollis C. Questions regarding your case report 'Acute dyskinesia on starting methylphenidate after risperidone withdrawal' [personal communication]. Email to: HB Krogh 9 October 2013.    ,[],,, Hollis 2013 [pers comm] ,additional,CD012069-bbs2-0532,
CD012069-bib-0727,"Hong SB, Kim JW, Choi BS, Hong YC, Park EJ, Shin MS, et al. ",Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention‐deficit/hyperactivity disorder, Psychiatry Research ,2014,220,    ,['citation-journal']," Hong SB, Kim JW, Choi BS, Hong YC, Park EJ, Shin MS, et al. Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention‐deficit/hyperactivity disorder.  Psychiatry Research 2014;220(1‐2):418‐25. [PUBMED: 25064383]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.psychres.2014.05.049', 'https://scholar.google.com/scholar_lookup?title=Blood+manganese+levels+in+relation+to+comorbid+behavioral+and+emotional+problems+in+children+with+attention‐deficit/hyperactivity+disorder+&author=SB+Hong&author=JW+Kim&author=BS+Choi&author=YC+Hong&author=EJ+Park&author=MS+Shin&publication_year=2014&hl=en']",25064383,https://doi.org/10.1016/j.psychres.2014.05.049, Hong 2014 ,additional,CD012069-bbs2-0533,
CD012069-bib-0728,"Hong SB, Im MH, Kim JW, Park EJ, Shin MS, Kim BN, et al. ",Environmental lead exposure and attention deficit/hyperactivity disorder symptom domains in a community sample of South Korean school‐age children, Environmental Health Perspectives ,2015,123,    ,['citation-journal']," Hong SB, Im MH, Kim JW, Park EJ, Shin MS, Kim BN, et al. Environmental lead exposure and attention deficit/hyperactivity disorder symptom domains in a community sample of South Korean school‐age children.  Environmental Health Perspectives 2015;123(3):271‐6. [PUBMED: 25280233]    Link to article     Google Scholar     ","['https://doi.org/10.1289/ehp.1307420', 'https://scholar.google.com/scholar_lookup?title=Environmental+lead+exposure+and+attention+deficit/hyperactivity+disorder+symptom+domains+in+a+community+sample+of+South+Korean+school‐age+children+&author=SB+Hong&author=MH+Im&author=JW+Kim&author=EJ+Park&author=MS+Shin&author=BN+Kim&publication_year=2015&hl=en']",25280233,https://doi.org/10.1289/ehp.1307420, Hong 2015 ,additional,CD012069-bbs2-0534,
CD012069-bib-0729,Houmann T. ,Inclusion of INDICES in a Cochrane systematic review [personal communication],,,, [Inklusion af INDICES i et Cochrane systematisk review]. Email to: EL Ramstad 13 September 2013.   ,['citation-other'], Houmann T. Inclusion of INDICES in a Cochrane systematic review [personal communication] [Inklusion af INDICES i et Cochrane systematisk review]. Email to: EL Ramstad 13 September 2013.    ,[],,, Houmann 2013 [pers comm] ,additional,CD012069-bbs2-0535,
CD012069-bib-0730,Hulvershorn LA. ,Methylphenidate [personal communication],,,,. Email to: EL Ramstad 28 August 2013.   ,['citation-other'], Hulvershorn LA. Methylphenidate [personal communication]. Email to: EL Ramstad 28 August 2013.    ,[],,, Hulvershorn 2013 [pers comm] ,additional,CD012069-bbs2-0536,
CD012069-bib-0731,Hungund A. ,Questions regarding the study 'Methylphenidate oral dose plasma concentrations and behavioral response in children' [personal communication],,,,. Email to: HB Krogh 11 September 2013.   ,['citation-other'], Hungund A. Questions regarding the study 'Methylphenidate oral dose plasma concentrations and behavioral response in children' [personal communication]. Email to: HB Krogh 11 September 2013.    ,[],,, Hungund 2013 [pers comm] ,additional,CD012069-bbs2-0537,
CD012069-bib-0732,"Huybrechts KF, Bröms G, Christensen LB, Einarsdóttir K, Engeland A, Furu K, et al. ",Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium, JAMA Psychiatry ,2018,75,    ,['citation-journal']," Huybrechts KF, Bröms G, Christensen LB, Einarsdóttir K, Engeland A, Furu K, et al. Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium.  JAMA Psychiatry 2018;75(2):167‐75. [DOI: 10.1001/jamapsychiatry.2017.3644; 29238795; PUBMED: PMC5838573]    Link to article     Google Scholar     ","['https://doi.org/10.1001/jamapsychiatry.2017.3644', 'https://scholar.google.com/scholar_lookup?title=Association+between+methylphenidate+and+amphetamine+use+in+pregnancy+and+risk+of+congenital+malformations:+a+cohort+study+from+the+international+pregnancy+safety+study+consortium+&author=KF+Huybrechts&author=G+Bröms&author=LB+Christensen&author=K+Einarsdóttir&author=A+Engeland&author=K+Furu&publication_year=2018&hl=en']",,https://doi.org/10.1001/jamapsychiatry.2017.3644, Huybrechts 2018 ,additional,CD012069-bbs2-0538,
CD012069-bib-0733,International Council for Harmonisation Expert Working Group. ,International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1) 1996,,,,. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 6 May 2011).   ,['citation-other'], International Council for Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1) 1996. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 6 May 2011).    ,[],,, ICH 1996 ,additional,CD012069-bbs2-0539,
CD012069-bib-0734,Ilgenli F. ,Regarding your study 'Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder' [personal communication],,,,. Email to: TD Nilausen 7 November 2013.   ,['citation-other'], Ilgenli F. Regarding your study 'Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder' [personal communication]. Email to: TD Nilausen 7 November 2013.    ,[],,, Ilgenli 2013 [pers comm] ,additional,CD012069-bbs2-0540,
CD012069-bib-0735,"Indredavik MS, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk AM. ",Psychiatric symptoms and disorders in adolescents with low birth weight, Archives of Disease in Childhood. Fetal and Neonatal Edition ,2004,89,    ,['citation-journal']," Indredavik MS, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk AM. Psychiatric symptoms and disorders in adolescents with low birth weight.  Archives of Disease in Childhood. Fetal and Neonatal Edition 2004;89(5):F445‐50. [DOI: 10.1136/adc.2003.038943]    Link to article     Google Scholar     ","['https://doi.org/10.1136/adc.2003.038943', 'https://scholar.google.com/scholar_lookup?title=Psychiatric+symptoms+and+disorders+in+adolescents+with+low+birth+weight&author=MS+Indredavik&author=T+Vik&author=S+Heyerdahl&author=S+Kulseng&author=P+Fayers&author=AM+Brubakk&publication_year=2004&hl=en']",,https://doi.org/10.1136/adc.2003.038943, Indredavik 2004 ,additional,CD012069-bbs2-0541,
CD012069-bib-0736,"Ioannidis JP, Contopoulos‐Ioannidis DG. ",Reporting of safety data from randomised trials, Lancet ,1998,352,    ,['citation-journal']," Ioannidis JP, Contopoulos‐Ioannidis DG. Reporting of safety data from randomised trials.  Lancet 1998;352(9142):1752‐3. [DOI: 10.1016/S0140‐6736(05)79825‐1; PUBMED: 9848355]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(05)79825-1', 'https://scholar.google.com/scholar_lookup?title=Reporting+of+safety+data+from+randomised+trials&author=JP+Ioannidis&author=DG+Contopoulos‐Ioannidis&publication_year=1998&hl=en']",,https://doi.org/10.1016/S0140-6736(05)79825-1, Ioannidis 1998 ,additional,CD012069-bbs2-0542,
CD012069-bib-0737,Ioannidis JP. ,"Adverse events in randomized trials: neglected, restricted, distorted, and silenced", Archives of Internal Medicine ,2009,169,    ,['citation-journal']," Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced.  Archives of Internal Medicine 2009;169(19):1737‐9. [DOI: 10.1001/archinternmed.2009.313; PUBMED: 19858427]    Link to article     Google Scholar     ","['https://doi.org/10.1001/archinternmed.2009.313', 'https://scholar.google.com/scholar_lookup?title=Adverse+events+in+randomized+trials:+neglected,+restricted,+distorted,+and+silenced&author=JP+Ioannidis&publication_year=2009&hl=en']",,https://doi.org/10.1001/archinternmed.2009.313, Ioannidis 2009 ,additional,CD012069-bbs2-0543,
CD012069-bib-0738,Irmak A. ,Supplemental data (treatment choice in association of ADHD with Williams and Moebius Syndromes) [personal communication],,,,. Email to: MJ Kielsholm 1 June 2016.   ,['citation-other'], Irmak A. Supplemental data (treatment choice in association of ADHD with Williams and Moebius Syndromes) [personal communication]. Email to: MJ Kielsholm 1 June 2016.    ,[],,, Irmak 2016 [pers comm] ,additional,CD012069-bbs2-0544,
CD012069-bib-0739,Jackson JW. ,The cardiovascular safety of methylphenidate, BMJ ,2016,353,    ,['citation-journal'], Jackson JW. The cardiovascular safety of methylphenidate.  BMJ 2016;353:i2874. [DOI: 10.1136/bmj.i2874; PMC4887615; PUBMED: 27245078]    Link to article     Google Scholar     ,"['https://doi.org/10.1136/bmj.i2874', 'https://scholar.google.com/scholar_lookup?title=The+cardiovascular+safety+of+methylphenidate&author=JW+Jackson&publication_year=2016&hl=en']",,https://doi.org/10.1136/bmj.i2874, Jackson 2016 ,additional,CD012069-bbs2-0545,
CD012069-bib-0740,"Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ",ADHD comorbidity findings from the MTA study: comparing comorbid subgroups, Journal of the American Academy of Child and Adolescent Psychiatry ,2001,40,    ,['citation-journal']," Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.  Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(2):147‐58. [DOI: 10.1097/00004583‐200102000‐00009]    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004583-200102000-00009', 'https://scholar.google.com/scholar_lookup?title=ADHD+comorbidity+findings+from+the+MTA+study:+comparing+comorbid+subgroups&author=PS+Jensen&author=SP+Hinshaw&author=HC+Kraemer&author=N+Lenora&author=JH+Newcorn&author=HB+Abikoff&publication_year=2001&hl=en']",,https://doi.org/10.1097/00004583-200102000-00009, Jensen 2001 ,additional,CD012069-bbs2-0546,
CD012069-bib-0741,Jones A. ,Inquiry to Celgene regarding dexmethylphenidate HCI [personal communication],,,, [Henvendelse til Celgene angående dexmethylphenidat HCl]. Email to: HB Krogh 22 November 2013.   ,['citation-other'], Jones A. Inquiry to Celgene regarding dexmethylphenidate HCI [personal communication] [Henvendelse til Celgene angående dexmethylphenidat HCl]. Email to: HB Krogh 22 November 2013.    ,[],,, Jones 2013 [pers comm] ,additional,CD012069-bbs2-0547,
CD012069-bib-0742,"Kadesjö B, Gillberg C. ",The comorbidity of ADHD in the general population of Swedish school‐age children, Journal of Child Psychology and Psychiatry and Allied Disciplines ,2001,42,    ,['citation-journal']," Kadesjö B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school‐age children.  Journal of Child Psychology and Psychiatry and Allied Disciplines 2001;42(4):487‐92. [DOI: 10.1111/1469‐7610.00742]    Link to article     Google Scholar     ","['https://doi.org/10.1111/1469-7610.00742', 'https://scholar.google.com/scholar_lookup?title=The+comorbidity+of+ADHD+in+the+general+population+of+Swedish+school‐age+children&author=B+Kadesjö&author=C+Gillberg&publication_year=2001&hl=en']",,https://doi.org/10.1111/1469-7610.00742, Kadesjö 2001 ,additional,CD012069-bbs2-0548,
CD012069-bib-0743,Kadesjö B. [ADHD hos barn och vuxna]. ,,ADHD in Children and Adults,2002,,.   ,['citation-book']," Kadesjö B. [ADHD hos barn och vuxna]. ADHD in Children and Adults. Stockholm: Socialstyrelsen, 2002.    ",[],,, Kadesjö 2002 ,additional,CD012069-bbs2-0549,
CD012069-bib-0744,Karabekiroglu K. ,Questions regarding your study 'Can we predict short‐term side effects of methylphenidate immediate‐release?' [personal communication],,,,. Email to: SS Nielsen 9 June 2016.   ,['citation-other'], Karabekiroglu K. Questions regarding your study 'Can we predict short‐term side effects of methylphenidate immediate‐release?' [personal communication]. Email to: SS Nielsen 9 June 2016.    ,[],,, Karabekiroglu 2016 [pers comm] ,additional,CD012069-bbs2-0550,
CD012069-bib-0745,"Kimko HC, Cross JT, Abernethy DR. ",Pharmacokinetics and clinical effectiveness of methylphenidate, Clinical Pharmacokinetics ,1999,37,    ,['citation-journal']," Kimko HC, Cross JT, Abernethy DR. Pharmacokinetics and clinical effectiveness of methylphenidate.  Clinical Pharmacokinetics 1999;37(6):457–70. [PUBMED: 10628897]    Link to article     Google Scholar     ","['https://doi.org/10.2165/00003088-199937060-00002', 'https://scholar.google.com/scholar_lookup?title=Pharmacokinetics+and+clinical+effectiveness+of+methylphenidate&author=HC+Kimko&author=JT+Cross&author=DR+Abernethy&publication_year=1999&hl=en']",10628897,https://doi.org/10.2165/00003088-199937060-00002, Kimko 1999 ,additional,CD012069-bbs2-0551,
CD012069-bib-0746,"Kjaergard LL, Villumsen J, Gluud C. ",Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses, Annals of Internal Medicine ,2001,135,    ,['citation-journal']," Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses.  Annals of Internal Medicine 2001;135(11):982‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-135-11-200112040-00010', 'https://www.ncbi.nlm.nih.gov/pubmed/11730399', 'https://scholar.google.com/scholar_lookup?title=Reported+methodologic+quality+and+discrepancies+between+large+and+small+randomized+trials+in+meta‐analyses+&author=LL+Kjaergard&author=J+Villumsen&author=C+Gluud&publication_year=2001&hl=en']",11730399,https://doi.org/10.7326/0003-4819-135-11-200112040-00010, Kjaergard 2001 ,additional,CD012069-bbs2-0552,
CD012069-bib-0747,Klykylo WM. ,Questions regarding your study 'Medication‐induced seizures' [personal communication],,,,. Email to: HB Krogh 16 September 2013.   ,['citation-other'], Klykylo WM. Questions regarding your study 'Medication‐induced seizures' [personal communication]. Email to: HB Krogh 16 September 2013.    ,[],,, Klykylo 2013 [pers comm] ,additional,CD012069-bbs2-0553,
CD012069-bib-0748,"Koisaari T, Michelsson K, Holopainen JM, Maksimainen R, Päivänsalo J, Rantala K, et al. ",Traffic and criminal behavior of adults with attention deficit‐hyperactivity with a prospective follow‐up from birth to the age of 40 years, Traffic Injury Prevention ,2015,16,    ,['citation-journal']," Koisaari T, Michelsson K, Holopainen JM, Maksimainen R, Päivänsalo J, Rantala K, et al. Traffic and criminal behavior of adults with attention deficit‐hyperactivity with a prospective follow‐up from birth to the age of 40 years.  Traffic Injury Prevention 2015;16(8):824‐30. [DOI: 10.1080/15389588.2015.1029068; PUBMED: 25837647]    Link to article     Google Scholar     ","['https://doi.org/10.1080/15389588.2015.1029068', 'https://scholar.google.com/scholar_lookup?title=Traffic+and+criminal+behavior+of+adults+with+attention+deficit‐hyperactivity+with+a+prospective+follow‐up+from+birth+to+the+age+of+40+years+&author=T+Koisaari&author=K+Michelsson&author=JM+Holopainen&author=R+Maksimainen&author=J+Päivänsalo&author=K+Rantala&publication_year=2015&hl=en']",,https://doi.org/10.1080/15389588.2015.1029068, Koisaari 2015 ,additional,CD012069-bbs2-0554,
CD012069-bib-0749,Kovacs M. ,,Children's Depression Inventory,1992,,.   ,['citation-book']," Kovacs M. Children's Depression Inventory. North Tonawanda (NY): Multi‐Health Systems, Inc, 1992.    ",[],,, Kovacs 1992 ,additional,CD012069-bbs2-0555,
CD012069-bib-0750,"Kovess V, Keyes KM, Hamilton A, Pez O, Bitfoi A, Koç C, et al. ",Maternal smoking and offspring inattention and hyperactivity: results from a cross‐national European survey, European Child and Adolescent Psychiatry ,2015,24,    ,['citation-journal']," Kovess V, Keyes KM, Hamilton A, Pez O, Bitfoi A, Koç C, et al. Maternal smoking and offspring inattention and hyperactivity: results from a cross‐national European survey.  European Child and Adolescent Psychiatry 2015;24(8):919‐29. [DOI: 10.1007/s00787‐014‐0641‐9]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00787-014-0641-9', 'https://scholar.google.com/scholar_lookup?title=Maternal+smoking+and+offspring+inattention+and+hyperactivity:+results+from+a+cross‐national+European+survey+&author=V+Kovess&author=KM+Keyes&author=A+Hamilton&author=O+Pez&author=A+Bitfoi&author=C+Koç&publication_year=2015&hl=en']",,https://doi.org/10.1007/s00787-014-0641-9, Kovess 2015 ,additional,CD012069-bbs2-0556,
CD012069-bib-0751,Kratochvil C. ,"Questions regarding your study 'Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open‐label trial' [personal communication]",,,,. Email to: FL Magnusson 24 June 2014.   ,['citation-other']," Kratochvil C. Questions regarding your study 'Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open‐label trial' [personal communication]. Email to: FL Magnusson 24 June 2014.    ",[],,, Kratochvil 2014 [pers comm] ,additional,CD012069-bbs2-0557,
CD012069-bib-0752,Lakic A. ,Answers to questions [personal communication],,,,. Email to: EL Ramstad 24 October 2013.   ,['citation-other'], Lakic A. Answers to questions [personal communication]. Email to: EL Ramstad 24 October 2013.    ,[],,, Lakic 2013 [pers comm] ,additional,CD012069-bbs2-0558,
CD012069-bib-0753,Larrañaga‐Fragoso P. ,Questions regarding your study 'The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder' [personal communication,,,,. Email to: SS Nielsen 6 June 2016.   ,['citation-other'], Larrañaga‐Fragoso P. Questions regarding your study 'The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder' [personal communication. Email to: SS Nielsen 6 June 2016.    ,[],,, Larrañaga‐Fragoso 2016 [pers comm] ,additional,CD012069-bbs2-0559,
CD012069-bib-0754,"Larsson H, Sariaslan A, Långström N, D'Onofrio B, Lichtenstein P. ",Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi‐experimental study, Journal of Child Psychology and Psychiatry and Allied Disciplines ,2014,55,    ,['citation-journal']," Larsson H, Sariaslan A, Långström N, D'Onofrio B, Lichtenstein P. Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi‐experimental study.  Journal of Child Psychology and Psychiatry and Allied Disciplines 2014;55(5):428‐35. [PUBMED: 24111650]    Link to article     Google Scholar     ","['https://doi.org/10.1111/jcpp.12140', ""https://scholar.google.com/scholar_lookup?title=Family+income+in+early+childhood+and+subsequent+attention+deficit/hyperactivity+disorder:+a+quasi‐experimental+study+&author=H+Larsson&author=A+Sariaslan&author=N+Långström&author=B+D'Onofrio&author=P+Lichtenstein&publication_year=2014&hl=en""]",24111650,https://doi.org/10.1111/jcpp.12140, Larsson 2014 ,additional,CD012069-bbs2-0560,
CD012069-bib-0755,"Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. ",The Yale Global Tic Severity Scale: initial testing of a clinician‐rated scale of tic severity, Journal of the American Academy of Child and Adolescent Psychiatry ,1989,28,    ,['citation-journal']," Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician‐rated scale of tic severity.  Journal of the American Academy of Child and Adolescent Psychiatry 1989;28(4):566‐73.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004583-198907000-00015', 'https://scholar.google.com/scholar_lookup?title=The+Yale+Global+Tic+Severity+Scale:+initial+testing+of+a+clinician‐rated+scale+of+tic+severity+&author=JF+Leckman&author=MA+Riddle&author=MT+Hardin&author=SI+Ort&author=KL+Swartz&author=J+Stevenson&publication_year=1989&hl=en']",,https://doi.org/10.1097/00004583-198907000-00015, Leckman 1989 ,additional,CD012069-bbs2-0561,
CD012069-bib-0756,Lee M. ,This is more data about BP [personal communication],,,,. Email to: M Holmskov 20 August 2014.   ,['citation-other'], Lee M. This is more data about BP [personal communication]. Email to: M Holmskov 20 August 2014.    ,[],,, Lee 2014 [pers comm] ,additional,CD012069-bbs2-0562,
CD012069-bib-0757,Lewis J. ,IQ in glaucoma patient treated with methylphenidate [personal communication],,,,. Email to: OJ Storebø 14 March 2014.   ,['citation-other'], Lewis J. IQ in glaucoma patient treated with methylphenidate [personal communication]. Email to: OJ Storebø 14 March 2014.    ,[],,, Lewis 2014 [pers comm] ,additional,CD012069-bbs2-0563,
CD012069-bib-0758,Li AY. ,Questions regarding your study [personal communication],,,,. Email to: HB Krogh 10 April 2013.   ,['citation-other'], Li AY. Questions regarding your study [personal communication]. Email to: HB Krogh 10 April 2013.    ,[],,, Li 2013 [pers comm] ,additional,CD012069-bbs2-0564,
CD012069-bib-0759,"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. ",The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ ,2009,339,    ,['citation-journal']," Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanation and elaboration.  BMJ 2009;339:b2700. [DOI: 10.1136/bmj.b2700]    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.b2700', 'https://scholar.google.com/scholar_lookup?title=The+PRISMA+statement+for+reporting+systematic+reviews+and+meta‐analyses+of+studies+that+evaluate+healthcare+interventions:+explanation+and+elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+Gøtzsche&author=JP+Ioannidis&publication_year=2009&hl=en']",,https://doi.org/10.1136/bmj.b2700, Liberati 2009 ,additional,CD012069-bbs2-0565,
CD012069-bib-0760,"Lichtenstein P, Hallder L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S, et al. ",Medication for attention deficit‐hyperactivity disorder and criminality, Engl J Med ,2012,367,    ,['citation-journal']," Lichtenstein P, Hallder L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S, et al. Medication for attention deficit‐hyperactivity disorder and criminality.  Engl J Med 2012;367(21):2006‐14. [DOI: 10.1056/NEJMoa1203241]    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJMoa1203241', 'https://scholar.google.com/scholar_lookup?title=Medication+for+attention+deficit‐hyperactivity+disorder+and+criminality&author=P+Lichtenstein&author=L+Hallder&author=J+Zetterqvist&author=A+Sjölander&author=E+Serlachius&author=S+Fazel&publication_year=2012&hl=en']",,https://doi.org/10.1056/NEJMoa1203241, Lichteinstein 2012 ,additional,CD012069-bbs2-0566,
CD012069-bib-0761,"Loke YK, Price D, Herxheimer A. ","Chapter 14: Adverse effects. In Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from handbok.cochrane.org.   ,['citation-other']," Loke YK, Price D, Herxheimer A. Chapter 14: Adverse effects. In Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbok.cochrane.org.    ",[],,, Loke 2011 ,additional,CD012069-bbs2-0567,
CD012069-bib-0762,"Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. ",Industry sponsorship and research outcome, Cochrane Database of Systematic Reviews ,2012,,    ,['citation-journal']," Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome.  Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.MR000033.pub2', 'https://scholar.google.com/scholar_lookup?title=Industry+sponsorship+and+research+outcome&author=A+Lundh&author=S+Sismondo&author=J+Lexchin&author=OA+Busuioc&author=L+Bero&publication_year=2012&hl=en']",,https://doi.org/10.1002/14651858.MR000033.pub2, Lundh 2012 ,additional,CD012069-bbs2-0568,
CD012069-bib-0763,"Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. ",Industry sponsorship and research outcome, Cochrane Database of Systematic Reviews ,2017,,    ,['citation-journal']," Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome.  Cochrane Database of Systematic Reviews 2017, Issue 2. [DOI: 10.1002/14651858.MR000033.pub3]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.MR000033.pub3', 'https://scholar.google.com/scholar_lookup?title=Industry+sponsorship+and+research+outcome&author=A+Lundh&author=J+Lexchin&author=B+Mintzes&author=JB+Schroll&author=L+Bero&publication_year=2017&hl=en']",,https://doi.org/10.1002/14651858.MR000033.pub3, Lundh 2017 ,additional,CD012069-bbs2-0569,
CD012069-bib-0764,Machado A. ,Possible inclusion of 'Is methylphenidate‐induced chorea responsive to chlorpromazine?' in a Cochrane systematic review [personal communication],,,,. Email to: A Machado 2 October 2013.   ,['citation-other'], Machado A. Possible inclusion of 'Is methylphenidate‐induced chorea responsive to chlorpromazine?' in a Cochrane systematic review [personal communication]. Email to: A Machado 2 October 2013.    ,[],,, Machado 2013 [pers comm] ,additional,CD012069-bbs2-0570,
CD012069-bib-0765,"Maia CR, Cortese S, Caye A, Deakin TK, Polanczyk GV, Polanczyk GV, et al. ",Long‐term efficacy of methylphenidate immediate‐release for the treatment of childhood ADHD,,2017,,    ,['citation-other']," Maia CR, Cortese S, Caye A, Deakin TK, Polanczyk GV, Polanczyk GV, et al. Long‐term efficacy of methylphenidate immediate‐release for the treatment of childhood ADHD. Journal of Attention Disorders2017; Vol. 21, issue 1:3‐13. [DOI: 10.1177/1087054714559643; PUBMED: 25501355]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Long‐term+efficacy+of+methylphenidate+immediate‐release+for+the+treatment+of+childhood+ADHD+&author=CR+Maia&author=S+Cortese&author=A+Caye&author=TK+Deakin&author=GV+Polanczyk&author=GV+Polanczyk&publication_year=2017&hl=en'],,, Maia 2017 ,additional,CD012069-bbs2-0571,
CD012069-bib-0766,McLaren JL. ,Questions regarding your case study 'Aripiprazole induced acute dystonia after discontinuation of a stimulant medication' [personal communication],,,,. Email to: HB Krogh 17 October 2013.   ,['citation-other'], McLaren JL. Questions regarding your case study 'Aripiprazole induced acute dystonia after discontinuation of a stimulant medication' [personal communication]. Email to: HB Krogh 17 October 2013.    ,[],,, McLaren 2013 [pers comm] ,additional,CD012069-bbs2-0572,
CD012069-bib-0767,Medicines and Healthcare Products Regulatory Agency (MHRA). ,Medicines information: SPC & PILs,,,,. www.mhra.gov.uk/Safetyinformation/Medicinesinformation/SPCandPILs/ (accessed 2 May 2017).   ,['citation-other'], Medicines and Healthcare Products Regulatory Agency (MHRA). Medicines information: SPC & PILs. www.mhra.gov.uk/Safetyinformation/Medicinesinformation/SPCandPILs/ (accessed 2 May 2017).    ,[],,, MHRA 2017 ,additional,CD012069-bbs2-0573,
CD012069-bib-0768,Mohammadi MR. ,"Questions regarding 'Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐ blind trial' [personal communication]",,,,. Email to: EL Ramstad 9 July 2013.   ,['citation-other']," Mohammadi MR. Questions regarding 'Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐ blind trial' [personal communication]. Email to: EL Ramstad 9 July 2013.    ",[],,, Mohammadi 2013 [pers comm] ,additional,CD012069-bbs2-0574,
CD012069-bib-0769,"Moher D, Pham B, Jones A, Cook DJ, Jadad A, Moher M, et al. ",Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analysis?, Lancet ,1998,352,    ,['citation-journal']," Moher D, Pham B, Jones A, Cook DJ, Jadad A, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analysis?.  Lancet 1998;352(9128):609‐13.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(98)01085-X', 'https://scholar.google.com/scholar_lookup?title=Does+quality+of+reports+of+randomised+trials+affect+estimates+of+intervention+efficacy+reported+in+meta‐analysis?+&author=D+Moher&author=B+Pham&author=A+Jones&author=DJ+Cook&author=A+Jadad&author=M+Moher&publication_year=1998&hl=en']",,https://doi.org/10.1016/S0140-6736(98)01085-X, Moher 1998 ,additional,CD012069-bbs2-0575,
CD012069-bib-0770,"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. ",Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement, PLoS Medicine ,2009,6,    ,['citation-journal']," Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement.  PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097; PMC2707599; PUBMED: 19621072]    Link to article     Google Scholar     ","['https://doi.org/10.1371/journal.pmed.1000097', 'https://scholar.google.com/scholar_lookup?title=Preferred+reporting+items+for+systematic+reviews+and+meta‐analyses:+the+PRISMA+statement&author=D+Moher&author=A+Liberati&author=J+Tetzlaff&author=DG+Altman&publication_year=2009&hl=en']",,https://doi.org/10.1371/journal.pmed.1000097, Moher 2009 ,additional,CD012069-bbs2-0576,
CD012069-bib-0771,"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. ",Preferred reporting items for systematic review and meta‐analysis protocols (PRISMA‐P) 2015 statement, Systematic Reviews ,2015,4,    ,['citation-journal']," Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta‐analysis protocols (PRISMA‐P) 2015 statement.  Systematic Reviews 2015;4(1):1‐9. [DOI: 10.1186/2046‐4053‐4‐1]    Link to article     Google Scholar     ","['https://doi.org/10.1186/2046-4053-4-1', 'https://scholar.google.com/scholar_lookup?title=Preferred+reporting+items+for+systematic+review+and+meta‐analysis+protocols+(PRISMA‐P)+2015+statement+&author=D+Moher&author=L+Shamseer&author=M+Clarke&author=D+Ghersi&author=A+Liberati&author=M+Petticrew&publication_year=2015&hl=en']",,https://doi.org/10.1186/2046-4053-4-1, Moher 2015 ,additional,CD012069-bbs2-0577,
CD012069-bib-0772,Montañes‐Rada F. ,"Possible inclusion of '50/50 prolonged‐release methylphenidate (medikinet®) twice daily, prospective open study' in a Cochrane systematic review [personal communication]",,,," [Metilfenidato de liberación prolongada 50/50 (medikinet®) dos veces al día,estudio abierto prospectivo]. Email to: EL Ramstad 4 November 2013.   ",['citation-other']," Montañes‐Rada F. Possible inclusion of '50/50 prolonged‐release methylphenidate (medikinet®) twice daily, prospective open study' in a Cochrane systematic review [personal communication] [Metilfenidato de liberación prolongada 50/50 (medikinet®) dos veces al día,estudio abierto prospectivo]. Email to: EL Ramstad 4 November 2013.    ",[],,, Montañes‐Rada 2013 [pers comm] ,additional,CD012069-bbs2-0578,
CD012069-bib-0773,MTA Cooperation Group. ,A 14‐month randomized clinical trial of treatment strategies for attention‐deficit/hyperactivity disorder. The MTA Cooperative Group, Archives of General Psychiatry ,1999,56,    ,['citation-journal'], MTA Cooperation Group. A 14‐month randomized clinical trial of treatment strategies for attention‐deficit/hyperactivity disorder. The MTA Cooperative Group.  Archives of General Psychiatry 1999;56(12):1073‐86. [DOI: 10.1001/archpsyc.56.12.1073]    Link to article     ,['https://doi.org/10.1001/archpsyc.56.12.1073'],,https://doi.org/10.1001/archpsyc.56.12.1073, MTA 1999 ,additional,CD012069-bbs2-0579,
CD012069-bib-0774,Mueller B. ,Supplemental information [personal communication],,,,. Email to: ML Kielsholm 15 June 2016.   ,['citation-other'], Mueller B. Supplemental information [personal communication]. Email to: ML Kielsholm 15 June 2016.    ,[],,, Mueller 2016 [pers comm] ,additional,CD012069-bbs2-0580,
CD012069-bib-0775,Munk K. ,Supplementary data [personal communication],,,, [Supplerende data]. Email to: ML Kielsholm 19 April 2016.   ,['citation-other'], Munk K. Supplementary data [personal communication] [Supplerende data]. Email to: ML Kielsholm 19 April 2016.    ,[],,, Munk 2016 [pers comm] ,additional,CD012069-bbs2-0581,
CD012069-bib-0776,"Musonda P, Farrington CP, Whitaker HJ. ",Sample sizes for self‐controlled case series studies, Statistics in Medicine ,2006,25,    ,['citation-journal']," Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self‐controlled case series studies.  Statistics in Medicine 2006;25(15):2618‐31. [DOI: 10.1002/sim.2477]    Link to article     Google Scholar     ","['https://doi.org/10.1002/sim.2477', 'https://scholar.google.com/scholar_lookup?title=Sample+sizes+for+self‐controlled+case+series+studies&author=P+Musonda&author=CP+Farrington&author=HJ+Whitaker&publication_year=2006&hl=en']",,https://doi.org/10.1002/sim.2477, Musonda 2006 ,additional,CD012069-bbs2-0582,
CD012069-bib-0777,"Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. ",The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses.  Journal of Clinical Epidemiology 2013;66(7):736‐42.e5. [DOI: 10.1016/j.jclinepi.2013.02.004]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2013.02.004', 'https://scholar.google.com/scholar_lookup?title=The+GRADE+approach+is+reproducible+in+assessing+the+quality+of+evidence+of+quantitative+evidence+syntheses+&author=RA+Mustafa&author=N+Santesso&author=J+Brozek&author=EA+Akl&author=SD+Walter&author=G+Norman&publication_year=2013&hl=en']",,https://doi.org/10.1016/j.jclinepi.2013.02.004, Mustafa 2013 ,additional,CD012069-bbs2-0583,
CD012069-bib-0778,"Myers JK, Bean LL. ",,A Decade Later: A Follow‐up of Social Class and Mental Illness,1968,,.   ,['citation-book']," Myers JK, Bean LL. A Decade Later: A Follow‐up of Social Class and Mental Illness. New York (NY): John Wiley & Sons, Inc, 1968.    ",[],,, Myers 1968 ,additional,CD012069-bbs2-0584,
CD012069-bib-0779,"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. ",A method for estimating the probability of adverse drug reactions, Clinical Pharmacology and Therapeutics ,1981,30,    ,['citation-journal']," Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions.  Clinical Pharmacology and Therapeutics 1981;30(2):239‐45. [PUBMED: 7249508]    Link to article     Google Scholar     ","['https://doi.org/10.1038/clpt.1981.154', 'https://scholar.google.com/scholar_lookup?title=A+method+for+estimating+the+probability+of+adverse+drug+reactions&author=CA+Naranjo&author=U+Busto&author=EM+Sellers&author=P+Sandor&author=I+Ruiz&author=EA+Roberts&publication_year=1981&hl=en']",7249508,https://doi.org/10.1038/clpt.1981.154, Naranjo 1981 ,additional,CD012069-bbs2-0585,
CD012069-bib-0780,National Collaborating Centre for Mental Health (NCCMH) commissioned by the National Institute for Health and Clinical Excellence. ,"Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72",,,,. www.nccmh.org.uk/downloads/ADHD/CG72FullGuideline.pdf (accessed 11 December 2015).   ,['citation-other']," National Collaborating Centre for Mental Health (NCCMH) commissioned by the National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. www.nccmh.org.uk/downloads/ADHD/CG72FullGuideline.pdf (accessed 11 December 2015).    ",[],,, NCCMH 2009 ,additional,CD012069-bbs2-0586,
CD012069-bib-0781,"Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, et al. ",Meta‐analysis of genome‐wide association studies of attention‐deficit/hyperactivity disorder, Journal of the American Academy of Child & Adolescent Psychiatry ,2010,49,    ,['citation-journal']," Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, et al. Meta‐analysis of genome‐wide association studies of attention‐deficit/hyperactivity disorder.  Journal of the American Academy of Child & Adolescent Psychiatry 2010;49(9):884‐97.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jaac.2010.06.008', 'https://scholar.google.com/scholar_lookup?title=Meta‐analysis+of+genome‐wide+association+studies+of+attention‐deficit/hyperactivity+disorder+&author=BM+Neale&author=SE+Medland&author=S+Ripke&author=P+Asherson&author=B+Franke&author=KP+Lesch&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.jaac.2010.06.008, Neale 2010 ,additional,CD012069-bbs2-0587,
CD012069-bib-0782,Newcorn JH. ,Co‐morbidity in adults with ADHD, CNS Spectrums ,2008,13,    ,['citation-journal'], Newcorn JH. Co‐morbidity in adults with ADHD.  CNS Spectrums 2008;13(Suppl 12):12‐5. [DOI: 10.1017/S1092852900003199]    Link to article     Google Scholar     ,"['https://doi.org/10.1017/S1092852900003199', 'https://scholar.google.com/scholar_lookup?title=Co‐morbidity+in+adults+with+ADHD&author=JH+Newcorn&publication_year=2008&hl=en']",,https://doi.org/10.1017/S1092852900003199, Newcorn 2008 ,additional,CD012069-bbs2-0588,
CD012069-bib-0783,National Collaborating Centre for Mental Health (NCCMH) commissioned by the National Institute for Health and Clinical Excellence. ,"Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72",,,,. www.nice.org.uk/guidance/cg72/resources/attention‐deficit‐hyperactivity‐disorder‐diagnosis‐and‐management‐975625063621 (accessed prior to 15 May 2017).   ,['citation-other']," National Collaborating Centre for Mental Health (NCCMH) commissioned by the National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. www.nice.org.uk/guidance/cg72/resources/attention‐deficit‐hyperactivity‐disorder‐diagnosis‐and‐management‐975625063621 (accessed prior to 15 May 2017).    ",[],,, NICE 2008 ,additional,CD012069-bbs2-0589,
CD012069-bib-0784,Niederhofer H. ,"Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication]",,,,. Email to: HB Krogh 31 July 2013.   ,['citation-other']," Niederhofer H. Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication]. Email to: HB Krogh 31 July 2013.    ",[],,, Niederhofer 2013 [pers comm] ,additional,CD012069-bbs2-0590,
CD012069-bib-0785,Niederhofer H. ,"Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication]",,,,. Email to: HB Krogh 31 July 2013.   ,['citation-other']," Niederhofer H. Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication]. Email to: HB Krogh 31 July 2013.    ",[],,, Niederhofer 2013b [pers comm] ,additional,CD012069-bbs2-0591,
CD012069-bib-0786,"Nigg JT, Casey BJ. ",An integrative theory of attention‐deficit/hyperactivity disorder based on the cognitive and affective neurosciences, Development and Psychopathology ,2005,17,    ,['citation-journal']," Nigg JT, Casey BJ. An integrative theory of attention‐deficit/hyperactivity disorder based on the cognitive and affective neurosciences.  Development and Psychopathology 2005;17(3):785‐806. [DOI: 10.1017/S0954579405050376]    Link to article     Google Scholar     ","['https://doi.org/10.1017/S0954579405050376', 'https://scholar.google.com/scholar_lookup?title=An+integrative+theory+of+attention‐deficit/hyperactivity+disorder+based+on+the+cognitive+and+affective+neurosciences+&author=JT+Nigg&author=BJ+Casey&publication_year=2005&hl=en']",,https://doi.org/10.1017/S0954579405050376, Nigg 2005 ,additional,CD012069-bbs2-0592,
CD012069-bib-0787,"Obel C, Zhu JL, Olsen J, Breining S, Li J, Grønborg TK, et al. ",The risk of attention deficit hyperactivity disorder in children exposed to maternal smoking during pregnancy ‐ a reexamination using a sibling design,,2016,,    ,['citation-other']," Obel C, Zhu JL, Olsen J, Breining S, Li J, Grønborg TK, et al. The risk of attention deficit hyperactivity disorder in children exposed to maternal smoking during pregnancy ‐ a reexamination using a sibling design. Journal of Child Psychology and Psychiatry2016; Vol. 57, issue 4:532‐7. [DOI: 10.1111/jcpp.12478; PUBMED: 26511313]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+risk+of+attention+deficit+hyperactivity+disorder+in+children+exposed+to+maternal+smoking+during+pregnancy+‐+a+reexamination+using+a+sibling+design+&author=C+Obel&author=JL+Zhu&author=J+Olsen&author=S+Breining&author=J+Li&author=TK+Grønborg&publication_year=2016&hl=en'],,, Obel 2016 ,additional,CD012069-bbs2-0593,
CD012069-bib-0788,"Owens JA, Spirito A, McGuinn M. ",The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school‐aged children, Sleep ,2000,23,    ,['citation-journal']," Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school‐aged children.  Sleep 2000;23(8):1043‐51.    Link to article     Google Scholar     ","['https://doi.org/10.1093/sleep/23.8.1d', ""https://scholar.google.com/scholar_lookup?title=The+Children's+Sleep+Habits+Questionnaire+(CSHQ):+psychometric+properties+of+a+survey+instrument+for+school‐aged+children+&author=JA+Owens&author=A+Spirito&author=M+McGuinn&publication_year=2000&hl=en""]",,https://doi.org/10.1093/sleep/23.8.1d, Owens 2000 ,additional,CD012069-bbs2-0594,
CD012069-bib-0789,"Pagsberg AK, Jeppesen P, Klauber DG, Jensen KG, Rudå D, Stentebjerg‐Olesen M, et al. ","Quetiapine extended release versus aripiprazole in children and adolescents with first‐episode psychosis: the multicentre, double‐blind, randomised tolerability and efficacy of antipsychotics (TEA) trial", Lancet Psychiatry ,2017,4,    ,['citation-journal']," Pagsberg AK, Jeppesen P, Klauber DG, Jensen KG, Rudå D, Stentebjerg‐Olesen M, et al. Quetiapine extended release versus aripiprazole in children and adolescents with first‐episode psychosis: the multicentre, double‐blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.  Lancet Psychiatry 2017;4(8):605‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S2215-0366(17)30166-9', 'https://scholar.google.com/scholar_lookup?title=Quetiapine+extended+release+versus+aripiprazole+in+children+and+adolescents+with+first‐episode+psychosis:+the+multicentre,+double‐blind,+randomised+tolerability+and+efficacy+of+antipsychotics+(TEA)+trial+&author=AK+Pagsberg&author=P+Jeppesen&author=DG+Klauber&author=KG+Jensen&author=D+Rudå&author=M+Stentebjerg‐Olesen&publication_year=2017&hl=en']",,https://doi.org/10.1016/S2215-0366(17)30166-9, Pagsberg 2017 ,additional,CD012069-bbs2-0595,
CD012069-bib-0790,Panei P. ,Questions regarding your study 'The Italian ADHD National Registry' [personal communication],,,,. Email to: HB Krogh 27 Janurary 2014.   ,['citation-other'], Panei P. Questions regarding your study 'The Italian ADHD National Registry' [personal communication]. Email to: HB Krogh 27 Janurary 2014.    ,[],,, Panei 2014 [pers comm] ,additional,CD012069-bbs2-0596,
CD012069-bib-0791,Panei P. ,Questions regarding your study 'Safety of methylphenidate and atomoxetine in children with attention‐deficit/hyperactivity disorder (ADHD): data from the Italian National ADHD Registry' [personal communication],,,,. Email to: HB Krogh 13 June 2016.   ,['citation-other'], Panei P. Questions regarding your study 'Safety of methylphenidate and atomoxetine in children with attention‐deficit/hyperactivity disorder (ADHD): data from the Italian National ADHD Registry' [personal communication]. Email to: HB Krogh 13 June 2016.    ,[],,, Panei 2016 [pers comm] ,additional,CD012069-bbs2-0597,
CD012069-bib-0792,"Papanikolaou PN, Churchill R, Wahlbeck K, Ioannidis JP. ",Safety reporting in randomized trials of mental health interventions, American Journal of Psychiatry ,2004,161,    ,['citation-journal']," Papanikolaou PN, Churchill R, Wahlbeck K, Ioannidis JP. Safety reporting in randomized trials of mental health interventions.  American Journal of Psychiatry 2004;161(9):1692‐7. [DOI: 10.1176/appi.ajp.161.9.1692; PUBMED: 15337661]    Link to article     Google Scholar     ","['https://doi.org/10.1176/appi.ajp.161.9.1692', 'https://scholar.google.com/scholar_lookup?title=Safety+reporting+in+randomized+trials+of+mental+health+interventions&author=PN+Papanikolaou&author=R+Churchill&author=K+Wahlbeck&author=JP+Ioannidis&publication_year=2004&hl=en']",,https://doi.org/10.1176/appi.ajp.161.9.1692, Papanikolaou 2004 ,additional,CD012069-bbs2-0598,
CD012069-bib-0793,"Pasini A, Paloscia C, Alessandrelli R, Porfirio MC, Curatolo P. ",Attention and executive functions profile in drug naive ADHD subtypes, Brain and Development ,2007,29,    ,['citation-journal']," Pasini A, Paloscia C, Alessandrelli R, Porfirio MC, Curatolo P. Attention and executive functions profile in drug naive ADHD subtypes.  Brain and Development 2007;29(7):400‐8. [PUBMED: 17207595]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.braindev.2006.11.010', 'https://scholar.google.com/scholar_lookup?title=Attention+and+executive+functions+profile+in+drug+naive+ADHD+subtypes&author=A+Pasini&author=C+Paloscia&author=R+Alessandrelli&author=MC+Porfirio&author=P+Curatolo&publication_year=2007&hl=en']",17207595,https://doi.org/10.1016/j.braindev.2006.11.010, Pasini 2007 ,additional,CD012069-bbs2-0599,
CD012069-bib-0794,Pelham WE. ,Pharmacotherapy for children with attention‐deficit hyperactivity disorder, School Psychology Review ,1993,22,    ,['citation-journal'], Pelham WE. Pharmacotherapy for children with attention‐deficit hyperactivity disorder.  School Psychology Review 1993;22(2):199‐227.    Link to article     Google Scholar     ,"['https://doi.org/10.1080/02796015.1993.12085647', 'https://scholar.google.com/scholar_lookup?title=Pharmacotherapy+for+children+with+attention‐deficit+hyperactivity+disorder&author=WE+Pelham&publication_year=1993&hl=en']",,https://doi.org/10.1080/02796015.1993.12085647, Pelham 1993 ,additional,CD012069-bbs2-0600,
CD012069-bib-0795,"Pelham WE, Gnagy EM, Burrows‐Maclean L, Williams A, Fabiano GA, Morrisey SM, et al. ",Once‐a‐day Concerta methylphenidate versus three‐times‐daily methylphenidate in laboratory and natural settings, Pediatrics ,2001,107,    ,['citation-journal']," Pelham WE, Gnagy EM, Burrows‐Maclean L, Williams A, Fabiano GA, Morrisey SM, et al. Once‐a‐day Concerta methylphenidate versus three‐times‐daily methylphenidate in laboratory and natural settings.  Pediatrics 2001;107(6):E105. [DOI: 10.1542/peds.107.6.e105; PUBMED: 11389303]    Link to article     Google Scholar     ","['https://doi.org/10.1542/peds.107.6.e105', 'https://scholar.google.com/scholar_lookup?title=Once‐a‐day+Concerta+methylphenidate+versus+three‐times‐daily+methylphenidate+in+laboratory+and+natural+settings+&author=WE+Pelham&author=EM+Gnagy&author=L+Burrows‐Maclean&author=A+Williams&author=GA+Fabiano&author=SM+Morrisey&publication_year=2001&hl=en']",,https://doi.org/10.1542/peds.107.6.e105, Pelham 2001 ,additional,CD012069-bbs2-0601,
CD012069-bib-0796,"Pelham WE, Burrows‐MacLean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, et al. ","Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD", Experimental and Clinical Psychopharmacology ,2005,13,    ,['citation-journal']," Pelham WE, Burrows‐MacLean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, et al. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.  Experimental and Clinical Psychopharmacology 2005;13(2):111‐26. [DOI: 10.1037/1064‐1297.13.2.111; PUBMED: 15943544]    Link to article     Google Scholar     ","['https://doi.org/10.1037/1064-1297.13.2.111', 'https://scholar.google.com/scholar_lookup?title=Transdermal+methylphenidate,+behavioral,+and+combined+treatment+for+children+with+ADHD+&author=WE+Pelham&author=L+Burrows‐MacLean&author=EM+Gnagy&author=GA+Fabiano&author=EK+Coles&author=KE+Tresco&publication_year=2005&hl=en']",,https://doi.org/10.1037/1064-1297.13.2.111, Pelham 2005 ,additional,CD012069-bbs2-0602,
CD012069-bib-0797,Perera H. ,Questions regarding your study 'Assessment of outcome of an ADHD treatment program using parent feedback' [personal communication],,,,. Email to: SS Nielsen 1 June 2016.   ,['citation-other'], Perera H. Questions regarding your study 'Assessment of outcome of an ADHD treatment program using parent feedback' [personal communication]. Email to: SS Nielsen 1 June 2016.    ,[],,, Perera 2016 [pers comm] ,additional,CD012069-bbs2-0603,
CD012069-bib-0798,"Perroud N, Cordera P, Zimmermann J, Michalopoulos G, Bancila V, Dayer A, et al. ",Comorbidity between attention deficit hyperactivity disorder (ADHD) and bipolar disorder in a specialized mood disorders outpatient clinic, Journal of Affective Disorders ,2014,168,    ,['citation-journal']," Perroud N, Cordera P, Zimmermann J, Michalopoulos G, Bancila V, Dayer A, et al. Comorbidity between attention deficit hyperactivity disorder (ADHD) and bipolar disorder in a specialized mood disorders outpatient clinic.  Journal of Affective Disorders 2014;168:161‐6. [DOI: 10.1016/j.jad.2014.06.053]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jad.2014.06.053', 'https://scholar.google.com/scholar_lookup?title=Comorbidity+between+attention+deficit+hyperactivity+disorder+(ADHD)+and+bipolar+disorder+in+a+specialized+mood+disorders+outpatient+clinic+&author=N+Perroud&author=P+Cordera&author=J+Zimmermann&author=G+Michalopoulos&author=V+Bancila&author=A+Dayer&publication_year=2014&hl=en']",,https://doi.org/10.1016/j.jad.2014.06.053, Perroud 2014 ,additional,CD012069-bbs2-0604,
CD012069-bib-0799,"Pitrou I, Boutron I, Ahmad N, Ravaud P. ",Reporting of safety results in published reports of randomized controlled trials, Archives of Internal Medicine ,2009,169,    ,['citation-journal']," Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials.  Archives of Internal Medicine 2009;169(19):1756‐61. [DOI: 10.1001/archinternmed.2009.306; PUBMED: 19858432]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Reporting+of+safety+results+in+published+reports+of+randomized+controlled+trials&author=I+Pitrou&author=I+Boutron&author=N+Ahmad&author=P+Ravaud&publication_year=2009&hl=en'],,, Pitrou 2009 ,additional,CD012069-bbs2-0605,
CD012069-bib-0800,"Pliszka S, The AACAP Work Group on Quality Issues. ",Practice parameter for the assessment and treatment of children and adolescents with attention‐deficit/hyperactivity disorder, Journal of the American Academy of Child and Adolescent Psychiatry ,2007,46,    ,['citation-journal']," Pliszka S, The AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention‐deficit/hyperactivity disorder.  Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(7):894‐921. [DOI: 10.1097/chi.0b013e318054e724; PUBMED: 17581453]    Link to article     Google Scholar     ","['https://doi.org/10.1097/chi.0b013e318054e724', 'https://scholar.google.com/scholar_lookup?title=Practice+parameter+for+the+assessment+and+treatment+of+children+and+adolescents+with+attention‐deficit/hyperactivity+disorder+&author=S+Pliszka&publication_year=2007&hl=en']",,https://doi.org/10.1097/chi.0b013e318054e724, Pliszka 2007a ,additional,CD012069-bbs2-0606,
CD012069-bib-0801,"Polanczyk G, Rohde LA. ",Epidemiology of attention‐deficit/hyperactivity disorder across the lifespan, Current Opinion in Psychiatry ,2007,20,    ,['citation-journal']," Polanczyk G, Rohde LA. Epidemiology of attention‐deficit/hyperactivity disorder across the lifespan.  Current Opinion in Psychiatry 2007;20(4):386‐92. [PUBMED: 17551354]    Link to article     Google Scholar     ","['https://doi.org/10.1097/YCO.0b013e3281568d7a', 'https://scholar.google.com/scholar_lookup?title=Epidemiology+of+attention‐deficit/hyperactivity+disorder+across+the+lifespan&author=G+Polanczyk&author=LA+Rohde&publication_year=2007&hl=en']",17551354,https://doi.org/10.1097/YCO.0b013e3281568d7a, Polanczyk 2007a ,additional,CD012069-bbs2-0607,
CD012069-bib-0802,"Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ",ADHD prevalence estimates across three decades: an updated systematic review and meta‐regression analysis, International Journal of Epidemiology ,2014,43,    ,['citation-journal']," Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta‐regression analysis.  International Journal of Epidemiology 2014;43(2):434‐42. [PUBMED: 24464188]    Link to article     Google Scholar     ","['https://doi.org/10.1093/ije/dyt261', 'https://scholar.google.com/scholar_lookup?title=ADHD+prevalence+estimates+across+three+decades:+an+updated+systematic+review+and+meta‐regression+analysis+&author=GV+Polanczyk&author=EG+Willcutt&author=GA+Salum&author=C+Kieling&author=LA+Rohde&publication_year=2014&hl=en']",24464188,https://doi.org/10.1093/ije/dyt261, Polanczyk 2014 ,additional,CD012069-bbs2-0608,
CD012069-bib-0803,Poulton A. ,Questions regarding your study 'Slowing of growth in height and weight on stimulants: a characteristic pattern' (2003) [personal communication],,,,. Email to: HB Krogh 9 November 2013.   ,['citation-other'], Poulton A. Questions regarding your study 'Slowing of growth in height and weight on stimulants: a characteristic pattern' (2003) [personal communication]. Email to: HB Krogh 9 November 2013.    ,[],,, Poulton 2013 [pers comm] ,additional,CD012069-bbs2-0609,
CD012069-bib-0804,Poulton A. ,Questions [personal communication],,,,. Email to: H Krogh 18 October 2013.   ,['citation-other'], Poulton A. Questions [personal communication]. Email to: H Krogh 18 October 2013.    ,[],,, Poulton 2013b [pers comm] ,additional,CD012069-bbs2-0610,
CD012069-bib-0805,Pranav D. ,Supplemental information [personal communication],,,,. Email to: Kielsholm ML 22 April 2016.   ,['citation-other'], Pranav D. Supplemental information [personal communication]. Email to: Kielsholm ML 22 April 2016.    ,[],,, Pranav 2016 [pers comm] ,additional,CD012069-bbs2-0611,
CD012069-bib-0806,"Ramstad E, Storebø OJ, Nilausen TD, Krog HB, Moreira‐Maia CR, Magnusson FL, Holmskov M, Skoog M, Rosendal S, Groth C, Gillies D, Zwi M, Kirubakaran R, Gluud C, Simonsen E. ",Hallicunations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention deficit hyperactivity disorder (ADHD): a Cochrane Systematic Review with Meta‐analysis and Trial Sequential Analysis., Scandinavian Journal of Child and Adolescent Psychiatry and Psychology ,2018 [Epub ahead of print],6,    ,['citation-journal']," Ramstad E, Storebø OJ, Nilausen TD, Krog HB, Moreira‐Maia CR, Magnusson FL, Holmskov M, Skoog M, Rosendal S, Groth C, Gillies D, Zwi M, Kirubakaran R, Gluud C, Simonsen E. Hallicunations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention deficit hyperactivity disorder (ADHD): a Cochrane Systematic Review with Meta‐analysis and Trial Sequential Analysis..  Scandinavian Journal of Child and Adolescent Psychiatry and Psychology 2018 [Epub ahead of print];6(1):ns.    Link to article     Google Scholar     ","['https://doi.org/10.21307/sjcapp-2018-003', 'https://scholar.google.com/scholar_lookup?title=Hallicunations+and+other+psychotic+symptoms+in+response+to+methylphenidate+in+children+and+adolescents+with+attention+deficit+hyperactivity+disorder+(ADHD):+a+Cochrane+Systematic+Review+with+Meta‐analysis+and+Trial+Sequential+Analysis.+&author=E+Ramstad&author=OJ+Storebø&author=TD+Nilausen&author=HB+Krog&author=CR+Moreira‐Maia&author=FL+Magnusson&author=M+Holmskov&author=M+Skoog&author=S+Rosendal&author=C+Groth&author=D+Gillies&author=M+Zwi&author=R+Kirubakaran&author=C+Gluud&author=E+Simonsen&publication_year=2018[Epubaheadofprint]&hl=en']",,https://doi.org/10.21307/sjcapp-2018-003, Ramstad 2018 ,additional,CD012069-bbs2-0612,
CD012069-bib-0807,Rappaport N. ,Psychopharmacology in the school setting [personal communication],,,,. Email to: Krogh HB 11 November 2013.   ,['citation-other'], Rappaport N. Psychopharmacology in the school setting [personal communication]. Email to: Krogh HB 11 November 2013.    ,[],,, Rappaport 2013 [pers comm] ,additional,CD012069-bbs2-0613,
CD012069-bib-0808,Rashid J. ,Questions regarding 'Methylphenidate and somatic hallucinations' ‐ possible inclusion in a Cochrane systematic review [personal communication],,,,. Email to: Ramstad EL 8 October 2013.   ,['citation-other'], Rashid J. Questions regarding 'Methylphenidate and somatic hallucinations' ‐ possible inclusion in a Cochrane systematic review [personal communication]. Email to: Ramstad EL 8 October 2013.    ,[],,, Rashid 2013 [pers comm] ,additional,CD012069-bbs2-0614,
CD012069-bib-0809,"Reeves BC, Deeks JJ, Higgins JPT, Wells GA. ","Chapter 14: Including non‐randomized studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 14: Including non‐randomized studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Reeves 2011 ,additional,CD012069-bbs2-0615,
CD012069-bib-0810,"Nordic Cochrane Centre, The Cochrane Collaboration. ",Review Manager 5 (RevMan 5),,2014,,.   ,['citation-other']," Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, Review Manager 2014 [Computer program] ,additional,CD012069-bbs2-0616,
CD012069-bib-0811,"Reynolds CR, Richmond BO. ",,Revised Children's Manifest Anxiety Scale. RCMAS Manual,1985,,.   ,['citation-book']," Reynolds CR, Richmond BO. Revised Children's Manifest Anxiety Scale. RCMAS Manual. Los Angeles (CA): Western Psychological Services, 1985.    ",[],,, Reynolds 1985 ,additional,CD012069-bbs2-0617,
CD012069-bib-0812,Ririe D. ,Questions regarding your study 'Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents' [personal communication],,,,. Email to: HB Krogh 15 October 2013.   ,['citation-other'], Ririe D. Questions regarding your study 'Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents' [personal communication]. Email to: HB Krogh 15 October 2013.    ,[],,, Ririe 2013 [pers comm] ,additional,CD012069-bbs2-0618,
CD012069-bib-0813,Roland F. ,Questions regarding your study 'Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention‐deficit/hyperactivity disorder in a natural setting' [personal communication],,,,. Email to: HB Krogh 10 December 2013.   ,['citation-other'], Roland F. Questions regarding your study 'Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention‐deficit/hyperactivity disorder in a natural setting' [personal communication]. Email to: HB Krogh 10 December 2013.    ,[],,, Roland 2013 [pers comm] ,additional,CD012069-bbs2-0619,
CD012069-bib-0814,Sabuncuoglu O. ,Severe adverse events IQ questions [personal communication],,,,. Email to: HB Krogh 11 October 2013.   ,['citation-other'], Sabuncuoglu O. Severe adverse events IQ questions [personal communication]. Email to: HB Krogh 11 October 2013.    ,[],,, Sabuncuoglu 2013 [pers comm] ,additional,CD012069-bbs2-0620,
CD012069-bib-0815,Saieh AC. ,"Possible inclusion of 'Methylphenidate: high blood pressure, an effect to take into account' in a Cochrane systematic review [personal communication]",,,," [Metilfenidata: hipertensión arterial, un efecto a tener en cuenta]. Emails to: EL Ramstad (23 October, 2 December 2013) 2 December 2013.   ",['citation-other']," Saieh AC. Possible inclusion of 'Methylphenidate: high blood pressure, an effect to take into account' in a Cochrane systematic review [personal communication] [Metilfenidata: hipertensión arterial, un efecto a tener en cuenta]. Emails to: EL Ramstad (23 October, 2 December 2013) 2 December 2013.    ",[],,, Saieh 2013 [pers comm] ,additional,CD012069-bbs2-0621,
CD012069-bib-0816,"Savović J, Jones H, Altman D, Harris R, Jüni P, Pildal J, et al. ",Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies, Health Technology Assessment ,2012,16,    ,['citation-journal']," Savović J, Jones H, Altman D, Harris R, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies.  Health Technology Assessment 2012;16(35):1‐82.    Link to article     Google Scholar     ","['https://doi.org/10.3310/hta16350', 'https://scholar.google.com/scholar_lookup?title=Influence+of+reported+study+design+characteristics+on+intervention+effect+estimates+from+randomised+controlled+trials:+combined+analysis+of+meta‐epidemiological+studies+&author=J+Savović&author=H+Jones&author=D+Altman&author=R+Harris&author=P+Jüni&author=J+Pildal&publication_year=2012&hl=en']",,https://doi.org/10.3310/hta16350, Savović 2012 ,additional,CD012069-bbs2-0622,
CD012069-bib-0817,"Scahill L, Riddle MA, McSwiggin‐Hardin M, Ort SI, King RA, Goodman WK, et al. ",Children's Yale‐Brown Obsessive Compulsive Scale: reliability and validity, Journal of the American Academy of Child and Adolescent Psychiatry ,1997,36,    ,['citation-journal']," Scahill L, Riddle MA, McSwiggin‐Hardin M, Ort SI, King RA, Goodman WK, et al. Children's Yale‐Brown Obsessive Compulsive Scale: reliability and validity.  Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(6):844‐52. [DOI: 10.1097/00004583‐199706000‐00023; PUBMED: 9183141]    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004583-199706000-00023', ""https://scholar.google.com/scholar_lookup?title=Children's+Yale‐Brown+Obsessive+Compulsive+Scale:+reliability+and+validity&author=L+Scahill&author=MA+Riddle&author=M+McSwiggin‐Hardin&author=SI+Ort&author=RA+King&author=WK+Goodman&publication_year=1997&hl=en""]",,https://doi.org/10.1097/00004583-199706000-00023, Scahill 1997 ,additional,CD012069-bbs2-0623,
CD012069-bib-0818,"Scahill L, Schwab‐Stone M. ",Epidemiology of ADHD in school‐age children, Child and Adolescent Psychiatric Clinics of North America ,2000,9,    ,['citation-journal']," Scahill L, Schwab‐Stone M. Epidemiology of ADHD in school‐age children.  Child and Adolescent Psychiatric Clinics of North America 2000;9(3):541‐55. [PUBMED: 10944656]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S1056-4993(18)30106-8', 'https://scholar.google.com/scholar_lookup?title=Epidemiology+of+ADHD+in+school‐age+children&author=L+Scahill&author=M+Schwab‐Stone&publication_year=2000&hl=en']",10944656,https://doi.org/10.1016/S1056-4993(18)30106-8, Scahill 2000 ,additional,CD012069-bbs2-0624,
CD012069-bib-0819,"Schachar RJ, Tannock R, Cunningham C, Corkum PV. ","Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate", Journal of the American Academy of Child and Adolescent Psychiatry ,1997,36,    ,['citation-journal']," Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.  Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(6):754‐63. [DOI: 10.1097/00004583‐199706000‐00011; PUBMED: 9183129]    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004583-199706000-00011', 'https://scholar.google.com/scholar_lookup?title=Behavioral,+situational,+and+temporal+effects+of+treatment+of+ADHD+with+methylphenidate&author=RJ+Schachar&author=R+Tannock&author=C+Cunningham&author=PV+Corkum&publication_year=1997&hl=en']",,https://doi.org/10.1097/00004583-199706000-00011, Schachar 1997 ,additional,CD012069-bbs2-0625,
CD012069-bib-0820,"Schmidt S, Petermann F. ",Developmental psychopathology: attention deficit hyperactivity disorder (ADHD), BMC Psychiatry ,2009,9,    ,['citation-journal']," Schmidt S, Petermann F. Developmental psychopathology: attention deficit hyperactivity disorder (ADHD).  BMC Psychiatry 2009;9:58. [DOI: 10.1186/1471‐244X‐9‐58]    Link to article     Google Scholar     ","['https://doi.org/10.1186/1471-244X-9-58', 'https://scholar.google.com/scholar_lookup?title=Developmental+psychopathology:+attention+deficit+hyperactivity+disorder+(ADHD)&author=S+Schmidt&author=F+Petermann&publication_year=2009&hl=en']",,https://doi.org/10.1186/1471-244X-9-58, Schmidt 2009 ,additional,CD012069-bbs2-0626,
CD012069-bib-0821,"Schroll JB, Penninga EI, Gøtzsche PC. ","Assessment of adverse events in protocols, clinical study reports, and published papers of trials of Orlistat: a document analysis", PLOS Medicine ,2016,13,    ,['citation-journal']," Schroll JB, Penninga EI, Gøtzsche PC. Assessment of adverse events in protocols, clinical study reports, and published papers of trials of Orlistat: a document analysis.  PLOS Medicine 2016;13(8):e1002101. [DOI: 10.1371/journal.pmed.1002101; PMC4987052; PUBMED: 27529343]    Link to article     Google Scholar     ","['https://doi.org/10.1371/journal.pmed.1002101', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+adverse+events+in+protocols,+clinical+study+reports,+and+published+papers+of+trials+of+Orlistat:+a+document+analysis+&author=JB+Schroll&author=EI+Penninga&author=PC+Gøtzsche&publication_year=2016&hl=en']",,https://doi.org/10.1371/journal.pmed.1002101, Schroll 2016 ,additional,CD012069-bbs2-0627,
CD012069-bib-0822,"Schubert I, Köster I, Lehmkuhl G. ","The changing prevalence of attention‐deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German state of Hesse, 2000–2007", Deutsches Ärzteblatt International ,2010,107,    ,['citation-journal']," Schubert I, Köster I, Lehmkuhl G. The changing prevalence of attention‐deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German state of Hesse, 2000–2007.  Deutsches Ärzteblatt International 2010;107(36):615‐21. [DOI: 10.3238/arztebl.2010.0615; PMC2947846; PUBMED: 20948775]    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=The+changing+prevalence+of+attention‐deficit/hyperactivity+disorder+and+methylphenidate+prescriptions:+a+study+of+data+from+a+random+sample+of+insurees+of+the+AOK+Health+Insurance+Company+in+the+German+state+of+Hesse,+2000–2007+&author=I+Schubert&author=I+Köster&author=G+Lehmkuhl&publication_year=2010&hl=en']",,, Schubert 2010 ,additional,CD012069-bbs2-0628,
CD012069-bib-0823,"Schulz KF, Chalmers I, Hayes RJ, Altman DG. ",Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA ,1995,273,    ,['citation-journal']," Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.  JAMA 1995;273(5):408‐12.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jama.1995.03520290060030', 'https://www.ncbi.nlm.nih.gov/pubmed/7823387', 'https://scholar.google.com/scholar_lookup?title=Empirical+evidence+of+bias.+Dimensions+of+methodological+quality+associated+with+estimates+of+treatment+effects+in+controlled+trials+&author=KF+Schulz&author=I+Chalmers&author=RJ+Hayes&author=DG+Altman&publication_year=1995&hl=en']",7823387,https://doi.org/10.1001/jama.1995.03520290060030, Schulz 1995 ,additional,CD012069-bbs2-0629,
CD012069-bib-0824,"Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, et al. ",Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention‐deficit/hyperactivity disorder, Archives of General Psychiatry ,2012,69,    ,['citation-journal']," Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, et al. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention‐deficit/hyperactivity disorder.  Archives of General Psychiatry 2012;69(9):952‐61. [DOI: 10.1001/archgenpsychiatry.2011.2053; PUBMED: 22945622]    Link to article     Google Scholar     ","['https://doi.org/10.1001/archgenpsychiatry.2011.2053', 'https://scholar.google.com/scholar_lookup?title=Common+and+unique+therapeutic+mechanisms+of+stimulant+and+nonstimulant+treatments+for+attention‐deficit/hyperactivity+disorder+&author=KP+Schulz&author=J+Fan&author=AC+Bédard&author=SM+Clerkin&author=I+Ivanov&author=CY+Tang&publication_year=2012&hl=en']",,https://doi.org/10.1001/archgenpsychiatry.2011.2053, Schulz 2012 ,additional,CD012069-bbs2-0630,
CD012069-bib-0825,Schumock G. ,Questions regarding your study 'Drugs associated with adverse events in children and adolescents' [personal communication],,,,. Email to: ML Kielsholm 6 June 2016.   ,['citation-other'], Schumock G. Questions regarding your study 'Drugs associated with adverse events in children and adolescents' [personal communication]. Email to: ML Kielsholm 6 June 2016.    ,[],,, Schumock 2016 [pers comm] ,additional,CD012069-bbs2-0631,
CD012069-bib-0826,Schwartz RH. ,Questions regarding 'Stuttering priapism associated with withdrawal from sustained‐release methylphenidate' [personal communication],,,,. Email to: EL Ramstad 5 September 2013.   ,['citation-other'], Schwartz RH. Questions regarding 'Stuttering priapism associated with withdrawal from sustained‐release methylphenidate' [personal communication]. Email to: EL Ramstad 5 September 2013.    ,[],,, Schwartz 2013 [pers comm] ,additional,CD012069-bbs2-0632,
CD012069-bib-0827,Scottish Intercollegiate Guidelines Network (SIGN). ,Management of attention deficit and hyperkinetic disorders in children and young people. A national clinical guideline,,,,. www.sign.ac.uk/pdf/sign112.pdf (accessed prior to 15 May 2017).   ,['citation-other'], Scottish Intercollegiate Guidelines Network (SIGN). Management of attention deficit and hyperkinetic disorders in children and young people. A national clinical guideline. www.sign.ac.uk/pdf/sign112.pdf (accessed prior to 15 May 2017).    ,[],,, Scottish Intercollegiate Guidelines Network (SIGN) ,additional,CD012069-bbs2-0633,
CD012069-bib-0828,"Sergeant JA, Geurts H, Huijbregts S, Scheres A, Oosterlaan J. ",The top and the bottom of ADHD: a neuropsychological perspective, Neuroscience and Biobehavioural Reviews ,2003,27,    ,['citation-journal']," Sergeant JA, Geurts H, Huijbregts S, Scheres A, Oosterlaan J. The top and the bottom of ADHD: a neuropsychological perspective.  Neuroscience and Biobehavioural Reviews 2003;27(7):583‐92. [PUBMED: 14624803]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.neubiorev.2003.08.004', 'https://scholar.google.com/scholar_lookup?title=The+top+and+the+bottom+of+ADHD:+a+neuropsychological+perspective&author=JA+Sergeant&author=H+Geurts&author=S+Huijbregts&author=A+Scheres&author=J+Oosterlaan&publication_year=2003&hl=en']",14624803,https://doi.org/10.1016/j.neubiorev.2003.08.004, Sergeant 2003 ,additional,CD012069-bbs2-0634,
CD012069-bib-0829,"Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab‐Stone ME, et al. ","The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC‐2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study", Journal of the American Academy of Child and Adolescent Psychiatry ,1996,35,    ,['citation-journal']," Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab‐Stone ME, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC‐2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study.  Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(7):865‐77. [PUBMED: 8768346]    Link to article     Google Scholar     ","['https://doi.org/10.1097/00004583-199607000-00012', 'https://scholar.google.com/scholar_lookup?title=The+NIMH+Diagnostic+Interview+Schedule+for+Children+Version+2.3+(DISC‐2.3):+description,+acceptability,+prevalence+rates,+and+performance+in+the+MECA+Study.+Methods+for+the+Epidemiology+of+Child+and+Adolescent+Mental+Disorders+Study+&author=D+Shaffer&author=P+Fisher&author=MK+Dulcan&author=M+Davies&author=J+Piacentini&author=ME+Schwab‐Stone&publication_year=1996&hl=en']",8768346,https://doi.org/10.1097/00004583-199607000-00012, Shaffer 1996 ,additional,CD012069-bbs2-0635,
CD012069-bib-0830,Shalev RS. ,Possible inclusion of 'Hallucinations during methylphenidate therapy' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 24 October 2013.   ,['citation-other'], Shalev RS. Possible inclusion of 'Hallucinations during methylphenidate therapy' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 24 October 2013.    ,[],,, Shalev 2013 [pers comm] ,additional,CD012069-bbs2-0636,
CD012069-bib-0831,"Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, et al. ",A systematic review and analysis of long‐term outcomes in attention deficit hyperactivity disorder: effects of treatment and non‐treatment, BMC Medicine ,2012,10,    ,['citation-journal']," Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, et al. A systematic review and analysis of long‐term outcomes in attention deficit hyperactivity disorder: effects of treatment and non‐treatment.  BMC Medicine 2012;10:99. [DOI: 10.1186/1741‐7015‐10‐99]    Link to article     Google Scholar     ","['https://doi.org/10.1186/1741-7015-10-99', 'https://scholar.google.com/scholar_lookup?title=A+systematic+review+and+analysis+of+long‐term+outcomes+in+attention+deficit+hyperactivity+disorder:+effects+of+treatment+and+non‐treatment+&author=M+Shaw&author=P+Hodgkins&author=H+Caci&author=S+Young&author=J+Kahle&author=AG+Woods&publication_year=2012&hl=en']",,https://doi.org/10.1186/1741-7015-10-99, Shaw 2012 ,additional,CD012069-bbs2-0637,
CD012069-bib-0832,Shibib S. ,Questions regarding 'Stimulant induced psychosis' ‐ possible inclusion in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 28 August to 25 October 2013.   ,['citation-other'], Shibib S. Questions regarding 'Stimulant induced psychosis' ‐ possible inclusion in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 28 August to 25 October 2013.    ,[],,, Shibib 2013 [pers comm] ,additional,CD012069-bbs2-0638,
CD012069-bib-0833,Silverman SL. ,From randomized controlled trials to observational studies, American Journal of Medicine ,2009,122,    ,['citation-journal'], Silverman SL. From randomized controlled trials to observational studies.  American Journal of Medicine 2009;122(2):114‐20. [DOI: 10.1016/j.amjmed.2008.09.030; PUBMED: 19185083]    Link to article     Google Scholar     ,"['https://doi.org/10.1016/j.amjmed.2008.09.030', 'https://scholar.google.com/scholar_lookup?title=From+randomized+controlled+trials+to+observational+studies&author=SL+Silverman&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.amjmed.2008.09.030, Silverman 2009 ,additional,CD012069-bbs2-0639,
CD012069-bib-0834,Sinzig J. ,Questions regarding your study 'Waiver of diagnosis before starting and undergoing therapy with methylphenidate: dangerous or justified' [personal communication],,,, [Verzicht auf eine diagnostik vor beginn und unter einer therapie mit methylphenidat: gefärlich oder gerechtfertigt?]. Email to: HB Krogh 19 December 2013.   ,['citation-other'], Sinzig J. Questions regarding your study 'Waiver of diagnosis before starting and undergoing therapy with methylphenidate: dangerous or justified' [personal communication] [Verzicht auf eine diagnostik vor beginn und unter einer therapie mit methylphenidat: gefärlich oder gerechtfertigt?]. Email to: HB Krogh 19 December 2013.    ,[],,, Sinzig 2013 [pers comm] ,additional,CD012069-bbs2-0640,
CD012069-bib-0835,"Skoog M, Saarimäki JM, Gluud C, Sheinin M, Erlendsson K, Aamdal S, et al. ",Transparency and registration in clinical research in the Nordic countries,,2015,,    ,['citation-other']," Skoog M, Saarimäki JM, Gluud C, Sheinin M, Erlendsson K, Aamdal S, et al. Transparency and registration in clinical research in the Nordic countries. NordicTrial Alliance, NordForsk2015:1‐108.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Transparency+and+registration+in+clinical+research+in+the+Nordic+countries&author=M+Skoog&author=JM+Saarimäki&author=C+Gluud&author=M+Sheinin&author=K+Erlendsson&author=S+Aamdal&publication_year=2015&hl=en'],,, Skoog 2015 ,additional,CD012069-bbs2-0641,
CD012069-bib-0836,Smeeth L. ,Questions regarding your abstract 'Spontaneous report safety signals profile and comparative Bayesian analysis of ADHD medication in children in the UK' [personal communication],,,,. Email to: HB Krogh 14 October 2013.   ,['citation-other'], Smeeth L. Questions regarding your abstract 'Spontaneous report safety signals profile and comparative Bayesian analysis of ADHD medication in children in the UK' [personal communication]. Email to: HB Krogh 14 October 2013.    ,[],,, Smeeth 2013 [pers comm] ,additional,CD012069-bbs2-0642,
CD012069-bib-0837,Sobanski E. ,"Regarding your study 'A non‐interventional study of extended‐release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment' [personal communication]",,,,. Email to: M Holmskov 11 July 2014.   ,['citation-other']," Sobanski E. Regarding your study 'A non‐interventional study of extended‐release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment' [personal communication]. Email to: M Holmskov 11 July 2014.    ",[],,, Sobanski 2014 [pers comm] ,additional,CD012069-bbs2-0643,
CD012069-bib-0838,Solanto MV. ,Neuropsychopharmacological mechanisms of stimulant drug action in attention‐deficit hyperactivity disorder: a review and integration, Behavioural Brain Research ,1998,94,    ,['citation-journal'], Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention‐deficit hyperactivity disorder: a review and integration.  Behavioural Brain Research 1998;94(1):127‐52. [DOI: 10.1016/S0166‐4328(97)00175‐7]    Link to article     Google Scholar     ,"['https://doi.org/10.1016/S0166-4328(97)00175-7', 'https://scholar.google.com/scholar_lookup?title=Neuropsychopharmacological+mechanisms+of+stimulant+drug+action+in+attention‐deficit+hyperactivity+disorder:+a+review+and+integration+&author=MV+Solanto&publication_year=1998&hl=en']",,https://doi.org/10.1016/S0166-4328(97)00175-7, Solanto 1998 ,additional,CD012069-bbs2-0644,
CD012069-bib-0839,Soyata A. ,Supplemental information [personal communication],,,,. Email to: MJ Kielsholm 22 April 2016.   ,['citation-other'], Soyata A. Supplemental information [personal communication]. Email to: MJ Kielsholm 22 April 2016.    ,[],,, Soyata 2016 [pers comm] ,additional,CD012069-bbs2-0645,
CD012069-bib-0840,"Sterne JAC, Higgins JPT, Reeves BC, on behalf of the development group for ACROBAT‐NRSI. ","A Cochrane Risk Of Bias Assessment Tool: for Non‐Randomised Studies of Interventions (ACROBAT‐NRSI), Version 1.0.0, 24 September 2014",,,,. www.riskofbias.info (accessed 25 May 2015).   ,['citation-other']," Sterne JAC, Higgins JPT, Reeves BC, on behalf of the development group for ACROBAT‐NRSI. A Cochrane Risk Of Bias Assessment Tool: for Non‐Randomised Studies of Interventions (ACROBAT‐NRSI), Version 1.0.0, 24 September 2014. www.riskofbias.info (accessed 25 May 2015).    ",[],,, Sterne 2014 ,additional,CD012069-bbs2-0646,
CD012069-bib-0841,"Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ",ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions,,2016,,    ,['citation-other']," Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ2016; Vol. 355, issue i4919. [DOI: 10.1136/bmj.i4919; PMC5062054; PUBMED: 27733354]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=ROBINS‐I:+a+tool+for+assessing+risk+of+bias+in+non‐randomised+studies+of+interventions&author=JA+Sterne&author=MA+Hernán&author=BC+Reeves&author=J+Savović&author=ND+Berkman&author=M+Viswanathan&publication_year=2016&hl=en'],,, Sterne 2016 ,additional,CD012069-bbs2-0647,
CD012069-bib-0842,"Stevenson RD, Wolraich ML. ",Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder, Pediatric Clinics of North America ,1989,36,    ,['citation-journal']," Stevenson RD, Wolraich ML. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.  Pediatric Clinics of North America 1989;36(5):1183‐97. [PUBMED: 2677938]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0031-3955(16)36764-5', 'https://scholar.google.com/scholar_lookup?title=Stimulant+medication+therapy+in+the+treatment+of+children+with+attention+deficit+hyperactivity+disorder+&author=RD+Stevenson&author=ML+Wolraich&publication_year=1989&hl=en']",2677938,https://doi.org/10.1016/S0031-3955(16)36764-5, Stevenson 1989 ,additional,CD012069-bbs2-0648,
CD012069-bib-0843,Stopper H. ,Question regarding your study 'Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?' [personal communication],,,,. Email to: EL Ramstad 10 October 2013.   ,['citation-other'], Stopper H. Question regarding your study 'Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?' [personal communication]. Email to: EL Ramstad 10 October 2013.    ,[],,, Stopper 2013 [pers comm] ,additional,CD012069-bbs2-0649,
CD012069-bib-0844,Stopper H. ,Questions regarding your study 'Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?' for a Cochrane Systematic Review [personal communication],,,,. Email to: HB Krogh 4 August 2014.   ,['citation-other'], Stopper H. Questions regarding your study 'Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?' for a Cochrane Systematic Review [personal communication]. Email to: HB Krogh 4 August 2014.    ,[],,, Stopper 2014 [pers comm] ,additional,CD012069-bbs2-0650,
CD012069-bib-0845,Stopper H. ,AW: Questions regarding your study,,,,. Email to: HB Krogh 21 March 2014.   ,['citation-other'], Stopper H. AW: Questions regarding your study. Email to: HB Krogh 21 March 2014.    ,[],,, Stopper 2014b [pers comm] ,additional,CD012069-bbs2-0651,
CD012069-bib-0846,"Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, et al. ",Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD), Cochrane Database of Systematic Reviews ,2015,,    ,['citation-journal']," Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).  Cochrane Database of Systematic Reviews 2015, Issue 11. [DOI: 10.1002/14651858.CD009885.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009885.pub2', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+for+children+and+adolescents+with+attention+deficit+hyperactivity+disorder+(ADHD)+&author=OJ+Storebø&author=E+Ramstad&author=HB+Krogh&author=TD+Nilausen&author=M+Skoog&author=M+Holmskov&publication_year=2015&hl=en']",,https://doi.org/10.1002/14651858.CD009885.pub2, Storebø 2015 ,additional,CD012069-bbs2-0652,
CD012069-bib-0847,"Swanson JM, Gupta S, Lam A, Shoulson I, Lerner MA, Modi N, et al. ",Development of a new once‐a‐day formulation of methylphenidate for the treatment of attention‐deficit/hyperactivity disorder: proof‐of‐concept and proof‐of‐product studies, Archives of General Psychiatry ,2003,60,    ,['citation-journal']," Swanson JM, Gupta S, Lam A, Shoulson I, Lerner MA, Modi N, et al. Development of a new once‐a‐day formulation of methylphenidate for the treatment of attention‐deficit/hyperactivity disorder: proof‐of‐concept and proof‐of‐product studies.  Archives of General Psychiatry 2003;60(2):204‐11. [PUBMED: 12578439]    Link to article     Google Scholar     ","['https://doi.org/10.1001/archpsyc.60.2.204', 'https://scholar.google.com/scholar_lookup?title=Development+of+a+new+once‐a‐day+formulation+of+methylphenidate+for+the+treatment+of+attention‐deficit/hyperactivity+disorder:+proof‐of‐concept+and+proof‐of‐product+studies+&author=JM+Swanson&author=S+Gupta&author=A+Lam&author=I+Shoulson&author=MA+Lerner&author=N+Modi&publication_year=2003&hl=en']",12578439,https://doi.org/10.1001/archpsyc.60.2.204, Swanson 2003 ,additional,CD012069-bbs2-0653,
CD012069-bib-0848,"Swanson JM, Wigal SB, Wigal T, Sonuga‐Barke E, Greenhill LL, Biederman J, et al. ",A comparison of once‐daily extended‐release methylphenidate formulations in children with attention‐deficit/hyperactivity disorder in the laboratory school (the Comacs study), Pediatrics ,2004,113,    ,['citation-journal']," Swanson JM, Wigal SB, Wigal T, Sonuga‐Barke E, Greenhill LL, Biederman J, et al. A comparison of once‐daily extended‐release methylphenidate formulations in children with attention‐deficit/hyperactivity disorder in the laboratory school (the Comacs study).  Pediatrics 2004;113(3 Pt 1):e206‐16. [PUBMED: 14993578]    Link to article     Google Scholar     ","['https://doi.org/10.1542/peds.113.3.e206', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+once‐daily+extended‐release+methylphenidate+formulations+in+children+with+attention‐deficit/hyperactivity+disorder+in+the+laboratory+school+(the+Comacs+study)+&author=JM+Swanson&author=SB+Wigal&author=T+Wigal&author=E+Sonuga‐Barke&author=LL+Greenhill&author=J+Biederman&publication_year=2004&hl=en']",14993578,https://doi.org/10.1542/peds.113.3.e206, Swanson 2004 ,additional,CD012069-bbs2-0654,
CD012069-bib-0849,Swanson J. ,The MTA follow‐up into adolescence: implications for personalized treatment,,2009,,    ,['citation-other']," Swanson J. The MTA follow‐up into adolescence: implications for personalized treatment. International Society for Research in Child and Adolescent Psychopathology (ISRCAP); 2009 June 19, Seattle. 2009.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+MTA+follow‐up+into+adolescence:+implications+for+personalized+treatment&author=J+Swanson&publication_year=2009&hl=en'],,, Swanson 2009 ,additional,CD012069-bbs2-0655,
CD012069-bib-0850,Tasdelen BI. ,Supplemental information [personal communication],,,,. Email to: SS Nielsen 16 June 2016.   ,['citation-other'], Tasdelen BI. Supplemental information [personal communication]. Email to: SS Nielsen 16 June 2016.    ,[],,, Tasdelen 2016 [pers comm] ,additional,CD012069-bbs2-0656,
CD012069-bib-0851,"Thomas R, Sanders S, Doust J, Beller E, Glasziou P. ",Prevalence of attention‐deficit/hyperactivity disorder: a systematic review and meta‐analysis, Pediatrics ,2015,135,    ,['citation-journal']," Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention‐deficit/hyperactivity disorder: a systematic review and meta‐analysis.  Pediatrics 2015;135(4):e994‐e1001. [DOI: 10.1542/peds.2014‐3482]    Link to article     Google Scholar     ","['https://doi.org/10.1542/peds.2014-3482', 'https://scholar.google.com/scholar_lookup?title=Prevalence+of+attention‐deficit/hyperactivity+disorder:+a+systematic+review+and+meta‐analysis&author=R+Thomas&author=S+Sanders&author=J+Doust&author=E+Beller&author=P+Glasziou&publication_year=2015&hl=en']",,https://doi.org/10.1542/peds.2014-3482, Thomas 2015 ,additional,CD012069-bbs2-0657,
CD012069-bib-0852,Thorell L. ,Possible inclusion of 'Children's self‐reports on perceived effects on taking stimulant medication for ADHD' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 17 October 2013.   ,['citation-other'], Thorell L. Possible inclusion of 'Children's self‐reports on perceived effects on taking stimulant medication for ADHD' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 17 October 2013.    ,[],,, Thorell 2013 [pers comm] ,additional,CD012069-bbs2-0658,
CD012069-bib-0853,Tomás Vila M. ,Questions regarding 'Visual hallucinations caused by methylphenidate' ‐ possible inclusion in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 9 September 2013.   ,['citation-other'], Tomás Vila M. Questions regarding 'Visual hallucinations caused by methylphenidate' ‐ possible inclusion in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 9 September 2013.    ,[],,, Tomás 2013 [pers comm] ,additional,CD012069-bbs2-0659,
CD012069-bib-0854,Tomás Vila M. ,Possible inclusion of 'Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 30 October 2013.   ,['citation-other'], Tomás Vila M. Possible inclusion of 'Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 30 October 2013.    ,[],,, Tomás 2013b [pers comm] ,additional,CD012069-bbs2-0660,
CD012069-bib-0855,"Treceño C, Martín Arias LH, Sáinz M, Salado I, García Ortega P, Velasco V, et al. ",Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate, Pharmacoepidemiology and Drug Safety ,2012,21,    ,['citation-journal']," Treceño C, Martín Arias LH, Sáinz M, Salado I, García Ortega P, Velasco V, et al. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.  Pharmacoepidemiology and Drug Safety 2012;21(4):435–41. [DOI: 10.1002/pds.2348; PUBMED: 22253017]    Link to article     Google Scholar     ","['https://doi.org/10.1002/pds.2348', 'https://scholar.google.com/scholar_lookup?title=Trends+in+the+consumption+of+attention+deficit+hyperactivity+disorder+medications+in+Castilla+y+León+(Spain):+changes+in+the+consumption+pattern+following+the+introduction+of+extended+release+methylphenidate+&author=C+Treceño&author=LH+MartínArias&author=M+Sáinz&author=I+Salado&author=P+GarcíaOrtega&author=V+Velasco&publication_year=2012&hl=en']",,https://doi.org/10.1002/pds.2348, Trecenõ 2012 ,additional,CD012069-bbs2-0661,
CD012069-bib-0856,Trugman J. ,Questions regarding your case report 'Cerebral arteritis and oral methylphenidate' [personal communication],,,,. Email to: HB Krogh 27 September 2013.   ,['citation-other'], Trugman J. Questions regarding your case report 'Cerebral arteritis and oral methylphenidate' [personal communication]. Email to: HB Krogh 27 September 2013.    ,[],,, Trugman 2013 [pers comm] ,additional,CD012069-bbs2-0662,
CD012069-bib-0857,Tølløfsrud C. ,About the article 'Young man with acute dilated cardiomyopathy' [personal communication],,,, [Ung mann med akutt dilatert kardiomyapati]. Email to: HB Krogh 24 November 2013.   ,['citation-other'], Tølløfsrud C. About the article 'Young man with acute dilated cardiomyopathy' [personal communication] [Ung mann med akutt dilatert kardiomyapati]. Email to: HB Krogh 24 November 2013.    ,[],,, Tølløfsrud 2013 [pers comm] ,additional,CD012069-bbs2-0663,
CD012069-bib-0858,"US Food, Drug Administration (FDA). ",Communication about an ongoing safety review of stimulant medications used in children with attention‐deficit/hyperactivity disorder (ADHD),,,,. 1.usa.gov/1M5AYoq (accessed 6 May 2011).   ,['citation-other']," US Food, Drug Administration (FDA). Communication about an ongoing safety review of stimulant medications used in children with attention‐deficit/hyperactivity disorder (ADHD). 1.usa.gov/1M5AYoq (accessed 6 May 2011).    ",[],,, US FDA 2011 ,additional,CD012069-bbs2-0664,
CD012069-bib-0859,"US Food, Drug Administration (FDA). ",FDA approved drug products,,,,. www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (accessed 14 May 2017).   ,['citation-other']," US Food, Drug Administration (FDA). FDA approved drug products. www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (accessed 14 May 2017).    ",[],,, US Food and Drug Administration (FDA) 2017 ,additional,CD012069-bbs2-0665,
CD012069-bib-0860,Valdizán Usón JR. ,Regarding your study 'Response to methylphenidate by adult and pediatric patients with attention‐deficit/hyperactivity disorder: the Spanish multicenter DIHANA study' [personal communication],,,,. Email to: M Holmskov 10 July 2014.   ,['citation-other'], Valdizán Usón JR. Regarding your study 'Response to methylphenidate by adult and pediatric patients with attention‐deficit/hyperactivity disorder: the Spanish multicenter DIHANA study' [personal communication]. Email to: M Holmskov 10 July 2014.    ,[],,, Valdizán 2014 [pers comm] ,additional,CD012069-bbs2-0666,
CD012069-bib-0861,Van der Oord S. ,"Regarding your study 'Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?' [personal communication]",,,,. Email to: TD Nilausen 2 January 2014.   ,['citation-other']," Van der Oord S. Regarding your study 'Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?' [personal communication]. Email to: TD Nilausen 2 January 2014.    ",[],,, Van der Oord 2014 [pers comm] ,additional,CD012069-bbs2-0667,
CD012069-bib-0862,"Van Lieshout RJ, Boyle MH, Saigal S, Morrison K, Schmidt LA. ",Mental health of extremely low birth weight survivors in their 30s, Pediatrics ,2015,135,    ,['citation-journal']," Van Lieshout RJ, Boyle MH, Saigal S, Morrison K, Schmidt LA. Mental health of extremely low birth weight survivors in their 30s.  Pediatrics 2015;135(3):452‐9. [PUBMED: 25667243]    Link to article     Google Scholar     ","['https://doi.org/10.1542/peds.2014-3143', 'https://scholar.google.com/scholar_lookup?title=Mental+health+of+extremely+low+birth+weight+survivors+in+their+30s&author=RJ+Lieshout&author=MH+Boyle&author=S+Saigal&author=K+Morrison&author=LA+Schmidt&publication_year=2015&hl=en']",25667243,https://doi.org/10.1542/peds.2014-3143, Van Lieshout 2015 ,additional,CD012069-bbs2-0668,
CD012069-bib-0863,Vandenbroucke JP. ,What is the best evidence for determining harms of medical treatment?, Canadian Medical Association Journal ,2006,174,    ,['citation-journal'], Vandenbroucke JP. What is the best evidence for determining harms of medical treatment?.  Canadian Medical Association Journal 2006;174(5):645‐6. [DOI: 10.1503/cmaj.051484; PMC1389828; PUBMED: 16505461]    Link to article     Google Scholar     ,"['https://doi.org/10.1503/cmaj.051484', 'https://scholar.google.com/scholar_lookup?title=What+is+the+best+evidence+for+determining+harms+of+medical+treatment?&author=JP+Vandenbroucke&publication_year=2006&hl=en']",,https://doi.org/10.1503/cmaj.051484, Vandenbroucke 2006 ,additional,CD012069-bbs2-0669,
CD012069-bib-0864,Vashi N. ,Questions regarding your article 'Allergic contact dermatitis caused by methylphenidate' [personal communication],,,,. Email to: HB Krogh 1 August 2013.   ,['citation-other'], Vashi N. Questions regarding your article 'Allergic contact dermatitis caused by methylphenidate' [personal communication]. Email to: HB Krogh 1 August 2013.    ,[],,, Vashi 2013 [pers comm] ,additional,CD012069-bbs2-0670,
CD012069-bib-0865,"Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, et al. ",Methylphenidate‐elicited dopamine increases in ventral striatum are associated with long‐term symptom improvement in adults with attention deficit hyperactivity disorder, Journal of Neuroscience ,2012,32,    ,['citation-journal']," Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, et al. Methylphenidate‐elicited dopamine increases in ventral striatum are associated with long‐term symptom improvement in adults with attention deficit hyperactivity disorder.  Journal of Neuroscience 2012;32(3):841‐9. [PUBMED: 22262882]    Link to article     Google Scholar     ","['https://doi.org/10.1523/JNEUROSCI.4461-11.2012', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate‐elicited+dopamine+increases+in+ventral+striatum+are+associated+with+long‐term+symptom+improvement+in+adults+with+attention+deficit+hyperactivity+disorder+&author=ND+Volkow&author=GJ+Wang&author=D+Tomasi&author=SH+Kollins&author=TL+Wigal&author=JH+Newcorn&publication_year=2012&hl=en']",22262882,https://doi.org/10.1523/JNEUROSCI.4461-11.2012, Volkow 2012 ,additional,CD012069-bbs2-0671,
CD012069-bib-0866,Wang LJ. ,Regarding two of your studies from 2011 [personal communication],,,,. Email to: TD Nilausen 21 December 2013.   ,['citation-other'], Wang LJ. Regarding two of your studies from 2011 [personal communication]. Email to: TD Nilausen 21 December 2013.    ,[],,, Wang 2013 [pers comm] ,additional,CD012069-bbs2-0672,
CD012069-bib-0867,Weber P. ,Questions regarding your study 'Nebenwirkungen einer Methylphenidat‐Therapie bei Schulkindern' [personal communication],,,,. Email to: HB Krogh 4 December 2013.   ,['citation-other'], Weber P. Questions regarding your study 'Nebenwirkungen einer Methylphenidat‐Therapie bei Schulkindern' [personal communication]. Email to: HB Krogh 4 December 2013.    ,[],,, Weber 2013 [pers comm] ,additional,CD012069-bbs2-0673,
CD012069-bib-0868,World Health Organization. ,,"International Classification of Diseases, Ninth Revision",1977,1,.   ,['citation-book']," World Health Organization. International Classification of Diseases, Ninth Revision. Vol. 1, Geneva: World Health Organization, 1977.    ",[],,, WHO 1977 ,additional,CD012069-bbs2-0674,
CD012069-bib-0869,World Health Organization. ,,The ICD‐10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines,1992,,.   ,['citation-book']," World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.    ",[],,, WHO 1992 ,additional,CD012069-bbs2-0675,
CD012069-bib-0870,Willcutt EG. ,The prevalence of DSM‐IV attention‐deficit/hyperactivity disorder: a meta‐analytic review, Neurotherapeutics ,2012,9,    ,['citation-journal'], Willcutt EG. The prevalence of DSM‐IV attention‐deficit/hyperactivity disorder: a meta‐analytic review.  Neurotherapeutics 2012;9(3):490‐9. [DOI: 10.1007/s13311‐012‐0135‐8]    Link to article     Google Scholar     ,"['https://doi.org/10.1007/s13311-012-0135-8', 'https://scholar.google.com/scholar_lookup?title=The+prevalence+of+DSM‐IV+attention‐deficit/hyperactivity+disorder:+a+meta‐analytic+review+&author=EG+Willcutt&publication_year=2012&hl=en']",,https://doi.org/10.1007/s13311-012-0135-8, Willcut 2012 ,additional,CD012069-bbs2-0676,
CD012069-bib-0871,Williams L. ,Regarding your study 'Misinterpreting emotional expressions in attention‐deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects' [personal communication],,,,. Email to: M Holmskov 26 August 2014.   ,['citation-other'], Williams L. Regarding your study 'Misinterpreting emotional expressions in attention‐deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects' [personal communication]. Email to: M Holmskov 26 August 2014.    ,[],,, Williams 2014 [pers comm] ,additional,CD012069-bbs2-0677,
CD012069-bib-0872,Witt KL. ,Questions regarding your study 'Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD' [personal communication],,,,. Email to: FL Magnusson 9 July 2014.   ,['citation-other'], Witt KL. Questions regarding your study 'Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD' [personal communication]. Email to: FL Magnusson 9 July 2014.    ,[],,, Witt 2014 [pers comm] ,additional,CD012069-bbs2-0678,
CD012069-bib-0873,"Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, et al. ","Randomized, controlled trial of OROS methylphenidate once a day in children with attention‐deficit/hyperactivity disorder", Pediatrics ,2001,108,    ,['citation-journal']," Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, et al. Randomized, controlled trial of OROS methylphenidate once a day in children with attention‐deficit/hyperactivity disorder.  Pediatrics 2001;108(4):883‐92. [PUBMED: 11581440]    Link to article     Google Scholar     ","['https://doi.org/10.1542/peds.108.4.883', 'https://scholar.google.com/scholar_lookup?title=Randomized,+controlled+trial+of+OROS+methylphenidate+once+a+day+in+children+with+attention‐deficit/hyperactivity+disorder+&author=ML+Wolraich&author=LL+Greenhill&author=W+Pelham&author=J+Swanson&author=T+Wilens&author=D+Palumbo&publication_year=2001&hl=en']",11581440,https://doi.org/10.1542/peds.108.4.883, Wolraich 2001 ,additional,CD012069-bbs2-0679,
CD012069-bib-0874,"Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. ",Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study, BMJ ,2008,336,    ,['citation-journal']," Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study.  BMJ 2008;336(7644):601–5.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.39465.451748.AD', 'https://scholar.google.com/scholar_lookup?title=Empirical+evidence+of+bias+in+treatment+effect+estimates+in+controlled+trials+with+different+interventions+and+outcomes:+meta‐epidemiological+study+&author=L+Wood&author=M+Egger&author=LL+Gluud&author=KF+Schulz&author=P+Juni&author=DG+Altman&publication_year=2008&hl=en']",,https://doi.org/10.1136/bmj.39465.451748.AD, Wood 2008 ,additional,CD012069-bbs2-0680,
CD012069-bib-0875,Yalcin O. ,Interest in including 'Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases' in a Cochrane systematic review [personal communication],,,,. Email to: EL Ramstad 27 March 2013.   ,['citation-other'], Yalcin O. Interest in including 'Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases' in a Cochrane systematic review [personal communication]. Email to: EL Ramstad 27 March 2013.    ,[],,, Yalcin 2013 [pers comm] ,additional,CD012069-bbs2-0681,
CD012069-bib-0876,Yilmaz AE. ,Question regarding your study 'Methylphenidate‐induced orofacial and extremity dyskinesia' [personal communication],,,,. Email to: T Nilausen 20 December 2013.   ,['citation-other'], Yilmaz AE. Question regarding your study 'Methylphenidate‐induced orofacial and extremity dyskinesia' [personal communication]. Email to: T Nilausen 20 December 2013.    ,[],,, Yilmaz 2013 [pers comm] ,additional,CD012069-bbs2-0682,
CD012069-bib-0877,Yook KH. ,Questions regarding 'Oobesity is associated with non‐response to prolonged‐release methylphenidate treatment in ADHD' [personal communication],,,,. Email to: EL Ramstad 20 August 2013.   ,['citation-other'], Yook KH. Questions regarding 'Oobesity is associated with non‐response to prolonged‐release methylphenidate treatment in ADHD' [personal communication]. Email to: EL Ramstad 20 August 2013.    ,[],,, Yook 2013 [pers comm] ,additional,CD012069-bbs2-0683,
CD012069-bib-0878,"Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. ",Childhood ADHD is strongly associated with a broad range of psychiatric disorders: a population‐based birth cohort study, Journal of Child Psychology and Psychiatry and Allied Disciplines ,2012,53,    ,['citation-journal']," Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders: a population‐based birth cohort study.  Journal of Child Psychology and Psychiatry and Allied Disciplines 2012;53(10):1036‐43. [PUBMED: 22647074]    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1469-7610.2012.02567.x', 'https://scholar.google.com/scholar_lookup?title=Childhood+ADHD+is+strongly+associated+with+a+broad+range+of+psychiatric+disorders:+a+population‐based+birth+cohort+study+&author=K+Yoshimasu&author=WJ+Barbaresi&author=RC+Colligan&author=RG+Voigt&author=JM+Killian&author=AL+Weaver&publication_year=2012&hl=en']",22647074,https://doi.org/10.1111/j.1469-7610.2012.02567.x, Yoshimasu 2012 ,additional,CD012069-bbs2-0684,
CD012069-bib-0879,Yu Z. ,Questions regarding your article 'Peripheral vasculopathy associated with psychostimulant treatment in children with attention‐deficit/hyperactivity disorder' [personal communication],,,,. Email to: HB Krogh 16 October 2013.   ,['citation-other'], Yu Z. Questions regarding your article 'Peripheral vasculopathy associated with psychostimulant treatment in children with attention‐deficit/hyperactivity disorder' [personal communication]. Email to: HB Krogh 16 October 2013.    ,[],,, Yu 2013 [pers comm] ,additional,CD012069-bbs2-0685,
CD012069-bib-0880,Zeni C. ,Regarding your study 'No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorder' [personal communication],,,,. Email to: CR Moreira Maia 14 September 2016.   ,['citation-other'], Zeni C. Regarding your study 'No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorder' [personal communication]. Email to: CR Moreira Maia 14 September 2016.    ,[],,, Zeni 2016 [pers comm] ,additional,CD012069-bbs2-0686,
CD012069-bib-0881,"Zoëga H, Furu M, Halldórsson M, Thomsen PH, Sourander A, Martikainen JE. ",Use of ADHD drugs in the Nordic countries: a population‐based comparison study, Acta Psychiatrica Scandinavica ,May 2011,123,    ,['citation-journal']," Zoëga H, Furu M, Halldórsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population‐based comparison study.  Acta Psychiatrica Scandinavica May 2011;123(5):360‐7. [DOI: 10.1111/j.1600‐0447.2010.01607.x; PUBMED: 20860726]    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1600-0447.2010.01607.x', 'https://scholar.google.com/scholar_lookup?title=Use+of+ADHD+drugs+in+the+Nordic+countries:+a+population‐based+comparison+study&author=H+Zoëga&author=M+Furu&author=M+Halldórsson&author=PH+Thomsen&author=A+Sourander&author=JE+Martikainen&publication_year=May2011&hl=en']",,https://doi.org/10.1111/j.1600-0447.2010.01607.x, Zoëga 2016 ,additional,CD012069-bbs2-0687,
CD012069-bib-0557,"Arnold‐von Saher RA, Boer F, Burggraaf J. ",The clinical use of a double‐blind placebo‐controlled trial with methylphenidate: advantages and limitations, Tijdschrift voor Psychiatrie ,2000,42,    ,['citation-journal']," Arnold‐von Saher RA, Boer F, Burggraaf J. The clinical use of a double‐blind placebo‐controlled trial with methylphenidate: advantages and limitations [Pleidooi voor een dubbelblinde proefbehandeling met methylfenidaat in de dagelijkse klinische praktijk van ADHD bij kinderen].  Tijdschrift voor Psychiatrie 2000;42(11):837‐44. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+clinical+use+of+a+double‐blind+placebo‐controlled+trial+with+methylphenidate:+advantages+and+limitations+&author=RA+Arnold‐vonSaher&author=F+Boer&author=J+Burggraaf&publication_year=2000&hl=en']",,, Arnold‐Von 2000 {published data only}  ,awaiting_assessment,CD012069-bbs2-0372,
CD012069-bib-0558,"Dalsgaard S, Kvist AP, Leckman JF, Nielsen HS, Simonsen M. ",Cardiovascular safety of stimulants in children with attention‐deficit/hyperactivity disorder: a nationwide prospective cohort study, Journal of Child and Adolescent Psychopharmacology ,2014,24,    ,['citation-journal']," Dalsgaard S, Kvist AP, Leckman JF, Nielsen HS, Simonsen M. Cardiovascular safety of stimulants in children with attention‐deficit/hyperactivity disorder: a nationwide prospective cohort study.  Journal of Child and Adolescent Psychopharmacology 2014;24(6):1‐9. [DOI: 10.1089/cap.2014.0020; PMC4137345; PUBMED: 24956171]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2014.0020', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+safety+of+stimulants+in+children+with+attention‐deficit/hyperactivity+disorder:+a+nationwide+prospective+cohort+study+&author=S+Dalsgaard&author=AP+Kvist&author=JF+Leckman&author=HS+Nielsen&author=M+Simonsen&publication_year=2014&hl=en']",,https://doi.org/10.1089/cap.2014.0020, Dalsgaard 2011 {published data only}  ,awaiting_assessment,CD012069-bbs2-0373,
CD012069-bib-0559,"Dalsgaard S, Leckman JF, Mortensen PB, Nielsen HS, Simonsen M. ",Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study, Lancet Psychiatry ,2015,2,    ,['citation-journal']," Dalsgaard S, Leckman JF, Mortensen PB, Nielsen HS, Simonsen M. Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.  Lancet Psychiatry 2015;2(8):702‐9. [DOI: 10.1016/S2215‐0366(15)00271‐0; PUBMED: 26249301]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S2215-0366(15)00271-0', 'https://scholar.google.com/scholar_lookup?title=Effect+of+drugs+on+the+risk+of+injuries+in+children+with+attention+deficit+hyperactivity+disorder:+a+prospective+cohort+study+&author=S+Dalsgaard&author=JF+Leckman&author=PB+Mortensen&author=HS+Nielsen&author=M+Simonsen&publication_year=2015&hl=en']",,https://doi.org/10.1016/S2215-0366(15)00271-0, Dalsgaard 2011 {published data only}  ,awaiting_assessment,CD012069-bbs2-0373,
CD012069-bib-0560,"Dalsgaard S, Nielsen HS, Simonsen M. ",Long‐term cardiac adverse effects of ADHD medication in children and adolescents: a nationwide register based follow‐up study, European Child and Adolescent Psychiatry ,2011,20,    ,['citation-journal']," Dalsgaard S, Nielsen HS, Simonsen M. Long‐term cardiac adverse effects of ADHD medication in children and adolescents: a nationwide register based follow‐up study.  European Child and Adolescent Psychiatry 2011;20(Suppl 1):S107. [DOI: 10.1007/s00787‐011‐0181‐5]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Long‐term+cardiac+adverse+effects+of+ADHD+medication+in+children+and+adolescents:+a+nationwide+register+based+follow‐up+study+&author=S+Dalsgaard&author=HS+Nielsen&author=M+Simonsen&publication_year=2011&hl=en']",,, Dalsgaard 2011 {published data only}  ,awaiting_assessment,CD012069-bbs2-0373,
CD012069-bib-0561,"Flapper BC, Koopman HM, Heltzel A. ",Methylphenidate a stimulant in treatment of children with minimal brain dysfunction, Tijdschrift voor Kindergeneeskunde ,1989,57,    ,['citation-journal']," Flapper BC, Koopman HM, Heltzel A. Methylphenidate a stimulant in treatment of children with minimal brain dysfunction.  Tijdschrift voor Kindergeneeskunde 1989;57(1):14‐20. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+a+stimulant+in+treatment+of+children+with+minimal+brain+dysfunction&author=BC+Flapper&author=HM+Koopman&author=A+Heltzel&publication_year=1989&hl=en']",,, Flapper 1989 {published data only}  ,awaiting_assessment,CD012069-bbs2-0374,
CD012069-bib-0562,"Husár M, Zerhau P. ",Priapism in childhood ‐ case report of 14‐year‐old boy, Rozhledy V Chirurgii ,2006,85,    ,['citation-journal']," Husár M, Zerhau P. Priapism in childhood ‐ case report of 14‐year‐old boy [Priapismus v dĕtsékm veku ‐ kazuistika 14 letého chlapce].  Rozhledy V Chirurgii 2006;85(7):329‐30. [PUBMED: 17044274]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Priapism+in+childhood+‐+case+report+of+14‐year‐old+boy&author=M+Husár&author=P+Zerhau&publication_year=2006&hl=en']",17044274,, Husár 2006 {published data only}  ,awaiting_assessment,CD012069-bbs2-0375,
CD012069-bib-0563,"Ince E, Algedik P, Demirdogen ES, Emul M, Demir T. ",The relationship between acute dyskinesia with a single dose of methylphenidate and recent risperidone discontinuation in a child with attention‐deficit/hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology ,2015,25,    ,['citation-journal']," Ince E, Algedik P, Demirdogen ES, Emul M, Demir T. The relationship between acute dyskinesia with a single dose of methylphenidate and recent risperidone discontinuation in a child with attention‐deficit/hyperactivity disorder.  Journal of Child and Adolescent Psychopharmacology 2015;25(4):378‐9. [DOI: 10.1089/cap.2014.0148; PUBMED: 25920038]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1089/cap.2014.0148', 'https://scholar.google.com/scholar_lookup?title=The+relationship+between+acute+dyskinesia+with+a+single+dose+of+methylphenidate+and+recent+risperidone+discontinuation+in+a+child+with+attention‐deficit/hyperactivity+disorder+&author=E+Ince&author=P+Algedik&author=ES+Demirdogen&author=M+Emul&author=T+Demir&publication_year=2015&hl=en']",,https://doi.org/10.1089/cap.2014.0148, Ince 2015 {published data only}  ,awaiting_assessment,CD012069-bbs2-0376,
CD012069-bib-0564,"Ishizaki A, Sugama M. ",Methylphenidate therapy in 141 patients with hyperkinetic disorder or with pervasive developmental disorder and hyperkinesia, No To Hattatsu ,2001,33,    ,['citation-journal']," Ishizaki A, Sugama M. Methylphenidate therapy in 141 patients with hyperkinetic disorder or with pervasive developmental disorder and hyperkinesia.  No To Hattatsu 2001;33(4):323‐8. [PUBMED: 11494575]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+therapy+in+141+patients+with+hyperkinetic+disorder+or+with+pervasive+developmental+disorder+and+hyperkinesia+&author=A+Ishizaki&author=M+Sugama&publication_year=2001&hl=en']",11494575,, Ishizaki 2001 {published data only}  ,awaiting_assessment,CD012069-bbs2-0377,
CD012069-bib-0565,Laezer KL. ,Effectiveness of psychoanalytic psychotherapy and behavioral therapy treatment in children with attention deficit hyperactivity disorder and oppositional defiant disorder," Journal of Infant, Child, and Adolescent Psychotherapy ",,14,    ,['citation-journal']," Laezer KL. Effectiveness of psychoanalytic psychotherapy and behavioral therapy treatment in children with attention deficit hyperactivity disorder and oppositional defiant disorder.  Journal of Infant, Child, and Adolescent Psychotherapy  2015, 2015;14(2):111‐28. [DOI: 10.1080/15289168.2015.1014991]CENTRAL    Link to article     ","['', 'https://doi.org/10.1080/15289168.2015.1014991']",,https://doi.org/10.1080/15289168.2015.1014991, Laezer 2015 {published data only}  ,awaiting_assessment,CD012069-bbs2-0378,
CD012069-bib-0566,"Mulas F, Roca P, Ros‐Cervera G, Gandía‐Benetó R, Ortiz‐Sánchez P. ",Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy, Revista de Neurologia ,2014,58,    ,['citation-journal']," Mulas F, Roca P, Ros‐Cervera G, Gandía‐Benetó R, Ortiz‐Sánchez P. Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy [Manejo farmacológico del trastorno por déficit de atención/hiperactividad con metilfenidato y atomoxetina en un contexto de epilepsia].  Revista de Neurologia 2014;58(Suppl 1):S34‐9. [PUBMED: 25252667]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Pharmacological+management+of+attention+deficit+hyperactivity+disorder+with+methylphenidate+and+atomoxetine+within+a+context+of+epilepsy+&author=F+Mulas&author=P+Roca&author=G+Ros‐Cervera&author=R+Gandía‐Benetó&author=P+Ortiz‐Sánchez&publication_year=2014&hl=en']",25252667,, Mulas 2014 {published data only}  ,awaiting_assessment,CD012069-bbs2-0379,
CD012069-bib-0568,"Ptáček R, Kuželová H, Paclt I, Žukov I. ",Effect of medication on anthropometric characteristic of ADHD children, Ceska a Slovenska Psychiatrie ,2008,104,    ,['citation-journal']," Ptáček R, Kuželová H, Paclt I, Žukov I. Effect of medication on anthropometric characteristic of ADHD children [Vliv medikace na antropometrické charakteristiky dětí s ADHD].  Ceska a Slovenska Psychiatrie 2008;104(8):415‐9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effect+of+medication+on+anthropometric+characteristic+of+ADHD+children&author=R+Ptáček&author=H+Kuželová&author=I+Paclt&author=I+Žukov&publication_year=2008&hl=en']",,, Ptáček 2008 {published data only}  ,awaiting_assessment,CD012069-bbs2-0380,
CD012069-bib-0567,"Ptáček R, Kuželová H, Paclt I, Žukov I, Fischer S. ",Developmental changes in children with ADHD and effecto [sic] of medication on growth, Psychiatrie ,2009,13,    ,['citation-journal']," Ptáček R, Kuželová H, Paclt I, Žukov I, Fischer S. Developmental changes in children with ADHD and effecto [sic] of medication on growth [Vyvojove zmeny u deti s ADHD a vliv medikace na rust].  Psychiatrie 2009;13(Suppl):104‐5. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Developmental+changes+in+children+with+ADHD+and+effecto+[sic]+of+medication+on+growth&author=R+Ptáček&author=H+Kuželová&author=I+Paclt&author=I+Žukov&author=S+Fischer&publication_year=2009&hl=en']",,, Ptáček 2008 {published data only}  ,awaiting_assessment,CD012069-bbs2-0380,
CD012069-bib-0569,"Radziuk AL, Kieling RR, Santos K, Rotert R, Bastos F, Palmini AL. ",Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult‐to‐treat epilepsies, Epilepsy and Behavior ,2015,46,    ,['citation-journal']," Radziuk AL, Kieling RR, Santos K, Rotert R, Bastos F, Palmini AL. Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult‐to‐treat epilepsies.  Epilepsy and Behavior 2015;46:215‐20. [DOI: 10.1016/j.yebeh.2015.02.019; PUBMED: 25940104]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.yebeh.2015.02.019', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+improves+the+quality+of+life+of+children+and+adolescents+with+ADHD+and+difficult‐to‐treat+epilepsies+&author=AL+Radziuk&author=RR+Kieling&author=K+Santos&author=R+Rotert&author=F+Bastos&author=AL+Palmini&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.yebeh.2015.02.019, Radziuk 2015 {published data only}  ,awaiting_assessment,CD012069-bbs2-0381,
CD012069-bib-0570,"Socanski D, Aurlien D, Herigstad A, Thomsen PH, Larsen TK. ",Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate?,,2015,,    ,['citation-other']," Socanski D, Aurlien D, Herigstad A, Thomsen PH, Larsen TK. Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate?. Seizure2015; Vol. 25:80‐3. [DOI: 10.1016/j.seizure.2015.01.002; PUBMED: 25645642]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Attention+deficit/hyperactivity+disorder+and+interictal+epileptiform+discharges:+it+is+safe+to+use+methylphenidate?+&author=D+Socanski&author=D+Aurlien&author=A+Herigstad&author=PH+Thomsen&author=TK+Larsen&publication_year=2015&hl=en']",,, Socanski 2015 {published data only}  ,awaiting_assessment,CD012069-bbs2-0382,
CD012069-bib-0571,"Sugama M, Ishizaki A. ",Clinical assessment of the effect of switch from immediate‐release to extended‐release methylphenidate in 181 patients with isolated attention deficit/hyperactivity disorder (AD/HD) or AD/HD associated with pervasive developmental disorder, No to Hattatsu ,2009,41,    ,['citation-journal']," Sugama M, Ishizaki A. Clinical assessment of the effect of switch from immediate‐release to extended‐release methylphenidate in 181 patients with isolated attention deficit/hyperactivity disorder (AD/HD) or AD/HD associated with pervasive developmental disorder.  No to Hattatsu 2009;41(6):436‐41. [PUBMED: 19928542]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Clinical+assessment+of+the+effect+of+switch+from+immediate‐release+to+extended‐release+methylphenidate+in+181+patients+with+isolated+attention+deficit/hyperactivity+disorder+(AD/HD)+or+AD/HD+associated+with+pervasive+developmental+disorder+&author=M+Sugama&author=A+Ishizaki&publication_year=2009&hl=en']",19928542,, Sugama 2009 {published data only}  ,awaiting_assessment,CD012069-bbs2-0383,
CD012069-bib-0574,,Polypharmacy in treating severe childhood aggression, Brown University Child and Adolescent Psychopharmacology Update ,2012,14,   ,['citation-journal'], Polypharmacy in treating severe childhood aggression.  Brown University Child and Adolescent Psychopharmacology Update 2012;14(1):1‐4. [DOI: 10.1002/cpu.20155]CENTRAL    ,[''],,, TOSCA 2011 {published data only}  ,awaiting_assessment,CD012069-bbs2-0384,
CD012069-bib-0572,"Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina BS, McNamara NK, et al. ",What does risperidone add to parent training and stimulant for severe aggression in child attention‐deficit/hyperactivity disorder?, Journal of the American Academy of Child and Adolescent Psychiatry ,2014,53,    ,['citation-journal']," Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina BS, McNamara NK, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention‐deficit/hyperactivity disorder?.  Journal of the American Academy of Child and Adolescent Psychiatry 2014;53(1):47‐60. [DOI: 10.1016/j.jaac.2013.09.022; PMC3984501; PUBMED: 24342385]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.jaac.2013.09.022', 'https://scholar.google.com/scholar_lookup?title=What+does+risperidone+add+to+parent+training+and+stimulant+for+severe+aggression+in+child+attention‐deficit/hyperactivity+disorder?+&author=MG+Aman&author=OG+Bukstein&author=KD+Gadow&author=LE+Arnold&author=BS+Molina&author=NK+McNamara&publication_year=2014&hl=en']",,https://doi.org/10.1016/j.jaac.2013.09.022, TOSCA 2011 {published data only}  ,awaiting_assessment,CD012069-bbs2-0384,
CD012069-bib-0573,"Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li Xi, et al. ",The treatment of severe child aggression (TOSCA) study: design challenges, Child and Adolescent Psychiatry and Mental Health ,2011,5,    ,['citation-journal']," Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li Xi, et al. The treatment of severe child aggression (TOSCA) study: design challenges.  Child and Adolescent Psychiatry and Mental Health 2011;5(1):36. [DOI: 10.1186/1753‐2000‐5‐36; PMC3231878; PUBMED: 22074813]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1753-2000-5-36', 'https://scholar.google.com/scholar_lookup?title=The+treatment+of+severe+child+aggression+(TOSCA)+study:+design+challenges&author=CA+Farmer&author=LE+Arnold&author=OG+Bukstein&author=RL+Findling&author=KD+Gadow&author=Xi+Li&publication_year=2011&hl=en']",,https://doi.org/10.1186/1753-2000-5-36, TOSCA 2011 {published data only}  ,awaiting_assessment,CD012069-bbs2-0384,
CD012069-bib-0575,"Gendron M, Rusak B, Rajda M, Corkum PV. ",Assessing the impact of methylphenidate on sleep in children with ADHD using polysomnography and actigraphy, Sleep ,2012,35,    ,['citation-journal']," Gendron M, Rusak B, Rajda M, Corkum PV. Assessing the impact of methylphenidate on sleep in children with ADHD using polysomnography and actigraphy.  Sleep 2012;35:A374. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Assessing+the+impact+of+methylphenidate+on+sleep+in+children+with+ADHD+using+polysomnography+and+actigraphy+&author=M+Gendron&author=B+Rusak&author=M+Rajda&author=PV+Corkum&publication_year=2012&hl=en']",,, Waldon 2016 {published data only}  ,awaiting_assessment,CD012069-bbs2-0385,
CD012069-bib-0576,"Waldon J, Begum E, Gendron M, Rusak B, Andreou P, Rajda M, et al. ",Concordance of actigraphy with polysomnography in children with and without attention‐deficit/hyperactivity disorder, Journal of Sleep Research ,2016,25,    ,['citation-journal']," Waldon J, Begum E, Gendron M, Rusak B, Andreou P, Rajda M, et al. Concordance of actigraphy with polysomnography in children with and without attention‐deficit/hyperactivity disorder.  Journal of Sleep Research 2016;25(5):524‐33. [PUBMED: 27140929]CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/jsr.12402', 'https://scholar.google.com/scholar_lookup?title=Concordance+of+actigraphy+with+polysomnography+in+children+with+and+without+attention‐deficit/hyperactivity+disorder+&author=J+Waldon&author=E+Begum&author=M+Gendron&author=B+Rusak&author=P+Andreou&author=M+Rajda&publication_year=2016&hl=en']",27140929,https://doi.org/10.1111/jsr.12402, Waldon 2016 {published data only}  ,awaiting_assessment,CD012069-bbs2-0385,
CD012069-bib-0577,"Yusufoglu C, Sonkaya AR, Taymur I. ",Henoch‐Schönlein Purpura with attention deficit hyperactivity disorder, Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] ,2014,24,    ,['citation-journal']," Yusufoglu C, Sonkaya AR, Taymur I. Henoch‐Schönlein Purpura with attention deficit hyperactivity disorder.  Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2014;24(Suppl 1):S158‐S159. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Henoch‐Schönlein+Purpura+with+attention+deficit+hyperactivity+disorder&author=C+Yusufoglu&author=AR+Sonkaya&author=I+Taymur&publication_year=2014&hl=en']",,, Yusufoglu 2014 {published data only}  ,awaiting_assessment,CD012069-bbs2-0386,
CD012069-bib-0882,"Storebø OJ, Pedersen N, Ramstad E, Krogh HB, Moreira‐Maia CR, Magnusson FL, et al. ",Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents ‐ assessment of harmful effects in non‐randomised studies, Cochrane Database of Systematic Reviews ,2016,,    ,['citation-journal']," Storebø OJ, Pedersen N, Ramstad E, Krogh HB, Moreira‐Maia CR, Magnusson FL, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents ‐ assessment of harmful effects in non‐randomised studies.  Cochrane Database of Systematic Reviews 2016, Issue 2. [DOI: 10.1002/14651858.CD012069]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD012069', 'https://scholar.google.com/scholar_lookup?title=Methylphenidate+for+attention+deficit+hyperactivity+disorder+(ADHD)+in+children+and+adolescents+‐+assessment+of+harmful+effects+in+non‐randomised+studies+&author=OJ+Storebø&author=N+Pedersen&author=E+Ramstad&author=HB+Krogh&author=CR+Moreira‐Maia&author=FL+Magnusson&publication_year=2016&hl=en']",,https://doi.org/10.1002/14651858.CD012069, Storebø 2016 ,other_versions,CD012069-bbs2-0688,
